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General abstract  
In a variety of vertebrate species, early life environmental cues are important 
drivers of an individual’s phenotypic trajectories, priming physiological 
pathways, with consequences for growth, reproductive-related traits and 
lifespan. These phenotypic responses are believed to be adaptive in the short-
term, but may impinge on health and survival over the long-term. Much of the 
work in this field has focused on the potential constraints imposed on animals 
after exposure to early life adversities, including nutritional deficit, sibling 
competition, and high predator pressure. Such stressful experiences can result in 
direct, but also indirect (via the maternal route) increases in the exposure to 
glucocorticoid stress hormones in the developing individuals. Glucocorticoids, 
whose production and secretion is regulated by the Hypothalamic-Pituitary-
Adrenal axis (HPA axis), have been hypothesised to be the main candidates 
mediating the programming effects of developmental stress. Earlier predictions 
based on this assumption came from studies conducted in mammals. In mammals 
it is particularly difficult to manipulate exposure to circulating hormones in 
developing individuals because of the physiological intimacy between mother 
and offspring via the placenta and lactation. Here, I circumvent this 
complicating factor by using the precocial Japanese quail as a study species. In 
chapter 2 I measure corticosterone (B, the main avian glucocorticoid) stress 
responses to a standardised environmental stressor in growing quail aged 8- and 
16-days-old. The results are consistent with those previously reported in other 
precocial birds, showing that the magnitude of the stress response (i.e. peak B 
within 30 min period) is higher in the 8- than the 16-day-old hatchlings. I find no 
differences in baseline B concentrations between the two groups. I then describe 
the main experiment in which I elevate B concentrations in ovo and/or in the 
endogenous circulation of the hatchlings (oral B administration from day 5 to day 
19 post-hatching) in order to obtain four distinct phenotypes: pre-hatching B-
treated birds, post-hatching B-treated birds, both pre- and post-hatching B-
treated birds, and controls. I examine the specific and combined effects of pre- 
and post-hatching B on (1) growth trajectories and physiological stress responses 
before sexual maturity (post-hatch day 22) and upon adulthood (post-hatch day 
64); (2) adult gene expression patterns within the hippocampus and 
hypothalamus, and (3) oxidative stress in the blood and the brain in the adults. 
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The main results of Chapter 3 show that post-hatching B, regardless of pre-
hatching experiences, decrease HPA axis responsiveness in the juveniles, but 
only in the female quail; whilst pre-hatching stress, when not combined with 
post-hatching B, increase HPA responsiveness in both sexes upon adulthood. I 
also show that both pre- and post-hatching B induce short-term alterations in 
triglyceride basal concentrations, which are linked with the sex and basal 
glucose concentrations of the birds; the effects of pre-hatching B exposure were 
visible also upon adulthood with sex-specific alterations on basal glucose 
concentrations. Overall these results suggest that early life stress can trigger 
both transient and permanent physiological changes, depending on the sex and 
the quality of both the pre- and post-hatching environment. In Chapter 4 I show 
that the gene expression responses to pre- and post-hatching B are overall 
subtle, results similar to those reported in previous genomic studies that have 
manipulated early life rearing environments. The effects are, however, 
distinguishable, strongly tissue-specific and involve well characterised key 
candidate genes in the regulation of the HPA axis. These data also suggest 
important novel regulatory mechanisms, likely linked with cellular redox state, 
which may be driving the long-term effects of developmental stress. Finally, in 
chapter 5, I show that developmental B induces alterations in the basal 
antioxidant defences upon adulthood. The magnitude of these effects, once 
more, depends upon the timing of exposure, interactions between the pre- and 
post-hatching B and the tissue examined. As there are no differences in terminal 
oxidative damage, these results suggest that the B-treated birds could avoid 
oxidative stress via altering body oxidative defences. In summary, my findings 
throughout this thesis, illustrate the complexity of glucocorticoid programming 
and the importance of integrating analyses at multiple levels, from physiology to 
genome-wide investigations. The results of this thesis also strengthen the 
importance of examining the effects of early life stress over differing life stages 
in order to consider the overall balance of costs and benefits that may 
ultimately affect Darwinian fitness and survival.    
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1. Chapter 
General Introduction  
 
1.1 The concept of Stress  
“Everybody knows what stress is and nobody knows what it is” is the perplexing 
comment posed by Hans Selye some forty years ago (Selye, 1974). The term 
“stress” is a notoriously broad concept in biology and the scientific community 
continues to make efforts to find an acceptable definition (Romero et al., 2009).  
The endocrinologist Hans Selye (1950) first coined the term “stress” and used 
this to include any condition that threatens an individual’s homeostasis. 
Homeostasis encompass the capacity of living organisms to maintain a stable 
internal environment, including body temperature, blood glucose, pH levels, and 
water balance (Cannon, 1929). Selye also introduced the term “stressor” to 
indicate “the causative agents that trigger the stress response”, defined as a 
cascade of emergency physiological and behavioural responses that re-establish 
homeostasis.  Part of the problem with this definition derives from the inability 
to define rigorously the concepts of stressor, homeostasis and stress response. 
Recently, however, it has been widely accepted that any unpredictable event 
including environmental factors (e.g. extreme weather conditions, food 
restriction, and exposure to parasites) as well as behavioural factors, like social 
instability, can all be considered as stressors (Levine and Ursin, 1991).  
Beyond the mere definitions, another problem in Selye’s concept of stress is the 
lack of consideration of animal species life histories, hence, the dynamic 
phenotypic changes, involving growth, reproduction and lifespan, throughout the 
individuals’ life cycle. The concept of “allostasis” (Sterling and Eyer, 1989; 
McEwen and Wingfield, 2003) is the first attempt to circumvent this weakness. 
Allostasis can be summarised as the process of maintaining homeostasis through 
changes in both environmental stimuli and physiological mechanisms and, 
therefore, takes into account the daily and seasonal physiological adjustments 
that constantly occur in the individual. However, it has been recently argued 
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that the allostasis model does not provide a framework to predict certain kinds 
of responses to stressful stimuli that may prepare (“prime” or “program”) the 
individual to better cope with the future environmental conditions (Romero et 
al., 2009). Examples of these potentially adaptive responses are those arising 
during development, when the individual is more especially sensitive to changes 
in anatomical structure and physiology (Seckl, 2001). It is widely accepted that 
early life experiences can potentially reset homeostatic settings and produce 
functional changes that can persist for the lifespan of the organism (reviewed by 
Seckl, 2004; Meaney et al., 2007). To date, the Reactive scope model proposed 
by Romero and colleagues (2009) represents the first attempt to integrate within 
the notion of stress the importance of species’ developmental strategies and 
their potential long-lasting effects in modifying future stress responses.   
In summary, stress is a complex phenomenon and many mechanisms still remain 
to be addressed. It is intriguing to note that while it has been now over 60 years 
since Selye identified the main physiological mediator of coping with stressors, 
we still do not fully understand how the stress physiology helps animals to 
survive. This is a point of crucial importance for Darwinian selection because a 
significant part of the variation in fitness and longevity among individuals is 
likely to be linked to differences in their ability to deal with any perturbation to 
homeostasis.  
 
1.2 The stress response and the biological 
relevance of the Hypothalamic-Pituitary Adrenal 
axis 
All vertebrate taxa elicit a similar non-specific and rapid physiological stress 
response to cope with a variety of stressors (Cannon, 1929; recently reviewed by 
Chang and Hsua, 2004). Within seconds to hours after the perception of the 
stressor, two components of the stress response are activated, the first called 
the “fight or flight response”, first described by Walter Cannon (1929), involving 
the immediate secretion of adrenalin from the adrenal cortex, and the second 
involving the activation of the Hypothalamic-Pituitary-Adrenal axis (HPA axis; 
Selye, 1974; Figure 1.1). The “fight or flight response” acts in the first seconds 
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and triggers a variety of physiological changes, including increased 
cardiovascular tone and respiration rate, that facilitate immediate physical 
reactions associated with a preparation for muscular action. Within minutes of 
the onset stressor, two neuropeptides from the paraventricular nucleus of the 
hypothalamus, corticotrophin-releasing hormone (CRH) and arginine vasopressin 
(AVP), act synergistically to stimulate the secretion of adrenocorticotropic 
hormone (ACTH) from corticotroph cells in the anterior pituitary gland. ACTH is 
then transported via the systemic circulation to the adrenal cortex, where it 
stimulates the production and secretion of glucocorticoid stress hormones 
(Nelson, 2005). In amphibians, reptiles and birds, the main biologically active 
glucocorticoid is corticosterone (B), whereas in most fish and mammals it is 
cortisol (among the exceptions are rodents, where it is B) (Harvey et al., 1984). 
The resultant increase in circulating glucocorticoid concentrations initiates an 
array of metabolic changes that stimulate hepatic gluconeogenesis, inhibit 
glucose uptake by peripheral tissues and suppress inflammation and numerous 
immune reactions (Munck et al., 1984). Such changes are thought to be 
adaptive, allowing the animals to move away from the source of danger and 
redirect physiology and behaviour towards immediate life-saving strategies, 
better known as “emergency life history stage”  (Wingfield et al., 1998). Avian 
research over the last decade has enormously contributed to elucidate the 
behavioural sub-stages mediating the development of the emergency life history 
stage and their links with stress hormones (Wingfield and Ramenofsky, 1997; 
Wingfield et al., 1998). In detail, the first event involves the deactivation of 
territorial behaviour and disruption of social hierarchies (Wingfield and Silverin, 
1986; Wingfield et al., 1998; Meddle et al., 2002), which could impinge on 
reproduction. For example, implants of B in free-living pied flycatchers (Ficedula 
hypoleuca) reduced parental care or resulted in complete abandonment of nests 
depending on the hormonal doses implanted (Silverin, 1986). The second sub-
stage is the activation of the emergency behaviour, which allows the animal to 
activate the appropriate behavioural strategy to respond to the perturbation, 
such as seek a refuge to hide, or leave and find an alternate habitat depending 
on the encountered environmental conditions (e.g. Astheimer et al., 1992; 
Breuner et al., 1998b). The last sub-stage is characterised by the termination of 
the emergency life history stage and recovery phase that allow the animal to 
return to its normal life history state (Astheimer et al., 1992). Importantly, such 
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sub-stages are not avian-specific but rather widespread across vertebrate taxa 
(recently reviewed by Wingfield and Romero, 2010).   
An adaptive stress response usually involves relatively low initial glucocorticoid 
concentrations that reach a physiological peak within minutes (usually 10-15min) 
of exposure to a stressor, with glucocorticoids returning to the previous baseline 
after the exposure to a stressor terminates (reviewed by Cockrem, 2013). The 
short-term nature of the stress response is, therefore, very important (e.g. 
Wingfield et al., 1998; Sapolsky, 2000). Glucocorticoids play a major role in 
switching off the stress response. Indeed, the positive top-down regulation of 
adrenocortical activity is counteracted via bottom-up negative feedback actions 
of glucocorticoids that bind to specific intracellular receptors in various neuronal 
structures, especially in the hippocampus and hypothalamus (Bons et al., 1976; 
Bradbury et al., 1994; de Kloet et al., 1996). There are two types of 
corticosteroid receptors: the higher affinity mineralocorticoid or type I (herein 
referred as MR) receptor and the lower affinity glucocorticoid or type II (herein 
referred as GR) receptor (Reul and de Kloet, 1985). Such different binding 
affinities of glucocorticoids to their receptors are thought to play a key role in 
the dynamic modulation of the stress response (Oitzl et al., 2010). Prolonged or 
repeated stimulation of the HPA axis, for instance via repeated exposure to 
stressful stimuli, can compromise the efficiency of negative feedback on the HPA 
axis, leading to chronically elevated circulating stress hormones. Elevated 
glucocorticoid concentrations over longer periods can be damaging and cause 
inhibition of the reproductive axis, suppression of the immune system, 
impairment of growth, increased cellular oxidative stress and neuronal cell 
death (Sapolsky, 1992; McEwen and Stellar, 1993; de Kloet et al., 2005a; 
Costantini et al., 2011a). However, there is also a growing proposal among 
behavioural endocrinologists and evolutionary ecologists that a prolonged 
elevation of stress hormones might be advantageous during specific life stages 
(e.g. long period of starvation during migration, persistent exposure to high 
predation pressure), and therefore, favoured by natural selection. Clearly, such 
advantages will depend on the overall balance between fitness benefits (e.g. 
increasing the likelihood of reproduction) and costs (e.g. increased risk factors 
for disease) throughout an animal’s lifespan (Monaghan, 2008).  
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Figure 1.1. Regulation of the Hypothalamic-Pituitary-Adrenal axis (HPA axis) in the mammalian 
brain. Briefly, after the perception of a stressor, the hypothalamic paraventricular nucleus (PVN) 
releases corticotrophin releasing hormone (CRH) and vasopressin (AVP), which stimulate the 
release of adrenocorticotrophin hormone (ACTH) in the anterior pituitary. ACTH in turn stimulates 
the production and secretion of glucocorticoids (corticosterone or cortisol depending on the 
species) from the adrenal cortex. Elevated glucocorticoids exert an array of metabolic and 
behavioural effects in order to maintain body homeostasis. The HPA axis is tightly regulated over 
time via negative feedback loops (indicated by the sign - ) on mineralocorticoid receptors (MR) and 
glucocorticoid receptors (GR) in the brain and anterior pituitary. Under acute stress conditions, 
feedback mechanisms operate efficiently and the effects of elevated glucocorticoids are only short-
term (within hours). Under chronic stressful conditions, feedback mechanisms are impaired causing 
prolonged activation of the HPA axis, with potential detrimental consequences on body processes. 
In the brain, MR have a higher affinity than GR for glucocorticoids. Therefore, at basal 
concentrations of glucocorticoids, MR are occupied whereas GR remain largely unoccupied. During 
acute stress, there is increased occupation of GR. Hippocampal MR are thought to be primarily 
involved in feedback regulation during basal secretion, while GR become important during stressful 
conditions. From de Kloet et al., 1999; Matthews, 2002; Sapolsky, 2002 (see also paragraph 1.2 for 
more detailed information on the HPA axis). Figure from Broonstra, 2004.   
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1.2.2 The importance of the HPA axis for the study of the 
long-term effects of stress on the phenotype  
In contrast to adrenalin, glucocorticoid hormones are lipophilic; which means 
that they can readily cross the blood-brain barrier and directly bind to 
corticosteroid receptors (Reul and de Kloet, 1985). Since the endocrine 
mediation of the stress response must affect the brain in order to affect 
behaviour, glucocorticoids are believed to be ideal candidates to study the long-
term effects of stressful conditions on the individual’s phenotype. Given the lack 
of consensus on the biological definition of stress (Section 1.1), it is important to 
clarify that, in this study, stress refers the HPA axis system that is activated in 
response to exposure to a stressor, and a stress response only occurs in response 
to an increase in glucocorticoid synthesis and secretion into the blood.   
 
1.3 The role of the early environment   
Early life experiences are key drivers of phenotypic trajectories and life history 
strategies (Mousseau and Fox, 1998; Monaghan, 2008). In early life, 
environmental factors can act directly, or indirectly, on the phenotype. Indirect 
effects are commonly known as “maternal effects” and refer to the ability of 
the mother, to influence the phenotypic development of her offspring (Mousseau 
and Fox, 1998; Wolf et al., 1998). Hormones are thought to be the main 
candidate mediators of such direct and indirect environmental effects on the 
phenotype. The first evidence supporting this idea was put forward by Charles H. 
Phoenix’s seminal study demonstrating that female guinea pigs exposed to 
exogenous testosterone as embryos, gonadectomised before puberty and treated 
with testosterone as adults exhibited masculinised sexual behaviours (i.e. 
mounting responses) (Phoenix et al., 1959). This study, coupled with later 
research carried out by Young and collaborators (e.g. Young et al., 1964), have 
posed the basis for the so termed “organisational-activation hypothesis”. This 
hypothesis highlights the importance of (1) the environmental stimuli during 
critical developmental periods, and (2) the dual action of testosterone in 
“organising” tissues and neuroendocrine pathways in early life vs. “activating” 
appropriate sex-specific responses later in life. A series of follow-up studies have 
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progressively expanded Phoenix’s hypothesis more broadly at different levels of 
biological organisation (cellular, molecular and genetic) and confirmed that the 
organisational and activational effects of sex steroid hormones can explain 
variations in a large variety of phenotypic traits, also involving non-gonadal 
tissues (reviewed by Arnold, 2009). Furthermore, there are now evidence 
showing that in vertebrates sexually dimorphic traits are due to a combination of 
gonadal hormones and the direct effects of genes encoded on the sex 
chromosomes (reviewed by Arnold, 2004). For example, a notable experiment by 
Gahr (2003) in the Japanese quail (Coturnix c. Japonica) demonstrated that 
when genetically female hypothalamic tissue was transplanted into the body of a 
male, testicular growth and testosterone secretion were lower than in genetic 
males receiving transplants of genetically male hypothalamus. These results 
suggest that the genetic sex of brain cells has important organisational effects, 
which can constrain the cell’s functional phenotype and the normal development 
of the hypothalamic-pituitary-gonadal axis.    
 
1.3.1 Early life stress and the concept of glucocorticoid 
programming  
Numerous experiments between 1970 and 1980 have focused attention on the 
potential organisational-activational role of stressful environmental stimuli 
during development on the phenotype. A key study in this field showed that 
male offspring of rats born from stressed mothers (i.e. using combination of 
restraint and light) exhibited demasculinisation and feminisation of sexual 
behaviours, with decreased ejaculatory pattern and increased lordotic behaviour 
(Ward,  1972).  Similar effects were confirmed later by another laboratory group 
(Dahlöf et al., 1977, 1978). Remarkably, it was later demonstrated that Ward’s 
restraint protocol imposed on the pregnant rat induced elevated B levels in both 
the mother and its offspring (Ward and Weisz, 1984). Such results can be 
interpreted as the first experimental evidence demonstrating that stressed 
mothers can potentially produce stressed offspring phenotypes. 
Following Ward’s earlier findings, several biomedical researchers and 
epidemiologists have focused on the long-term phenotypic effects associated 
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with stressors experienced during both the pre- and post-natal development. For 
example, a large body of literature in humans has suggested consistent 
correlations among low birth weight, infant feeding or adverse socio-economic 
conditions during infancy with an increased propensity to a wide range of 
metabolic disorders into adulthood, notably hypertension, insulin resistance, 
type 2 diabetes and cardiovascular diseases (e.g. Barker et al., 1990, 1993; 
Lissau and Sorensen, 1994; Lithell et al., 1996; Forsdahl, 1977; recently 
reviewed by Godfrey et al., 2007). In light of the original Phoenix’s hypothesis 
and Ward’s findings, glucocorticoids and changes in the HPA activity have been 
hypothesised to be the main drivers of such effects via programming mechanisms 
occurring during development that persist throughout life. This phenomenon is 
today more generically known as pre-natal glucocorticoid programming or peri-
natal glucocorticoid programming” (Seckl, 2001, 2004; Meaney et al., 2007; 
Cottrell and Seckl, 2009).  
 
1.3.1.1 Experimental studies on pre-natal/pre-hatching stress    
Accumulating evidence across a variety of vertebrate taxa, from fish to 
mammals, show that stressed mothers with elevated endogenous glucocorticoids 
can expose their embryos to these circulating stress hormones through the 
placenta or their presence in the egg (reviewed in Henriksen et al., 2011). For 
example, in birds, Hayward and Wingfield (2004) were the first to provide 
experimental evidence in an avian model (the Japanese quail), that adult 
females implanted with B produced eggs with higher concentrations of yolk B 
than control females. The concentration increase was observed after 1 week the 
treatment started, which is a time compatible with the time interval required 
for yolk formation in pre-ovulatory follicles (Hayward and Wingfield, 2004). 
Similar findings were found later in the barn swallow (Hirundo rustica), with 
females exposed to predators laying eggs with higher B concentrations in the 
albumin compared to control females (Saino et al., 2005). In the latter study the 
increase was observed the day after the start of the treatment (Saino et al., 
2005), which is the expected time range of steroid hormones deposition in the 
albumen post-ovulation (Warren and Scott, 1935). Although the literature on 
glucocorticoid-mediated maternal effects is growing in birds, to date the 
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majority of the studies have mainly focused on maternal androgens (reviewed by 
Groothuis et al., 2005; Groothuis and Schwabl, 2008). Such studies have 
contributed to demonstrate that elevated yolk androgens can lead to both short-
term effects on offspring behaviour, such as enhanced nestling growth and 
begging rates (e.g. Schwabl, 1996; Eising et al., 2001; Eising and Groothuis, 
2003; but see Sockman and Schwabl, 2000; Pilz et al., 2004) and long-term 
effects in adult exploratory behaviour as well as the development and expression 
of sexually dimorphic traits (Ruuskanen and Laaksonon, 2010; Schweitzer et al., 
2013). Despite the consolidated knowledge in birds that maternal steroid 
hormones accumulate in the egg, there are still limited information regarding 
the exact mechanisms underlying their transfer and deposition to the eggs. In 
contrast to sex steroids that are produced locally in the cell layers of the 
follicular wall surrounding the growing oocyte during vitellogenesis (Bahr et al., 
1983; Okuliarova et al., 2010), glucocorticoids need to be transported from the 
adrenal glands to the oocyte via the blood circulation, and how exactly this 
occurs remains to be answered.  
Beyond the mechanisms of transfer of maternal stress hormones to the offspring, 
there are a line of experimental evidence, from fish to mammals, showing that 
pre-natal/pre-hatching elevated glucocorticoids can shape a wide array of 
phenotypic responses, including alterations in growth trajectories, cognition and 
competitive abilities, stress-related behaviours both in wild and captive animals’ 
populations (e.g. fish: Sloman, 2010; reptiles: De Fraipont et al., 2000; birds: 
Hayward and Wingfield, 2004; Rubolini et al., 2005; mammals: review by 
Weinstock, 2008). To date, only a surprising small number of studies, and mainly 
in birds, have examined the effects of elevated maternal pre-natal stress on the 
activity of the offspring HPA axis. The results from these experiments showed 
that elevation of maternal plasma B concentrations or direct elevation of B in 
ovo, as well as a range of stressful protocols can all have the potential to induce 
long-term alterations in the dynamics of the offspring stress responses post-
hatching (e.g. Hayward and Wingfield, 2004; Hayward et al., 2006; Love and 
Williams, 2008; Haussmann et al., 2012). To the best of my knowledge, there is 
only one study in birds that examined the effects of pre-hatching stressful 
manipulations (mimicked via in ovo injection with B) on corticosteroid receptors 
(MR and GR), and exclusively on GR (Ahmed et al., in press). The latter study 
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found a diminished expression of the GR protein content in the hypothalamus of 
pre-hatching B-exposed chickens when adults in comparison with the controls, 
but no differences were found in GR gene expression within the same brain area 
(Ahmed et al., in press). However, these effects were observed only when a high 
dose of B was injected in the egg yolk, whereas no effects were seen in the birds 
that were exposed to a low dose of B pre-hatching (Ahmed et al., in press). 
Although these results are promising, more studies across different vertebrate 
species looking at both GR and MR receptors in the brain will be needed to 
clarify the potential long-lasting changes of these systems in response to pre-
hatching stressful conditions.  
The effects of pre-natal stress on the HPA system have been studied in much 
more details in laboratory rats. These studies lead to the common assumption 
that maternal pre-natal stress produce offspring that, as adults, exhibit 
increased HPA axis responsiveness, with steeper increases in peak glucocorticoid 
concentrations and a slower return to baseline levels in response to acute stress 
(reviewed by Kapoor et al., 2006). These alterations in the stress response have 
been associated with weaker negative feedback capacity due to a decreased 
number of GR and MR receptors in the hippocampus of the adult offspring 
(Barbazanges et al., 1996; Levitt et al., 1996; Welberg et al., 2001; Emack et 
al., 2008). Recent reviews of the available mammalian literature, however, 
highlighted many inconsistent patterns across studies, probably due to different 
intensity and timing of the stressor, sex and the age of the offspring (e.g. 
Weinstock, 2008; Henriksen et al., 2011). For example, studies in rats and mice 
indicate that long-term alterations in the programming of the HPA axis of the 
offspring appear only if the maternal stressor occurs at least once daily between 
days 14 and 21 of gestation (e.g. Henry et al., 1994; Maccari et al., 2003; Koenig 
et al., 2005), suggesting the presence of specific sensitive windows in which the 
elevation of glucocorticoids can induce long-lasting changes in the 
developmental trajectories (reviewed by Weinstock, 2008). Similar pre-natal 
critical periods appear to exist also in guinea pigs (Kapoor et al., 2006) and 
common marmoset (Pryce et al., 2011). Such pre-natal sensitive windows are 
thought to be caused by differences in the ability of the embryo HPA axis to 
respond to maternal stressors during gestation and are thought to be especially 
dependent on the appearance of MR and GR in the brain (Weinstock, 2008). 
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However, this hypothesis to date remains to be experimentally tested. Another 
factor that could contribute to explain the high variations across the mammalian 
literature regards the potential mechanisms that can regulate/counteract the 
effects of maternal pre-natal glucocorticoids on the offspring (Shams, 1998; 
Seckl and Meaney, 2004). In fact in mammals, it is now well established that the 
access of maternal glucocorticoids to the embryo is partially regulated by the 
type 2 isoform of the placental enzyme 11β-hydroxysteroid dehydrogenase (11β-
HSD2). This isoform catalyses the rapid inactivation of active glucocorticoids (B 
or cortisol) into their inert metabolites (11-dehydrocorticosterone or cortisone 
respectively) (Murphy et al., 1974). Placental 11β-HSD2 activity has been shown 
to vary significantly among individuals in both rats (Benediktsson et al., 1993) 
and humans (Stewart et al., 1995). Experimental work in rats demonstrated that 
acute stress on pre-natal day 20 up-regulated placental 11β-HSD2 activity by 
160% (Welberg et al., 2005). The latter study also showed that maternal chronic 
stress experienced during the third week of pregnancy (pre-natal days 14-19) did 
not alter placental 11β-HSD2 activity, but it reduced the capacity to up-regulate 
the enzyme in the placenta by 90% when the dams were faced with an acute 
stressor (Welberg et al., 2005). Moreover, a study in mice showed that          
11β-HSD2-/- offspring of either 11β-HSD2+/- or 11β-HSD2-/- mothers had reduced 
birth weight and exhibited higher anxiety than 11β-HSD2+/+ littermates, providing 
evidence for the key role of feto-placental 11β-HSD2 in pre-natal glucocorticoid 
programming (Holmes et al., 2006). Altogether these data indicate that 11β-
HSD2 is likely to play a key role in modulating glucocorticoid access from the 
mother body to the embryo, a mechanism potentially evolved to protect the 
embryo from some of the negative effects observed in pre-natally stressed 
individuals. This idea appears reinforced by recent studies that have found 11β-
HSD2 also in the ovary of zebra finch (Taeniopygia guttata) (Katz et al., 2010) 
and in the gonads and oviduct of chickens (Gallus gallus) (Klusonova et al., 
2008), suggesting that the presence of this enzyme could have the same function 
as in mammals also in egg-laying vertebrate species. Overall these data also 
upgrade the role of the embryo in the response mechanism underlying pre-natal 
programming: the general idea of the embryo as a passive receiver with the 
mother having the windward in the parent-offspring conflict appears now 
outdated (Carere and Balthazart, 2007; Groothuis and Schwabl, 2008). 
Therefore, in conclusion, despite the large amount of studies in mammals, many 
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questions, such as developmental windows, interactions between variation in 
maternal HPA axis activity and different embryonic responsiveness to the effects 
of glucocorticoids, and especially, the proximate mechanisms underlying the 
long-lasting effects on offspring physiology and behaviour, remained mainly 
unresolved.  
 
1.3.1.2 Experimental studies on post-natal/post-hatching stress    
After birth/post-hatching, several stressor types (i.e. sibling competition, low 
food provisioning, maternal separation or direct glucocorticoid administration) 
can lead to increases in endogenous glucocorticoids in the growing offspring 
across a variety of vertebrate groups (e.g. reptiles: Meylan et al., 2002; birds: 
Kitaysky et al., 1999; Spencer et al. 2003; Spencer et al., 2009; mammals: 
Rosenfeld et al., 1992). These consequent alterations in endogenous stress 
hormone concentrations have been shown to produce changes in several 
phenotypic traits, such as song, competitive and dispersal behaviour (e.g. 
Meylan et al., 2002; Spencer et al., 2003; Spencer and Verhulst, 2007); and, 
especially, alterations in the adult HPA responsiveness and/or in the gene 
expression of corticosteroid receptors in a brain-region specific fashion (Spencer 
et al., 2009; Banerjee et al., 2012).  In fact, Banerjee and collaborators (2012) 
showed that adult zebra finches that hatched from maternally-deprived nests 
had diminished GR mRNA expression levels within the hypothalamus when 
compared to the non-maternally deprived adults, but no treatment differences 
were observed within both the hippocampus and cerebellum on GR; on contrast, 
MR mRNA levels in the maternally-deprived birds were lower than in the control 
group within all these brain regions. Again, as for the studies in birds on pre-
hatching stress (Paragraph 1.3.1.1), the latter work is, to the best of my 
knowledge, the only experimental work that looked at the long-term effects of 
post-hatching stressors (although not using a direct manipulation with B) on the 
corticosteroid receptors in the brain and more studies are needed to elucidate 
the proximate mechanisms.     
The abundant literature of post-natal stress programming in rats primarily 
involves alterations in mother-pup interactions. For instance, adult rat offspring 
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born from mothers who naturally exhibit high levels of care were found to show 
dampened HPA stress responses, as well as elevated expression of GR receptors 
in the hippocampus and decreased expression of CRH in the paraventricular 
nucleus of the hypothalamus (Liu et al., 1997). These adult offspring were also 
less fearful in comparison to the adults that as juveniles experienced low levels 
of maternal care. Importantly, such observed phenotypic changes could be 
reversed by cross-fostering the biological offspring of high- and low-care mothers 
(Francis et al., 1999). On the other hand, prolonged separation of the pups from 
the mother causes the opposite effects on the adult offspring HPA axis, with 
enhanced stress responsiveness (Plotsky and Meaney, 1993), underscoring the 
importance of considering the type and intensity of the stressor when 
considering the potential effects on the adult phenotype.  
At least in mammals and similarly as occurs during the pre-natal development 
(see Paragraph 1.3.1.1 above), the effects of glucocorticoid hormone exposure 
during post-natal development on the nervous system and behaviour appear to 
be stronger during specific post-natal sensitive periods. Although most of the 
research on this field focused on the effects of steroid hormone exposure during 
pre-natal or early post-natal development, it has been suggested that 
adolescence (broadly defined as the period of life that includes attainment of 
sexual maturity; Spear, 2000) can also be another critical sensitive period of life 
(Spear, 2000; recently reviewed by Brown and Spencer, 2013). However, studies 
focused on the effects of adolescent stress on HPA axis development show 
variable outcomes (reviewed by McCormick et al., 2010), and again, such large 
variation in the results may be explained by differences in stressor types and 
intensity. Although all vertebrates undergo the critical transition from an 
immature state (pre-puberty) to one that is capable of reproduction, only a few 
studies in species different from mammalian models investigated the effects of 
stress specifically during puberty/adolescence. This is partially due to the 
difficulties in establishing a clear/discrete separation in the continuum of the 
physiological processes occurring between pre-puberty and puberty in several 
vertebrate species, especially in seasonally breeding species with intermittent 
reproductive activation (reviewed by Perfito and Bentley, 2009). The few studies 
carried out in birds suggest that stressful manipulations specifically during 
adolescence, such as housing conditions or unpredictable light:dirk cycles, can 
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have the potential to modulate both stress reactivity and behaviour in later life 
(Heiblum et al., 2000; Lindqvist et al., 2007). Although these studies highlight 
the importance of this period of life also in bird species, more studies are 
needed to examine whether the underlying effects of the observed changes in 
the latter studies are determined directly by glucocorticoids and not by indirect 
changes (and interacting effects) in other hormones, such as sex steroids 
(reviewed by Brown and Spencer, 2013).   
 
1.3.1.3 Interaction between pre-natal/pre-hatching and post-
natal/post-hatching stressors 
Overall the literature suggests that pre- and post-natal/hatching environments 
can impinge on the same behavioural and endocrine pathways associated with 
the HPA axis system. Lines of evidence suggests that environmental experiences 
occurring during these two developmental periods can have different long-
lasting effects on the adult phenotype. More importantly, the effects of pre-
natal stress can also depend on the quality of the post-natal rearing 
environments. For example in rats, post-natal handling can reverse the increase 
in emotional reactivity or the effects induced by pre-natal stress (Wakshlak and 
Weinstock, 1990).  A similar suppression of the effects of pre-natal stress in the 
rat model has been reported on the HPA axis activity as a consequence of post-
natal adoption (Maccari et al., 1995). These experimental data have emphasised 
the importance of considering interactive stimuli occurring throughout the 
differing stages of development when investigating the effects of developmental 
stress. At the same time, they reinforce the hypothesis that the HPA axis may be 
the main biological substrate for such interactions (Maccari et al., 1995).  
In order to test this hypothesis experimentally, however, it would be important 
to control and, hence, to be able to manipulate direct and indirect 
environmental components acting on the growing individuals.  As it has been 
recently pointed out, in mammals the relatively inaccessibility of the embryo, as 
well as the prolonged physiological intimacy between the mother and offspring 
via the placenta and the transfer of milk challenge direct experimental 
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manipulations on the developing individuals (Spencer et al., 2009; Henriksen et 
al., 2011).  
1.3.1.4 The advantages of egg-laying vertebrates and the bird as a 
model   
Egg-laying vertebrates have been shown to be better models for conducting 
direct manipulations of the pre- and/or post-natal environment (fish: 
McCormick, 2000; reptiles: Meylan et al., 2002; birds: Love and Williams, 2008). 
In fact, the egg once deposited/laid represents a sealed environment and it is 
content may be manipulated with none or very minimal direct influences of the 
mother, with the exception of her incubation behaviour (Groothuis et al., 2005). 
This physical separation between the mother and the embryo also facilitates 
descriptive research to investigate, for example, correlations of nutrients and 
hormones deposited in the egg with the mother’s body conditions during egg 
formation. Also, post hatching, the lack of direct maternal hormone transfer 
between the mother and its offspring through lactation allows better controlled 
experimental manipulations of endogenous glucocorticoids in the juveniles (e.g. 
Spencer et al., 2009). As discussed earlier (Paragraph 1.3.1.1), birds are a 
classical model to study hormone-mediated mechanisms of maternal effects 
(recently reviewed by Groothuis et al., 2005; Groothuis and Schwabl, 2008). 
First, there are substantial evidence showing that steroid hormones, including 
glucocorticoids, are deposited into the yolk of the egg over the course of 1 week 
before laying (e.g. Hackl et al., 2003; Hayward and Wingfield, 2004; Almasi et 
al., 2012) and approximately over the last 24h into the albumen (e.g. Warren 
and Scott, 1935; Conrad and Scott, 1938; Hackl et al., 2003; Saino et al., 
2005).Therefore, the hormone yolk content is considered a good proxy of the 
physiological state of the mother over a relatively long timeframe; whereas the 
albumen is limited to a much shorter range period. Importantly, both yolk 
androgen and glucocorticoid concentrations respond to artificial selection for 
behaviour (Gil and Faure, 2007; Hayward et al., 2005), suggesting that hormone 
deposition in the egg may be a trait under natural selection. Second, the 
neuroendocrine and endocrine regulatory pathways, including those related to 
the stress physiology and HPA axis, have been well characterised in several bird 
species and showed high degree of similarities with mammals (Wingfield, 2005a). 
Several tracing and functional experiments in different bird species have 
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demonstrated connectivity throughout steroid-sensitive brain areas, such as 
those within the hypothalamus, midbrain and amygdala (e.g. Briganti et al., 
1996; Balthazart and Absil, 1997; Cheng et al., 1999; Riters and Alger, 2004), 
and a variety of steroid-dependent behaviours, including parental behaviour, 
aggression and sexual responses (e.g. Balthazart et al., 1998; Thompson et al., 
1998; Ruscio and Adkins-Regan, 2004). Such connectivity shows high degree of 
similarity with mammalian findings (reviewed by Goodson et al., 2005). 
Importantly, investigations on immediate early gene responses in birds (using 
antibodies for Fos and Zenk, also known as egr-1) have shown that birds and 
mammals exhibit similar patterns of activation following agonistic encounters 
(Goodson and Evans, 2004) and copulatory behaviour (Ball et al., 2007; Charlier 
et al., 2005). Such parallel between neuroendocrinology and behaviour in 
mammals and birds facilitates comparative research in a more adaptive and 
evolutionary framework (Henriksen et al., 2011).    
 
1.4 The study species: the Japanese quail   
The Japanese quail (Coturnix c. japonica) belongs to the order of Galliformes 
and the family Phasianidae and has been domesticated since the 11th century in 
China from wild populations in Eastern Asia (Huss et al., 2008). The Japanese 
quail is an ideal model for the study of developmental stress. First of all, recent 
studies carried out in Japanese quail have demonstrated that the yolk B content 
of the egg can be successfully manipulated via injection of known physiological 
doses of exogenous B soon after laying, without significant effects on embryonic 
mortality (Hayward et al., 2006; Boogert et al., 2013). Second, fertile eggs are 
artificially incubated and this eliminates sources of variations, for instance those 
due to parental incubation efforts and assures an ideal standardisation of 
experimental condition throughout the pre-hatching stages of development. 
Third, the precocial development of quail prevents post-hatching maternal 
hormonal input. In fact, the juveniles are able to walk, see, hear and feed 
themselves independently soon upon hatching. In natural conditions, post-hatch 
maternal care are characterised by brooding behaviour during approximately 2 
weeks of age (Mills et al., 1997). In captivity, brooding temperature can be 
successfully simulated using heat lamps for the first 2 weeks of post-hatching 
Chapter 1  35 
 
life. Using the Japanese quail, therefore, I was able to manipulate 
experimentally the quality of the post-hatching environment via directly 
administrating exogenous doses of B within the relevant physiological ranges in 
the absence of the potential confounding factor of maternal care. Furthermore, 
puberty in this species is reached relatively rapidly, between 6-8 weeks of age, 
with females maturing slightly later than males (Ottinger, 2001). Overall the 
easiness to breed quail and reliably in captivity as well as their rapid 
development has made this species a widely used model in laboratories all over 
the world and a great deal of the endocrine and neuroendocrine systems, 
including those relating the stress physiology, have been already described and 
confirmed high similarities with other vertebrate groups, especially mammals 
(Ottinger et al., 2001; 2004). Finally, quail are often a preferred model in 
behavioural endocrinology than the domestic chicken due to their smaller size, 
but also because quail have not been intensively selected by poultry industry for 
specific traits, such as egg or meat production as the chicken (Ball and 
Balthazart, 2010). The recent sequencing of the chicken genome, a species 
closely related to quail, is of great importance to, at least in part, overcome the 
limitation due to the relatively limited genetic information in quail.  
 
1.5 Outline of the thesis   
The overall aim of this thesis was to examine how and the extent to which, 
developmental stress influences individuals’ phenotypic trajectories and HPA 
axis programming in later life using the Japanese quail as study species. The use 
of this avian model allowed me to experimentally alter the quality of both the 
pre- and post-hatching environment mimicking exposure to standardised 
stressors and analyse the potential short- and long-term interactions between 
pre- and post-hatching exposure to B on the HPA axis phenotype. This research 
combines traditional methods to measure hormonal and cellular stress responses 
coupled with the most recent high-throughput technologies to measure global 
gene expression patterns in target brain tissues. The use of this integrative 
approach has strengthened my ability to collate a wide range of scientific 
approaches together that allowed me to further the understanding of overall 
regulatory patterns underlying stress. More specifically, the objectives of this 
thesis were to address the following questions:   
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 Can Japanese juvenile quail mount a stress response? If yes, does this 
ability change with age during post-natal development (Chapter 2)?   
 Does pre- and post-hatching exposure to B cause changes in growth 
patterns, HPA responsiveness, glucose and triglyceride stress responses in 
juvenile and adult quail? Do the short- and long-term effects of 
developmental stress differ (Chapter 3)?       
 Does pre- and post-hatching exposure to B cause long-lasting gene 
expression pattern changes in the hippocampus and hypothalamus into 
adulthood (Chapter 4)? 
 Does pre- and post-hatching exposure to B cause long-lasting changes in 
the body oxidative balance in the adult quail (chapter 5)?   
I finally conclude the thesis with a general discussion in which the results of 
these experimental studies are related to previous findings and potential future 
directions are also identified (Chapter 6).  
 
 
 
37 
2. Chapter  
Post-hatch age-related changes in the stress 
response in developing Japanese quail  
 
2.1. Abstract  
Vertebrate species respond to stressful environmental conditions by activating a 
stress response under the control of the Hypothalamic-Pituitary-Adrenal axis 
(HPA axis). During an individual’s development, the HPA axis undergoes phases 
of maturation, which are likely to be co-evolved with the specific developmental 
strategy (“Developmental hypothesis”). The large variation of life histories in 
birds within the altricial-precocial range makes this taxon an excellent model to 
study such interactions in a comparative framework. Here, I examine the HPA 
axis responsiveness in Japanese quail hatchlings aged 8- or 16-days by measuring 
baseline and stress-induced corticosterone (B) concentrations during a 
standardised environmental stressor. I also estimate the strength of correlation 
between B and the birds’ morphometric traits (body mass, structural size and 
body condition) in both the age classes. I find that the magnitude of the stress 
response is higher in the 8-day-old hatchlings than in the 16-day-old birds. There 
are no differences in baseline levels between the two age groups. The results 
also suggest links between stress-induced B levels with body mass and body size 
in the younger hatchlings, but not in the older birds. These patterns support the 
few studies conducted in other precocial species and fit well within the 
“Developmental Hypothesis”. The age-related decline in the stress 
responsiveness in precocial birds may be the optimal trade-off to respond 
promptly to environmental stressors during the earlier stages of development 
and to minimise excessive loss of energy later on life when the birds may be less 
vulnerable to stressors, such as predator attacks.   
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2.2 Introduction 
Living organisms respond and adapt to the current environmental conditions by 
adjusting their physiology, behaviour or morphology (reviewed recently by 
Wingfield, 2013). In vertebrate species, the ways in which such individuals’ 
responses are regulated depend upon a variety of factors, such as the genetic 
background, sex, body condition, and social interactions (Wingfield, 2008). An 
individual’s age may also be a critical factor in the modulation of such 
responses, especially during the early life stages (Monaghan, 2008). In fact, the 
capacity of growing animals to  perceive environmental signals and, 
consequently, transduce these cues into appropriate neural and hormonal 
responses can be influenced by internal factors, for example the individual’s 
ontogeny, or by external factors determined by the physical environment.  
A physiological system that is likely to play a key role in transmitting 
environmental signals is the Hypothalamic-Pituitary-Adrenal axis (HPA axis; 
Sapolsky, 1992). The HPA axis regulates the release of glucocorticoid stress 
hormones from the adrenal glands into the blood circulation. Temporary rises in 
glucocorticoid concentrations result in the mobilisation of body energy resources 
(i.e. glucose and triglycerides) that enhance immediate survival, suspend 
ongoing activities and allow individuals to move away from the perturbation, 
such as a predator attack or inclement weather (Breuner and Hahn, 2003; 
Breuner et al., 1998b; Wingfield et al., 1998; Sapolsky et al., 2000). Protracted 
activation of the HPA axis, however, can lead to chronically elevated circulating 
concentrations of glucocorticoids, with potential detrimental effects on the 
immune system, reproductive activities and brain functioning (Sapolsky, 2000; 
de Kloet et al., 2005a). The individual, therefore, needs to be able to efficiently 
modulate the release of baseline and stress-induced stress hormones, trading-off 
the need for mounting the stress response and the necessity to limit excessive 
and unnecessary loss of energy. Importantly, in the majority of vertebrate 
species (i.e. reptiles, amphibians, birds, and mammals; Romero, 2002), such re-
allocation of energetic resources follows distinct seasonal patterns. For 
example, in several passerines baseline and stress-induced corticosterone (B) 
concentrations (respectively in 72% and 86% of the species), the primary active 
glucocorticoid in birds, is highest during the breeding season and lowest during 
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the pre-basic moult (reviewed by Romero, 2002; see also Liebl et al., 2013). An 
up-regulated adrenocortical responsiveness may be an adaptive strategy for 
breeding animals to be more responsive towards predator attacks and assure 
protection to their offspring (i.e. “Energy Mobilisation Hypothesis” - Ketterson 
and Nolan, 1999; Romero, 2002); while, on the other hand, a down-regulated 
HPA axis during moulting may help individuals to maximise investment in feather 
quality, probably by suppressing the protein catabolic activity of glucocorticoids 
(Romero et al., 2005). Such seasonal fluctuations in the adrenocortical 
sensitivity and reactivity, however, are likely to differ or be more complex 
depending on the specific life history of the species. For example, several Arctic 
breeding birds show attenuated, or even suppressed, B stress responses during 
the breeding season (e.g. Wingfield et al., 1994a, b; Silverin et al., 1997; 
Silverin and Wingfield, 1998) and have been shown to be insensitive to the 
behavioural effects of high B levels (Astheimer et al., 2000; Meddle et al., 2001; 
Meddle et al., 2003; although see Meddle et al., 2002). Moreover, the breeding 
stage and the sex can also play an important role in the modulation of 
adrenocortical responsiveness. For example, the Arctic breeding male Smith’s 
longspurs (Calcarius pictus) do not show any attenuation of their HPA axis early 
in the breeding season on arrival at their breeding grounds during territorial 
establishment, but do show a diminished stress response later during the 
parental phase, when, intriguingly, moult also occurs (Meddle et al., 2003).   
Despite the large body of literature, especially in birds, on the physiological 
variation underlying physiological stress responses, most of this work has been 
carried out in adult individuals (recently reviewed by Cockrem, 2013). The 
effects of stressful conditions during pre- and/or post-natal development can 
have permanent effects on developmental processes, including impaired growth 
and long-term alterations in growth trajectories (e.g. Morici et al., 1997; 
Spencer and Verhulst, 2007; Spencer et al., 2009), sexual differentiation (e.g. 
Ward and Stehm, 1991), adult stress responsiveness (e.g. Hayward and 
Wingfield, 2004; Spencer et al., 2009; Banerjee et al., 2012; Marasco et al., 
2012 or Chapter 3 in this thesis) as well as changes in stress-related adult 
behaviours (Maccari et al., 1995; Davis et al., 2008). Newborn altricial 
laboratory rodents display a hypo-responsive HPA axis during their first two 
weeks of post-natal life, with low and stable B concentrations and a diminished 
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stress response (Sapolsky and Meaney, 1986; Levine, 1994). A similar HPA axis 
quiescence has been reported in altricial and semi-altricial birds during the early 
post-natal developmental windows (e.g. Romero et al., 1998; Sims and 
Holberton, 2000; Love et al., 2003; Wada et al., 2007; reviewed by Wada, 2008). 
In contrast, in precocial birds, the HPA axis appears to be functional much 
earlier in life, at least from the pre-hatching mid-incubation stages (Tanabe et 
al., 1986). Moreover, while non-precocial young birds often show maximal or 
similar adult-like stress responses as fledglings (Love et al., 2003; Walker et al., 
2005; Wada et al., 2008), precocial hatchlings exhibit elevated baselines and 
maximal HPA responsiveness at hatching (Kalliecharan and Hall, 1976; Tanabe et 
al., 1986; Carsia et al., 1987), which tend to decline with increasing post-natal 
age (Wentworth and Hussein, 1985; Carsia et al., 1987; Holmes et al., 1989; 
Dickens and Romero, 2010). Overall, such inter-species variation patterns 
suggests that the physiological capacity of a juvenile bird to deal with the 
environmental challenges depends upon the degree of post-hatching parental 
dependence as well as its capacity to thermoregulate, locomote and forage 
independently (i.e. “Developmental Hypothesis”- Schwabl, 1999; Kitaysky et al., 
2003; Blas et al., 2006; Wada, 2008) . Therefore, altricial birds that hatch 
almost naked, blind and are fully dependent on their parents are predicted to 
exhibit little or no glucocorticoid release in response to the environmental 
perturbations experienced as nestlings; while precocial birds that can feed 
independently from their parents fairly soon after hatching are predicted to 
develop the HPA axis earlier than altricial species in order to appropriately 
respond to the external environment.  
The aim of the current study was to examine the post-natal development of the 
adrenocortical responses to a standardised environmental stressor in the 
precocial Japanese quail. Specifically, the main objectives were (i) to examine if 
quail hatchlings were able to mount a B stress response to a standardised 
environmental stressor; if yes, (ii) to test whether such capacity would differ 
across differing stages of post-natal development, and finally, (iii) to investigate 
the potential relationships between the stress response, morphometric traits and 
energetic conditions in the growing individuals. These objectives were 
accomplished by evaluating the ability of the quail hatchlings to release B in 
response to a standardised capture-restraint-stress protocol (Wingfield et al., 
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1982) at post-natal day (PN) 8 and PN16, during the linear phase of growth, and 
analysing the strength of potential correlations between body mass, structural 
size and body condition with both baseline and stress-induced B. I predicted that 
the adrenocortical activity during a standardised restraint stress protocol would 
decline with post-natal age due to the highly precocial nature of Japanese quail 
kept in captive conditions (i.e. “Developmental hypothesis”, see above for 
references). Also, I expected that B (both baseline and stress-induced levels) 
would negatively correlate with the morphometric traits measured since 
glucocorticoids are known to promote energy expenditure and can impair 
increases in body mass and structural size (Sapolsky et al., 2000). Due to the 
limited literature in juvenile bird species and the high variation in 
developmental mode in this taxon, it is hard to predict whether baseline B levels 
would be a more relevant biological parameter than stress-induce B levels to 
explain variations in morphometric traits. However, a recent comparative study 
in breeding free-living males of a large variety of passerine species suggested 
that stress-induced B levels may be a stronger predictor of body mass than 
baseline B levels (Hau et al., 2010).  
 
2.3 Material and Methods 
The animal work was conducted at the Cochno Farm and Research Centre, 
University of Glasgow, UK. All indoor rooms were climate controlled at 19°C. All 
the eggs used for this experiment were derived from the in-house breeding 
stock. Breeding quail (n = 10 females and 5 males) lived in trios (2 females:1 
male) in 79 X 48 X 58cm enclosures. For the present experiment, a total of 45 
eggs were collected, marked according to maternal identity (identified by colour 
and marking patterns) and incubated (incubator Ova-Easy 190A, Brinsea 
Products, Sandford, UK) at 37.5oC and 55% humidity while being turned twice 
hourly. Of 45 eggs, 33 eggs were fertile (73%) and 25 quail hatched (76%). At 
hatching, quail were labelled with unique colour combinations using nail varnish 
applied on the feathers and placed back in the incubator to allow the plumage 
of the birds to dry. All the experimental quail were sexed post-mortem as this 
cannot be achieved by plumage pattern before 2-3 weeks of age (see below). 
Between 24 and 36h after hatching all the juveniles were housed in brooders, 
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each divided into smaller compartments using cardboard dividers. Quail housed 
in the same brooder compartment (n = 2 or 3) were age-matched and randomly 
assigned to one of the following experimental groups: (a) PN8: standardised 
capture-restraint-stress protocol at post-hatching day 8 (n=13, females: 8; 
males: 5); (b) PN16: standardised capture-restraint-stress protocol at post-
hatching day 16 (n = 12; females: 10; males: 2). PN8 and PN16 were chosen 
because these two time points are within the period in which the juveniles show 
a steep phase of linear growth (e.g. Chapter 3, Figure 3.1) and modulation of 
adrenocortical responsiveness during this time is likely to be biologically 
relevant. Furthermore, PN8 was the earliest time point in which I could obtain 
enough plasma from each individual bird for the hormonal analyses. The birds 
were tested at specific ages to minimise possible confounds due to HPA axis 
activity changes, which are known to occur, especially during development (e.g. 
Schwabl, 1999). Brooding temperature was 35.5oC with a daily decline from PN3 
of 1-1.5oC until the end of the experiment. Nail varnish markers were replaced 
with individual leg-bands in the hatchlings allocated to the PN16 experimental 
groups when they reached 7-8 days. Food (turkey starter crumbs, Dodson and 
Horrell, Kettering, Northamptonshire, UK) and water were provided ad libitum; 
all the animals were kept on a 12h:12h light:dark cycle (lights on 7am-7pm). 
 
2.3.1 Standardised capture-restraint-stress protocol 
The day prior to the standardised capture-restraint-stress protocol, body mass 
for each bird was measured to the nearest 0.1g using a balance (Fisher 
Scientific, Bishop Meadow Road, Loughborough, Leicestershire, UK); tarsus and 
head plus bill lengths were measured to the nearest 0.1mm using a digital 
calliper (Fisher Scientific, Bishop Meadow Road, Loughborough, Leicestershire, 
UK). The following day, the hatchlings were removed from their brooders 
between 8.30 and 12.49h and a blood sample (approximately 75µl) was 
immediately collected by brachial venipuncture into heparinised capillary tubes 
within approximately 1.5min (= T0, mean ± s.e.m., 1.20min ± 0.11) of capture. 
Since B titers in birds do not start to rise until 2-3min after capture (Romero and 
Reed, 2005), all these initial blood samples were considered to reflect baseline 
concentrations. Importantly, all the birds (n = 2 or 3) housed within the same 
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brooder compartment were caught and bled at the same time; birds housed in 
different brooders were visually isolated in order to assure minimal disturbance 
during the capture procedure. Each bird was then placed into a cardboard box 
(15 X 15 X 12cm), which was placed over a mini brooder (Brinsea Products, 
Sandford, UK) to keep the hatchlings warm and two further blood samples were 
taken approximately at 10min (= T10, mean ± s.e.m., 10.72min ± 0.15) and 
30min (= T30, mean ± s.e.m., 30.60min ± 0.14) following capture after which 
time the birds were returned to their brooder. In the majority of bird species, 
plasma B concentrations peaks at 10-15min after handling and declines at 30-
40min (Cockrem, 2013; Wall, 2010 in the Japanese quail). Therefore the 
measurements taken at T10 and T30 were expected to represent the magnitude 
of the stress response and the recovery efficiency to baseline, respectively. 
Blood samples were kept on ice for up to 4h before being centrifuged and 
plasma withdrawn and stored at 20oC for later hormonal analyses. The 
experiment ended the following day when the birds were sacrificed by cervical 
dislocation or by intra-peritoneal administration of 1ml of Euthatal (sodium 
pentobarbital, 200mg/ml; Merial Animal Health, Harlow, UK).  
 
2.3.2 B Radioimmunoassay   
Assays for measuring plasma B concentrations were conducted at the School of 
Veterinary Medicine, Jarrett Building, University of Glasgow, UK. All the B assays 
conducted for the work of this thesis employed a double antibody 
Radioimmunoassay along with at least 1 standard curve of known amounts of B 
(concentration range: 20ng/ml–0.038ng/ml), following a similar protocol to that 
described in Wingfield et al. (1991). Specifically, B was first extracted from 20μl 
of plasma using 10mm diameter glass tubes (Fisher Scientific Ltd, Loughborough, 
Leicestershire, UK). In order to measure the recovery efficiency (estimate of the 
accuracy of the extraction procedure), tracer amounts (≈3000 cpm) of [1, 2, 6, 
7–3H] B label (GE Healthcare, Chalfont St Giles, Buckinghamshire, UK) were 
added to each sample and incubated for 1h at 4ºC. Then 1ml of diethyl ether 
(Rathburn Chemicals, Walkerburn, UK) was added to each tube and samples 
were placed on dry ice for 5min. The obtained supernatant from each sample, 
containing the extracted B, was decanted into an empty glass tube. Samples 
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were then allowed to dry at 40ºC using a sample concentrator (Techne, 
Scientific Laboratory Supplies, East Riding of Yorkshire, UK) and air block (KFN 
Neuberger, Oxfordshire, UK). Once dried, samples were reconstituted with 300µl 
of assay buffer (0.01M PBS, 0.25% BSA; pH = 7.4) and maintained at 4ºC for at 
least 2h before proceeding with the next assay steps. Then, 50µl of each 
extracted sample was placed into plastic assay tubes (size 3.5ml, Sarstedt, 
Leicester, UK) with 1ml scintillation liquid (National Diagnostics, Atlanta, 
Georgia, USA), and counted in a liquid scintillation analyser (Packard, 1600 TR) 
to measure the recovery efficiencies. Subsequently, four plastic assay tubes for 
each of the following were set up: (1) “Totals” containing 100µl of B label 
(≈10000cpm) in 200µl assay buffer; (2) “Non-specific binding” containing 100µl 
of B label in 200µl assay buffer; (3) “Maximum binding” containing 100µl of B 
label, 100µl of primary antibody (anti-B antiserum, code B3-163, Esoterix, Austin 
TX - dilution 1: 100 in assay buffer and Normal Rabbit Serum, Sigma-Aldrich, 
Dorset, UK - dilution 1:400 in assay buffer). Tubes containing either samples 
(100µl, in duplicate) or standards (100µl, in triplicate) also received 100µl of 
primary antibody (same solution as with the maximum binding tubes), followed 
by 100µl of B label. In each assay, together with the quail samples, chicken 
plasma and two-B-spiked chicken plasma pools that gave approximately 80, 70 
and 50% binding on the standard curve, respectively, were included as quality 
controls. The tubes were then vortexed and incubated at 4ºC for 24h. The 
following day, 100µl of a second antibody (Goat anti-rabbit IgG, Sigma-Aldrich, 
Dorset, UK), diluted 1:50 in assay buffer, was added to all the tubes except to 
the totals. The tubes were then vortexed before being incubated at 4ºC for a 
further 24h. Following this, 400µl of microcellulose (Sigmacell Cellulose, Type 
20, Sigma-Aldrich, Dorset, UK) diluted in assay buffer (0.1g/100ml) was added to 
all the tubes except to the Totals. The tubes were then spun for 50min at 
2000rpm and the supernatant aspirated. The remaining pellets were 
reconstituted with 50µl of 0.1M sodium hydroxide, vortexed and 1ml of 
scintillation fluid was added before counting on the counter. Counts obtained for 
the standards and unknown samples were analysed and converted to 
concentrations in the unknown samples using the universal assay calculator Assay 
Zap (version 2.69, Biosoft, Cambridge, UK).  
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2.3.2.1 B analyses 
Extraction efficiencies estimated for each sample averaged (mean ± s.e.m.) 
84.77% ± 0.01. Samples collected at each age were run in two separate assays 
and the mean assay sensitivity was 0.2ng/ml. The intra-assay coefficients of 
variation were 25% and 4%, while the inter-assay coefficients of variation at 80, 
70 and 50% binding were 8%, 17% and 17%, respectively and were calculated 
using the chicken quality controls (as explained in Paragraph 2.3.2). 
Comparability between the two assays was assured by the quality controls, 
which were within the expected range of concentrations in both assays, as well 
as by interpolating the standard curves performed in each assay.  
 
2.3.3 Statistical analysis 
Data analysis was performed in PASW statistics 19.0 (Armonk, NY: IBM Corp.) 
using Linear Mixed Effect models (LMEs) fitted by restricted maximum likelihood. 
One female in the PN8 group was excluded from the analysis because of the lack 
of a T10 sample. Potential age-differences in the dynamics of the stress response 
(i.e. T0, T10 and T30) were investigated using a repeated-measure approach 
with age, time of sampling and their interaction as fixed factors, while mother 
identity was included as an additional random factor to control for pseudo-
replication due to the presence of hatchlings sharing the same mother. Age-
related differences in the adrenocortical activity were further examined in three 
separate LMEs using the following response variables: (a) baseline B (i.e. T0 
samples); (b) peak B (i.e. difference between the highest B concentrations at 
either T10 or T30 minus baseline B concentrations) and (c) the change in B 
between T10 and T30. Peak B and the change in B between T10 and T30 are 
considered good estimate of the magnitude of the stress response and the 
recovery to baseline levels, respectively. In all the LMEs, age was included as 
fixed factor and mother as random factor. To meet the assumptions of the LME 
modelling, B concentrations measured across the stress response as well as peak 
B were log10-transformed for normality; all model residuals were normally 
distributed. Sex was never included as a factor in the analyses because sample 
size was female-biased, especially in the PN16 group. However, the same model 
Chapter 2  46 
 
performed in the dataset after excluding the data from the males from both PN8 
and PN16 groups showed the same significant statistical outcome. Moreover, in 
preliminary analyses potential sex-differences in the adrenocortical responses 
within the PN8 group of birds were examined by performing a LME with sex, time 
of sampling and their interaction as fixed factor, while mother was included as a 
random factor; neither sex nor its interaction with time of sampling were 
significant in the model (p > 0.3 for both).  
An index of body size for each individual bird was estimated by extracting the 
first component scores from a Principal Component Analysis (PCA) with tarsus 
length and head plus bill length (PCA: eigenvalue = 1.90; total variance = 
95.06%). Body condition (i.e. body mass corrected for body size) was then 
calculated as the residuals from a linear regression between body mass and body 
size, similarly to previous studies (e.g. Love et al., 2005; Angelier et al., 2009). 
The relationships between (1) body mass, (2) body size, (3) tarsus length, (4) 
head plus bill length and (5) body condition with B were then tested using 
Pearson’s tests, which were carried out separately by age and by sampling time. 
Similarly as before, these correlations were performed without splitting the data 
by sex. Sexual dimorphism in body mass values in our quail population started to 
appear after the third week of post-hatching life (see Table 3.2 in Chapter 3). In 
fact, in the PN8 group, there were no differences in any of the body 
measurements recorded between the two sexes (t-test: 0.08 < p < 0.67). In the 
PN16 group, the statistical outcome did not change when removing the 2 males 
from the dataset. However, as the data in the PN16 group are female-biased I 
am unable to exclude potential sex-related differences between B and the 
morphological data recorded.     
 
2.4 Results 
2.4.1 HPA axis responsiveness at PN8 and PN16 
B concentrations during the capture-restraint protocol were significantly 
affected by age and by sampling interval (age: F1, 21.12 = 12.48, p = 0.002; 
sampling interval: F2, 35.89 = 71.07, p = 0.0001, Figure 2.1). There were no 
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differences in baseline B concentrations between the two age classes (F1, 21.96 = 
0.564, p = 0.461). However, the dynamics of the stress response across the 30-
min period differed between the two age classes (interaction age X time of 
sampling: F2, 35.89 = 4.44, p = 0.019). Specifically, as illustrated in Figure 2.1, in 
the 8-day-old hatchlings B concentrations increased and peaked at T10 and on 
average remained stably high until T30, whereas in the 16-day-old hatchlings B 
concentrations peaked at T10 and declined at T30. Age was a significant 
predictor of the magnitude of the stress response (F1, 21.57 = 6.38, p = 0.019), 
with 8-day-old hatchlings showing significantly higher peak B concentrations 
than 16-day-old hatchlings (Figure 2.2). There were no differences between the 
two age classes in the change in the hormone concentration between T10 and 
T30 (F1, 20.13 = 1.22, p = 0.283).  
 
Figure 2.1. Changes in corticosterone concentrations (B) in Japanese quail aged 8 (open circles) 
or 16 days (filled circles) during a standardised restraint-stress 30 min protocol. Data are shown as 
un-transformed means ± s.e.m. Linear Mixed Model: age x time of sampling interaction, p = 0.02; * 
indicates significant differences. Sample sizes: PN8 = 12, females: 7, males: 5; PN16, females: 10, 
males: 2.  
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Figure 2.2. Difference between the highest corticosterone (B) concentrations (either T10 or T30) 
and baseline (peak B ng/ml) in Japanese quail at post-hatching day (PN) 8 and PN16 during a 
standardised restraint stress 30 min protocol. Linear Mixed Model: age, p = 0.02; * indicates 
significant differences. Data are presented as un-transformed means ± s.e.m.  
 
2.4.2 Correlation of morphometry and body condition with B at 
PN8 and PN16 
In the PN8 experimental group there was a significant negative correlation 
between stress-induced concentrations of B at T10 and body mass (rs = -0.601, p 
= 0.039, Figure 2.3), but there were no significant correlations of these two 
parameters at T0 and T30 (full statistics reported in Table 2.1). Similar 
significant relationships were found between B concentrations at T10 and tarsus 
length and body size (Figure 2.3, tarsus: rs = -0.696, p = 0.012; body size: rs = -
0.765, p = 0.004; in Table 2.1 for full statistics on the other parameters). Head 
plus bill length was not correlated with the variation in the stress hormone 
levels over the stress response in the 8-day-old juveniles (Table 2.1, Figure 2.3); 
despite this, the overall body size strongly co-varied with stressed-induced B 
concentrations (T10: rs = -0.765, p = 0.004, Figure 2.3). 
In the 16-day-old juveniles there were some significant relationships between B 
concentrations and specific morphological traits at T30 (Table 2.1). However, as 
can be seen from the figures (Figure 2.4), the strength of these correlations was 
strongly biased by 2 highly influential observations from two individual females 
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(0.84 < Cook’s distance < 2; Cook, 1977; Bollen and Jackman, 1990) and the 
significance disappeared when they were removed from the dataset.  
Table 2.1 Correlations (Pearson’s tests) between corticosterone (B) baselines (i.e. T0) and stress-
induced B concentrations (i.e. T10 and T30) across a standardised restraint-stress 30 min protocol 
and morphometric measures (i.e. body mass, tarsus length, head plus bill, body size), and body 
condition in Japanese quail hatchlings aged 8- and 16 days (PN8 or PN16, respectively). Outcome 
in bold indicate significant correlations (p < 0.05).   
 
PN8    PN16   
Body mass rs p  Body mass rs p 
T0 -0.320 0.310  T0 -0.230 0.472 
T10 -0.601 0.039  T10 -0.143 0.658 
T30 -0.493 0.103  T30 * -0.666 0.018 
Tarsus length rs p  Tarsus length rs p 
T0 -0.468 0.125  T0 -0.370 0.237 
T10 -0.696 0.012  T10 0.018 0.955 
T30 -0.528 0.077  T30 * -0.668 0.018 
Head plus bill 
length rs p  
Head plus bill 
length rs p 
T0 -0.076 0.815  T0 -0.039 0.904 
T10 -0.494 0.102  T10 -0.134 0.678 
T30 -0.077 0.812  T30 -0.320 0.311 
Body size rs p  Body size rs p 
T0 -0.308 0.330  T0 -0.180 0.575 
T10 -0.765 0.004  T10 -0.081 0.801 
T30 -0.341 0.278  T30 -0.491 0.105 
Body 
condition rs p  
Body 
condition rs p 
T0 -0.121 0.707  T0 0.186 0.562 
T10 -0.421 0.173  T10 0.188 0.558 
T30 -0.048 0.883  T30 * 0.614 0.034 
* Exclusion of 2 outliers (2 females) resulted in the absence of significance 
(see also Figure 2.4). 
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Figure 2.3 Morphometric traits (body mass, tarsus length, head plus bill length, body size) and 
energetic resources (body condition) associated with individual variation in stress-induced 
corticosterone (B) concentrations during a standardised restraint stress protocol 10 min following 
the capture in Japanese quail aged 8 days (PN8); circles: females; triangles: males; p < 0.05 
denotes significant correlations; rs = Pearson’s coefficient of correlation.  
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Figure 2.4 Morphometric traits (body mass, tarsus length, head plus bill length, body size) and 
energetic resources (body condition) associated with individual variation in stress-induced 
corticosterone (B) concentrations during a standardised restraint stress protocol after 30 min of the 
capture in Japanese quail aged 16 days (PN16). Circles: females; triangles: males; p < 0.05 
denotes significant results; rs = Pearson’s coefficient of correlation. The removal of 2 females 
(statistical outliers highlighted in red) resulted in the absence of significance (see Paragraph 2.4.2 
for details on the statistics).  
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2.5. Discussion  
In this study I examined post-hatching B stress responses to a standardised 
environmental stressor and the potential links between B and (1) individual 
morphometry and (2) body condition in Japanese quail hatchlings aged 8 and 16 
days. To the best of my knowledge, this study is the first attempt investigating 
the hypothesis of potential HPA axis-age-related differences across differing 
post-hatching stages of development in this avian model system. I point out, 
however, that in the present study I was unable to analyse potential sex-specific 
differences on the post-hatching development of the HPA axis because the data 
were female-biased.   
The results from the present study suggest that, in the Japanese quail, the 
juvenile HPA axis responsiveness declines with post-hatching age, in accordance 
with the “Developmental Hypothesis” (e.g. Schwabl 1999; Blas et al., 2006). 
Specifically, I found that the 8-day-old hatchlings showed higher maximal stress 
responsiveness over the 30-min restraint period than the 16-day-old hatchlings. 
As there were no significant differences in baselines between the two ages, the 
difference in the magnitude of the stress response is likely to be the result of 
the ontogenetic decrease in adrenocortical activity with post-hatching age. 
These findings support previous work in other precocial species (e.g. Holmes et 
al., 1989; Dickens and Romero 2010). In contrast to these results, a gradual 
increase in the HPA responsiveness has been reported in non-precocial birds for 
which adrenocortical responses show higher or comparable adult-like activity 
patterns when the nestlings reach fledging (Sims and Holberton 2000; Love et 
al., 2003; Walker et al., 2005; Wada et al., 2007). The results of this study 
suggest that there were no significant differences in the recovery trajectories to 
baseline (i.e. B change between T10 and T30) between the PN8 and PN16 young 
quail. Here, sample collection was based on prior published work in birds 
(including the Japanese quail), which indicates that a 30 min restraint period is 
an adequate protocol to analyse the overall shape of the stress response (i.e. 
maximum responsiveness and recovery to baseline) (Cockrem, 2013; Wall, 2010). 
It should be noted, however, that there was a high variation in the younger 8-
day-old birds at T30. Future studies may wish to include more sampling times in 
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order to investigate in more detail potential age-related changes in the HPA axis 
negative feedback efficiency. 
In an attempt to explore the “Developmental Hypothesis” and the links between 
the ontogeny of the HPA axis across the differing developmental strategies, it 
has been proposed that hatching in precocial species may be equivalent to 
fledging in non-precocious species (Wada, 2008). Consequently, the elevated 
stress responsiveness observed in precocial birds near hatching would correspond 
to the B peaks described near fledging in non-precocious species (Wada, 2008). 
The accelerated development of the adrenocortical activity in precocial birds 
compared to altricial species is also confirmed by studies performed in the 
precocial embryos. For example, studies in the chicken and mallard duck 
consistently showed that embryos have detectable endogenous baseline B 
concentrations and can exhibit a stress response after ACTH injection or painful 
stimuli from at least the second half of incubation (Wise and Frye, 1973; Hall, 
1977; Scott et al., 1981; Carsia et al., 1987; Holmes et al., 1990; Tona et al., 
2005). To the best of my knowledge, we lack studies on embryonic B secretion 
and HPA axis activity in altricial and semi-altricial species. However, as 
mentioned in the Introduction (Paragraph 2.1), the data available in non-
precocious species post-hatching suggest that the nestlings have limited capacity 
to activate the adrenocortical response at least during the early nestling stages. 
Altricial nestlings are nest-bound and parent-dependent, with limited capacity 
to escape from environmental threats, such as predators. Therefore, a hypo-
responsive HPA axis before reaching independence may have been evolved to 
prevent unnecessary rises in stress hormone concentrations, which would not 
help the chicks to move away from the challenge, but might negatively impact 
on the animal’s growth (Blas et al., 2006; Spencer et al., 2009). Much less clear, 
however, is the adaptive significance underlying the decline in the HPA axis 
responsiveness with post-hatching age in precocial birds. Glucocorticoids have an 
important modulatory role in cognition both during adulthood and development 
(Sandi and Rose, 1994; McEwen and Sapolsky, 1995; Loscertales et al., 1997). It 
has been proposed that elevated B concentrations in the first days after hatching 
in precocial birds may promote cognitive processes, including filial imprinting, 
learning events and social stress (Frigerio et al., 2001). Moreover, precocial 
birds grow at slower rates than altricial birds (Lesage and Gauthier,1997). In this 
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study both 8- and 16-day old quail were clearly able to mount B stress responses, 
similarly as in other precocial species (Holmes et al., 1989; Dickens and Romero 
2010). Such capacity, which appears delayed in altricial species (e.g. Schwabl, 
1999; Sims and Holberton, 2000; Wada et al., 2007) might expose precocial birds 
to frequent repeated acute surges of endogenous B concentrations in response to 
daily stressors, and the metabolic effects of these elevated endogenous B levels 
may impact negatively on growth. This led me to speculate that in precocial 
birds the potential costs of having evolved an active/hyper-responsive HPA axis 
on growth patterns may be compensated by a higher investment in cognitive 
abilities, which may be more important for survival during the critical post-
hatching time windows when the juveniles are likely to be more vulnerable to 
mortality. More work is needed to further explore the biological variation of the 
ontogeny of the stress system in order to improve our understanding of its 
evolutionary significance in vertebrate animals. The high degree of 
developmental strategy variation in birds across the precocial-altricial spectrum 
makes avian systems ideal models for furthering our understanding in this area. 
In both 8- and 16-day old quail baseline B levels did not correlate with any 
morphometric measurements recorded. However, body mass and body size in 
the younger 8-day-old quail correlated with the variation in B concentrations at 
T10, with lighter and smaller individuals showing higher stress-induced levels. 
The negative correlation between stress-induced B at T10 and body size was 
driven by the tarsus length and not by the head plus bill length. These findings 
partially support my predictions and are in agreement with previous work 
showing negative relationships between body mass or structural size and stress-
induced or chronically elevated B levels (Lesage and Gauthier, 1997; Saino et 
al., 2005; Dickens and Romero, 2010). Surprisingly, none of the morphometric 
traits measured in the 16-day-old hatchlings significantly co-varied with B. I 
propose three non-mutually exclusive explanations for such potential age-
related differences. First, there may be specific developmental windows, likely 
during the very early stages of post-hatching development, in which quail may 
be more plastic to adapt their body mass and shape in response to the quality of 
the living environment. An alternative possibility is that differences in the 
relationship between stress hormones and morphometry are the result of 
physiological constraints, for example due to metabolic demand differences 
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related to the size of the juvenile individuals rather to their age. In fact, as 
glucocorticoids often promote mobility (Breuner et al., 1998a, b) it is plausible 
that the lighter and smaller juveniles may have had higher metabolic rates, 
which in turn were associated with enhanced HPA responsiveness. Thirdly, I 
cannot exclude the possibility of sex-specific differences in the regulation of the 
body mass and skeletal elements with the HPA axis responsiveness. For instance, 
there is the suggestion that males may be more susceptible than females to the 
effects of pre-hatching stress on growth (Love et al., 2005; Hayward et al., 
2006; Love and Williams, 2008). The experimental groups in this study were 
female-biased, especially at PN16 when there were only 2 males compared with 
10 females, meaning that I could not explore potential dependencies between 
the HPA axis and sex. Overall, I acknowledge that these data are correlative and 
therefore provide only a presumed link between the intensity of B stress 
responses and the individual’s morphometry within specific developmental 
windows in the Japanese quail. I also point out that the lack of correlations 
between baseline B levels and the recorded morphometric traits may be the 
consequence of the limited sample size used in this study. Rigorous experimental 
manipulations across differing stages of development would be needed to 
disentangle the factors contributing to phenotypic variation and the intensity of 
the stress system in the juveniles. Such factors are likely to involve both active 
and passive regulatory processes modulating the adrenocortical secretion in 
response to environmental stressors. I also point out that baseline B levels 
should be a better indicator of morphometric and body condition rather than 
stress-induced B levels.  
 
I did not find any significant correlation between B and the body condition at 
either age. Although a variety of studies carried out in adult bird species did find 
negative correlations between baseline or the magnitude of the stress response 
and body condition (e.g. Schwabl and Kriner, 1991; Gwinner et al., 1992; Love 
et al., 2005), the results from this study support the main trends emerging from 
the limited work conducted in juvenile birds (Romero et al., 1998; Schwabl, 
1999; Sims and Holberton, 2000; Love et al., 2003). Furthermore, a recent study 
in which juvenile European starlings (Sturnus vulgaris) where chronically 
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exposed to stress during both the pre- and post-hatching developmental stages 
reported a negative correlation between stress-induced B levels and body 
condition in the stressed-juveniles but not in the controls (Love and Williams, 
2008). Similarly, poor quality food and dietary restriction in back-legged 
kittiwake (Rissa tridactyla) juveniles lowered body energy reserves and 
enhanced baseline and HPA axis responsiveness (Kitaysky et al., 1999). 
Altogether, these data suggest that prolonged, rather than temporary elevations 
of stress hormones may be involved in changes of the energetic conditions. 
Experimental manipulation in order to modify endogenous energy reserves in 
young individuals can be a valid experimental approach to test such a 
suggestion.  
 
2.6. Conclusion 
The results from this study showed that the juvenile stress reactivity in Japanese 
quail declined with post-hatching age. These data concur with those found in the 
few other studied precocial species and are in accordance with the 
“Developmental Hypothesis”. Moreover, the results confirm the presence of 
relevant links between circulating glucocorticoid stress hormones and the 
individual’s morphometry (i.e. body mass and structural size), but also suggest 
that such associations vary throughout development. The limited sample size in 
this study constrained my ability to examine sex-specific changes in the 
development of the HPA axis post-hatching and future studies with larger 
number of birds are needed to examine this relevant aspect. Moreover, future 
research investigating the ontogeny of the adrenocortical responses across a 
wider developmental window, ideally starting from the pre-hatching stages, will 
be extremely useful to test predictions between potential age-related 
differences and the species’s developmental mode. The large variety of 
developmental strategies in birds across the precocial-altricial spectrum makes 
this taxon a reliable model to study HPA axis development in the context of life-
histories trade-off variation and to link it with the evolutionary mechanisms of 
stress physiology among vertebrate species.  
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3. Chapter  
Pre- and post-hatching stress in context: effects 
on the post-hatching stress physiology in growing 
and adult Japanese quail 
 
A version of this chapter is published as: Marasco, V., Robinson, J., Herzyk, P. 
and Spencer, K.A. 2012. Pre- and Post-natal stress in context: effects on the 
stress physiology in a precocial bird. Journal of Experimental Biology, 215: 3955-
3964. 
 
3.1 Abstract 
Developmental stress can significantly influence physiology and survival in many 
species. Mammalian studies suggest that pre- and post-natal stress can have 
different effects (i.e. hyper- or hypo-responsiveness) on the hypothalamic–
pituitary–adrenal (HPA) axis. In mammals, the physiological intimacy between 
mother and offspring constrains the possibility to control, and therefore 
manipulate, maternal pre- and post-natal influences. Here, using the Japanese 
quail as study species, I elevate levels of the glucocorticoid stress hormone 
corticosterone (B) in ovo and/or in the endogenous circulation of juveniles. I 
examine the effects of treatments on B, glucose, glycerol and triglyceride stress 
responses at two different ages, in juvenile and adult quail. In juveniles, B data 
reveal a sex-specific effect of post-hatching treatment regardless of the previous 
pre-hatching protocol, with post-hatching treated females showing attenuated 
stress responses (i.e. quicker return to baselines) in comparison with the other 
groups, while no differences are observed among males. In adulthood, the birds 
that hatched from eggs in which yolk B levels were experimentally elevated 
show higher B concentrations over the stress response compared with controls. 
This effect is not evident in birds subjected to either post-hatching treatment or 
the combined treatments. There are no effects on glycerol or glucose in the 
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juveniles. However, post-hatching B manipulation induces short-term alterations 
in basal triglyceride concentrations in the juveniles, which are linked with sex 
and basal glucose concentrations of the birds; whilst pre-hatching B treatment 
induce long-term alterations on basal glucose and these effects, similarly as 
before, interact with sex. These results demonstrate that (1) early 
glucocorticoid exposure can have both transient and long-term effects on the 
HPA axis, depending upon the developmental stage and sex and (2) elevated 
endogenous B levels post-hatching can modulate the effects induced by exposure 
to elevated B pre-hatching on the HPA activity. 
 
3.2 Introduction 
Environmental cues during the sensitive periods of early life can shape 
developmental trajectories and influence a wide range of phenotypic traits later 
in life (Mousseau and Fox, 1998; Monaghan, 2008). A considerable number of 
studies have investigated to what extent developmental stress can modulate 
endocrine systems and influence adult health outcomes (Ward, 1972; Barker et 
al., 1990; Gluckman et al., 2007). In vertebrates, environmental stressors such 
as food shortages or extreme weather can activate the Hypothalamic-Pituitary-
Adrenal axis (HPA axis; Wingfield, 1994; Breuner et al., 1998b; reviewed by 
Romero, 2004). This activation leads to a short-term surge of glucocorticoids, 
which mobilise energy resources and divert behaviour to life-saving strategies 
(Wingfield et al., 1998). In the long-term, however, elevated stress hormones 
can compromise HPA axis functioning and can have negative implications for the 
nervous and immune systems, body energy balance and redox physiology 
(McEwen and Stellar, 1993; Sapolsky, 2000; de Kloet et al., 2005a; Costantini et 
al., 2011a). There is increasing evidence to suggest that if laying/gravid females 
experience stressful stimuli, which elevate endogenous glucocorticoids (e.g. 
predation pressure, social instability, unpredictable feeding or direct 
glucocorticoid exposure), their embryos can also be exposed to these circulating 
stress hormones through the placenta (Seckl, 2004; Kaiser and Sachser, 2005) or 
their presence in the egg (fish: McCormick, 1999; reptiles: De Fraipont et al., 
2000; Meylan et al., 2002; birds: Hayward and Wingfield, 2004; Love et al., 
2005; Saino et al., 2005). Similarly after birth, post-natal/post-hatching 
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stressors such as sibling competition, low food provisioning, maternal 
deprivation or direct glucocorticoid administration can lead to an increase in 
endogenous glucocorticoids in the offspring (reptiles: Meylan et al., 2002; birds: 
Kitaysky et al., 1999; Love et al., 2003; Spencer et al., 2003; Spencer et al., 
2009; mammals: Rosenfeld et al., 1992; Fey and Trillmich, 2008). Recent 
research in a variety of vertebrate taxa has shown that early life glucocorticoid 
manipulations can influence a wide range of phenotypic traits, including growth 
(Spencer and Verhulst, 2007; Saino et al., 2005), metabolic rate (Sloman, 2010), 
stress-related behaviours and cognitive performances (Vallée et al., 1997; Vallée 
et al., 1999; De Fraipont et al., 2000; Meylan et al., 2002; Rubolini et al., 2005; 
Spencer and Verhulst, 2007; Sloman, 2010; Boogert et al., 2013), and can 
suppress survival chances into adulthood (Monaghan et al., 2012).   
It has been suggested that the organisational role of developmental exposure to 
stress hormones on the phenotype is likely to be caused by changes in HPA axis 
activity that modulate sensitivity to environmental stressors later in life 
(recently reviewed by Harris and Seckl, 2011). Pioneering studies in mammalian 
models (primarily rodents), suggest that the effects of pre-natal stress on the 
offspring HPA axis may be different from those caused by post-natal stress. In 
fact, while maternal pre-natal stress often results in HPA hyper-responsiveness, 
with pre-natally stressed offspring exhibiting enhanced and prolonged stress 
hormone release in response to stress (Henry et al., 1994; Barbazanges et al., 
1996; Kapoor et al., 2006); post-natal exposure to stressors, such as “neonatal 
handling”, can produce dampened stress responsiveness (Levine et al., 1967; 
Meaney and Aitken, 1985; Vallée et al., 1996; Liu et al., 1997; Macrì et al., 
2004). Importantly, several post-natal manipulations in rat pups are known to 
cause changes in the amount of maternal care provided by the dams, which to a 
certain degree, can buffer or counteract the effects of previous pre- and post-
natal stressors (Maccari et al., 1995; see also review by Macrì and Würbel, 2006). 
On one hand, these data raise the question, surprisingly understudied, of 
interactive influences between pre- and post-natal experiences. However, they 
also draw attention to the difficulties in determining whether the observed 
effects are mediated by altered maternal HPA axis, by direct changes in the 
offspring HPA reactivity, or by an interaction of both as recently proposed (Macrí 
and Würbel, 2006). Birds offer advantages over mammalian species to 
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experimentally manipulate pre- and post-hatching environments, minimising 
interactions with the mother’s physiology (reviewed by Henriksen et al., 2011 
and Schoech et al., 2011; see also Love and Williams, 2008; Spencer et al., 
2009). Precocial birds in captive conditions can be reared without post-hatching 
maternal contact, thereby excluding the potential confounding actions of 
maternal care. Furthermore, avian and mammalian neuroendocrine systems are 
highly conserved (Wingfield, 2005a), facilitating comparative approaches in a 
more evolutionary framework (Groothuis et al., 2005). 
The few studies conducted in birds to date have demonstrated that pre- 
(Hayward and Wingfield, 2004; Hayward et al., 2006; Love and Williams, 2008; 
Haussmann et al., 2012) or post-hatching stressful conditions (Love and Williams, 
2008; Spencer et al., 2009) can lead to long-term effects on the HPA axis 
physiology. However, more studies are needed to fully understand the directions 
of these modifications as they are likely to differ across bird species and life 
stages. To this end it is important to consider both pre- and post-hatching 
contexts (Love and Williams, 2008; Monaghan, 2008). Furthermore, there is little 
information in birds about the links between early life stress and changes in 
metabolic energy expenditure (Spencer and Verhulst, 2008), and to what extent 
they are linked with HPA axis modifications. High glucocorticoids in early life 
may induce changes in metabolic responses that can help juveniles to deal with 
stressful circumstances in the short-term, but can have costs into adulthood 
(Gluckman et al., 2007; Cottrell and Seckl, 2009). The stress system has a key 
role in the control of glucose transport: in several vertebrate species acute 
stress can increase circulating glucose concentrations (Curi et al., 1990; 
Widmaier and Kunz, 1993; Carragher and Rees, 1994; Remage-Healey and 
Romero, 2000, 2001). At the same time, such an increase in available energy 
may be enhanced by the activation of the breakdown of plasma triglycerides into 
glycerol and free-fatty acids (Remage-Healey and Romero, 2001). Although it is 
known that the prolonged elevation of glucocorticoids can cause changes in 
glucose and lipid metabolism (Norris, 1997), the effects of experimentally 
elevated stress hormones during early life on these metabolites have received 
little attention.  
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The main aim of the present study was to analyse whether, and the extent to 
which, exposure to stress hormones during differing developmental stages would 
influence the HPA system and its related metabolism in the Japanese quail. 
Specifically, the objectives of this study were (i) to analyse if the exposure to 
physiological stress hormone levels during pre- and post-hatching development 
would cause changes in the dynamics of the stress responses of B 
(corticosterone, the main glucocorticoid in birds) and plasma metabolites 
involved in glucose transport and lipid metabolism in the short- and long-term 
and, (ii) to examine potential short- and long-lasting interactive effects between 
pre- and post-hatching stressful stimuli. To accomplish such objectives, I 
mimicked a prolonged exposure to physiological stress through direct 
manipulations with B in ovo and/or in the juvenile quail. I then performed a 
standardised environmental stress test (Wingfield et al., 1982) at two distinct 
post-hatching stages, in juvenile and adult non-breeding quail, and measured 
responses to stress of B, glucose, glycerol and triglycerides. I also monitored 
growth rates to assess direct vs. indirect effects of developmental B on the 
stress responses (Metcalfe and Monaghan, 2001; Spencer et al., 2009). It has 
been suggested that precocial birds may be especially sensitive to poor/stressful 
environmental conditions experienced pre-hatching (Metcalfe and Monaghan, 
2001). In fact, precocial birds show larger embryonic growth rates and larger 
brain masses at hatching than altricial birds, which, on the opposite, have their 
major period of morphological, as well as neuroendocrine and neural 
development (i.e. cell proliferation and differentiation, synapse formation and 
myelination) post-hatching (Rogers, 1995; Starck and Ricklefs, 1998). Based on 
these relevant developmental differences between altricial and precocial bird 
species, it appears reasonable to predict that in the Japanese quail pre-hatching 
exposure to B would produce a stronger and longer-lasting impact than post-
hatching exposure to B. I tested this prediction by comparing the effects of pre-
hatching B, post-hatching B and their combined effect on the HPA axis 
physiology and its related metabolism. 
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3.3 Material and methods  
3.3.1 Experimental design 
The animal work was conducted at the Cochno Farm and Research Centre, 
University of Glasgow, UK. All indoor rooms were climate controlled at 19°C on a 
12:12-h light-dark cycle (lights on 7am-7pm). Eggs used in this experiment were 
obtained from this breeding stock. Breeding quail (n = 20 females, 10 males) 
were housed in trios (2 females:1 male) in 79 X 48 X 58 cm enclosures that were 
maintained throughout the experimental period (September 2010-March 2011). 
Fresh-laid eggs were collected, identified by colour and pattern and marked 
according to maternal identity. Four groups of experimental birds were 
established and treated as follows: 1. pre-hatching and post-hatching untreated 
birds (CC); 2. pre-hatching B-treated and post-hatching untreated birds (BC); 3. 
pre-hatching untreated and post-hatching B-treated birds (CB); 4. pre-hatching 
B-treated and post-hatching B-treated birds (BB). Treatment order was 
counterbalanced across females. The experiment was repeated twice (batch 1: 
September 2010-December 2010; batch 2: December 2010-March 2011).  
 
3.3.1.1 Pre-hatching environment and pre-hatching hormonal 
manipulation  
The eggs were incubated at 37.5oC and 55% humidity while being turned twice 
hourly (incubator Ova-Easy 190A, Brinsea Products Ltd, UK). The day on which 
incubation started was designated as embryonic day 0 (E0). At day E5, fertile 
eggs were identified using a bright light source and selected for the yolk 
hormonal manipulation with B. The eggs were then injected at the conical tip 
with 10µl of a sterile solution of B (Sigma Aldrich, Poole, UK; concentration B: 
850 ng/ml) dissolved in peanut oil (B-eggs; n = 74) or with 10µl of sterile peanut 
oil alone (C-eggs; n = 74) using a SGE syringe (Fisher Scientific, Loughborough, 
UK). Here, E5 rather E0 (e.g. Hayward et al., 2006) was chosen as this is the 
point at which it is possible to reliably determine egg fertility in the Japanese 
quail. Injection prior to this point would have meant that I might inject non-
fertile eggs, which will not develop and hence artificially inflate the perceived 
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number of animals used in the study. Importantly, in birds the egg yolks are 
stratified in layers at laying and hormone concentrations, including B, differ 
among these layers (e.g. Lipar et al., 1999; Almasi et al., 2012). Yolk layers 
break down after a few days of incubation with the yolk becoming mixed. The 
injection protocol used here, therefore, ensured that B levels were elevated 
once yolk layers have ceased to exist. Pilot dye studies were carried out prior to 
the experiment to determine the depth of injection required to place the 
hormone into the yolk (Karen Spencer’s personal communication). The dose of B 
injected (8.5ng) was designated to elevate endogenous B concentrations within 
the yolk by 1.8x Standard Deviation (SD) of the mean above control eggs, similar 
to previous studies in birds (Rubolini et al., 2005; Saino et al., 2005; Hayward et 
al., 2006; Love and Williams, 2008). This physiological increase was confirmed to 
be within the relevant biological levels by previous pilot work that quantified 
yolk B concentrations in a sample of eggs (n = 8) taken from a previous 
generation of our breeding females using both Radioimmunoassay and Liquid 
Chromatography-Mass Spectroscopy (Boogert et al., 2013). Needle punctures 
were then sealed with a transparent and breathable wound dressing (Germolene 
New Skin, UK). As soon as the injected area appeared dry, the egg was returned 
to the incubator. At day E14 eggs were transferred into hatchers within the same 
incubator, and humidity was increased to 70-75%. In each hatcher, eggs were 
separated according to maternal identity with plastic dividers so that the 
identity of the birds could be determined post-hatching.  
 
3.3.1.2 Post-hatching environment and post-hatching hormonal 
manipulation  
Upon hatching (between days E17-E19; hatch rates averaged 61.1% and there 
were no significant differences in hatching success between C-eggs and B-eggs, 
t-test = 2.0, p = 0.2), quail were labelled with unique colour combinations using 
nail varnish, weighed to the nearest 0.01g (hatching mass, day PN0) using a 
balance (Fisher Scientific, Bishop Meadow Road, Loughborough, Leicestershire, 
UK) and placed back into the hatcher to allow the plumage of the birds to dry.  
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Subsequently, quail hatched from B-eggs were assigned to either the BC 
treatment (final n: female = 10, male = 6) or the BB treatment (final n: female = 
9, male = 9); quail hatched from C-eggs were assigned either to the CC 
treatment (final n: female = 9, male = 14) or CB treatment (final n: female = 10, 
male = 10). After 24-36 hours post-hatching (day PN1), the birds were weighed 
again and housed in 4 different treatment-specific enclosures in a single room 
(in the second batch treatment-specific enclosure positions were reversed to 
control for an enclosure effect). Food (turkey starter crumbs, Dodson and 
Horrell, Northamptonshire, UK) and water were available ad libitum. A brooding 
lamp was placed over each enclosure to ensure an initial brooding temperature 
of 35.5oC for the first 3 days of age (from day PN3 temperature declined daily by 
1-1.5oC until day PN19 when warming bulbs were switched off and the birds 
were subjected to the ambient temperature of 19oC). Enclosures were each 
divided into 2 or 3 compartments with cardboard dividers so that juveniles of 
the same age were housed in the same compartment (n = 2 to 7).  
Between days PN5-19, birds in the CB and BB treatments were subjected to oral 
supplementation with B, while birds in the CC and BC were given carrier alone 
using mealworms injected with B (Tenebrio molitor, size 13-18mm) (Breuner et 
al., 1998a). To ensure the birds would ingest mealworms they were provided 
with un-injected mealworms for 3 days prior to the experimental manipulations. 
During the oral B manipulation period, mealworms were removed from the fridge 
and injected with 10µl of B solution dissolved in peanut oil (concentration B: 
4.5mg/ml between days PN5-15 and 9mg/ml between days PN16-19) or 10µl of 
peanut oil using a syringe (Hamilton, UK). To confirm that each bird was eating 
one single mealworm per day, juveniles within the same brooder compartment 
were separated with transparent dividers during feeding. Generally mealworms 
were fully ingested within the first 5-10 minutes (and always within 18min). To 
ascertain that the post-hatching manipulation was physiological and mimicked a 
standardised acute stressor, I carried out pilot work prior to the start of the 
experiment. I first measured the natural variation of acute stress responses in a 
group of birds from a previous generation of the breeding stock at PN8 (n = 12) 
and PN16 (n = 12). The results from this study are reported in detail in Chapter 
2. On the basis of the former data and the literature in birds (Hull et al., 2007; 
Spencer and Verhulst, 2007; Spencer et al., 2009; Wall and Cockrem, 2009), I 
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then performed a second experiment and tested the effects of two different B 
doses, a high-B dose of 0.45mg and a low-B dose of 0.045mg in 4 independent 
groups of birds at day PN8 and PN16 (high-B, N = 5; low-B, N = 4 at both ages). I 
administered a single oral dose to each individual bird using injected mealworms 
as described above and took a blood sample 10min post-B supplementation. The 
low-B dose at day PN8 elevated plasma B levels by 1.8x SD of the mean above 
the 10-min B peak determined previously, while at day PN16 there was no 
significant change in plasma B levels. The high-B dose was supra-physiological at 
both ages. For the current study, I therefore scaled the hormonal dose to 
produce a daily physiological 10-min B peak for each age interval (e.g. Spencer 
et al., 2009): 0.045 mg/day between days PN5-15 and an intermediate B dose of 
0.09mg/day between days PN16-19. During the present experiment, I tested 
whether the B dose of 0.09mg/day was biologically relevant by sampling a sub-
sample of birds at day PN16 as described above. Plasma B levels in CB and BB 
birds were found to be similar to the 10 min-B peak observed in the first pilot 
study at PN16 (n = 11, pooled data: mean ± s.e.m., 18.77 ± 4.55ng/ml).  
At day PN19 juveniles were sexed by sexual dimorphic plumage and singly 
housed in 61 X 46 X 51cm enclosures, in visual and auditory contact with 
conspecifics. Post-natal mortality rates averaged 8.1%.  
 
3.3.2 Analysing the short- and long-term effects of pre- 
and post-hatching B exposure 
3.3.2.1 Growth  
Body mass was measured to the nearest 0.01g at regular intervals until day 
PN64; from day PN3 onwards tarsus length and head plus bill length were also 
measured to the nearest 0.1mm with a digital calliper (Fisher Scientific, Bishop 
Meadow Road, Loughborough, Leicestershire, UK). All the body measurements 
were taken only by myself to minimise technical variations. Blind measurements 
to bird treatment could not be achieved as birds were housed in treatment-
specific brooders until PN19.  
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3.3.2.2 Standardised capture-restraint-stress protocol 
Acute stress responses were measured using a standardised capture-restraint 
protocol on days PN22 and PN64. I chose PN22 (3 weeks of age) and PN64 (9 
weeks of age) because I wanted to test the effects of developmental B exposure 
in the short-term soon after the end of the post-hatching treatment and over the 
long-term in non-breeding sexually mature individuals, respectively. In fact, 
Japanese quail reach puberty between 6-8 weeks (Ottinger, 2001). Therefore 
the quail sampled at PN64 were fully grown and capable of breeding if they 
would have been stimulated with an appropriate reproductive induction protocol 
(Robinson and Follett, 1982). Birds were removed from their cages between 
09:15 and 12:40h and a basal blood sample (T0) was collected within 2 (mean ± 
s.e.m, 1.43 ± 0.04) min of opening the cage (Wingfield et al., 1982). Each bird 
was then placed into an opaque box (14.5 X 13.5 X 14.5 cm) and further stress-
induced blood samples were taken after 10 (mean ± s.e.m, 10.52 ± 0.08) min 
and 30 (mean ± s.e.m, 30.31 ± 0.06) min of opening the cage (T10 and T30, 
respectively). 20µl of T0 and T30 samples were immediately used to measure 
glucose concentrations using a glucose meter (GlucoMen Visio, Manarini 
Diagnostics, Firenze, Italia). T0 and T30 glucose samples were chosen to 
represent basal and stress-induced glucose levels, respectively (e.g. Curi et al., 
1990; Carragher and Rees, 1994; Remage-Healey and Romero, 2000, 2001). Each 
batch of glucose strips (n=50) comes with an individual barcode. For each 
glucose meter barcode used, I estimated the intra- and inter-assay coefficients 
of variation by measuring normal and high quality control solutions provided by 
the manufacturer. The intra-assay variation for normal and high quality controls 
was 3.25% and 3.18%, respectively. The inter-assay variation for normal and high 
quality controls was 4.34% and 1.81%, respectively. Once the stress response 
protocol was concluded, body mass, tarsus length and head plus bill 
measurements were taken for each bird. Remaining blood samples were kept on 
ice for up to 4h before being centrifuged and plasma aliquots withdrawn and 
stored at -20oC.  
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3.3.2.3 B Radioimmunoassay 
B was extracted from 10- to 30-µl plasma samples (mean ± s.e.m., 21.81 ± 0.15µl 
plasma) and measured by Radioimmunoassay using the protocol described in 
Chapter 2, Section 2.3.2. Extraction efficiencies averaged 93% ± 0.003 s.e.m. B 
samples from the same individuals were analysed in the same assay and samples 
from different treatments were randomised among the assays (n = 3). The intra-
assay coefficients of variation were 10% and 20% and 23%, while the inter-assay 
variation at 80%, 70% and 50% binding were 17%, 18% and 9%, respectively.  
Table 3.1 Percentage of undetectable corticosterone (B) samples across the treatment groups at 
post-hatching (PN) day 22 and 64 during a standardised capture-restraint protocol within 2, 10 and 
30 min (T0, T10 and T30, respectively) of opening the cage.   
 
 
 
 
 
 
 
 
Unexpectedly, concentrations of B in 53.7% of the samples were undetectable. 
In fact, it should be noted that plasma B concentrations were much lower than 
in the previous study (Chapter 2). This was not due to technical problems with 
the Radioimmunoassay itself as the quality controls, which were the same as the 
quality controls used in the previous study (Chapter 2), were within the 
expected concentration range. Therefore the large number of undetectable 
samples represented a true biological effect, likely consequence of the frequent 
handling of the birds for taking morphological measurements as discussed in 
Day PN22: Treatment 
Time CC BC CB BB 
T0 95.7 68.8 80.0 83.3 
T10 47.8 12.5 45.0 22.2 
T30 56.5 37.5 65.0 61.1 
  
Day PN64: Treatment 
Time CC BC CB BB 
T0 73.9 53.3 70.0 72.2 
T10 56.5 12.5 35.0 50.0 
T30 34.8 18.8 50.0 55.6 
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Paragraph 3.5.1. Preliminary chi-square tests showed that the likelihood of 
encountering undetectable values differed significantly across the stress 
responses. At both days PN22 and PN64, the highest percentage of undetectable 
values was observed in the T0 samples (day PN22: X2 = 38.53, df = 2, p < 0.0001; 
T0 = 83.1%, T10 = 33.8%, T30 = 55.8%; day PN64: X2 = 16.76, df = 2, p < 0.0001; 
T0 = 68.8%, T10 = 40.3 %, T30 = 40.3 %). I then performed additional chi-square 
tests at each time of sampling to test for a potential treatment effect. At day 
PN22 there was no effect of treatment in the T0 and T30 samples (T0: X2 = 5.07, 
df = 3, p = 0.17; T30: X2 = 3.07, df = 3, p = 0.38), while there was a tendency in 
the T10 samples (X2 = 7.47, df = 3, p = 0.06) due to a lower percentage of 
undetectable levels in the BC and BB groups (Table 3.1). Similarly, at day PN64 
there was no effect of treatment in the T0 and T30 samples (T0: X2 = 1.57, df = 
3, p = 0.67; T30: X2 = 5.90, df = 3, p = 0.12). At T10, I found a significant 
treatment effect (X2 = 8.59, df = 3, p = 0.03) due to a lower percentage of 
undetectable samples in the BC adult quail (Table 3.1). In order to investigate in 
a further statistical model these potential treatment differences (see paragraph 
below), I set undetectable B concentrations to the individual detection limits of 
each sample, calculated according to the individual extraction efficiencies and 
plasma volumes (mean ± SEM, 1.64 ± 0.29ng/ml), as shown in Landys et al., 
(2010). This approach provides the most conservative estimate for statistical 
comparisons.  
 
3.3.2.4 Glycerol and triglyceride assays  
Glycerol and triglyceride levels were measured using the Serum Triglyceride 
Determination kit (Sigma-Aldrich, Dorset, UK). This assay has a two-step reaction 
sequence: it first measures free (i.e. unbound) plasma glycerol levels and then 
plasma triglyceride levels by using a lipoprotein lipase to cleave the triglyceride 
to glycerol and free fatty acids. In both the reactions, the glycerol is measured 
by colorimetric spectrophotometry at 540 nm. Consequently, the assay allows 
correcting all triglyceride measurements for the initial free glycerol 
measurements, which correspond to the “true triglyceride” (herein referred as 
“triglyceride”) concentrations. The lack of this correction has been shown to 
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result in an overestimation of circulating triglyceride concentrations 
(Howdieshell et al., 1995).   
In this study, I adapted the assay to 96-well plate readers (Corning Life Sciences, 
Amsterdam, The Netherlands) by scaling down the volume of the assay reagents, 
glycerol standard (concentration: 0.26mg/ml, Sigma-Aldrich, Dorset, UK) and 
plasma samples of 5 fold. This allowed me to reduce the volume of plasma 
samples to 2µl. To validate the assay, I first analysed the kinetics of the two 
reactions by incubating the reference (or blank), standard and plasma samples 
(T0 or T30) taken from a random sub-set of birds at PN22 or PN64 (n = 10) in a 
plate reader (Thermo Scientific Multiskan Spectrum, ThermoFisher, Vantaa, 
Finland) at 25ºC for 30min (incubation started immediately after adding the 
reactive reagent provided in the kit). I set the program in the plate reader in 
order to take the readings every min over the incubation period. Both the 
reactions showed their asymptote and stability at 10-15min of incubation. 
Therefore for the later analyses, I choose to take a single reading at 15min of 
incubation following the manufacturer’s recommendations. Secondly, I made up 
2 plasma pools to be used as quality controls for the later analyses. These pools 
gave absorbance values at approximately 0.4 and 0.1, corresponding respectively 
to a normal and low absorbance relative to the previously measured quail 
samples (herein referred as normal and low quality controls, respectively). 
Thirdly, I generated a glycerol standard curve (assay buffer PBS) to confirm that 
the absorbance was proportional to the known glycerol concentrations and a 
good parallelism with the previously measured quail samples. Finally, I 
estimated the intra- and inter-day plate variations using two plates over two 
different days for the reference and glycerol standard, which were on average 
within 10%.  
After these preliminary tests, I performed the analyses with all the experimental 
samples. Samples from the same individual were measured in the same plate 
and samples from the different treatment groups were randomised across plates 
(n = 7). I measured glycerol and triglyceride concentrations in the T0 and T30 
samples, which are meant to represent, respectively, basal and stressed-induced 
levels (Remage-Healey and Romero, 2001). I was unable to perform the analyses 
on 7 samples at day PN22 (T0: males, CC = 2; BC = 1, CB = 1, BB = 2; T30: 
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female, CC = 1) and 3 samples at PN 64 (T0: males, BC = 1; CB = 1, and BB = 1) 
because of the lack of plasma (B Radioimmunoassay was performed beforehand). 
As the triglyceride assay is linear up to 10mg/ml, the samples in which 
concentrations were above this value (i.e. almost all the females at PN64) were 
re-measured after being diluted in PBS buffer (dilution factors ranged from 1:2 
to 1:5 according to the initial concentration measurements). The glycerol and 
triglyceride concentrations values were then calculated according to the 
reference and standard absorbance values as indicated by the Manufacturer. The 
intra-plate coefficient of variation for the normal and low quality controls was 
respectively 2.1% and 1.2% for the glycerol analyses and 5.8% and 4.5% for the 
triglyceride analyses. The inter-plate coefficient of variation for the normal and 
low quality controls was respectively 10.9% and 6.0% for the glycerol analyses 
and 6.6% and 5.5% for the triglyceride analyses.  
 
3.3.3 Statistical analysis  
Data analysis was performed in PASW statistics, version 19 (SPSS, Inc., 2009, 
Chicago, IL, www.spss.com) using Linear Mixed Effect models (LMEs) fitted by 
Restricted Maximum Likelihood or Generalized Linear models (GLMs). To meet 
the assumptions of the LME, response variables were transformed for normality 
when needed, all model residuals were normally distributed. Fixed factors were 
treatment, sex and their interaction; while batch and maternal identity were 
entered as random factors.  
The growth curve between days PN1-36 was split into three discrete age 
intervals: days PN1-3, days PN8-19 and days PN22-36, which corresponded to 
periods before, during and after the post-hatching B treatment, respectively. 
For each interval, I estimated individual body mass growth rates by calculating 
the slope of a linear regression fitted for each bird. Likewise, I determined 
tarsus and head plus bill growth rates between days PN8-19 and between days 
PN22-36. These two measures of skeletal growth were transformed into a unique 
body size growth index by extracting the first component scores from a Principal 
Component Analysis (PCA) in each age interval (PCA days PN8-19 (PCA1): 
eigenvalue = 1.27, total variance = 63.44%; PCA days PN22-36 (PCA2): eigenvalue 
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= 1.26, total variance = 63.24%). Similarly, the first component scores from a 
PCA on tarsus and head plus bill absolute values measured at day PN64 (PCA day 
PN64 (PCA3): eigenvalue = 1.38; total variance = 69.15%) gave a body size index. 
Hatching mass, body mass growth rates and body mass at day PN64 were 
analysed in separate LMEs to disentangle potential short-and long-term effect of 
developmental B exposure. When needed, hatching mass values or the 
appropriate PCA was added into the LME as covariate (Table 3.2). 
B, glucose, glycerol and triglyceride data were split by age (day PN22 and PN64) 
as I was specifically interested in examine short- and long-term effects of B on 
these physiological parameters. Except for B stress responses, basal levels (T0) 
and the response to stress (delta: the change in glucose, glycerol or triglyceride 
concentrations between T0 and T30) were analysed in separate models. In the 
LMEs for the glucose data, the glucose strip barcode was included as an 
additional random factor. Glucose and glycerol concentrations at day PN22 and 
PN64, as well as triglyceride concentrations at day PN22 were log10-transformed. 
Basal triglyceride levels and delta triglycerides at day PN64 could not be 
normalised because they were highly skewed (-1.8 < skewness < 1.5) and the 
data were analysed using GLMs with a gamma probability distribution and log-
link function without the inclusion of random factors (the models with their 
inclusions were not resolvable).   
As plasma triglycerides are well known to be affected by glucose metabolism 
through the insulin signalling pathways (Saltiel and Kahn, 2001), in a preliminary 
analyses I included glucose or delta glucose as covariate in the models 
performed for basal or delta triglyceride data, respectively.  Except for the 
analysis of basal triglycerides at PN22, the inclusion of glucose did not alter the 
statistical outcomes obtained from the models performed without glucose, nor 
did glucose co-varied significantly with any of the variables (p > 0.05). Here, 
therefore, I reported the results from the full models without glucose apart from 
basal triglyceride analysis at PN22.  B concentrations were inverse-transformed 
and the HPA responsiveness was analysed using similar LME as for the previous 
analyses with the addition of a repeated measure approach, to examine changes 
in B levels over the time of sampling (i.e. T0, T10, and T30). I included the 
interactions that were biologically meaningful to the study design: treatment x 
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time of sampling; treatment x sex, treatment x time of sampling x sex. In all the 
models, non-significant effects (p > 0.05) were dropped using a backward 
procedure following Crawley (1993). Post-hoc analyses for main effects were 
performed using the available Bonferroni method in PASW, which applies an 
adjustment to p-values to account for multiple comparisons. Significant 
interactions were further investigated in separate models using pre-hatching and 
post-hatching treatment as two distinctive fixed factors, each of them with two 
levels (C = control or B = corticosterone exposure). Unless otherwise specified, 
data are presented as mean ± s.e.m. 
 
3.4 Results  
3.4.1 Effects of pre- and post-hatching B exposure on 
growth 
Hatching mass did not differ across treatments, sex or their interaction (Table 
3.2a, Figure 3.1). Similarly, there were no treatment differences in body mass 
growth up to day PN3; there was no effect of sex, or hatching mass on growth 
(Table 3.2b, Figure 3.1). During the post-hatching B manipulation (days PN5-19), 
I found no differences in growth between B-treated and control birds. There was 
a significant positive co-variation between body mass growth rates and PCA1, 
but the slopes did not differ across groups (Table 3.2c; Figure 3.1). Once post-
hatching B exposure had ceased, neither treatment nor its interaction with sex 
were significant for growth rates between days PN22-36 or for body mass at day 
PN64 (Table 3.2d-e; Figure 3.1); there was a significant effect of sex on both 
variables (Table 3.2d-e), with females showing larger growth and body mass than 
males. Also, growth between days PN22-36 and body mass at day PN64 co-varied 
positively with PCA2 and PCA3, respectively, but I found no other effects of 
these variables (Table 3.2d-e). 
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Figure 3.1 Increase in the body mass in the four treatment groups (i.e. CC, BC, CB and BB) during 
the first 36 days of post-hatching (PN) life. Sample sizes: CC = 23; BC = 16; CB = 20; BB = 18. 
Data represent means ± s.e.m. 
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Table 3.2 Results of Linear Mixed Effect modelling (LMEs) of  potential short- 
and long-term effects of treatment, sex and their interaction on measures of 
post-hatching (PN) body mass or growth rates at day (a) PN0, (b) days PN1-3; (c) 
days PN8-19, (d) days PN22-36 and (e) day PN64. At days PN1-3, days PN8-19, 
days PN22-36 and day PN64, the appropriate covariate (hatching mass, PCA1, 
PCA2, PCA3, respectively) and its interactions with treatment and sex were 
included to control for body size. Superscripts: * denotes excluded factors during 
the stepdown procedure, numbers refers to the order of removal. In bold, 
significant factors (p < 0.05).  
(a) Day PN0: hatching mass d.f. F P 
 treatment 3, 58.05 1.54 0.21 
 sex * 
2 1, 59.66 0.21 0.65 
 treatment x sex *
, 1 3, 54.78 1.29 0.29 
(b) Days PN1-3: body mass growth d.f. F p 
 treatment 3, 66.64 0.22 0.88 
 sex *
, 5 1, 69.24 0.47 0.49 
 hatching mass *
, 6 1, 44.65 0.97 0.33 
 treatment x sex *
, 3 3, 60.08 0.68 0.68 
 treatment x hatching mass *
, 2 3, 57.48 0.19 0.90 
 sex x hatching mass *
, 4 1, 65.07 2.19 0.14 
 treatment x sex x hatching mass *
, 1 3, 56.40 0.84 0.48 
(c)Days PN8-19: body mass growth d.f. F p 
 treatment 3, 58.38 2.28 0.09 
 PCA1  1, 65.44 19.29 < 0.0001 
 sex *
, 5 1, 62.15 0.53 0.47 
 treatment x sex *
, 3 3, 54.09 0.79 0.51 
 treatment x PCA1 *
, 2 3, 55.64 0.37 0.77 
 sex x PCA1 *
, 4 1, 60.89 0.67 0.41 
 treatment x sex x PCA1 *
, 1 3, 51.24 0.61 0.61 
(d) Days PN22-36: body mass growth d.f. F p 
 treatment 3, 60.85 2.88 0.14 
 sex 1, 64.94 5.23 0.02 
 PCA2 1, 69.55 18.28 < 0.0001 
 treatment x sex *
, 3 3, 54.31 1.13 0.34 
 treatment x PCA2 *
, 4 3, 60.23 1.74 0.17 
 sex x PCA2 *
, 2 1, 61.57 0.012 0.91 
 treatment x sex x PCA2 *
, 1 3, 52.31 1.56 0.21 
(e)Day PN64: body mass  d.f. F p 
 treatment 3, 62.51 0.44 0.72 
 sex 1, 70.51 79.21 < 0.0001 
 PCA3 1, 69.58 57.30 < 0.0001 
 treatment x sex *
, 3 3, 61.12 0.68 0.57 
 treatment x PCA3 *
, 2 3, 62.69 0.47 0.70 
 sex x PCA3 *
, 4 1, 57.12 2.94 0.09 
 treatment x sex x PCA3 *
, 1 3, 57.38 0.12 0.95 
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3.4.2 Effects of pre- and post-hatching B exposure on the 
acute stress response   
3.4.2.1 Day PN22  
B stress response. As expected, B levels during the standardised restraint stress 
protocol were significantly affected by sampling interval (Table 3.3a). Overall, 
baselines were lower than both stress-induced B levels (post-hoc: T0 values vs 
T10 and T30 values: p < 0.0001 in both pair-wise comparisons), whereas there 
were no differences between B levels at T10 and T30 (post-hoc: p = 0.49). There 
were no effects of sex on B concentrations, nor any treatment effects (Table 
3.3a). However, there was a significant interaction between treatment and sex 
in terms of the shape of the stress response (Table 3.3a). In fact, as shown in 
Figure 3.2a, in females, stress response patterns in the groups that experienced 
post-hatching B, regardless of pre-hatching experiences, peaked at T10 and then 
decreased between T10 and T30, while in groups that did not experience post-
hatching B, stress levels peaked at T10 and tended, on average, to remain stable 
until T30. Juvenile males showed different patterns, with B levels peaking at 
T10 in all groups, apart from the BC males where stress levels tended to increase 
until T30 (Figure 3.2b). Post-hoc analysis confirmed that the post-hatching 
treatment was driving the observed sex-specific differences over the stress 
response in females (post-hatching B x sex x time interaction: F4,101.66 = 2.79, p = 
0.03; p > 0.54 for all the other interactions). High variation in the BC males at 
T30 was due to one individual showing B levels of 26.46ng/ml. As this data point 
did not bias the statistical model (- 0.4 < model residuals < 0.4) and its removal 
from the analysis did not change the significant patterns in the statistical 
outcome, this value was kept in the final model. 
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Figure 3.2.Corticosterone (B) temporal responses to acute stress (standardised capture-restraint 
stress protocol) across treatment groups (i.e. CC, BC, CB and BB) at post-hatching day 22 in (a) 
female quail and (b) male quail. As can be seen, CB and BB females exhibited shorter stress 
responses in comparisons with BC and CC females while no significant differences were observed 
among males (Linear Mixed Model: post-hatching B x sex x time of sampling interaction, p = 0.03; * 
indicates significant differences). Sample sizes: CC female = 9, male = 14; BC female = 10, male = 
6; CB female = 10, male = 10; BB female = 9, male = 9. Data represent un-transformed means ± 
s.e.m. and included undetectable samples that were assigned individual detection limits.  
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Glucose, glycerol and triglyceride stress responses. Full descriptive statistics 
of basal and delta glucose, glycerol and triglyceride concentrations are reported 
in Table 3.4a. Basal glucose concentrations were not affected by treatment, sex 
or their interaction (Table 3.5a). In all juvenile quail, acute stress raised glucose 
concentrations, but such increases did not differ across treatments or between 
males and females (Table 3.5a). Basal glycerol concentrations were significantly 
higher in females than males regardless of the treatment group (females: 0.16 ± 
0.01mg/ml; males: 0.12 ± 0.01mg/ml) and there was no effect of developmental 
B exposure on this response variable (Table 3.5a). Similar to the glucose 
response, overall glycerol levels tended to increase at the end of the stress 
protocol, but there was no effect of treatment, sex or their interaction (Table 
3.5a). Regardless of treatment, juvenile females showed higher basal 
triglycerides than males (females: 1.49 ± 0.07mg/ml; males: 1.19 ± 0.10mg/ml). 
There was an effect of treatment on basal triglycerides, which was both sex- and 
glucose-dependent (Table 3.5a). Post-hoc analysis revealed that these complex 
interactions were driven by post-hatching B (pre-hatching B x sex x glucose 
interaction: F1, 56.16 = 0.37, p = 0.55; post-hatching B x sex x glucose interaction: 
F1, 57.29 = 4.25, p = 0.04; p > 0.1 for all the other interactions). In fact, the 
juvenile males, and not the juvenile females, that were treated post-hatching 
(i.e. CB and BB) tended to have lower basal triglyceride and higher glucose 
levels compared to the birds that were not treated with B post-hatching (i.e. CC 
and BC) (Figure 3.3b and Figure 3.4). Moreover, all the B-treated females 
showed on average higher basal triglycerides than the CC birds (Figure 3.3a).  
In all the juvenile quail acute stress decreased triglycerides (Table 3.4a), but 
such a decrease did not differ among the treatment groups or sex (Table 3.5a).  
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Figure 3.3 The interaction between corticosterone (B) exposure and sex in relation to basal 
triglyceride concentrations at post-hatching day 22 in (a) female quail and (b) male quail.  
Triglycerides were higher in all the B-treated females (BC, CB, BB) compared with the CC females; 
whereas males in the CB and BB groups showed lower triglycerides compared with the males in 
the CC and BC groups (Linear Mixed Models: treatment x sex interaction, p = 0.04, different letters 
indicate significant differences).    
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Figure 3.4 The correlation between basal triglyceride and basal glucose at post-hatching day 22 in 
(a) female quail and (b) male quail. As can be seen, in the males, and not in the females, 
triglyceride concentrations were explained by variation in basal glucose concentrations (Linear 
Mixed Models: post-hatching B x sex x glucose interaction, p = 0.04), with males exposed to B 
post-hatching (CB and BB) showing lower triglycerides and higher glucose concentrations and the 
post-hatching control males (CC and BC) showing opposite patterns. Sample sizes: CC female = 9, 
male = 12; BC female = 10, male = 5; CB female = 10, male = 9; BB female = 9, male = 7. Data 
represent un-transformed means ± s.e.m.  
  
(b) Male
(a) Female
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Table 3.3 Results of Linear Mixed Effect modelling (LMEs) of potential short- and long-term effects 
of treatment, sex and their interactions on HPA axis responsiveness at (a) post-hatching (PN) day 
22 and (b) day PN64 (see text for details). Superscripts: * denotes excluded factors during the 
step-down procedure, numbers refers to the order of removal. In bold, significant factors (p < 0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.2.2 Day PN64 
B stress response. Once again B concentrations during the capture-restraint 
protocol changed significantly over the stress response (post-hoc: T0 values vs 
T10 and T30 min values: p < 0.0001 in both pair-wise comparisons; T10 values vs 
T30 values: p = 1.00); however, there were no significant interactive effects 
(Table 3.3b; Figure 3.5). I found an overall effect of treatment (Table 3.3b) due 
to significantly higher hormone concentrations in BC birds compared with CC 
birds (post-hoc: p = 0.03; for all the other pair-wise comparisons: p > 0.12). 
Overall plasma B concentrations in females tended to be higher than B 
concentration in males regardless of the treatment groups, but these differences 
did not reach statistical significance (Table 3.3b)   
 (a) Day PN22: d.f. F p 
 treatment 3, 66.05 2.38 0.08 
 time  2, 99.71 27.09 < 0.0001 
 sex 1, 66.05 1.48 0.23 
 treatment x sex 3, 66.05 0.07 0.98 
 treatment x time  6, 99.71 0.49 0.82 
 treatment x sex x time  8, 99.71 2.38 0.02 
    
(b) Day PN64: d.f. F p 
 treatment 3, 70.79 3.25 0.03 
 time 2, 99.47 10.71 < 0.0001 
 sex *, 4 1, 69.02 3.17 0.08 
 treatment x sex *, 3 3, 64.09 0.24 0.87 
 treatment x time *, 2 6, 96.09 0.31 0.93 
 treatment x sex x time *, 1 8, 89.54 0.67 0.72 
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Glucose, glycerol and triglyceride stress responses. Full descriptive statistics 
of basal glycerol and triglyceride concentrations over the stress response are 
shown in Table 3.4b. I found a sex-specific treatment effect on basal glucose 
concentrations, but no main effects of treatment and sex (Table 3.5b).  Post-hoc 
analysis revealed that the significant interaction was driven by pre-hatching B 
(pre-hatching B x sex interaction: F1, 62.43 = 10.70, p = 0.002; post-hatching B x 
sex interaction: F1, 67.95 = 0.07, p = 0.79). In fact, males and females that 
experienced pre-hatching B exhibited reversed basal glucose patterns compared 
with males and females that were not exposed to elevated B pre-hatching B, 
with increased levels in BC and BB males compared with CC and CB males, and 
decreased levels in BC and BB females compared with CC and CB females (Figure 
3.6). Also, the combined early B treatments tended to affect basal glucose levels 
(interaction: F1, 65.56 = 3.70, p = 0.06), with no differences between the sexes 
(pre-hatching B x post-hatching B x sex interaction: F1, 67.82 = 0.25, p = 0.62). 
Contrary to what was observed early in life, glucose concentrations remained on 
average stable between T0 and T30, with no significant differences across 
treatments and sexes (Table 3.5b). Both basal glycerol concentrations and 
stress-induced glycerol levels were not affected by the treatment, sex or their 
interactions (Table 3.5b). Basal and stress-induced triglycerides were higher in 
females than males (T0: females: 12.18 ± 1.63mg/ml, males: 1.33 ± 0.25mg/ml; 
delta: females: -4.21 ± 1.40mg/ml, males: 0.20 ± 0.39mg/ml), but there was no 
effect of treatment or its interaction with sex (Table 3.5b). As observed earlier 
in life, overall acute stress tended to increase glycerol and decrease triglyceride 
concentrations (Table 3.4b). 
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Figure 3.5. Corticosterone (B) temporal responses to acute stress (standardised capture-restraint 
protocol) across treatment groups (i.e. CC, BC, CB and BB) at post-hatching day 64 in (a) female 
quail and (b) male quail. Regardless of the sexes, hormone concentrations were overall higher in 
BC birds compared with CC birds (Linear Mixed Models: treatment, p = 0.03; * indicates significant 
differences). Sample sizes: CC female = 9, male = 14; BC female = 10, male = 6; CB female = 10, 
male = 10; BB female = 9, male = 9. Data represent un-transformed means ± s.e.m. and included 
undetectable samples that were assigned individual detection limits. 
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Figure 3.6. The interaction between corticosterone (B) exposure and sex in relation to basal 
glucose concentrations at post-hatching day 64 in (a) female quail and (b) male quail. As can be 
seen from the figure, glucose concentrations were lower in BC and BB females compared with CC 
and CB females, and higher in BC and BB males compared with CC and CB males (Linear Mixed 
Models, pre-hatching B x sex interaction, p = 0.002; different letters indicate significant 
differences). Sample sizes: CC female = 9, male = 14; BC female = 10, male = 6; CB female = 10, 
male = 10; BB female = 9, male = 9. Data represent un-transformed means ± s.e.m.  
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Table 3.4 Descriptive statistics of basal (T0) concentrations and acute stress responses (T30 – T0) 
of glucose, glycerol and triglyceride concentrations in (a) 22-day-old (day PN22) and (b) 64-day-old 
(day PN64) Japanese quail across the 4 treatment groups (CC, BC, CB and BB).  
 
 
(a) day PN22 
            
 
Glucose 
 
CC
 
BC
 
CB
 
BB
  
mean s.e.m. 
 
mean s.e.m. 
 
mean s.e.m. 
 
mean s.e.m. 
 
T0 
 
13.80 0.44 
 
13.20 0.57 
 
13.50 0.45 
 
13.30 0.60 
 
T30 - T0 
 
1.60 0.41 
 
1.00 0.36 
 
2.40 0.53 
 
1.20 0.43 
              
 
Glycerol 
 
CC 
 
BC 
 
CB 
 
BB 
  
mean s.e.m. 
 
mean s.e.m. 
 
mean s.e.m. 
 
mean s.e.m. 
 
T0  
 
0.15 0.01 
 
0.12 0.01 
 
0.17 0.03 
 
0.13 0.02 
 
T30 - T0 
 
0.09 0.04 
 
0.07 0.02 
 
-0.01 0.03 
 
0.04 0.03 
              
 
Triglycerides 
 
CC 
 
BC 
 
CB 
 
BB 
  
mean s.e.m. 
 
mean s.e.m. 
 
mean s.e.m. 
 
mean s.e.m. 
 
T0 
 
1.27 0.08 
 
1.51 0.12 
 
1.34 0.16 
 
1.33 0.13 
 
T30 - T0 
 
-0.11 0.16 
 
-0.54 0.12 
 
-0.12 0.16 
 
-0.29 0.12 
              (b) day PN64 
            
 
Glucose 
 
CC 
 
BC 
 
CB 
 
BB 
  
mean s.e.m. 
 
mean s.e.m. 
 
mean s.e.m. 
 
mean s.e.m. 
 
T0 
 
13.26 0.62 
 
14.26 0.74 
 
13.73 0.53 
 
13.59 0.68 
 
T30 - T0 
 
0.50 0.63 
 
-1.00 1.02 
 
-0.20 0.66 
 
0.10 0.81 
              
 
Glycerol 
 
CC 
 
BC 
 
CB 
 
BB 
  
mean s.e.m. 
 
mean s.e.m. 
 
mean s.e.m. 
 
mean s.e.m. 
 
T0 
 
0.13 0.01 
 
0.22 0.05 
 
0.24 0.05 
 
0.18 0.02 
 
T30 - T0 
 
0.04 0.02 
 
0.06 0.05 
 
-0.02 0.04 
 
0.09 0.03 
              
 
Triglycerides 
 
CC 
 
BC 
 
CB 
 
BB 
  
mean s.e.m. 
 
mean s.e.m. 
 
mean s.e.m. 
 
mean s.e.m. 
 
T0 
 
4.66 1.56 
 
9.07 2.89 
 
8.40 2.11 
 
6.37 2.15 
 
T30 - T0 
 
-2.31 1.28 
 
-1.74 1.28 
 
-2.84 2.19 
 
-1.15 1.29 
85 
Chapter 3 
 
Table 3.5 Results of Generalised Mixed Effect modelling of potential short- and long-term effects of 
treatment, sex and their interaction on basal or delta glucose, glycerol and triglyceride 
concentrations (delta = difference between basal and stress-induced concentrations, see text for 
details) at (a) post-hatching day (PN) 22 and (b) day PN64. Superscripts: * denotes excluded 
factors during the step-down procedure, numbers refers to the order of removal. In bold, significant 
factors (p < 0.05). 
 
(a) PN22       
Basal glucose d.f. F p 
 
treatment 3, 65.61 0.22 0.88 
 
sex *,2 1, 68.94 0.07 0.93 
 
treatment x sex *,1 3, 66.27 1.93 0.13 
     Delta glucose d.f. F p 
 
treatment 3, 66.14 1.26 0.29 
 
sex *,2 1, 70.35 0.2 0.66 
 
treatment x sex *,1 3, 63.05 1.77 0.16 
     Basal Glycerol d.f. F p 
 
treatment 3, 65.03 1.14 0.338 
 
sex 1, 65.43 8.67 0.004 
 
treatment x sex*1 3, 61.54 0.76 0.523 
     Delta glycerol d.f. F p 
 
treatment 3, 64.58 2.40 0.076 
 
sex*2 1, 64.65 0.17 0.681 
 
treatment x sex*1 3,60.47 0.60 0.614 
     Basal Triglyceride d.f. F p 
 
treatment 3, 53.32 2.85 0.046 
 
sex 1, 54.81 8.17 0.006 
 
treatment x sex 3, 52.14 2.92 0.042 
 
Glucose 1,13.97 3.41 0.086 
 
treatment x glucose 3,54.00 2.78 0.051 
 
Sex x glucose 1,54.50 11.47 0.001 
 
treatment x sex x glucose 3,51.98 3.71 0.017 
 
 
 
     
 
Delta triglycerides  d.f. F p 
 
treatment 6, 64.40 1.62 0.193 
 
sex*2 1,64.60 2.10 0.152 
 
treatment x sex*1 3,60.39 1.28 0.288 
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(b) PN64       
Basal glucose d.f. F p 
 
treatment 3, 66.76 1.68 0.18 
 
sex 1, 67.43 2.06 0.16 
 
treatment x sex 3, 67.14 3.48 0.02 
     Delta glucose 
   
 
treatment 3, 60.21 0.45 0.72 
 
sex *,2 1, 68.06 0 0.96 
 
treatment x sex *,1 3, 60.95 0.65 0.58 
     Basal Glycerol d.f. F p 
 
treatment 3, 66.02 2.16 0.101 
 
sex*2 1, 68.08 0.12 0.727 
 
treatment x sex*1 3, 63.87 0.51 0.677 
     Delta glycerol d.f. F p 
 
treatment 3, 69.60 1.65 0.187 
 
sex*2 1, 68.76 0.04 0.84 
 
treatment x sex*1 3, 65.71 0.26 0.855 
     Basal Triglycerides  d.f. F p 
 
treatment 3, 69 3.87 0.27 
 
sex 1, 69 130.89 <0.0001 
 
treatment x sex*1 3, 66 3.79 0.28 
     Delta triglycerides  d.f. F p 
 
treatment 3, 69 2.83 0.42 
 
sex 1, 69 5.32 0.02 
  treatment x sex*1 3, 66 0.45 0.93 
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3.5 Discussion 
The present study clearly shows that the exposure to elevated stress hormones 
during development had an organisational impact on post-hatching HPA stress 
physiology. These findings are supported by previous studies and reinforce the 
hypothesis that the HPA activity is an important mediator to consider when 
addressing the effects of early life stress on shaping the phenotype. My 
experimental protocol involved a direct physiological manipulation of B exposure 
during pre- and post-hatching development. I am able, therefore, to attribute 
the effects induced by exogenous B to one (or both) of these developmental 
periods. To the best of my knowledge, this is the first avian study that 
attempted to quantify both the short- and long-term effects of developmental 
glucocorticoids on the HPA system, as well as glucose and lipid biochemistry 
during a standardised environmental stress test.  
 
3.5.1 Pre- and post-hatching effects of B on HPA axis 
responsiveness 
At day PN22, prolonged exposure to post-hatching B mediated HPA 
responsiveness in females but not in males, regardless of previous pre-hatching 
manipulations. Contrary to my predictions, therefore, elevated yolk B levels 
modified neither HPA axis function, nor the short-term effects of post-hatching 
treatment on the stress system. These results were unexpected as previous 
studies using similar manipulations in the egg, found significant effects on post-
hatching growth, immunity or behaviours in juveniles of other bird species (Love 
et al., 2005; Rubolini et al., 2005; Saino et al., 2005; Davis et al., 2008). These 
studies were conducted in field conditions where a number of environmental 
confounding factors cannot be completely excluded. Also, variation seen across 
studies may also be explained by changes in HPA axis sensitivity across an 
individual’s life cycle, especially during post-hatching growth (Schwabl, 1999; 
Sims and Holberton, 2002; Wada et al., 2008; Chapter 2 of this thesis). 
Intriguingly, the effect of glucocorticoid exposure in ovo became evident only 
later in life. In fact, at day PN64, birds that had been exposed to B only during 
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their pre-hatching development (BC) experienced a higher total exposure to 
circulating concentrations of B during acute stress compared to the controls, 
indicating that HPA responsiveness in such treated birds was hyper-regulated. It 
should be noted that stress responses in the adult birds that experienced the 
combined treatments (BB) were similar to those observed in the control (CC) and 
post-hatching B-treated birds (CB). Taken together these results suggested that 
the experimental elevation of endogenous B post-hatching may have somehow 
“mitigated” the long-lasting impact produced by pre-hatching B exposure and 
reinforced the importance of interactive influences between these two time 
windows as shown in mammalian studies (Maccari et al., 2005; Vallée et al., 
1997; Vallée et al., 1999). As previously suggested, pre-hatching B may have 
modified HPA axis function through an elevation of basal circulating B levels 
(Coe et al., 2003; Gutteling et al., 2005). The undetectable samples, especially 
at T0, constrained my ability to test for potential treatment differences in 
baselines. Similar low B levels during restraint have been reported in the same 
species and are likely to be the result of frequent handling for morphological 
measurements (Hayward and Wingfield, 2004; Hayward et al., 2006). In this 
study, I took morphological measurements in all the individuals at a specific age. 
The effect of handling, therefore, was standardised to all the birds. It is unlikely 
that the low hormone concentrations could be a sign of incomplete maturation 
of the HPA axis as birds from previous generations (same breeding population 
used in this experiment) were able to mount a B stress response at least from 
day 5 post-hatching.  
There have been few studies in birds that explored the effects of pre-hatching 
glucocorticoid exposure on post-hatching HPA function, and the results of these 
are mixed. Studies during early post-hatching stages reported diminished HPA 
responsiveness in starlings at fledging (Sturnus vulgaris) (Love and Williams, 
2008), and no effects or hyper-responsiveness in juvenile chickens (Gallus gallus) 
(Lay and Wilson, 2002; Haussmann et al., 2012, respectively). Long-term studies 
in Japanese quail found HPA hyper-responsiveness in adults hatched from B-
implanted mothers (Hayward and Wingfield, 2004) and, in contrast, HPA hypo-
responsiveness in females, but not in males, when the hormone was injected 
directly in the yolk (Hayward et al., 2006). This discrepancy has been explained 
by differences in the distribution of B in the egg when injected, as opposed to 
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when deposited by the mother (Hayward et al., 2006). However, since the B 
dose used in this work raised yolk B levels to a similar physiological range as 
Hayward et al., (2006), other factors may be involved. For instance, the timing 
of egg injection differed: in this study eggs were injected at day E5, whereas in 
Hayward et al., (2006) injection was performed at day E0. In mammals the 
effects of pre-natal stress can change depending on the duration of early stress 
exposure (Kapoor and Matthews, 2008). Sensitive windows might also occur in 
birds and more comparative work is needed to investigate this hypothesis.  
The sex-specific effect observed in this study following the post-hatching 
corticosteroid manipulation suggests that growing females are more susceptible 
than males to alterations in their stress responses after facing prolonged 
environmental perturbations. Studies in zebra finches (Taeniopygia guttata) 
suggest that females may be more sensitive than males to early post-hatching 
stress exhibiting lower growth patterns, reduced incubation effort and 
decreased survival (Verhulst et al., 2006; Spencer et al., 2010; although see 
Spencer and Verhulst, 2007). However, the short-term effects of post-hatching 
stress on HPA activity have been hardly explored. Previous work demonstrated 
that reduced food provisioning in nestling starlings induced an exaggerated peak 
in B release in response to acute stress at fledging, with smaller females showing 
the largest increase (Love and Williams, 2008). I measured the dynamics of the 
stress response, including the peak response, but also the change over time 
(between T10 and T30). My data suggest that in post-hatching B-treated females 
hormone concentrations returned to baseline more quickly than in post-hatching 
control females. This is indicative of changes in the duration, rather than the 
magnitude of adrenocortical B secretion. It has been proposed that post-
natal/hatching stress may produce adaptive responses in the short-term, helping 
the juveniles to maximise their immediate chance of survival in low quality 
environments (Meaney, 2001; Love and Williams, 2008).  Data from this study 
would support this idea as truncated stress responses could be an adaptive 
strategy to avoid the costs associated with high glucocorticoid concentrations 
(Wingfield, 2005b). Recent work in zebra finches showed that prolonged 
exogenous B in nestlings produced HPA hyper-responsiveness in adulthood and 
decreased survival (Spencer et al., 2009; Monaghan et al., 2012); similar HPA 
alterations were observed in maternally-deprived individuals into adulthood 
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(Banerjee et al., 2012). This discrepancy reinforces the importance of 
considering the specific developmental strategy (precocial vs. altricial), as well 
as the life stage when investigating phenotypic effects of early life stress.  
The mechanism underlying the short-term shift in HPA physiology observed in 
this study remains unresolved. Similar short-term alterations have been reported 
in rat pups subjected to daily handling during the first 21 days of post-natal life 
(Meaney and Aitken, 1985). Such changes have been linked to enhanced 
concentrations of glucocorticoid receptors (GR) in the hippocampus (Meaney and 
Aitken, 1985; see also Meaney, 2001 for a review), which are known to increase 
the efficiency of glucocorticoid negative-feedback (Sapolsky et al., 2000). In 
fact, GR are predominantly occupied during acute stress when endogenous 
glucocorticoid levels are elevated; while mineralocorticoid receptors (MR) are 
largely occupied at basal concentrations of glucocorticoids and are thought to be 
primarily involved in feedback regulation during basal secretion (see General 
Introduction, Paragraph 1.2 and Figure 1.1 for more detail on the 
neuroendocrine regulation of the HPA axis). Therefore, modifications in the 
density of GR may explain the effects observed in this study in the post-hatching 
B-treated females. Although research on these systems in juvenile birds is 
lacking to date, recent work in adult birds showed that chronic stress can 
sensitise the HPA axis by altering central corticosteroid receptors (Hodgson et 
al., 2007; Dickens et al., 2009). More work is required to test the biological 
relevance of such factors in this model species. 
 
3.5.2 Pre- and post-hatching effects of B in basal and 
stress-induced glucose, glycerol and triglycerides 
Basal triglyceride concentrations were affected by developmental B in the 
juvenile 22-day-old quail. The treatment effect was inter-linked with the sex of 
the birds and basal glucose concentrations. Although these data are interesting, 
the interpretation of such patterns is not straightforward. First, it appeared that 
the B treatment, regardless of the developmental period it occurred, produced 
an increase of lipid biosynthesis in the juvenile females. As Japanese quail 
females are naturally heavier and fattier than the males, this may be indicative 
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of a higher susceptibility of females than males to short-term changes in lipid 
stores in response to early life stressful conditions. In the males, the effect of 
the treatment seemed more complex as it was dependent on post-hatching B 
treatment and basal glucose. The lower concentrations of triglycerides in the 
post-hatching B-treated males might be the result of enhanced available fuel via 
increase of glucose and free-fatty acids. This hypothesis would then fit well with 
the observed negative correlation between basal glucose and triglycerides 
among the post-hatching B exposed males and with the lack of these trends in 
the males that did not experience the post-hatching B protocol. In the 
awareness of the difficulties in disentangling causes vs consequences explaining 
these changes in the blood glucose and lipid chemistry, these data represent the 
first experimental suggestion in birds that prolonged exposure to developmental 
stress has the power to induce modifications in body energy balance pathways. 
Similarly, as seen with the B stress responses, later in life only the effects of 
pre-hatching B exposure persisted with changes in basal glucose, and again this 
effect was sex-linked. In fact, I found that the sexes were influenced by pre-
hatching B exposure in opposite directions. The reversed patterns were more 
evident in birds treated only during their pre-hatching development. This 
metabolic alteration appeared in line with the long-term effect induced by pre-
hatching B on adrenocortical activity and supports the hypothesis of links 
between basal B and basal glucose levels, as shown in other bird species 
(Remage-Healey and Romero, 2000). Furthermore, these data support findings in 
mammals where pre-natal stress has been shown to induce persistent changes in 
glucose metabolism (Vallée et al., 1996; Nyirenda et al., 1998; Lesage et al., 
2004; Benyshek et al., 2006; although see D’mello and Lin, 2006), which can 
differ between the sexes (Franko et al., 2010). There are indications that these 
alterations may compromise adult health and increase vulnerability to metabolic 
diseases (Cottrell and Seckl, 2009). I point out, however, that the nature of 
these data remains speculative as I still know little about how glucocorticoids 
influence energy balance and expenditure in birds. 
I did not find any treatment differences in the responses to stress in any of the 
blood metabolites at any life stage. Other systems or hormones, such as the 
autonomic nervous system or insulin, may co-operate with the HPA axis in the 
transport and breakdown of energy in response to stress (Havel and Taborsky, 
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1989; Remage-Healey and Romero, 2001) and more studies are warrant in order 
to test the potential regulatory interactions. Finally, it should be noted that at 
day PN22 glucose increased at the end of the restraint in all the birds, regardless 
of the treatment. In contrast, triglyceride concentrations on average were 
diminished in response to stress, both in the juvenile and adult quail. These data 
support the hypothesis that lipids appear to be the primary source of energy in 
birds (Remage-Healey and Romero, 2001; Bairlein and Gwinner, 1994), but also 
raise the unexplored questions of different regulating mechanisms of the stress 
system in the stimulation of energy release depending on the individual’s life 
stage.  
 
3.5.3 Pre- and post-hatching effects of B on growth 
Pre- and/or post-hatching B did not induce any significant effects on growth over 
the short- or long-term. This result was unexpected as stressful experiences 
often depress growth in the short-term (Eriksen, 2003; Hayward and Wingfield, 
2004; Saino et al., 2005; Janczak et al., 2006; Spencer and Verhulst, 2007; 
Mueller et al., 2009; Spencer et al., 2009). Studies of pre-hatching stress in birds 
have also suggested that males are more affected than females (Love et al., 
2005; Hayward et al., 2006; Love and Williams, 2008). Again, I did not find sex-
specific patterns. This study adds to the few studies in birds that deviate from 
the above trends, finding no effects of developmental exposure to 
glucocorticoids on growth (Kitaysky et al., 2003; Rubolini et al., 2005; 
Haussmann et al., 2012). In the long-term, the lack of treatment differences 
were expected as the growth decline in response to developmental 
glucocorticoid often disappear over the longer period (Hayward and Wingfield, 
2004; Spencer and Verhulst, 2007; Spencer et al., 2009). This can be obtained by 
a period of steady slow growth, or by a period of compensatory growth. The 
distinction is biologically important as compensatory growth can have long-
lasting physiological costs (Metcalfe and Monaghan, 2001). I, therefore, conclude 
that the effects of pre- and post-hatching B treatments observed on the HPA axis 
physiology, triglyceride and glucose metabolism are direct effects of B itself and 
not indirect effects due altered growth trajectories.  
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3.6 Conclusion 
In conclusion, the present study supports the hypothesis that developmental 
exposure to B can induce transient and permanent changes on the HPA axis and 
related metabolic pathways, which depend upon the developmental stage and 
sex. Importantly, I show that the impact of pre-hatching exposure to B on HPA 
axis functioning may be modulated by post-hatching stressful environmental 
conditions experienced during growth (here mimicked via oral administration of 
exogenous B). Although the underlying mechanisms of such shifts in the stress 
system are currently unknown in birds, these results corroborate findings in 
many mammalian models, suggesting that the organisational role of 
developmental glucocorticoid programming on the phenotype is a widespread 
phenomenon among vertebrates. Future longitudinal studies that can track 
potential dynamic changes of the effects of developmental stress into 
adulthood, from the peak of reproductive success until senescence, will be 
extremely useful to further our understanding of the long-term effects of 
developmental stress on fitness outcomes, survival expectancy and ageing 
processes. Furthermore, more studies are needed to link the physiological 
changes caused by developmental stressful environments with changes in stress-
related behaviours and cognitive abilities in order to test predictions of the 
possible adaptive meaning of glucocorticoid programming. Finally, the results 
from this study emphasise the use of avian models in developmental research as 
they have the potential to tease apart indirect maternal and direct 
environmental stimuli acting on early life phenotypic plasticity. In fact, the high 
degree of variation in developmental strategies and life-histories in birds offer 
an excellent opportunity to undertake comparative approaches to further our 
understanding of potential ultimate costs and benefits of early life stress on 
young and aging phenotypes.  
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4.1 Abstract  
Developmental stress can potentially induce long-term phenotypic changes into 
adulthood. The sensitivity of developing individuals to stressful conditions can 
vary across differing developmental stages, producing a variety of phenotypes in 
later life. Although the mechanisms remain unclear, accumulating evidence 
suggests that such effects are mediated via programmed gene expression 
changes in specific brain regions primarily affected by the actions of 
glucocorticoid hormones. Here, using the Japanese quail as a study species, I 
examine the long-term effects of pre- and/or post-hatching exposure of the 
stress hormone corticosterone (B) on the hippocampal and hypothalamic 
transcriptomes in adulthood using RNA-sequencing technology. The two 
developmental hormonal manipulations result in four treatment groups: pre-
hatching B exposed quail, post-hatching B exposed quail, pre- and post-hatching 
B exposed quail, and controls. Overall, the results suggest that the effects of 
developmental B on the brain transcriptome signature are strongly tissue-
specific and the magnitude of these effects appears stronger in the hippocampus 
than in the hypothalamus. The analysis indentifies gene expression patterns that 
(1) respond in a similar way to both pre- and post-hatching B across the 3 B-
exposed phenotypes relative to the control birds or, (2) respond specifically to 
one of the B treatment in the pre- or post-hatching B-treated birds relative to 
the pre- or post-hatching control birds. Furthermore, the dynamics of genes’ 
responses are altered by the interactive effects of pre- and post-hatching B 
treatment, producing cumulative or compensatory effects in the birds that 
experience the combined B protocols. Taken together, these results highlight 
the importance of considering the effects of multiple stressors experienced 
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across the stages of development as they can give rise to differing adult 
phenotypes.   
 
4.2 Introduction 
An individual’s phenotype is the result of its own genetic-make up and the 
environmental conditions that it has experienced over its life cycle (West-
Eberhard, 2003; Monaghan, 2008).  The integration of genetics in the field of 
behavioural and evolutionary biology is of central importance for the 
understanding of the genetic basis underlying phenotypic variation at both the 
population and individual levels (Jensen et al., 2008). Until recently, this 
multidisciplinary effort was restricted to sub-systems of interest in order to 
identify candidate genes involved in the regulation of specific phenotypic 
pathways, such as those controlling metabolic activities or specific human 
diseases. However, there is an increasing appreciation that the interplay 
between the genotype and the resultant phenotypes is a complex phenomenon, 
often involving multiple inter-connected pathways (Agrawal, 2001; Pigliucci, 
2005). Experimental investigations on a much bigger scale are, therefore, a more 
suitable tool in order to disentangle such complexity and examine overall 
genetic responses to changing environmental conditions (Rockman and Kruglyak, 
2006).   
The study of the long-lasting effects of early life experiences in later life has 
long intrigued human epidemiologists and biomedical scientists. It has been 
more than 30 years since the psychologist Robert Plomin started his research on 
twins, which is still ongoing. His studies have contributed to our understanding 
of the importance of the so termed “non-shared environmental stimuli” in 
shaping adult individuals with the same or very similar genetic starting material 
(e.g. Plomin et al., 1977; Trouton et al., 2002). Another fruitful area in this 
context is the earlier observational work in humans that has suggested a role of 
early life adversities, including small birth size and poor quality diet during 
neonatal life, in altering the susceptibility/propensity to adult diseases and 
mortality, generally known as “developmental origins of health and disease’’ 
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phenomenon (Barker et al., 1990; recently reviewed by Gluckman et al., 2007; 
Godfrey et al., 2007). Despite several lines of evidence indicating that such links 
are likely to be very important, the underlying, and especially, causal 
mechanisms that impact on the nervous system, and consequently, on physiology 
and behaviour, are still relatively unexplored.   
The Hypothalamic-Pituitary-Adrenal axis (HPA axis) is believed to be the main 
candidate mediator of the effects of early life stressful conditions on the 
phenotype. The mechanisms of actions of the HPA axis are highly conserved 
across vertebrates and have been described in detail in the General Introduction 
(Chapter 1, Section 1.2). Briefly, in response to a variety of stressors, 
hypothalamic corticotrophin-releasing hormone (CRH) and arginine vasopressin 
(AVP) stimulate the secretion of adrenocorticotrophic hormone (ACTH) from the 
pituitary into the circulatory blood system. ACTH is then carried to the adrenal 
glands where it stimulates the production and release of glucocorticoids. 
Glucocorticoids act primarily via two intracellular receptors: the lower affinity 
glucocorticoid (GR) and the higher affinity mineralocorticoid (MR) receptors and 
their mRNA expression and amounts in specific brain structures, especially in the 
hypothalamus and hippocampus, have a key role in terminating the stress 
response (Reul and de Kloet, 1985; de Kloet et al., 1998). In mammalian models, 
the effects of circulating glucocorticoid concentrations in the hippocampus, a 
brain structure involved in learning and memory processes, are profound. Both 
studies in vitro and in vivo have demonstrated that such effects are mediated by 
MR and/or GR receptors via transcriptional activation or repression of target 
genes involved in a variety of cellular processes such as energy production; 
cellular metabolism; protein synthesis, trafficking and turnover; signal 
transduction; neuronal connectivity and excitability (Pearce and Yamamoto, 
1993; Datson et al., 2001). A shift in the balance of activated MR:GR ratio can 
alter such cellular processes with consequences for hippocampal circuitry 
integrity and synaptic transmission (de Kloet et al., 1998). Additionally, 
chronically elevated concentrations of glucocorticoids are damaging for 
hippocampal neuronal viability, either directly or indirectly by increasing their 
vulnerability to neurotoxic and oxidative stress insults (McIntosh and Sapolsky, 
1996; Sapolsky, 1996; Datson et al., 2012). Although studies in different species 
than mammals are very limited, recent research in both domesticated and wild 
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birds indicate that the avian hippocampus is sensitive to the effects of both 
acute and chronic stress, with detectable changes at least in MR and possibly, in 
the MR:GR balance. In fact, adult zebra finches (Taeniopygia guttata) selected 
for exaggerated corticosterone (B) stress responses showed significantly lower 
hippocampal MR mRNA expression than non-selected adult controls, while no 
differences were detected in hippocampal GR mRNA expression between the two 
experimental groups (Hodgson et al., 2007). Similar results were observed in 
chronically stressed adult European starlings (Sturnus vulgaris) within the 
hippocampus in comparison with non-chronically stressed adults (Dickens et al., 
2009). Since these changes in MR hippocampal gene expression density have 
been linked with changes in spatial cognitive performances (Hodgson et al., 
2007), it is likely that the effects of sustained elevated B levels have genome-
wide effects in this brain area, similarly as in mammals. The effects of 
glucocorticoids in the hypothalamus have received much less attention than 
those induced in the hippocampus. However, there is line of experimental 
evidence in vivo demonstrating direct links between glucocorticoid 
supplementation and hypothalamic gene expression alterations in cell signalling 
and communication, metabolism and cytoskeleton regulation (Nishida et al., 
2006). To the best of my knowledge, no studies to date have examined 
simultaneously (within the same experimental individuals) the global gene 
expression pattern changes occurring in response to HPA axis activation/or its 
chronic stimulation across multiple target neuronal structures, such as the 
hippocampus and the hypothalamus. 
The first studies that have analysed experimentally the effects of early life 
stressful events on the individuals’ phenotype were carried out in laboratory 
rats. Such pioneering studies have demonstrated significant associations 
between naturally occurring maternal care variations and the development of 
stable individual differences in the adult offspring HPA stress responses. In fact, 
adult offspring of “high caring mothers” (i.e. high levels of licking, grooming and 
arched-back nursing behaviours) showed diminished HPA stress reactivity 
compared to the offspring of “low caring mothers” (i.e. low levels of licking, 
grooming and arched-back nursing behaviours) (Liu et al., 1997). Intriguingly, 
cross-fostering studies have demonstrated that these physiological differences 
were reversed when the biological offspring of “low caring dams” were reared 
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by “high caring dams” (and vice-versa) (Francis et al., 1999). These findings 
have raised the hypothesis that variations in maternal care could be an 
important non-genomic driver for programming the individual differences in the 
responses to stress. Follow-up research has indeed supported this hypothesis, 
revealing direct links between changes in the stress system and changes in the 
transcriptome (i.e. the complete set of transcripts in a cell/group of cells or 
tissue type/s and their quantity at a given time for a specific developmental 
stage or physiological condition) of the hippocampus in the adult offspring 
(Weaver et al., 2006). These observed modifications involved less than 1% of 
transcripts of the total transcriptome (Weaver et al., 2006); hence, the changes 
were subtle, but significant and involved transcripts regulating cellular 
metabolism and energy production; signal transduction and protein production, 
trafficking and turnover. Exposure to stress of gravid females can also have 
enduring effects on the offspring phenotypic trajectories, a phenomenon known 
as “the foetal programming of the HPA axis” (Seckl, 2001, 2004). Indeed, 
glucocorticoids of maternal origin do cross the placental and blood-brain barrier 
(Zarrow et al., 1970). Maternal pre-natal stressors in rats can induce increases in 
the turnover of brain noradrenergic neurones in the adult offspring (Takahashi et 
al., 1992); enhance the duration of stress-induced B secretion during acute 
stress as well as decrease hippocampal MR and GR receptors into adulthood 
(Maccari et al., 1995; Barbanzanges et al., 1996; Levitt et al., 1996). Thus, both 
pre-natal hormones of maternal origin, likely glucocorticoids, and the effects of 
post-natal environmental stressors acting on the developing individual’s own 
stress system may be important modulators of the potential changes in the brain 
transcriptome controlling the HPA axis. Surprisingly, this hypothesis has never 
been experimentally tested.  
Recently a number of experimental studies, carried out in models other than 
laboratory rats, have analysed the effects of early life stress on behaviour and 
physiology, and have highlighted the evolutionary inertia of developmental 
stress programming across vertebrate taxa (reviewed by Henriksen et al., 2011; 
Love et al., 2013).  Much of this work has been conducted in bird species. 
Studies that have examined the long-term effects of direct pre- or post-hatching 
exposure to B have reinforced the idea that glucocorticoids can be key drivers in 
shaping phenotypic trajectories, including the response to acute stress (e.g. 
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Hayward and Wingfield, 2004; Hayward et al., 2006; Spencer et al., 2009; 
Marasco et al., 2012 or Chapter 3 of this thesis). More recent avian literature has 
also emphasised the importance of manipulating both the pre- and post-hatching 
developmental environments in order to analyse experimentally the interactive 
actions of stressful events, which, indeed do occur and are likely to have 
biological relevance (Love and Williams, 2008; Marasco et al., 2013 (Chapter 5); 
Zimmer et al., 2013). To the best of my knowledge, the potential long-lasting 
effects of such interactions on the brain transcriptome profiles on target HPA 
axis structures have not been tested.  
The recent development of high-throughput next generation transcriptome 
sequencing, also termed RNA sequencing (herein referred as “RNA-seq”), offers 
an attractive tool to map and quantify transcriptomes, and importantly, to link 
them with specific experimental conditions, for instance those defining a 
particular phenotypic conditioning (Wang et al., 2009). In more detail, RNA-seq 
facilitates the conversion of a population of RNA (total or fractioned, such as 
poly (A) +) to a library of cDNA fragments and each molecule is then sequenced 
to obtain short-sequences (between 30-400 bases). These “short-reads” can be 
mapped onto the reference genome to produce a global transcriptome map, 
allowing gene expression quantification and differential expression analysis 
across differing biological conditions. RNA-seq provides several key advantages 
over other existing technologies, such as hybridisation-based approaches (i.e. 
tiling arrays, microarrays) or the more traditional Sanger sequencing platforms 
(i.e. cDNA- or Expressed-Sequence-Tag- sequencing) (reviewed by Wang et al., 
2009). For example, RNA-seq has higher sensitivity and a much larger dynamic 
range of expression levels over which transcripts can be detected when 
compared with microarrays (Mortazavi et al., 2008); it also provides high levels 
of accuracy and technical reproducibility for the quantification of expression 
levels (Marioni et al., 2008). Furthermore, RNA-seq does not necessarily rely on 
the genomic sequence of the study species as transcripts can also be assembled 
de novo without the use of the genomic sequence, although this approach of 
analysis is computationally more intensive and challenging (Oshlack et al., 
2010). However, it should also be noted that RNA-seq platforms and methods of 
analyses are demanding and still under active development. Some of the 
difficulties discussed in Wang et al. (2009) include the development of methods 
100 
Chapter 4 
 
to store, retrieve and process large amounts of data; aligning methods to reduce 
mapping errors, such as those resulting from sequence reads matching multiple 
locations in the genome; statistical methods to analyse complex experimental 
design, such as those with repeated measurements and more than two 
experimental conditions. While a lot of work has been done within the last three 
years to significantly improve alignment techniques (Trapnell et al., 2012), the 
pace of progress regarding the statistical analysis  is much less pronounced and 
more complicated than was originally expected (Auer and Doerge, 2010; Oshlack 
et al., 2010).   
The main aim of the present study was to examine the potential long-term 
effects of both pre- and/or post-hatching developmental stress on gene 
expression pattern of target neuronal HPA structures, the hippocampus and 
hypothalamus, using the Japanese quail as the study species. The present 
experiment was specifically designed to analyse to what extent the early post-
hatching environment could directly alter the effects of previous pre-hatching 
maternal stress on hippocampal and hypothalamic gene expression patterns as 
well as to obtain an estimate of the tissue-specificity of such changes. According 
to the previously conducted work discussed above, I expected that both pre- and 
post-hatching exposure to stress hormones would induce changes in the 
hippocampus and hypothalamus of adult quail. I also expected that these 
changes might be modified in response to the combined interacting effects of 
pre- and post-hatching B as a result of enhanced induced-phenotypic plasticity in 
the developing quail (Monaghan, 2008). Finally since the effects of 
glucocorticoids are known to be tissue-specific, especially across differing brain 
structures (reviewed by Meijer et al., 2003), I also predicted that the effects of 
the B protocols would differ depending on the brain region.  
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4.3 Methods  
Experimental methods 
4.3.1 Pre- and post-hatching exposure to B 
The birds used in this study are part of the main experiment of my PhD project 
described in detail in Chapter 3 (Section 3.3.1). Briefly, pre-hatching stress was 
mimicked by exposure to corticosterone (B) in ovo; whilst post-hatching (PN) 
stress was mimicked via daily oral supplementation of B to the juvenile quail 
from PN5 to PN19. The combination of these two protocols resulted in four 
groups of experimental birds: (1) pre-hatching and post-hatching untreated birds 
(CC); (2) pre-hatching B-treated and post-hatching untreated birds (BC); (3) pre-
hatching untreated and post-hatching B-treated birds (CB), and (4) pre-hatching 
B treated and post-hatching B treated birds (BB). Upon adulthood, PN days 69-
73, the birds were sacrificed by intraperitoneal administration of 2ml of Euthatal 
(sodium pentobarbital, 200mg/ml; Merial Animal Health, Harlow, UK).  
 
4.3.2 Isolation of hippocampi and hypothalami 
The brains were removed within (mean ± s.e.m.) 10.57 ± 0.20 min post-mortem, 
immediately placed on dry ice and stored at -80ºC for further dissection. To 
perform the dissections, the brains were placed ventral side up into a frozen 
custom made brain holder (Workshop, University of Glasgow, UK) with a 1mm 
graduated scale, and a 2mm-thick coronal section was then obtained using two 
razor blades positioned approximately 4mm from the rostral pole and 2mm from 
the cerebellum. Two equivalent bilateral punches of the hippocampus (1mm 
diameter each) and one single punch of the hypothalamus (2mm diameter) were 
recovered from the slices using the brain topography of the chicken brain atlas 
as a reference (coronal brain sections interaural 2.08-2.56mm, Figures 18-20 in 
Puelles et al., 2007; see also Figure A1 in the Appendix), such that tissue 
collection was standardised across animals. Tissues from hippocampus and 
hypothalamus were stored separately in collection tubes (Eppendorf, Hamburg, 
Germany) and placed back to -80 ºC until analysis. Hippocampi from 2 birds (1 
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BB group and 1 CB group) could not be obtained as they were damaged during 
the dissection process. The hippocampus and the hypothalamus were selected 
for the transcriptome analyses as both these brain areas have a key role in the 
regulation of the HPA axis. The high costs of the transcriptome analyses 
constrained the possibility to analyse other tissues, notably pituitary and adrenal 
glands, which are also fundamental HPA axis targets. Moreover, as the effects of 
elevated glucocorticoids during development can induce widespread effects in 
the nervous system at both the cellular and gene expression level (e.g. reviewed 
by Welberg and Seckl, 2001), the inclusion of another part of the brain to be 
used as a control (i.e. in which no gene expression changes would be expected) 
in the transcriptome analyses was not applicable in this experimental context.  
4.3.3 RNA extractions 
Total RNA was extracted using the Rneasy Microarray Tissue Mini Kit (Qiagen, 
Manchester, UK). Briefly, each tissue sample was homogenised in 1ml Qiazol lysis 
reagent. The homogenates were then spun for 5min (14000 x g) and the obtained 
supernatant was transferred to a new collection tube (Eppendorf AG, Hamburg, 
Germany). After addition of 200µl chloroform, the homogenate was shaken 
vigorously for 15s and incubated for 5min at room temperature. Homogenates 
were then spun (14000 x g) for 15 min at 4ºC to separate the aqueous and 
organic phases. One volume (500µl) of 70% ethanol was added to the upper 
aqueous phase, and transferred onto the Rneasy spin column, where the total 
RNA was bound to the membrane, while phenol and other contaminants were 
washed away. Then, a DNase digestion step was undertaken to remove potential 
DNA contaminants using RNase-Free DNase Set (Qiagen, Manchester, UK). After 
washing the Rneasy spin column membrane with 350µl of wash buffer (provided 
by the manufacturer), 80µl of DNase solution (DNase stock diluted 1:70 with the 
provided buffer) was added directly to the membrane and incubated for 15min 
at room temperature. The Rneasy spin column membrane was then washed, first 
with 350µl of wash buffer (the same as the one used before the DNase digestion 
step) and then with 500µl of a second type of wash buffer (both buffers were 
provided in the kit). The Rneasy spin column membrane was placed in a 
collection tube (Eppendorf, Hamburg, Germany) and RNA was then eluted in 
30µl RNase-free water.   
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Both purity and integrity of RNA, two essential requirements for the overall 
success of RNA-based analyses (Bustin et al., 2009), were assessed respectively 
using a Nanodrop spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, 
USA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). 
Across all individual quail, hippocampal and hypothalamic RNA concentrations 
averaged (mean ± SEM) 158.86 ± 6.89ng/µl and 193.06 ± 6.39ng/µl, respectively.  
Agilent RNA integrity scores (RIN), which ranges from 1 (totally degraded) to 10 
(intact), for the hippocampal and hypothalamic samples averaged (mean ± 
s.e.m.) 8.84 ± 0.06 and 9.16 ± 0.06, respectively.  
 
4.3.4 RNA pooling 
Total RNA extracted from the hippocampi and hypothalami of 48 randomly 
selected quail (out of 77 birds) were used for the transcriptome-sequencing. All 
samples conformed to the manufacturer’s (Illumina, Little Chesterford, Essex, 
UK) quality requirements (RIN ≥ 8). For each tissue, 3 RNA biological replicates 
were prepared by pooling RNA from 4 birds (2 males and 2 females) per 
treatment, resulting in a total of 12 pooled samples per tissue. Each pool 
contained the same amount of RNA from each individual bird (500ng, 2000ng in 
total). The same pools of individuals were used for each tissue. Birds sharing the 
same mother were avoided within the same pool to control for potential pseudo-
replication. The choice of pooling RNA samples was established a priori, when 
designing the experiment. In fact, RNA pooling is a common practice in 
transcriptome analyses due to their elevated costs and the approach of 
independently replicating biological pooled samples in each treatment condition 
is assumed to give a good estimate of the overall biological variability 
(Kendziorski et al., 2003; Kerr, 2003; Rudolf et al., 2013). I acknowledge that 
pooling males and females together may result in false negatives for the genes 
that are differently regulated between the two sexes. Despite the awareness of 
specific sex-specific differences in the effects of elevated glucocorticoid 
exposure during development on physiological and behavioural patterns (e.g. 
Henriksen et al., 2011; Chapter 3 of this thesis), here, the approach of using 
both the sexes was preferred because the primary focus of the current study was 
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to gather global gene expression pattern differences across the treatments 
beyond the differences between the two sexes. Moreover, choosing only one sex 
would have reduced the number of birds in each biological pool, potentially 
increasing biological variation.  
 
4.3.5 cDNA library preparation    
The RNA pooled samples were then processed for RNA-seq using standard 
TruSeq™ RNA Sample Preparation kit (Illumina, Little Chesterford, Essex, UK). 
Briefly, the poly-A containing mRNA molecules were purified using poly-T oligo-
attached magnetic beads. The mRNA was fragmented and the fragments were 
then synthesised into first strand c-DNA using reverse transcriptase. Then, 
second strand cDNA was obtained using DNA polymerase I and RNase H. In the 
next steps, cDNA fragments were processed in order to allow the ligation of the 
adapters at the fragment ends, generating flow-cell-suitable templates. The 
products were then purified and enriched by PCR to obtain the final cDNA 
libraries. Fragment distribution among the libraries was assessed using the 
Agilent 2100 Bioanalyzer DNA 100 chip. As indicated by the Manufacturer (see 
also Wang et al., 2009 for a mini-review on cDNA library construction), fragment 
size averaged 309.16 ± 2.25 bases (mean ± s.e.m).   
 
4.3.6 High-throughput sequencing  
Sequencing was performed on a Genome Analyzer IIX (GAIIX) platform at the 
Glasgow Polyomics Facility (University of Glasgow, UK) following the 
Manufacturer’s recommendations (Illumina, Little Chesterford, Essex, UK). The 
GAIIX relies on a flow cell with eight lanes (or channels) and massively parallel 
the sequencing of millions of short cDNA fragments in each lane. Briefly, the 
cDNA libraries were first hybridised onto the flow cell covered with 
complementary surface-bound primers. Each sample was loaded in one lane, 
resulting in a total of 24 lanes in 6 different flow cells; samples from different 
treatments were randomised across sequencing flow cells and lanes within flow 
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cells to control for sources of variation due to the flow cell and lane (Auer and 
Doerge, 2010). Hybridised cDNA templates were then extended via isothermal 
bridging amplification in order to create an ultra-high density sequencing flow-
cell with approximately 30.000.000 clusters per lane. Each cluster contains 
about 1000 copies of the same template. The flow cell was then transferred 
from the Illumina cluster station to the genome analyser. At each cycle, the 
fragments in each cluster were sequenced using a four-color sequencing-by-
synthesis technology that employs reversible terminators with removable 
florescent dyes (Sequencing reagents version 5, Illumina, Little Chesterford, 
Essex, UK) and the signals emitted recorded. The sequencing run terminated 
after 76 cycles and yielded reads (i.e. sequences of nucleotides) with a 
maximum length of 76 bases.   
 
4.3.7 Microarray validation 
4.3.7.1 RNA hybridisation 
Microarray experiments were conducted at the Glasgow Polyomics Facility 
(University of Glasgow, UK). In order to perform a technical cross-platform 
comparison between RNA-seq and microarrays, Microarray libraries were 
constructed using the same total RNA hippocampal pools (n = 12, see Section 
4.3.4. for details on sample preparation) that were previously used for the 
sequencing. Affymetrix GeneChip® Chicken Genome Array was used because: (1) 
quail and chicken are closely related species belonging to the same Family 
(Phasianidae); (2) genomic DNA hybridisation of quail to the chicken arrays 
showed that more than 80% of the signal probes were not statistically different 
between the two species, confirming high inter-specific DNA sequence 
conservation (Nakao et al., 2008).  
Prior the start of RNA hybridisation, the quality of all RNAs was re-assed by 
Agilent 2100 Bioanalyser (Agilent Technologies, Santa Clara, CA, USA) to exclude 
potential degradation due to the length of storage (Figure A2, Appendix). As 
expected the obtained RIN numbers were all higher than 8 (range: 8.40-9.20), 
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conforming the Manufacturer’s guidelines (Affymetrix Inc., Santa Clara, CA, 
USA). 500ng of total RNA per sample pool was used for library preparation using 
Ambion WT Expression kit, followed by Affymetrix GeneChip® WT Terminal 
labelling kit according to Affymetrix’s instructions. Briefly, the workflow starts 
by generating first- and then second-strand cDNA, which are then synthesised in 
complementary RNA (cRNA) using in vitro transcription. Concentrations of cRNA 
in each sample were measured using a Nanodrop spectrophotometer (Thermo 
Fisher Scientific, Wilmington, DE, USA); cRNA quality was confirmed using the 
Agilent 2100 Bioanalyser (Agilent Technologies, Santa Clara, CA, USA).  A total of 
15μg of cRNA was used to synthesise sense-strand cDNA that was then processed 
for the fragmentation and terminal labelling. Prepared samples were hybridised 
for 16 hours at 45ºC on the GeneChip® Chicken Genome Arrays, which contained 
coverage of 32773 transcripts corresponding to over 28000 genes. The arrays 
were washed and stained using Affymetrix procedures on the Fluidics Station 450 
and scanned on the GeneChip Scanner 3000 7G. Raw data from the scanned 
images (n = 12 files, CEL format) were generated using the GeneChip® Command 
Console Software (version 3.2, Affymetrix). 
 
4.3.7.2 Genomic DNA hybridisation  
In order to improve the sensitivity of the high-density oligonucleotide arrays 
when applied to closely related species I used the method developed by 
Hammond et al. (2005). This method allowed me to empirically determine the 
optimal hybridisation efficiency of the GeneChip® Chicken Genome Array probes 
when hybridised to the quail genomic DNA (gDNA), by masking out the probes 
which are inactive due to the difference in sequence between the species, as 
otherwise the hybridisation mismatches would attenuate the overall signal 
calculated across the probe-sets (Ji et al., 2004). I extracted quail gDNA from 
approximately 6mg spleen tissue from 1 randomly selected individual (out of the 
77 experimental quail) using the DNeasy Blood and Tissue kit (Qiagen, 
Manchester, UK). Then, I assessed concentrations and purity of the extracted 
gDNA using the Nanodrop (Thermo Fisher Scientific, Wilmington, DE, USA). Then, 
a total of 500ng gDNA was labelled using the Bioprime DNA labelling System 
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(Invitrogen, Paislely, UK) and hybridised to the GeneChip® Chicken Genome 
Array, followed by washing, staining and scanning processes as described above. 
The GeneChip® Command Console Software (version 3.2, Affymetrix) was used to 
generate the raw data (n = 1 file, CEL format) of the scanned image. 
 
4.3.8 Quantitative real time Polymerase Chain Reaction 
(qPCR) validation 
Traditionally, qPCR is used to validate the gene expression levels measured by 
high-throughput technologies, such as RNA-seq and microarrays. Therefore, I 
compared the gene expression measures obtained by the above mentioned 
platforms with qPCR for the following 5 genes: vasotocin-neurophysin VT(the 
official gene symbol in the chicken genome is AVP as it is considered homologous 
to the mammalian gene encoding arginine vasopressin; however here herein 
referred as AVT to avoid misleading interpretations); transthyretin (TTR); 
superoxide dismutase extracellular 3 (SOD3); glutathione S-transferase Alpha 3 
(GSTA3); guanine nucleotide binding protein (G-protein), Gamma 11 (GNG11) 
(Table 4.1). These genes were chosen for the technical validation across the 
three technologies for three main reasons. First, they are all biologically 
relevant: AVT is implicated in centrally regulated homeostatic processes and 
neuroendocrine responses to stress, as well as in the control of social and 
reproductive behaviours (reviewed by Goodson and Bass, 2001); TTR is a known 
carrier of thyroid hormones and retinal binding protein in the cerebrospinal fluid 
and its gene expression has been shown to be altered by maternal stress in rats 
(Kohda et al., 2006; Wei et al., 2012); SOD3 and GSTA3 are both encoding 
enzymes involved in cellular antioxidant defence processes; GNG11 plays a role 
in transmembrane signalling system and is thought to be involved in cellular 
senescence in humans (Hossain et al., 2006). Second, the above mentioned 
genes were consistently differentially expressed in both the RNA-seq and 
microarrays experiments as measured with RankProducts analyses. Third, in both 
these technologies they showed maximal fold changes differences across the 
treatments. To minimise the technical source of variation, I used the same 
hippocampal RNA pools previously used for the RNA-seq and microarrays 
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analysis. All the qPCR analyses were carried out at the School of Psychology and 
Neuroscience (University of St. Andrews, UK) using a Stratagene MX 3005P 
(Agilent Technologies, Wokingham Berkshire, UK). Although RNA-seq analyses 
revealed other relevant genes to be differentially expressed (e.g. MR and BDNF, 
see Paragraphs 4.4.7.1 and 4.4.8.1), they were not selected for qPCR as they 
were not included in the top-gene lists and the main aim of qPCR was to achieve 
a technical rather than biological validation of the RNA-seq results.     
Table 4.1The 5 genes analysed by quantitative real time PCR (qPCR), cDNA sequence accession 
number from NCBI  Reference Sequence Database (RefSeq: 
http://www.ncbi.nlm.nih.gov/refseq/) with forward (F) and reverse (R) primer sequence and 
probes (Perfect probe, FAM-labelled). 
Gene mRNA primer sequence 5’- to 3’ 
Accession 
number 
Vasotocin-neurophysin VT 
(AVT) 
F: ATGTGCCATGGACGCCG 
R: CCAGCACCGTCAGGTTCTT 
Probe: cTCCGCTGCCTCTTCTGCCTGCTCtcggag 
NM_205185 
Transthyretin (TTR) 
F: ATGAATATGCTGATGTGGTGTTC 
R: GCAGTTGTTGAGTAAGAGAAAGG 
Probe: caACCGCCATTATACCATCGCTGCTCTCCTcggttg 
NM_205335 
Superoxide dismutase, 
extracellular 3 (SOD3) 
F: CCAACCTCTTCGCCACAAT 
R: CAGCATTTCCATTTTCCAGACT 
Probe: acTTGCCCTTGCCCATGTCATCTTCCTGCgcaagt 
XM_420760 
Glutathione S-Transferase  
Alpha 3 (GSTA3) 
F: CAGTTATTGAAGTTATGCCAAGATG 
R: GATTGTATTTCCCTGCGATGTAG 
Probe: aATCCCTGCTGTTCCATCAACTGCCACTGtgggatt 
NM_204818 
Guanine Nucleotide Binding 
Protein (G-Protein),  
Gamma 11 (GNG11) 
F: GATGATCTGAGCGAGAAGGAC 
R: TCGGAGCACTTGGACACC 
Probe: TGCCTCTCCAGCTTCACTTCTTTCCGGAtgaggca 
XM_00123433 
 
4.3.8.1 Reverse Transcription 
First-stranded cDNA was synthesised from total RNA (concentration: 
approximately 250ng) from each sample pool in a reaction mixture (50µl) 
containing Moloney-Murine Leukaemia Virus (M-MLV) Reverse Transcriptase 
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(200units/µl; Invitrogen, Life Technologies, Paisley, UK); random hexamers 
(50µM; Promega, Southampton, UK); dNTPs (10mM); Rnasin (40units/µl; 
Promega), dithiothreitol (DTT; 0.1M), and the appropriate volume of free 
DNAse/RNAse free water, similarly as described in Shaughnessy and Murphy 
(1993). The reaction was first incubated at 65ºC for 5min, then at 37ºC for 50min 
and finally at 70ºC for 15min. The cDNA formed was used as a template for 
qPCR.    
 
4.3.8.2 Primer design and validation  
Primers for amplifying the candidate genes were designed and validated by 
Primerdesign (Southampton, UK). The validation was conducted by testing the 
primers on a quail cDNA sample pool (prepared by pooling cDNA from 4 randomly 
chosen birds used in the present experiment) that I had provided to the 
Manufacturer. The specificity of the primers was regarded as acceptable when 
the following two conditions were achieved: (1) single sharp peak on the melting 
curve, and (2) good reproducibility between the expected thermocycling 
temperature for the amplification (Tm) and the observed Tm of the melting 
curve in accordance with the MIQE (Minimum Information for publication of qPCR 
Experiment) guidelines (Bustin et al., 2009). The probes for each primer were 
then synthesised and tested again on the same provided cDNA template to 
assure the overall efficiency of the probe (Perfect probe, FAM-labelled). It 
should be point out that the gene AVT and the gene encoding mesotocin 
neurophysin MT have a distinct chromosome location in the chicken genome and 
the primers were designed in order to assure no cross-reactivity between these 
two genes.   
 
4.3.8.3 Reference gene validation 
The most common method to normalise qPCR data involves the use of a 
reference gene in order to control for variations in yield in RNA extraction, 
reverse-transcription and efficiency of amplification (Huggett et al., 2005). A 
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fundamental characteristic of a reference gene is its invariant expression under 
the described experimental conditions. As recommended (Bustin et al., 2009), I 
experimentally determined the optimal number and choice of the reference 
genes prior of conducting the qPCR assays (Vandesompele et al., 2002). This 
study was carried out in a sub-set of cDNA hippocampal samples (n = 1 male and 
1 female per each treatment group) randomly chosen among the experimental 
subjects used in this experiment. Briefly, gene expression levels of 6 candidate 
reference genes (1. β-actin or ACTB; 2. Glyceraldehyde-3-phosphate 
dehydrogenase or GAPDH; 3. Tyrosine 3-Monooxygenase/Tryptophan 5-
Monooxygenase Activation Protein, Zeta Polypeptide or YWHAZ; 4. Succinate 
dehydrogenase complex, subunit A, flavoprotein or SDHA; 5. Splicing factor 3a, 
subunit 1 or SF3A1, and 6. Ubiquitin C or UBC) were determined using the 
geNorm kit (Primer design, Southampton, UK) by qPCR. For each qPCR reaction, 
15µl of a PCR mixture and 5µl of cDNA sample (concentration: 5ng/µl) were 
loaded into the well of a 96-plate plate (Primerdesign, Southampton, UK). PCR 
mixtures were prepared daily separately for each reference gene following the 
Manufacturer’s instructions so that each reaction contained: 1µl of primer 
provided in the kit (concentration: 300nM), 10µl of qPCR Mastermix containing 
SYBR green dye (Primerdesign Precision 2X qPCR Mastermix) and 4µl of 
RNAse/DNAse free water. All qPCR reactions were performed in duplicate in a 
unique plate; a reagent blank was included to detect potential contamination by 
genomic DNA. Thermal cycling conditions were: 10min at 95°C (enzyme 
activation), and 50 cycles of 15s at 95°C (denaturation step) and 1min at 60°C 
(primer annealing and elongation). The data were statistically analysed using the 
software “qbase” (Primerdesign, Southampton, UK). This software includes a 
module for geNorm analysis that calculates the gene expression stability 
measure (M) for a reference gene as the average pair-wise variation for that 
gene with all the other tested reference genes (Vandesompele et al., 2002). 
Stepwise deletion of the gene with the highest M value allows ranking of the 
tested genes according to their M values. The analysis performed in the 
measured cDNA samples showed that YWHAZ and β-actin had the lowest M 
values (0.30 and 0.32, respectively) relatively to the other candidate references 
(M ≥ 0.34 for all the others). β-actin was found to be the most stable gene in 
another independent experiment with similar pre- and post-hatching stressful 
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manipulations using brain tissues from adult quail that were obtained from the 
same local breeder (Cedric Zimmer’s personal communication). Given my own 
results and the consistencies with the latter study, β-actin was regarded as the 
most appropriate internal control in the present experiment.  
 
4.3.8.4 qPCR assays  
qPCR was performed using oligonucleotide primers and Taqman probes for β-
actin (reference gene), AVT, TTR, SOD3, GSTA3 and GNG11; sequences for all 
the primers and probes are reported in Table 4.1. qPCR were performed using 
the protocol Brilliant III Ultra-Fast qPCR Master Mix kit (Agilent Technologies, 
Santa Clara, USA).  Each qPCR reaction mixtures (20µl) contained the provided 
Master Mix (10µl); gene-specific primers and probe (1µl); provided reference dye 
(diluted 1:500 in DNAse/RNAse free water) to compensate for non-PCR related 
variation in fluorescence; cDNA template (5µl; concentration: 1ng/µl), and 
finally DNAse/RNAse free water (3.7µl). Thermal cycling conditions were 3min at 
95ºC (initial denaturation step) followed by 50 cycles of 15s at 95ºC and 20s at 
60ºC (primer annealing and elongation). All qPCR reactions were performed in 
duplicate and a reagent blank (also in duplicate) per each gene was included 
within each plate. Gene expression measurements for the 6 genes from each 
individual bird were run in the same plate and individual birds from the different 
treatment groups were randomised across the plates (n = 14). The intra-plate 
coefficient of variation averaged (mean ± SEM) 1.02 ± 0.08%.  
mRNA expression for all the genes was quantified using the comparative cycle 
threshold method (Schmittgen and Livak, 2008) relatively to β-actin.  
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Data analysis methods 
4.3.9 Raw data quality control 
The reads obtained from the sequencing runs were quality checked using the 
Phred Quality (Q) scores (Ewing et al., 1998). Q scores are defined as a property 
that is logarithmically related to the base calling error probabilities. For 
example, a Q score of 30 to a base is equivalent to the probability of an 
incorrect base call 1 in 1000 times (i.e. the base call accuracy is 99.9%). 
Therefore, Q scores ≥ 30 indicate high accuracy. Here, the raw sequencing data 
(containing both the sequences and the associated per base Q scores) were 
generated using Casava version 1.7.0 and stored in 24 files in fastQ format (Cock 
et al., 2009). Initial standard investigations using FastQC software (version .10.0, 
http://www.bioinformatics.bbsrc.ac.uk) confirmed the presence of adapter 
sequences in small proportion (<0.5%) of 3’end of reads due to the corresponding 
cDNA fragments being shorter than 76 bases. It is standard procedure to remove 
the reads contaminated with the adapters to avoid problems with downstream 
analyses. I used an “in-house” software routinely employed in the Glasgow 
Polyomics Facility to remove these contaminated reads and re-analysed each 
individual sample using FastQC to ascertain the absence of adapter 
contamination (data not shown). I then used a Perl script written by Pawel 
Herzyk, which contrary to FastQC, allowed me to graphically represent the Q 
scores in each sequencing cycle per base-call and their associated standard 
deviations across multiple samples.     
 
4.3.10 Trimming and mapping of the RNA-seq reads 
Currently, there are two main valid strategies for assembling reads into genomic 
features, (1) “align-then-assemble” (alignment-first) or (2) “assemble-then-
align” (assemble first or “de novo assembly”) (Haas and Zody, 2010). In species 
lacking a reference genome (as with the Japanese quail), both approaches can 
use the genome of a closely related species for alignment purposes (e.g. Toth et 
al., 2007).  As the primary focus of the current project was to identify 
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potentially differentially expressed genes, without attempting to discover novel 
transcripts, the alignment-first approach was used. This approach confers the 
advantage of a predefined gene-space (i.e. the gene model of the related 
species), allowing for direct comparisons across treatments (Ward et al., 2012). 
Remarkably, this method is also more sensitive for weakly expressed genes than 
the de novo assembly, which instead requires a relatively large sequencing depth 
across the transcript length (Francis et al., 2013). The genome of the chicken 
(Gallus gallus) was chosen as a reference model for the following reasons: (1) 
both chicken and quail are closely related species and belong to the same Family 
(Phasianidae); (2) the high degree of conservation between the two species had 
been recently confirmed by comparative mapping of macrochromosomes (Kayang 
et al., 2006) and by successful application of chicken Affymetrix microarrays to 
Japanese quail gene expression study (Nakao et al., 2008); (3) the chicken model 
provides the best quantitative annotation in comparisons with the other avian 
sequenced genomes, the zebra finch and the turkey.  
Preliminary alignment of quail reads to the chicken genome using the Bowtie 
aligning software (Langmead et al., 2009) showed that only a very small 
percentage of reads (< 40%) aligned to the chicken reference genome when up to 
two mismatches were allowed. Consequently, the 76 bases long reads were 
shortened to 36 bases. The trimming of the reads also assured high quality reads 
(Q scores range: 38-34) with a flatter error profile along the read (Figure 4.4), 
and provided a reasonable compromise between the high number of aligned 
reads and the small number of reads mapped to more than one location in the 
genome (Pawel Herzyk’s personal communication). The final read alignment was 
performed using TopHat version 1.3.2 (http://tophat.cbcb.umd.edu; Trapnell et 
al., 2009), a transcriptomics read aligner able to align reads spanning the exonic 
borders. TopHat was provided with two source of information:  
1. The genomic sequence of the chicken reference genome (FASTA file 
“galGal3” downloaded from http://genome.ucsc.edu and assembled by 
the International Chicken Genome Sequencing Consortium (2004), May 
2006 release): this is a text-based format containing the nucleotide 
sequences of the reference genome in which the bases are represented 
using single-letter codes; 
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2. The chicken genome annotation (WASHUC2 release-65, GTF file 
Gallus_gallus.WASHUC2.65.gtf”, downloaded from http://www.ensembl.org 
and appropriately modified to ensure chromosome name compatibility 
with the FASTA file): this file contains the localisation of the functional 
elements in the genomic sequence (e.g. protein coding genes and location 
of exons within a gene, promoters, tRNA and other RNAs).   
Briefly, the TopHat pipeline first aligns the reads to the reference genome using 
the aligner Bowtie (Langmead et al., 2009). Bowtie, however, does not allow 
alignments between a read and the genome to contain large gaps; hence, it fails 
to align the reads that span an exon boundary. TopHat pipeline can circumvent 
this limitation (Trapnell et al., 2009; Trapnell et al., 2012). First, TopHat 
collects the initially unmapped reads and then assembles the mapped reads. As 
explained in details in Li et al. (2008), during the assembly the mapped 
sequences flanking potential donor/acceptor splice sites (using the canonical 
GT...AG model as more than 99% of introns obey this rule; Mount, 1982) within 
neighbouring regions are joined together to form potential splice junctions. 
TopHat then breaks the initially unmapped reads into smaller segments and 
attempts to align each of them independently to the genome. The previously 
predicted splice junctions sequences are eventually confirmed when a certain 
number of a read’s segments map to the genome far apart from one another 
(between 100 and several hundred kilobases).  
For the final TopHat runs, the default parameters were used, except for a few 
parameters as detailed in Table A1 (Appendix). The deviations from the TopHat 
default settings allowed me to obtain a reasonably high number of quail aligned 
reads to the chicken reference minimising the change of reads mapped to more 
than one location in the genome (Pawel Herzyk’s personal communication). 
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4.3.11 Quantification and normalisation of expression 
signal 
Accurate quantification of the mapped RNA-seq reads requires the employment 
of normalisation methods in order to adjust for varying lane sequencing depths 
and potentially other technical and biological biases (Mortazavi et al., 2008; 
Bullard et al., 2010). Here, I used the TopHat output files (BAM format) to 
quantify and normalise RNA-seq reads using one of the following two methods of 
normalisation depending on the downstream type of analysis: 
1. Number of Fragments mapped Per Kilobase of exon per Million reads 
mapped (herein referred as “FPKM”) implemented in the software 
Cufflinks (Trapnell et al., 2012); 
2. Normalised read counts by combining the software HTSeq and Bayseq 
(Anders and Huber, 2010; Hardcastle and Kelly, 2010).   
The FPKM measure of read density is a function of the molar concentration of a 
transcript in the starting sample by normalising for the transcript length and for 
the total read number in the measurement (Mortazavi et al., 2008). This 
method, therefore, accounts for potential bias due to transcripts with different 
lengths within samples and between samples. In fact, longer genes are more 
likely to be detected as differentially expressed (Oshlack et al., 2009). FPKM 
also controls for the potential overestimating expression values from the reads 
mapping to multiple position in the genome due to sequence repeats and 
homology (Mortazavi et al., 2008). A full description of how FPKM were obtained 
using Cufflinks is provided in the Section 4.3.12.1 below.     
The second normalisation approach does not take into account the gene length. 
Indeed, normalising the reads with respect to gene length was not crucial in this 
experiment as my objective was to compare the expression level of the same 
genes between samples and not to compare expression levels genes to genes 
(i.e. the biases will affect the same gene in the same way across samples). First, 
HTSeq (version 0.5.3p9; Anders and Huber, 2010; http://www-
huber.embl.de/anders/HTSeq) was used to count how many reads map to each 
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gene. The software was provided with (1) the alignment files (SAM format; 1 file 
per sample; 24 files in total), and (2) the chicken annotation GTF file. SAMtools 
Perl Script was used to convert the TopHat alignment files from BAM to SAM 
format (http://samtools.sourceforge.net/; Li et al., 2009). For the HTSeq run, 
the default parameters were used, except for the strandedness (this was set as 
“--stranded=no” because the reads from this experiment had not been made 
with a strand-specific protocol). The obtained raw counts were normalised in the 
software Bayseq prior to the statistical analysis (version 1.8.0, Hardcastle and 
Kelly, 2010; see also Section 4.3.12.2 below) using the 75th percentile of nonzero 
count distribution within each sample (Bullard et al., 2010). This normalisation 
approach has been shown to be a more robust choice over the standard total-
count normalisation, and the overall performance is best among several other 
existing normalisation methods (Bullard et al., 2010).   
 
4.3.12 Differential expression analysis  
Due to the short-history of RNA-seq, the detection of differentially expressed 
genes is a challenging task. Currently there are still no standard procedures. 
Therefore, here, the data were analysed using three different statistical 
packages (Cufflinks, Bayseq, and RankProducts) and the results were compared. 
Cufflinks does expression quantification and normalisation itself employing the 
FPKM, which are then used to detect differentially expressed genes; whilst 
Bayseq and RankProducts use the normalised read counts.   
 
4.3.12.1 Cufflinks 
Cufflinks is an open-source package under continuous development and provides, 
together with TopHat and Bowtie, a complete RNA-seq workflow known 
informally as “tuxedo suite” (http://cufflinks.cbcb.umd.edu; Trapnell et al., 
2010; Trapnell et al., 2012). Cufflinks provides two workflows, (a) “discovery 
mode” where transcripts are built up de-novo from the TopHat alignment data 
using Cufflinks and Cuffmerge modules, followed by differential expression 
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analysis within Cuffdiff module, or (b) “conservative mode” where differential 
expression is analysed using transcript definitions provided in the annotation GTF 
file only, and the Cuffdiff module is directly piped to the TopHat output. Here, I 
have applied the “conservative mode” as I was not interested in discovering new 
transcripts, and, preliminary testing of the “discovery mode” revealed a lack of 
consistency between different software versions (data now shown).   
Cufflinks was provided with (1) the alignment TopHat files (BAM format; 3 
biological replicates per treatment, 12 files in each run), and (2) the chicken 
annotation GTF file, appropriately modified to contain all the required 
attributes. With this approach, results from two different Cufflinks versions 
(1.3.0 and 2.0.1) were consistently similar at the gene expression level and, 
here, I reported the data from the most recent version at the time of the 
analyses (2.0.1, June 2012). As Cufflinks performs only pair-wise comparisons, I 
analysed treatment groups sequentially and separately per tissue, resulting in 6 
contrasts per tissue (as shown in Table 4.4). Prior to statistical testing, Cufflinks 
fits a model of fragment count variances across replicates of each treatment. 
The variance is estimated using (1) the negative binomial distribution when a 
gene had a single isoform (Anders and Huber, 2010), or (2) the beta negative 
binomial distribution when a gene had multiple isoforms. For each gene, the 
log2-fold change between the FPKM values in two experimental conditions and 
their estimated variances produce a variable that is approximately normally 
distributed to which standard statistics can be applied (Student’s t test, two-
tailed); p-values are then adjusted for multiple testing using Benjamini-
Hochberg correction (Benjamini and Hochberg, 1995) and are reported as q-
values (Storey, 2003). To enhance accuracy of differential analyses, the upper 
quartile normalisation (“--upper-quartile-norm”) and the multi-mapped read 
correction (“--multi-read-correct”) were enabled (Bullard et al., 2010; Mortazavi 
et al., 2008). The minimum number of alignments in a locus needed to conduct 
significance testing between samples was set to 1 (“--min-alignment-count”, 
default is 10).  
Exploratory Principal Component Analysis (PCA) plots were performed to assess 
sample grouping across replicates (Partek Genomic Suite, Partek Inc., St. Louis, 
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MO, USA), where samples were represented by an ordered sequence of 
transcript abundances. 
 
4.3.12.2 Bayseq 
Bayseq (version 1.8.0, Hardcastle and Kelly, 2010) is a package from the open-
resource Bioconductor project (http://bioconductor.org; Gentleman et al., 2004) 
implemented in the R environment (version 2.14.2; http://www.r-project.org). 
Similar to Cufflinks, Bayseq is a parametric statistical method that relies on the 
negative binomial distribution to estimate the variance within RNA-seq data 
(Hardcastle and Kelly, 2010). Differently from Cufflinks, however, Bayseq 
implements a Bayesian approach to empirically derive posterior probabilities 
(i.e. the conditional probability that is assigned after the relevant evidence, or 
axiom, is satisfied; Bolstad, 2007) of the observed data given a predefined 
model. Bayseq empirical modelling is based on the assumption that samples 
behaving similarly to each other should follow the same prior distribution, 
whereas samples behaving differently should have different distributions. 
Posterior probabilities are then converted to False Discovery Rate values (FDR).  
Here, Bayseq was primarily chosen because it is the only package that enables 
analyses of experimental designs with more than two conditions. In a four 
condition experiment as in my study, there are 15 possible different model 
combinations: 1 in which there is no differential expression (NDE model) of any 
kind and 14 models showing differential expression (DE models). Of the latter 
there are 4 models in which 1 of the treatments shows differential expression 
compared to the other 3 treatments, 9 models in which 2 treatments show 
differential expression compared to the other 2 treatments, which can be 
combined together or considered as 2 independent groups, and, finally, 1 model 
in which data from all the 4 treatments are different from each other. All the 
models were performed separately in each tissue. Bayseq was also used to carry 
out pair-wise comparisons in each tissue, as described for Cufflinks.  
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4.3.12.3 RankProducts 
RankProducts (Breitling et al., 2004) is a well-established non-parametric 
method for the detection of differential gene expression in microarrays. 
RankProducts has been shown to be more accurate and powerful in comparisons 
with other classical approaches in the presence of noisy datasets with low 
numbers of replicates (Breitling and Herzyk, 2005; Jeffery et al., 2006). Despite 
the large use of RankProducts in microarray experiments, this novel non-
parametric method is not limited to microarrays analyses, but has the potential 
to be applied  to a variety of “omics” (i.e. transcriptome, proteome and 
metabolome) studies as long as the data can be expressed as ranked lists 
(Breitling et al., 2004).  Briefly, RankProducts sorts experimental gene 
expression values by geometric mean of their ranks calculated over all pair-wise 
comparisons using all the sample replicates within a given pair of conditions. 
Ranks are calculated after sorting expression values by log2-fold changes within 
each contrast. 
I analysed the data using RankProd package (version 2.28.0) available from the 
Bioconductor library (http://bioconductor.org; Gentleman et al., 2004) 
implemented in the R environment (version 2.14.2; http://www.r-project.org). 
An important assumption of RankProducts is that the measurement variance is 
approximately equal across all the genes (Breitling et al., 2004; Breitling and 
Herzyk, 2005), which can be met using the started-log data transformation 
(Rocke and Durbin, 2003). Here, a variant of the started-log procedure were 
used where: 4 different constants (1, 8, 16 or 32) were added to the normalised 
counts (produced by Bayseq) in each pair-wise comparison. The highest shifting 
factor (32) appeared to minimise the deviation from constant variance and was, 
therefore, chosen as the final normalisation algorithm [i.e. log2 (normalised 
counts + 32)] before performing RankProducts (Pawel Herzyk’s personal 
communication). The data were analysed separately by tissue using a pair-wise 
approach as described in Cufflinks and Bayseq. RankProducts was carried out 
using the “data from single origin” option; ranks and p-values were calculated 
using 1000 permutations. The analysis controlled for the multiple testing error 
using the Percentage of False-Positives (PFP), which estimates FDR (Storey and 
Tibshirani, 2003).    
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4.3.12.4 Comparison among Cufflinks, Bayseq and RankProducts 
The results obtained by Cufflinks, Bayseq and RankProducts were compared by 
analysing the genes in common across the three approaches using FDR ≤ 0.20 as 
cut-off.  Less stringent cut-offs (0.30 < FDR < 0.20) have been shown to be a 
good strategy to minimise the loss of differentially expressed gene candidates 
when comparing statistical methods with different assumptions in the presence 
of noisy datasets (Zheng, 2012). The comparison was performed in each contrast 
(separately in hippocampus and hypothalamus) and separately in both the up- 
and down-regulated genes. I used the Ensembl identifier 
(http://www.ensembl.org) assigned per each individual gene to merge the 
datasets produced by the 3 packages using R (version 2.14.2; http://www.r-
project.org). For the graphical representation of the comparative data I used 
proportional Venn diagrams (http://omics.pnl.gov/software/VennDiagramPlotter.php). 
 
4.3.13 Vector Analysis 
The results obtained from the RankProducts analysis were further processed 
within the Vector Analysis. Vector Analysis enables a comparison of gene 
expression changes across multiple experimental environments and a dynamic 
analysis of how individuals in each experimental environment respond to a 
specific common stimulus (Breitling et al., 2005). Therefore, Vector Analysis was 
particularly appropriate in the context of this study because it allowed me to 
quantify the extent to which the expression of a given gene may have been 
modified in the adult quail by the independent or combined exposure to pre- 
and post-hatching B in the context of the different developmental environments. 
The basic principle of Vector Analysis is the transformation of expression 
changes of a given gene in two experimental environments into a unique vector 
(|Vsum|), which can be visualised in the Cartesian plane. The length of |Vsum| 
positively correlates with the consistency of the gene expression changes across 
all the possible pair-wise comparisons of the replicate samples; whereas the 
direction of Vsum indicates the type of behavioural prototype (Figure 4.1). 
Vector Analysis also assigns a non-parametric p-value to each prototype by 
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randomly sampling the measured expression values and calculating the |Vsum| 
for these random data. Therefore, by using pre-defined Vsum- and p- cut-off 
values, Vector Analysis confers a higher degree of objectivity than other existing 
graphical tools, such as Venn Diagrams, to further characterise the dynamics of 
genes’ responses in multiple experimental environments.  
 
Figure 4.1Graphical representation of the Vector Analysis performed to examine (a) the long-term 
responses of post-hatching corticosterone (B) exposure given the pre-hatching environments, i.e. 
control (horizontal axis) or exposure to B (vertical axis), and (b) the long-term responses of pre-
hatching B given the post-hatching environments, i.e. control or exposure to B. On the two axes are 
reported the log2-fold changes of genes in response to the developmental environments. In (a) are 
reported two hypothetical vectors (|Vsum|): gene 1 (in red) is strongly up-regulated in both the 
environments; while gene 2 (in green) is specifically down-regulated in the control environment. In 
(a) and (b), the Cartesian plane is systematically sub-divided into sectors corresponding to the 
following prototypical behaviours: genes that show inconsistent responses in either environments 
(“unchanged”, in white); genes that show similar responses in both environments (in blue); genes 
that show opposite responses in both environments (in red), and finally, genes that are specifically 
down-regulated in one environment and not in the other one (in yellow). From Breitling et al., 
(2005) (modif.).  
 
As Vector Analysis enables a two-dimensional representation at a time, here, I 
performed two separate analyses in each tissue using the genes that at least in 
one of the six contrasts showed FDR ≤ 0.10 in the RankProduct analyses (490 
genes in the hippocampus and 302 genes in the hypothalamus). Then, I 
122 
Chapter 4 
 
compared these two analyses in pairs (Figure 4.1), a similar approach to that 
used in previous work (Kilian et al., 2007). The first analysis focused on 
analysing the responses of post-hatching B given the pre-hatching environments, 
which were (1) “pre-hatching exposure to B” using the contrast BB vs BC (Figure 
4.1a) or (2) “pre-hatching exposure to carrier only” using the contrast CB vs CC. 
The second analysis focused on analysing the responses of pre-hatching B given 
the post-hatching environments, which were (1) “post-hatching exposure to B” 
using the contrast BB vs CB or (2) “post-hatching exposure to carrier only” using 
the contrast BC vs CC (Figure 4.1b).   
 
4.3.13.1 Behavioural categories 
The data from these two analyses were filtered (using |Vsum| = 40 and p = 0.1 
as cut-off values) in order to keep statistically significant and high consistency 
data. The resulted data were then decomposed into classes corresponding to the 
following behavioural categories:  
I. Pre and post-hatching B responsive genes: the genes that showed similar 
significant responses in both the pre- and post-hatching environments as a 
consequence of exposure to B regardless of the developmental timing (Figure 
4.2-I).  
II. Specific pre-hatching B responsive genes: the genes that showed (1) no 
response to post-hatching B in either pre-hatching environments, and (2) similar 
significant responses to pre-hatching B in both the post-hatching environments 
(Figure 4.2-II).  
III. Specific post-hatching B responsive genes: the genes that showed (1) similar 
significant responses to post-hatching B in both the pre-hatching environments, 
and (2) no response to pre-hatching treatment in either post-hatching 
environments (Figure 4.2-III); 
  
123 
Chapter 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. Graphical illustration of the behavioural categories (I, II, III) used to filter the Vector 
Analysis results. In all the graphs, the stars represent the vectors |Vsum| of hypothetical genes: 
coloured in red the significant up-regulated genes in one or both the pre- and post-hatching 
environments; in green the significant down-regulated genes in one or both the environments; and 
in black the genes whose responses were not significant specifically in one environment. A gene 
was significant when: |Vsum| ≥ 40 and p ≤ 0.1 and non-significant when: |Vsum| ≤ 40 and p ≥ 0.1.  
124 
Chapter 4 
 
Interacting pre- and post-hatching B responsive genes: the genes that showed 
(1) similar significant responses to post-hatching B in both the pre-hatching 
environments and (2) similar significant responses to pre-hatching B in both the 
post-hatching environments. In this category two distinct biologically relevant 
patterns were distinguished depending on whether the similar responses within 
the two environments are similar or opposite when compared between the 
environments. Specifically:  
Similar between-environment responses:  
IV. This implied a “cumulative effect” via elevating or attenuating expression 
depending on whether the fold changes BB/CB, BC/CC, BB/BC and CB/CC 
were all positive and similar, or, all negative and similar (Figure 4.3-IV).  
Opposite between-environment responses: this implied a “null effect”, which 
could occur in two distinct ways:  
V. Via elevating gene expression in the BC birds with the fold changes BB/CB 
and BC/CC both positive and similar to each other whilst the fold-changes 
BB/BC and CB/CC were both negative and similar to each other (Figure 4.3-V), 
or,    
VI. Via elevating gene expression in the CB birds with the fold changes BB/CB and 
BC/CC both negative and similar to each other, whilst the fold-changes BB/BC 
and CB/CC were positive and similar to each other (Figure 4.3-VI).     
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Figure 4.3. Graphical illustration of the behavioural categories (IV, V, VI) used to filter the Vector 
Analysis results. In all the graphs, the stars represent the vectors |Vsum| of hypothetical genes: 
coloured in red the significant up-regulated genes in one or both the pre- and post-hatching 
environments; in green the significant down-regulated genes in one or both the environments; and 
in black the genes whose responses were not significant specifically in one environment. A gene 
was significant when: |Vsum| ≥ 40 and p ≤ 0.1 and non-significant when: |Vsum| ≤ 40 and p ≥ 0.1.  
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4.3.14 Gene annotation and functional analysis 
The web-based functional annotation tool “Database for Annotation, 
Visualization and Integrated Discovery” or “DAVID” (version v6.7, 
http://david.abcc.ncifcrf.gov/) was used to annotate the significant candidate 
genes identified by RankProducts and Vector Analysis. A unique list of Ensembl 
identifiers were uploaded via the web interface and the background was 
selected as Gallus Gallus.  
Ingenuity Pathway Analysis (IPA, Ingenuity Systems, 
http://www.ingenuity.com/products/ipa) was used to identify possible 
biological processes associated with the differentially expressed significant gene 
lists obtained after applying the behavioural categories as described above 
(Section 4.3.13.1). For each gene list containing at least 14 genes, a unique list 
of gene identifiers (Ensembl IDs) was submitted to the IPA server. Here, each 
Ensembl IDs was mapped to its corresponding gene object in the Ingenuity 
Knowledge Base (IKB) via ortholog mapping (to their vertebrate counterparts 
including Human, Mouse and Rat). All information in the IKB is curated from the 
published literature and co-functioning genes are supported by evidence 
extracted from the underlying publications. The IKB converts each submitted 
gene list into a shorter dataset of well-characterised, non-redundant “focus” 
genes. These genes are then projected onto a global molecular network 
generated from the information contained in the IKB and a number of small 
networks (here, up to 35 genes in total per network, default parameter) can be 
algorithmically generated on the basis of their inter-connectivity. Subsequently, 
for each network the genes associated with biological functions are identified 
and Fisher’s exact test is then used to calculate p-values, determining the 
probability that each biological function assigned to a given network is due to 
chance alone. The Fisher exact test p-values are converted to the score equal to 
-log10(p-value). The whole dataset of the “focus” genes is then analysed in order 
to identify the most representative gene functional and canonical pathways 
classes. The “focus” genes associated with the canonical pathways are identified 
and the significance of such association is measured in two ways:  
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1. A ratio of the number of genes from the datasets that map to a given 
pathway, divided by the total number of genes that map to that pathway, 
is displayed;   
2. The Fisher’s exact test is used to calculate p-values and determines the 
probability that the association between the genes in the dataset and a 
given canonical pathway is explained by chance alone.  
Finally, IPA analysis also identifies the “upstream regulators” (i.e. any molecule, 
such as a transcription factor, cytokines, receptors or other chemicals, that can 
affect the expression of another molecule) that may be responsible for the 
observed gene expression changes in order to enhance the understanding of the 
biological activities occurring in the analysed tissue/s or cell/s.    
 
4.3.15 Microarray data analysis 
4.3.15.1 Probe selection using gDNA hybridisation  
The raw data (n = 1 file, CEL format) obtained from the hybridisation of quail 
gDNA to the GeneChip® Chicken Array contained hybridisation intensities 
between the Japanese quail genomic fragments and all the chicken probes. The 
GeneChip® Chicken Array use probe-sets, each comprising 11 probe-pairs to 
quantify abundance for each transcript. Each probe-pair consists of a perfect-
match (PM) and a mismatch (MM) probe: the PM probe is a 25-base sequence 
complementary to the target transcript, while the MM probe is identical to the 
PM probe except for the presence of a single mismatch at the 13th base. The 
information about positioning of individual probes on the array and grouping the 
probe-pairs into probe-sets is specified in the chip definition file (cdf file). Using 
Xspecies software (version 2.1, Hammond et al., 2005)  I have modified the 
GeneChip® Chicken Array cdf file so that it would retain only the probe-pairs in 
which the PM probe has a gDNA hybridisation intensity signal greater than the 
user predefined threshold (Hammond et al., 2005).  
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As I did not have any a priori definition for threshold intensity settings, I 
performed a pilot study (i.e. Hammond et al., 2005; Graham et al., 2010) to 
determine the best intensity value that could maximise the removal of probe-
pairs that hybridized weakly, but, at the same time, minimising the loss of 
probe-sets. The new modified cdf files were produced with the following gDNA 
hybridisation threshold intensities: 50; 100; 150; 200; 250; 300; 350; 400; 450; 
500; 600; 700; 800; 900 and 1000. Consistent with the previous studies 
(Hammond et al., 2005; Graham et al., 2010), Figure 4.4a shows that the number 
of probe-pairs retained in the probe mask files reduced rapidly at increasing 
thresholds, while the number of probesets retained reduced at a much slower 
rate. At gDNA hybridisation intensity threshold of 200, 62.24 % of probe-pairs 
were removed in the probe-mask file, whilst 95.19 % of probesets were 
maintained. As at threshold intensities higher than 200 the number of probesets 
starts decreasing at a faster rate (Figure 4.4b), the use of this value appeared 
optimal for the present experiment. Therefore the cdf file obtained using a 
threshold intensity of 200 was chosen for undertaking the later transcriptome 
analysis.  
 
Figure 4.4 Number of probe-pairs (a) and probe-sets (b) used to examine the transcriptome of the 
Japanese quail, as a function of the quail genomic DNA (gDNA) hybridisation intensity thresholds  
used to modify the chip definition files.  
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4.3.15.2 Statistical transcriptome analysis  
Prior of analyses, Affymetrix library files were downloaded 
(http://www.affymetrix.com/support/technical/libraryfilesmain.affx, August 2012). 
These files provided the chicken genome version galgal3 (Ensembl release 60); 
the cdf file for GeneChip® Chicken Array was modified as described above 
(Section 4.3.15.1). Raw data cel files (n = 12) of the RNA hybridised samples 
were normalised using the GC-content by the Robust Multichip Average method 
within Genomics Suite (Partek, Saint Louis, USA). Normalised data were quality 
checked using the available metrics in Partek software. Normalised raw data 
resulted in a total of 36684 probesets. Probesets lacking an annotation (gene 
symbol and/or Ensembl Identifier) were filtered out (27.7 % of total probesets) 
and only the annotated transcripts (26522) were statistically analysed.  
Principal Component Analysis (PCA) plots were first performed to assess 
replicate clustering within each condition. The log2-transformed normalised 
signal intensities of annotated transcripts were then analysed using two-way 
ANOVA to identify the genes that were differentially expressed by the pre- or 
post-hatching treatment, or their potential interactions. To control for false 
positives, p-values were adjusted for multiple comparisons using false discovery 
rate (FDR or q-value) (Benjamini and Hochberg, 1995); a cut-off of FDR ≤ 0.1 was 
used to identify differentially expressed genes.  
Independently from ANOVA, I also performed the non-parametric RankProducts 
(Breitling et al., 2004) to analyse differential expression in pair-wise 
comparisons as described above (section 4.3.12.1), and then compared the data 
with those obtained from the RNA-seq experiment. 
 
4.3.15.3 Comparison between RNA-seq and Microarrays  
In order to achieve an objective comparison between Microarrays and RNA-seq 
platforms, a common unique set of transcripts between the two platforms were 
identified using the Ensembl identifiers; all the other non-common transcripts 
were filtered out. To analyse the correlation between RNA-seq and Microarray 
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data, I performed non-parametric Spearman-correlation tests between each 
biological replicate using both common and non-redundant Ensembl identifiers 
between the two technologies (n = 7172). The redundancies were mainly due to 
the nature of the Microarray data as there may be multiple probe-sets mapping 
to the same transcript.  In order to compare the potentially differentially 
expressed genes detected by RankProducts from RNA-seq and Microarray data, I 
first obtained 6 databases (one per each pair-wise comparison) of common 
transcripts between the two platforms, and then, I selected the common up- and 
down-regulated genes using the non-stringent FDR cut-off value of 0.20 (Zheng, 
2012).  
 
4.3.16 Hardware specifications  
TopHat and Cuffdiff were run on a shared server with 16 cores, 16GB RAM and 
24TB hard-disk (Glasgow Polyomics Facility, University of Glasgow, UK). All the 
other packages used were run on desktop computers with at least 4GB RAM.  
 
4.4 Results 
4.4.1 RNA quality control 
The RNA quality of all the 48 individuals selected for the RNA-seq experiment 
was excellent in both the hippocampus and hypothalamus (RINs: mean ± SEM, 
9.10 ± 0.06 and 9.34 ± 0.05, respectively). Importantly, storage time did not 
alter the RNA quality in the RNA hippocampal pools, which was assessed just 
prior the start of the microarray experiments (RIN: mean ± SEM, 8.90 ± 0.04; see 
also Figure A2 in the Appendix for the electropherogram images).   
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4.4.2 Raw data quality control 
The Phred quality distributions per sequencing cycle for all the 24 samples can 
be seen in Figure 4.5.  In both the hippocampal and hypothalamic samples the 
accuracy of the reads was overall high throughout the sequencing runs (Q ≥ 30). 
However, as expected from Illumina technology, the error score associated to 
the base-calls in each cycle tended to increase after approximately 30-35 cycles.  
 
4.4.3 Read Alignment   
I extracted key alignment metrics from the TopHat outputs, as shown in Table 
4.2. As can be seen, between 56% and 62% of reads mapped to the reference 
genome. After correcting for multiple mapping, I found between 52% and 57% 
unique hits to the reference genome. The number of reads spanning the 
predicted splice junctions varied between 856832 and 1552242, which 
corresponded to 6.4-7.2% of all the mapped reads.  
   
 
 
 
 
 
 
 
 
  
Table 4.2 Alignment basic statistics across the 3 biological replicates in each treatment (CC, BC, CB 
and BB) in (a) hippocampus and (b) hypothalamus. Data were expressed as % relatively to the total 
number of sequenced reads. The latter information was extracted from the FastQC summary outputs.   
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Figure 4.5 Plots showing the average Illumina quality Phred scores (estimating the accuracy of the 
reads) and their corresponding standard deviations (referred as “SD in the legend and estimating 
the error score) in each cycle per base-call along the 76 bases reads in the (a) hippocampus (n = 
12) and (b) hypothalamus (n = 12) across the three pooled biological replicates (repl 1, repl 2 and 
repl 3) in each experimental treatment group (CC, BC, CB, or BB). The values were calculated 
using a Perl script written by Pawel Herzyk. The dotted line at the level of the 36
th
 base represents 
the length chosen to trim the reads that were then used in the further analyses as after this 
sequencing cycle the quality of the cycle per base-call tended to decrease consistently across all 
the samples.  
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4.4.4 PCA 
The PCA plot of all the RNA-seq samples clearly shows 2 tissue-specific 
expression patterns along the PC1, which explained 28.1% of the global variation 
(Figure 4.6).  
The PCA plot with only the hippocampal samples showed a larger variation in the 
BB and CB samples in comparison with the CC and BC samples (Fig 4.7a). In the 
hypothalamus, replicate samples within the CC, BC or BB treatment showed a 
good clustering among each other, while high within-treatment variability was 
detected in the CB samples (Figure 4.7b). Such high within-treatment variation 
is likely to represent true biological variation (due to the RNA pooling approach), 
rather than technical biases of the RNA-seq analysis (see Paragraph 4.5.2 for a 
discussion on this aspect). This complicating factor was taken into consideration 
and minimised in the differential gene expression statistical analysis by filtering 
out the data that showed inconsistent gene expression responses within the 
treatment biological replicates according to the specific biological questions of 
this study (see Paragraphs 4.4.5.2, 4.4.6, and 4.4.7).     
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Figure 4.6 Principal Component Analysis plot (PCA) of all RNA-seq sample (n = 24) using the 
FPKM produced by Cufflinks (n = 17914 transcripts). Data are clustered by tissue type using the 
centroid function, regardless of the treatment groups. Red circles: hippocampal samples; blue 
circles: hypothalamic samples. PC #1 = first component, explaining 28.1% of the variation across 
genes; PC #2 = second component, explaining 10.1% of the variation across genes, and PC #3 = 
third component, explaining 7.29% of the variation across genes. Similar PCA plot was obtained 
using the RNA-seq count data obtained by HT-Seq (data not shown). 
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Figure 4.7 Principal Component Analysis (PCA) plots of RNA-seq samples in the (a) hippocampal 
samples (n = 12) and (b) hypothalamic samples (n = 12) using the FPKM produced by Cufflinks (n 
= 17914 transcripts). Data are clustered by treatment groups (using the centroid function). Purple 
circles = CC; blue circles = BC; green circles = CB, and red circles = BB. PC #1 = first component, 
PC #2 = second component; PC #3 = third component; % values measure the variation explained 
by each component.  Similar PCA plots were obtained using the count data obtained using HT-Seq 
(data not shown).  
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4.4.5 Pilot study: RNA-seq intra-platform statistical 
comparison    
4.4.5.1 Bayseq multi-factorial models  
In the hippocampus 4 out of 14 DE models showed genes with FDR ≤ 0.20 for a 
total number of 32 genes, whereas in the hypothalamus only 1 out of 14 DE 
models showed 2 genes with FDR ≤ 0.20 (Table 4.3). Annotation of these genes 
and statistics is reported in Table A2 and A3 (Appendix); as can be noticed, 
there was a high biological variation. The top- differentially expressed genes 
(FRD: 0.05-0.1) tended to have low count scores (i.e. counts < 5) and are likely 
to be false positives (Table A2).  
Table 4.3 Number of genes with FRD ≤ 0.20 in Bayseq models (DE). Treatment groups in brackets 
define group of samples with the same distribution. In each treatment group there are 3 biological 
replicates. 
Model name Model description Tissue Genes FRD ≤ 0.20 
DE2 (CC, BC, CB) (BB) hippocampus 11 
DE4 (BC, BB, CB) (CC) hippocampus 9 
DE6 (CC, BB) (BC, CB) hippocampus 3 
DE7 (CC, CB) (BC, BB) hippocampus 9 
DE5 (CC, BC) (BB, CB) hypothalamus 2 
 
4.4.5.2 Differential expression pair-wise analyses using Cufflinks, 
Bayseq and RankProducts 
The total number of genes at FDR ≤ 0.20 across Cufflinks, Bayseq and 
RankProducts are shown in Table 4.4. As can be seen, RankProducts showed a 
tendency to capture larger number of genes, followed closely by Cufflinks whilst 
Bayseq found far less genes among the majority of the contrasts. Furthermore, 
the concordance between Cufflinks and RankProducts was high with 80.26 ± 
14.73% (mean ± SD) of shared genes in the hippocampus and 79.78 ± 18.95% 
(mean ± SD) of common genes in the hypothalamus (Figures 4.8-4.11). Full 
details of the genes that were differentially expressed across all the three 
methods in each contrast are presented in Table A4 (Appendix).  
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In the hippocampus, the contrast BC vs CC is of particular interest because it 
showed the most enriched gene lists in Cufflinks, Bayseq and RankProducts with, 
respectively, 18 and 41 up- and down-regulated genes across all three methods 
(corresponding respectively to 58.57% and 39.13% of the genes detected by 
Bayseq) (Figure 4.8). 
Table 4.4 Total number of differentially expressed genes at FDR ≤ 0.20 across Cufflinks, Bayseq 
and RankProducts in the (a) hippocampus and (b) hypothalamus. Arrows indicate gene expression 
directional changes (down- or up-regulation) and refers to the 2
nd
 class vs 1
st
 class.   
 
 (a) Hippocampus    
Contrast 
(2nd class vs 1st class) 
Cufflinks 
 
Bayseq 
 
RankProducts 
 
BC vs CC 180 80 70 46 349 324 
CB vs CC 45 9 1 0 79 5 
BB vs CC 90 52 13 2 185 75 
CB vs BC 6 37 0 1 29 13 
BB vs BC 32 141 5 0 172 142 
BB vs CB 33 99 0 0 7 97 
 
(b) Hypothalamus Contrast 
(2nd class vs 1st class) 
Cufflinks 
 
Bayseq 
 
RankProducts 
 
BC vs CC 32 37 0 1 32 56 
CB vs CC 6 43 0 0 15 42 
BB vs CC 20 86 3 63 68 263 
CB vs BC 14 32 0 0 53 54 
BB vs BC 15 64 2 19 37 188 
BB vs CB 6 1 0 0 3 13 
 
The RankProducts down-regulated gene list from the  BC vs CC comparison 
included most of the genes that were detected by Cufflinks and Bayseq (95.5% 
and 92.8%, respectively) plus 43.8% more genes; similarly, RankProducts up-
regulated gene list in the same contrast included 93.4% and 92.5% of the genes 
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captured respectively by Cufflinks and Bayseq, and added 68.51% more genes. 
Importantly, among the relevant up-regulated genes there were those coding the 
MR receptor (nuclear receptor subfamily 3, group C, member 2) and the G-
protein-coupled estrogen receptor; while among the top down-regulated genes 
there were somatostatin II; proenkephalin; transthyretin; superoxide dismutase 
3, extracellular; growth hormone regulated TBC protein 1 (Table A4a, 
Appendix).  
In the hypothalamus, the contrast BB vs CC showed the mostly populated gene 
lists across the three methods and the expression differences were skewed 
towards an up-regulation: 43 up-regulated genes in the BB birds compared to the 
CC birds were shared among Cufflinks, Bayseq and RankProducts (corresponding 
to 68.2% of the total genes captured by Bayseq; Figure 4.10). Again, 
RankProducts appeared to be the least conservative by including 100% and 96.8% 
of the genes found by Cufflinks and Bayseq, respectively, and found 159 more 
genes (Figure 4.10). Of particular interest is the significantly higher expression 
detected by the three packages of two types of serotonin receptors (5-
hydroxytryptomine receptor 2C and 5-hydroxytryptomine receptor 3A) in the 
pre- and post-hatching B-exposed birds compared with the controls (Table A4b, 
Appendix).   
In summary, the comparison across the three statistical methods within each 
pair-wise contrasts suggested that RankProducts was the best statistic due to the 
limited number of biological replicates for each treatment; large intra-replicate 
variation within each treatment and the overall good reproducibility with 
Cufflinks data, showing on average approximately 80% of overlapping genes in 
both the hippocampal and hypothalamic tissues between these two packages.  
RankProducts showed higher sensitivity than Cufflinks and Bayseq, consistently 
detecting higher numbers of differentially expressed candidate genes in almost 
all comparisons. However, in the awareness that the larger number of genes 
detected by RankProducts might also include a higher proportion of false 
positives, RankProducts data were further filtered using Vector Analysis 
(Breitling et al., 2005) as explained in detail below (Section, 4.4.7). To some 
extent the use of Vector Analysis also allowed me to overcome the limitation 
due to the pair-wise comparison approach.     
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Figure 4.8 Proportional Venn Diagrams showing all the number of genes within the hippocampus 
in common across Cufflinks, Bayseq, and RankProducts (indicated as RankProd) at FDR ≤ 0.20 in 
the contrasts BC vs CC, CB vs CC, and BB vs CC. Comparisons were performed separately for 
down- and up-regulated genes (as indicated by the arrows); gene expression directional changes 
refer to the 2
nd
 class vs 1
st
 class.      
Hippocampus 
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Figure 4.9 Proportional Venn Diagrams showing all the number of genes within the hippocampus 
in common across Cufflinks, Bayseq, and RankProducts (indicated as RankProd) at FDR ≤ 0.20 in 
the contrasts CB vs BC, BB vs BC, and BB vs CB. Comparisons were performed separately for 
down- and up-regulated genes (as indicated by the arrows); gene expression directional changes 
refer to the 2
nd
 class vs 1
st
 class 
Hippocampus 
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Figure 4.10 Proportional Venn Diagrams showing all the number of genes within the hypothalamus 
in common across Cufflinks, Bayseq, and RankProducts (indicated as RankProd) at FDR ≤ 0.20 in 
the contrasts BC vs CC, CB vs CC, and BB vs CC. Comparisons were performed separately for 
down- and up-regulated genes (as indicated by the arrows); gene expression directional changes 
refer to the 2
nd
 class vs 1
st
 class 
Hypothalamus 
Cufflinks (6) 
RankProd (15) 
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Figure 4.11 Proportional Venn Diagrams showing all the number of genes within the hypothalamus 
in common across Cufflinks, Bayseq, and RankProducts (indicated as RankProd) at FDR ≤ 0.20 in 
the contrasts CB vs BC, BB vs BC, and BB vs CB. Comparisons were performed separately for 
down- and up-regulated genes (as indicated by the arrows); gene expression directional changes 
refer to the 2
nd
 class vs 1
st
 class. 
Hypothalamus 
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4.4.6 RankProducts analysis 
The number of significant candidate genes revealed by RankProducts across the 
pair-wise contrasts in both the hippocampal and hypothalamic samples is shown 
in Table 4.5. 
Table 4.5 Number of significant transcripts (FDR ≤ 0.10) that were up- or down- regulated across 
the pair-wise comparisons in the (a) hippocampus and (b) hypothalamus.  
(a) Hippocampus   
Contrast: 
(2nd class vs 1st class) 
up-regulated genes 
under 2nd class 
down-regulated genes 
under 2nd class 
BC vs CC 159 231 
CB vs CC 3 21 
BB vs CC 19 127 
CB vs BC 4 10 
BB vs BC 53 43 
BB vs CB 43 2 
   
(b) Hypothalamus  
 
Contrast: 
 
(2nd class vs 1st class) 
up-regulated genes 
under 2nd class 
down-regulated genes 
under 2nd class 
BC vs CC 56 32 
CB vs CC 21 5 
BB vs CC 159 22 
CB vs BC 24 31 
BB vs BC 117 19 
BB vs CB 10 3 
 
As can be seen, overall, RankProducts detected a higher number of candidate 
genes in the hippocampus than in the hypothalamus. The top 20 up-and down-
regulated genes per each comparison in both the tissues are shown in Table A5 
(Appendix). Specifically, in the hippocampus, the birds exposed to B only pre-
hatching showed the highest number of differentially expressed genes when 
compared with the adult controls; the differences were skewed towards a 
repression of gene expression with the fold changes for the down-regulated 
genes ranging from -18.2 to -1.5, whilst the fold changes for the up-regulated 
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significant genes ranging from 1.9 to 1.4 (Table A5a, Appendix). The birds that 
were treated both pre- and post-hatching also showed several down-regulated 
genes (fold change ranged from -28.1 to -1.6; Table A5a, Appendix) when 
compared to the control individuals and among the top down-regulated genes 
there were transthyretin, arrestin, and extracellular-superoxide dismutase 3 
similar to what was observed in the BC vs CC comparison. In the hypothalamic 
samples, the comparisons between BB vs CC and BB vs BC showed the highest 
number of significantly expressed candidate genes and, in contrast with what 
was observed in the hippocampus, the transcriptome differences were skewed 
towards an overall increase in gene expression with fold changes ranging from 
3.3 to 1.4 (Table A5b, Appendix).   
 
4.4.7 Vector analysis and behavioural categories  
A graphical summary and the number of genes that were filtered according to 
the behavioural categories using the Vector Analysis (Section 4.3.13.1) are 
reported in Figures 4.12-4.16 and Table 4.6 (in Table A6 in the Appendix is 
shown the complete lists of genes for each category). 
Table 4.6 Number of genes belonging to each behavioural category (see Section 4.3.13.1 for full 
methodological details) in the hippocampal and hypothalamic samples.  
 
Behavioural category Hippocampus Hypothalamus 
I. Pre- and post-hatching B responsive genes 62 19 
II. Pre-hatching B responsive genes 29 14 
III. Post-hatching B responsive genes 0 88 
IV. Pre- and post-hatching B responsive genes:  
“cumulative effect” 
30 3 
V. Interacting pre- and post-hatching B responsive genes: 
“null effect” via elevating expression in BC and reducing 
expression in CB 
0 5 
VI. Interacting pre- and post-hatching B responsive genes: 
“null effect” via elevating expression in CB and reducing 
expression in BC 
1 2 
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4.4.7.1 Hippocampus 
Consistently with the pair-wise RankProducts analysis, the overall long-lasting 
effects induced by the pre-hatching exposure to B in the hippocampus were 
stronger than those induced by post-hatching B (Figures 4.12-4.13). In fact, 
while no genes were specifically regulated by post-hatching B alone, 29 genes 
(5.92% of the total 490 genes) were detected as specifically regulated by pre-
hatching B (Figure 4.12-II). The changes observed in these pre-hatching B 
sensitive genes were strongly skewed towards a repression of their expression, 
with 28 genes down-regulated and only 1 gene up-regulated. Moreover, there 
were 62 genes (12.65% of the total) that were affected by the overall effect of 
pre- and post-hatching B, regardless of the timing of exposure, meaning that in 
such genes the abundance values across the B-treated birds (i.e. BC, CB and BB) 
were similar, but significantly different when compared to the control birds 
(Figure 4.12-I). Similarly as before, the changes in transcript abundance of such 
genes were skewed towards a down-regulation (49 genes were down-regulated 
and 13 were up-regulated). Importantly, the gene encoding the MR receptor 
(NR3C2) and not the GR receptor (NR3C1) was significantly up-regulated in the 
B-phenotypes compared to the controls (Figure 4.14; Table A6, Appendix). In 30 
transcripts (6.12% of the total) the long-term effects of pre- and post-hatching B 
were “cumulative” in the birds that experienced both the protocols: 28 genes 
were down-regulated and only 2 genes up-regulated (Figure 4.13-IV). 
Interestingly, the pre- and post-hatching treatment induced opposite effects on 
AVT, with post-hatching B elevating its expression and pre-hatching B decreasing 
it (Figure 4.13-VI). As result of this opposite interaction the expression values in 
the BB birds were similar to those observed in the control (“null effect”).  
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Figure 4.12 Up-regulated (red) and down-regulated (green) genes within the hippocampus filtered 
according to the behavioural categories I and II described in full detail in the Section 4.3.13.1.   
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Figure 4.13 Up-regulated (red) and down-regulated (green) genes within the hippocampus filtered 
according to the behavioural categories IV and VI described in full detail in the Section 4.3.13.1.   
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Figure 4.14 Expression values (counts) of the gene coding (a) the mineralocorticoid receptor or 
MR (NR3C2), (b) the glucocorticoid receptor or GR (NR3C1), and (c) the comparison of the MR/GR 
expression ratio across the treatment groups (CC, BC, CB, and BB) in the hippocampal samples. 
In (a) * indicates significant differential expression (behavioural category I, see also Figures 4.2-I 
and 4.12-I).  
 
4.4.7.2 Hypothalamus 
In contrast with what was observed in the hippocampus, in the hypothalamus the 
magnitude of the long-term effects of post-hatching B was higher than that 
caused by pre-hatching B and, overall, the genes’ dynamic changes across the 
post-hatching B-treated birds were skewed towards an up-regulation (Figures 
4.15-4.16). In fact, the expression of 88 hypothalamic genes (22.64% of the total 
302 transcripts; 85 and 3 genes were up- and down-regulated, respectively) was 
specifically modulated by B administered during the post-hatching development 
(Figure 4.15-III), whereas only 14 transcripts (4.63% of the total, 10 and 4 genes 
were up- and down-regulated, respectively) were specifically regulated by the 
exposure to B in ovo (Figure 4.15-II).  Only a few number of genes (n = 19, of 
(a) (b) 
(c) 
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which 12 were up-regulated and 7 down-regulated; 6.29% of the total) showed 
the same dynamic responses to the pre- and post-hatching B protocols when 
compared to the controls (Figure 4.15-I). As shown in Figure 4.16-IV, cumulative 
interacting changes in the birds that experienced the combined stress exposure 
were identified in 3 transcripts (0.99%), of which 2 (C-type lectin domain family 
3; member B and similar to protocadherin gamma C5) and 1 
(ENSGALG00000023036, not annotated) were respectively up- and down-
regulated. The negative interactions of pre- and post-hatching B were seen in 7 
genes (2.32% of the total) with 5 genes (pappalysin 2; similar to neuropilin-2a1 
receptor; neuropilin 2; adhesion molecule with Ig-like domain 2; 
ENSGALG00000016258 (not annotated); chloride intracellular channel 5) showing 
a “null effect” via up-regulation of pre-hatching B and down-regulation of post-
hatching B and (Figure 4.16-V), and 2 genes (complement component 1, q 
subcomponent-like 4;  ENSGALG00000024011 (not annotated)) showing a “null 
effect” via up-regulation of post-hatching B and down-regulation of pre-hatching 
B (Figure 4.16-VI).    
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Figure 4.15 Up-regulated (red) and down-regulated (green) genes within the hypothalamus filtered 
according to the behavioural categories I, II and III described in full detail in the Section 4.3.13.1.   
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Figure 4.16 Up-regulated (red) and down-regulated (green) genes within the hypothalamus filtered 
according to the behavioural categories IV, V and VI described in full detail in the Section 4.3.13.1.    
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4.4.8 Functional analysis 
4.4.8.1 Hippocampus 
Pre- and post-hatching B responsive genes (category I, Figures 4.2-I and 4.12-
I). The submission to the IPA server of 62 pre- and post-hatching B responsive 
genes resulted in successful mapping of 48 genes (38 down- and 10 up-regulated 
genes, respectively), and of these, 45 were considered as non-redundant “focus” 
genes with records in the IPA database (Table A7a, Appendix). The significant 
biological functions associated with the long-term effects of pre- and post-
hatching B are shown in Table A8a (Appendix). The most significant biological 
category was associated with “Renal and Urological Disease” and included the 
gene coding the MR receptor (NR3C2, see also Figure 4.14) as well as arginine 
vasopressin receptor AVPR2 (mammalian homolog of AVTR2 in birds – IPA analysis 
is based on mammalian genomic findings as explained in Paragraph 4.3.14). The 
most enriched significant biological function was “Nervous System Development 
and Function” with 14 focus genes, including the brain-derived neurotrophic 
factor (BDNF), NR3C2, superoxide dismutase 3 (SOD3), neuronal differentiation 6 
(NEUROD6), Ca++ - dependent secretion activator 2 (CADPS2), and agrin (AGRN). 
The genes BDNF, NR3C2 and CADPS2 are known modulator of several stress-
related behaviours, such as spatial memory and exploratory behaviour (Table 
A8a, Appendix). The network analysis revealed the existence of 6 networks with 
the scores between 30 and 3, which together contained 43 out of 45 genes. The 
top network (Figure 4.17) contained 14 “focus” genes and included NR3C2, 
BDNF, SOD3, AVPR2, tyrosinase-related protein 1 (TYRP1), and TIMP 
metallopeptidase inhibitor 3 (TIMP3).  The most significant canonical pathway 
identified was Superoxide Radicals Degradation with SOD3 and TYRP1 (p = 9.15E-
05, ratio = 0.25), which are both involved in oxidation-reduction processes. 
Interestingly, the upstream analysis identified the hormone B among the top 5 
regulators (p = 7.02E-04) for the target genes BDNF, NR3C2 and secreted 
frizzled-related protein 1 (SFRP1).  
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Pre-hatching B responsive genes (category II, Figures 4.2-II and 4.12-II). Out of 
29 pre-hatching B responsive genes, 25 were successfully mapped to IPA (23 
genes were “focus” genes) and are shown in Table A7a (Appendix). All the 
significant biological functions linked with the specific long-term effects induced 
by exposure to B in ovo are shown in Table A8a (Appendix). The top significant 
biological function was associated with “Endocrine System Development and 
Function” and included cytochrome P450, family 19, subfamily A, polypeptide 1 
or aromatase (CYP19A1); melanocortin 4 receptor (MC4R); transthyretin (TTR), 
and Wolfram syndrome 1 (wolframin) or WFS1. The most enriched biological 
function belonged to the class “Molecular Transport” and included TTR, 
CYP19A1, MC4R, proenkephalin (PENK), and melanocortin 5 receptor (MC5R). 
The network analysis found 3 networks with the scores ranging from 27 to 2, 
which contained 22 genes out of 25. The top network (Figure 4.18) contained 11 
focus genes, including TTR, PENK, CYP19A1, WFS1, and MC4R. The top 5 
canonical pathways included from 3 to 1 focus genes. The canonical pathway 
with the highest number of molecules (p = 4.1E-03, ratio = 0.01) was “G-Protein 
Coupled Receptor Signalling” with the genes MC4R, MC5R and RAS guanyl 
releasing (RASGRP1). The upstream analysis identified a significant association 
between the synthetic glucocorticoid dexamethasone and the genes CYP19A1, 
MC4R, PENK, TTR and fibulin 1 (FBLN) (p = 1.17E-02).  
Interacting pre- and post-hatching B responsive genes: “cumulative effect” 
(category IV, Figures 4.3-IV and 4.13-IV). Out of 29 pre- and post-hatching B 
responsive genes showing cumulative responses in the adult birds that 
experienced both the B-treatment protocols, 26 successfully mapped to IPA 
server and were all “focus” genes (Table A7a, Appendix). The significant 
biological functions associated with the cumulative effects induced by pre- and 
post-hatching B are shown in Table A8a (Appendix). The most enriched biological 
category was “Molecular Transport” and included 3 genes encoding solute carrier 
transporters (SLC6A11, SLC24A3, and SLC4A11), the gene encoding the glutamate 
receptor GRIP2, and the G-protein coupled receptor tachykinin receptor 1 
(TACR1). A total of 2 networks were identified (scores 47 and 17) and included 
all the 26 focus genes. The network with the highest score included 18 focus 
genes and was associated with “Neurological Disease, Cell Morphology, Cell-To-
Cell Signalling and Interaction” (Figure 4.19) and included SLC4A11, SLC6A11, 
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myosin VIIA (MYO7A), and the growth differentiation factor 10 (GDF10).  There 
were 3 significant canonical pathways associated with GABA Receptor Signalling 
and Glutamate degradation (p ≤ 7.62E-03; ratio: 0.25-0.08) with the gene 
glutamate decarboxylase 1 (GAD1) and the solute carrier family 6 (SLC6A11).  
 
4.4.8.2 Hypothalamus 
Pre- and post-hatching B responsive genes (category I, Figures 4.2-I and 4.15-
I). 12 out of 19 pre- and post-hatching B responsive genes mapped to IPA server. 
All the mapped genes except for one were “focus” genes (Table A7b, Appendix). 
The main biological functions included only between 1 and 4 genes and are 
shown in Table A8b (Appendix). The top biological function was “Behaviour” 
with the genes encoding the neuropeptides hormone cholecystokinin (CCK) and 
the Rac GTPase activating protein 1 (RACGAP1), which have been shown to be 
linked with emotional and anxiety-like behaviour. The most enriched biological 
class was “Cancer” that included again CCK and RACGAP1, plus calbidin 2 
(CALB2), and the transcription regulator prospero homeobox 1 (PROX1). The 
upstream analysis revealed that CCK is a B-dependent gene (p = 4.87E-02). A 
total of 2 networks with respectively 9 and 3 focus genes (score 25 and 3, 
respectively) were identified. The top network was associated with “Energy 
Production, Nucleic Acid Metabolism and Small Molecule Biochemistry” (Figure 
4.20) and included CCK, RACGAP1, PROX1, CALB2.  
Pre-hatching B responsive genes (category II, Figures 4.2-II and 4.15-II). Out of 
14 specifically pre-hatching B responsive genes, 12 mapped to the IPA server. All 
the submitted genes apart from PRDM12 were “focus” genes (Table A7b, 
Appendix).  The significant biological functions are reported in Table A8b 
(Appendix). The top biological function was linked with lipid metabolism and 
contained 5 focus genes: glycoprotein hormones, alpha polypeptide (CGA); 
luteinising hormone, choriogonadotrophin receptor (LHCGR); protein kinase C, 
beta (PRKCB); transient receptor potential cation channel, subfamily C, member 
4 (TRPC4), and hematopoietic prostaglandin D sinthase (HPGDS). The top 
significant biological category containing the highest number of genes was 
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associated with “Molecular Transport” (Table A8b, Appendix). Two networks 
(scores 28 and 3) were identified and overall contained respectively 10 and 1 
focus genes. Among the genes incorporated in the top network (Figure 4.21) 
there were the gene encoding HPDGS, CGA, LHCGR, RAS, dexamethasone 
induced 1 (RASD1) and inositol 1, 4, 5 – trisphosphate receptor, type 3 (ITPR3). 
The top canonical pathway was “nNOS Signaling in neurones” (associated with 
nitric oxide formation) and included PRKCB and RASD1 (p = 5.24E-04, ratio = 
0.038). The upstream analysis revealed a significant association between 
dexamethasone and the CGA, RASD1 as well as ITPR3 (p = 3.01E-02).  
Post-hatching B responsive genes (category III, Figures 4.2-III and 4.15-III). Out 
of 88 post-hatching B responsive genes, 72 mapped to the IPA server. Of these 72 
genes, 66 were “focus” genes (Table A7b, Appendix). The significant biological 
functions are reported in Table A8b (Appendix). The top significant biological 
function was “Neurological Disease” with 27 genes and included 3 types of 
serotonin receptors (HTR1D, HTR2C, and HTR3A); corticotrophin releasing 
hormone receptor 2 (CRHR2); adenosine A1 receptor (ADORA1); cytochrome P450 
family 27, subfamily A, polypeptide 1 (CYP27A1); somatostatin receptor 5 
(SSTR5).  Not surprisingly, the upstream analysis revealed a dependency 
between SSTR5 and CYP27A1 and the synthetic stress hormone dexamethasone 
(p = 4.93E-02). Some of the above mentioned genes were also linked with 
several behavioural traits, such as anxiety, learning and cognition (ADORA1, 
CRHR2, and HTR2C). A total of 7 networks were identified and their scores 
ranged from 39 to 2 and all together included 63 out of 66 focus genes. The first 
top network (Figure 4.22) incorporated 18 focus genes (all up-regulated) and was 
associated with “Neurological Disease, Psychological Disorders, Cell Signalling”. 
This network included the genes encoding the 3 serotonin receptors (HTR1D, 
HTR2C, and HTR3A), ADORA1, SSTR5 as well as CRHR2. The top canonical 
pathway was “Serotonin Receptor Signalling” (p = 2.38E-04, ratio = 0.067) with 
all the 3 serotonin receptors mentioned above.  
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Figure 4.17 First top significant network generated by Ingenuity Pathway Analysis showing the down-regulated genes (green) and up-regulated genes (red) in the 
hippocampus (score: 30) that were altered by both pre- and post-hatching corticosterone (B) exposure. The network is displayed with nodes (i.e. genes) and edges (i.e. 
biological interactions among nodes); in white, the genes not user-specific added into the network due to interactions with the submitted genes. Solid lines connecting 
the genes indicate direct interactions between the nodes and dashed lines implied indirect interactions.  
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Figure 4.18 First top significant network generated by Ingenuity Pathway Analysis showing the down-regulated genes (green) and up-regulated genes (red) in the 
hippocampus (score: 27) that were specifically altered by pre-hatching corticosterone (B) exposure. The network is displayed with nodes (i.e. genes) and edges (i.e. 
biological interactions among nodes); in white, the genes not user-specific added into the network due to interactions with the submitted genes. Solid lines connecting 
the genes indicate direct interactions between the nodes and dashed lines implied indirect interactions.  
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Figure 4.19 First top significant network generated by Ingenuity Pathway Analysis showing the down-regulated genes (green) and up-regulated genes (red) in the 
hippocampus (score: 47) that induced cumulative effects in the birds that were exposed to both pre- and post-hatching corticosterone (B). The network is displayed 
with nodes (i.e. genes) and edges (i.e. biological interactions among nodes); in white, the genes not user-specific added into the network due to interactions with the 
submitted genes. Solid lines connecting the genes indicate direct interactions between the nodes and dashed lines implied indirect interactions.  
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Figure 4.20 First top significant network generated by Ingenuity Pathway Analysis showing the down-regulated genes (green) and up-regulated genes (red) in the 
hypothalamus (score: 25) that were altered by both pre- and post-hatching corticosterone (B) exposure. The network is displayed with nodes (i.e. genes) and edges 
(i.e. biological interactions among nodes); in white, the genes not user-specific added into the network due to interactions with the submitted genes. Solid lines 
connecting the genes indicate direct interactions between the nodes and dashed lines implied indirect interactions. 
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Figure 4.21 First top significant network generated by Ingenuity Pathway Analysis showing the down-regulated genes (green) and up-regulated genes (red) in the 
hypothalamus (score: 28) that were specifically altered by pre-hatching corticosterone (B) exposure. The network is displayed with nodes (i.e. genes) and edges (i.e. 
biological interactions among nodes); in white, the genes not user-specific added into the network due to interactions with the submitted genes. Solid lines connecting 
the genes indicate direct interactions between the nodes and dashed lines implied indirect interactions. 
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Figure 4.22 First top significant network generated by Ingenuity Pathway Analysis showing the down-regulated genes (green) and up-regulated genes (red) in the 
hypothalamus (score: 39) that were specifically altered by post-hatching corticosterone (B) exposure. The network is displayed with nodes (i.e. genes) and edges (i.e. 
biological interactions among nodes); in white, the genes not user-specific added into the network due to interactions with the submitted genes. Solid lines connecting 
the genes indicate direct interactions between the nodes and dashed lines implied indirect interactions.  
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4.4.9 Validation 
4.4.9.1 Microarrays 
4.4.9.1.1. PCA 
The PCA explained 41.7% of the overall variation in global hippocampal gene 
expression. The PCA mapping showed a good clustering across the replicates 
within each treatment group, although variation was high both in the CC and BB 
groups (Figure 4.23). Consistently with the RNA-seq data, there was a clear 
separation between the CC and the BC birds along the horizontal PC1 (Figure 
4.23).  
 
Figure 4.23 Principal Component Analysis (PCA) mapping of the hippocampal microarray samples 
(n = 12) using the normalised expression abundance values of the annotated (with an Ensembl 
Identifier and/or gene name) probesets (n = 26522). Data are clustered by treatment group (CC in 
purple, BC in blue, CB in green or BB in red) using the centroid function. PC1 = first component, 
explaining 19.8% of the overall variation; PC2 = second component, explaining 11.6%, and PC3 
explaining 10.4% of the variation across annotated probesets. 
Principal Component Analysis mapping (41.7%)
P
C
  #
2
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1
.6
%
PC #3 10.4%
163 
4.4.9.1.2 Two-way ANOVA 
There were no effects of pre-hatching or post-hatching treatment as main factor 
(q > 0.2 in both). There were no interaction effects between the pre- and post-
hatching treatments (interactions: pre-hatching B X post-hatching B, pre-
hatching B X pre-hatching C, post-hatching B X post-hatching C, all q > 0.2). The 
post-hoc comparison found no differentially expressed genes, except two genes 
(scaffold attachment factor B2, SAFB2; tektin 3, TEKT3; q < 0.05 in both) in the 
contrast BB vs CB. 
 
4.4.9.1.3 RankProducts  
The number of the differentially expressed genes across the pair-wise 
comparisons is shown in Table 4.7.  
Table 4.7 Number of significant genes (FDR ≤ 0.10) that were up- or down- regulated across the 
pair-wise comparisons in the hippocampal samples.  
 
Contrast: 
(2nd class vs 1st class) 
Up-regulated genes 
under 2nd class 
Down-regulated genes 
under 2nd class 
BC vs CC 47 100 
CB vs CC 22 35 
BB vs CC 18 89 
CB vs BC 52 52 
BB vs BC 65 48 
BB vs CB 89 60 
 
As observed in the RNA-seq analysis, the largest number of differentially 
expressed genes was skewed towards a down-regulation in the pre-hatching B- 
treated birds (BC and BB) when compared with the controls in the contrast BC vs 
CC and BB vs CC. In fact, the fold changes in the contrast BC vs CC for the down-
regulated genes ranged from -18.33 to -2.48, and from -26.64 to -2.39 in the 
contrast BB vs CC; whilst the fold changes for the significantly up-regulated 
genes ranged from 12.56 to 2.49 in BC vs CC comparison and from 8.16 to 2.82 in 
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BB vs CC. Genes of relevant interest that were repressed in the birds that 
experienced exposure to B in ovo alone when compared to the adult controls 
where vasotocin-neurophysin VT (FDR = 0.04); transthyretin (FDR = 0.04); 
superoxide dismutase 3, extracellular (FDR = 0.05) and glutathione S-transferase 
alpha 3 (FDR = 0.04), both regulating oxidation processes; and two guanine 
nucleotide binding G-protein (gamma 11 and gamma 13; FDR = 0.07 for both). 
Interestingly, transthyretin; superoxide dismutase 3, extracellular, and guanine 
nucleotide binding G-protein 11 were also significantly repressed in the pre- and 
post-hatching B-treated birds when compared to the adult controls (0.005 
<FRD<0.04). Also, down-regulated in the BB birds when compared with CC birds 
where the genes proenkephalin (FDR = 0.03) and somatostatin receptor II (FDR = 
0.06). Although the effects of post-hatching B appeared much less pronounced 
than those induced by pre-hatching B, it is important to remark that vasotocin-
neurophysin VT, transthyretin and proenkephalin were in contrast up-regulated 
(0.01 < FDR < 0.09) in the CB birds compared with the BB birds.  
 
4.4.9.1.4 Comparison of absolute gene expression values from RNA-seq and 
Microarrays  
There was a high dispersion in the scatter plots across the entire range of gene 
expression values measured by RNA-seq and Microarrays, although the genes 
expressed at higher abundance where better correlated than those expressed at 
lower abundance in at least one of the platform (Figure 4.24) Despite the 
correlation between the RNA-seq log2 counts and the Microarray log2 intensities 
was highly statistically significant (p < 2.2E-16 for all), the Spearman’s 
correlation coefficient (rho) was relatively low (mean ± SEM: 0.58 ± 0.17), 
ranging from 0.57 to 0.60.   
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Figure 4.24 Inter-platform expression correlation plots between the Microarrays data and RNA-
sequencing data based on 7172 common non-redundant Ensembl transcripts. Each panel shows 
RNA-sequencing log2 counts compared to Microarray log2 intensity values derived from the same 
RNA hippocampal samples. In each graph is indicated the treatment group (CC, BC, CB or BB) 
with the numbers (1, 2, 3) representing the biological replicate in each treatment group.  
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4.4.9.1.5 Comparison of the differentially expressed genes between RNA-seq 
and Microarrays 
The number of genes from both RNA-seq and Microarrays with a FDR cut-off of 
0.20 and the number of shared genes between the two platforms are shown in 
the Figures 4.25-4.26; the Ensembl identifiers, annotation of these genes and 
fold-changes in both the platforms is reported in Table A9 (Appendix).The 
percentage (%) of overlapping gens between RNA-seq and Microarray data ranged 
from 44.16% to 0 (mean ± SEM: 15.58% ± 4.50%), indicating a poor overall 
concordance between the two platforms. The maximal concordance was found in 
the down-regulated genes in the adult birds that had experienced exposure to B 
in ovo in comparison with the adult control birds (BC vs CC: 44.16% of shared 
genes; BB vs CC: 34.44% of shared genes); interestingly, 18 genes were 
consistently down-regulated in both these two comparisons (Table A10, 
Appendix). Among the relevant top down-regulated genes there were 
transthyretin; superoxide dismutase 3, extracellular and glutathione S-
transferase alpha 3.  
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Figure 4.25 Proportional Venn Diagrams showing all the number of genes in common between 
RNA-seq and Microarrays at FDR ≤ 0.20 in the contrasts BC vs CC, CB vs CC and BB vs CC in 
the hippocampal samples. Comparisons were performed separately for down- and up-regulated 
genes (as indicated by the arrows); gene expression directional changes refer to the 2
nd
 class vs 1
st
 
class.      
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Figure 4.26 Proportional Venn Diagrams showing all the number of genes in common between 
RNA-seq and Microarrays at FDR ≤ 0.20 in the contrasts CB vs BC, BB vs BC and BB vs CB in the 
hippocampal samples. Comparisons were performed separately for down- and up-regulated genes 
(as indicated by the arrows); gene expression directional changes refer to the 2
nd
 class vs 1
st
 class.      
 
4.4.9.2 qPCR 
The comparative data showing the expression patterns obtained by using RNA-
seq and Microarrays for the genes AVP, TTR, SOD3, GSTA3 and GNG11 are in 
good agreement with those obtained by using qPCR (Figures 4.27-4.29); in fact, 
almost all genes showed concordant directional fold changes across the three 
169 
Chapter 4 
 
techniques (Figures 4.30-4.31). The few discrepancies observed for SOD3, 
GSTA3, and GNG11 regarded expression differences of low intensity 
(approximately absolute fold change of 2).    
 
Figure 4.27 Absolute expression values for the genes (a) AVT and (b) TTR from RNA-seq, 
Microarrays and qPCR. RNA-seq counts were obtained using HT-Seq; Microarrays expression 
intensities were normalised using the GC-content by the Robust Multichip Average; qPCR 
expression values were normalised using the comparative threshold method relatively to β-actin 
(ACTB).   
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Figure 4.28 Absolute expression values for the genes (a) SOD3 and (b) GSTA3 from RNA-seq, 
Microarrays and qPCR. RNA-seq counts were obtained using HT-Seq; Microarrays expression 
intensities were normalised using the GC-content by the Robust Multichip Average; qPCR 
expression values were normalised using the comparative threshold method relatively to β-actin 
(ACTB).   
 
  
(a) (b) 
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Figure 4.29 Absolute expression values for the gene GNG11 from RNA-seq, Microarrays and 
qPCR. RNA-seq counts were obtained using HT-Seq; Microarrays expression intensities were 
normalised using the GC-content by the Robust Multichip Average; qPCR expression values were 
normalised using the comparative threshold method relatively to β-actin (ACTB).   
  
(a) 
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Figure 4.30 Fold changes for AVT, TTR, and SOD3 derived on the basis of samples processed 
using RNA-seq, Microarrays and qPCR across the 6 pair-wise comparisons. Plotted values 
represent expression averages from the 3 biological replicates.   
 
AVT 
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Figure 4.31 Fold changes for GSTA3 and GNG11 derived on the basis of samples processed 
using RNA-seq, Microarrays and qPCR across the 6 pair-wise comparisons. Plotted values 
represent expression averages from the 3 biological replicates.   
 
4.5 Discussion 
The findings presented in this study suggested that the Japanese quail exposed 
to exogenous B as embryos and/or juveniles showed distinct tissue-specific 
modifications in global gene expression patterns in their hippocampi and 
hypothalami when adults. The genes’ dynamic responses to pre- and post-
hatching B were overall weak, but discernible and involved well characterised 
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key candidate genes in the regulation of the HPA system, such as 
mineralocorticoid receptor (MR), vasotocin-neurophysin VT (AVT; homolog of 
arginine vasopressin in mammals) and its receptor AVTR2, somatostatin and 
serotonin receptors, as well as in the priming actions of early life experiences, 
such as brain-derived neurotrophic factor (BDNF) and Ca++ - dependent 
secretion activator 2 (CADPS2). This study also contributed to novel information 
regarding the potential regulatory mechanisms driving the long-term effects of 
early life stress, likely to be linked with oxidative stress. These data, to the best 
of my knowledge, represent the first attempt that had experimentally quantified 
the long-term potential cumulative and opposing gene expression responses 
resulting from the combined exposure to pre- and post-hatching B.  
The overall weak gene expression changes observed in this experiment are in 
line with the few previous studies that have examined the impact of variations 
in early life environmental experiences on the brain transcriptome signature 
over the long-term (Weaver et al., 2006; Lindqvist et al., 2007; Nätt et al., 
2009; Goerlich et al., 2012). However, in this specific experimental context, the 
low magnitude of the treatment effect may also be the consequence of 
additional complicating factors that may have decreased both sensitivity and 
accuracy of the RNA-seq differential expression analysis, primarily the 
background noise due to the high variation across the limited number of 
biological replicates and the lack of the quail sequence genome. Despite the 
efforts made in order to ascertain quality, comparability and reliability of the 
RNA-seq data by undertaking different and novel statistical approaches as well 
as to validating the results using other technologies, I am unable to completely 
exclude the possibility that other gene expression pattern changes associated 
with the long-term effects of glucocorticoid exposure may be revealed by a 
more detailed analysis, for instance by de-novo assembly of the quail 
transcriptome. For future studies, other techniques other than genome-wide 
approaches, such as in situ hybridisation and immunohistochemistry, will also be 
suitable methods for further validating the biological reliability of the candidate 
genes reported in this study. 
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4.5.1 The long-term gene expression dynamic responses 
to B exposure during pre- and post-hatching 
development in the hippocampus and hypothalamus 
4.5.1.1 Pre- and post-hatching B sensitive genes  
The results clearly showed that physiological overexposure to B, regardless of 
the developmental stage, induced consistent gene expression alterations across 
the B-exposed phenotypes relative to the controls in adulthood. These changes 
were highly specific within tissues and stronger in the hippocampus than in the 
hypothalamus. Of particular interest were the effects observed in the 
hippocampus in which the expression signals of classic genetic markers of early 
life stress, such as MR (gene NRC32), BDNF and CADPS2, were altered and 
clustered together in the top significant network (Section 4.4.8.1, Figure 4.17). 
The functional analysis confirmed the known association of MR with B, but it also 
showed specific co-regulation of MR with the other two B-dependent genes, 
BDNF and SFRP1, via the extracellular signal-regulated kinase 1/2 (ERK1/2) 
pathway, which mediates cell proliferation and apoptosis (Mebratu and 
Tesfaigzi, 2009). The over-expression of BDNF in the B-treated birds relative to 
the controls was directly associated with CADPS2, which was also over-expressed 
in these birds. The mechanism of actions involved in the promotion of 
hippocampal BDNF expression in response to increases of CADPS2 has been 
recently elucidated in the rat model (Shinoda et al., 2011). Detailed mammalian 
literature indicates that BDNF is a key regulator of brain development and 
neuronal plasticity, especially in the hippocampus where it is highly active and 
expressed (Ernfors et al., 1991). Importantly, BDNF mRNA expression in the brain 
is strongly influenced by early life stressful experiences (reviewed by Cirulli et 
al., 2009) and recent studies in birds have shown similar significant associations 
(Lindqvist et al 2007; Chaudhury and Wadhwa, 2009). Hippocampal BDNF 
expression in rats is altered by both pre-natal stress protocol (i.e. maternal 
restraint) and post-natal stressful manipulations, such as maternal separation 
(Roceri et al., 2002; Lippmann et al., 2007; Zuena et al., 2008). However, the 
dynamics of the directional changes induced by these early life stressful 
protocols on BDNF expression vary across studies, probably because of differing 
time points, duration and intensity of the stressor employed and interactions 
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with other factors, such as sex (reviewed by Gomez-Pinilla and Vaynman, 2005; 
Cirulli et al., 2009;). It becomes therefore difficult to draw a functional 
interpretation of the over-expression of BDNF observed in this experiment. 
Nevertheless, several studies in adult individuals have shown that chronic B 
treatment reduces mRNA BDNF expression in the hippocampus over the short-
period (review by Schaaf et al., 2000). Decreased BDNF levels are thought to 
affect hippocampus-related learning and anxiety-like behaviours (Duman and 
Monteggia, 2006; Martinowich et al., 2007).  Hence, in light of these studies, I 
would speculate that the over-expression of hippocampal BDNF in the B-exposed 
quail might be an adaptive mechanism activated to buffer potential hippocampal 
learning impairments or increased anxiety-related traits. Such potential effects 
in the B-treated quail might also have been mediated by the simultaneous up-
regulation of hippocampal MR compared to the control quail. In fact, down-
regulation of MR has been associated with impaired spatial memory abilities in 
zebra finch lines selected for exaggerated B stress responses (Hodgson et al., 
2007). Future studies are needed to clarify the biological validity of this 
hypothesis. For example, a fed-baited eight-arm radial arm maze, modified 
version of an eight-arm radial maze test validated in the Japanese quail (Suhr et 
al. 2010), could be a suitable behavioural test to examine whether hippocampal 
changes in BDNF and MR mRNA are associated with changes in spatial memory 
and learning, and whether developmental exposure to B (or other stressful 
protocols that mimic environmental stressful conditions) can contribute to alter 
these potential links upon adulthood.    
The analysis of the gene signature of early life stress also suggested that 
hippocampal oxidative balance was altered in the adult B-treated phenotypes 
due to the down-regulation of both superoxide dismutase 3 (SOD3) and 
tyrosinase-related protein 1 (TYRP1) (Section 4.4.8.1, Figure 4.17). The 
sequences of these genes show a high degree of conservation across vertebrate 
groups and they are both related to the oxidative defence signalling pathway. In 
fact, SOD genes represent the first line of defence against the damaging effects 
induced by reactive oxygen species, converting superoxide radicals to hydrogen 
peroxide and water. TYRP1, in addition to its role in melanin synthesis (together 
with TYR and TYRP2) has a catalytic activity and participates at the secondary 
line of defence, which eventually detoxifies hydrogen peroxide into water and 
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oxygen (Scheiber, 2012). Therefore the decline of both SOD3 and TYRP1 suggest 
potential changes in antioxidant enzymatic levels possibly in response to 
elevated concentrations of reactive oxygen species in the hippocampus of the 
pre- and post-hatching B exposed birds. Given that the SOD genes identified so 
far (SOD1, SOD2 and SOD3) are highly compartmentalised in the cell (Parge et 
al., 1992), the specific under-regulation of SOD3 mRNA is indicative of localised 
cellular oxidative responses within the extracellular space. Taken together, 
these data confirm the relevant associations between glucococorticoid hormones 
and oxidative stress (Costantini et al., 2011a), but also reinforce the idea that 
overexposure to stress hormones can have the power to permanently influence 
the oxidative signalling cascade (Haussmann et al., 2012; Marasco et al., 2013 or 
Chapter 5 in this thesis). Given that oxidative stress is known to be implicated in 
a series of adult neurological diseases and can accelerate ageing processes, the 
long-term term implications of such alterations in the brain can possibly impinge 
on long-term survival and warrant further detailed investigations.        
In contrast to the hippocampus, in the hypothalamus only a limited number of 
genes appeared to be responsive to pre –and post-hatching B in this study species 
(Section 4.4.8.2, Figure 4.20). The good clustering observed among these few 
genes, however, was promising and overall the enriched functional categories 
pointed to increased susceptibility to diseases, such as cancer. Although these 
results support the “Developmental origins of health and disease” phenomenon 
(e.g. Gluckman et al., 2007), it is important to remark that the functional 
analysis used here is strongly biased by the biomedical literature, which rarely 
considers any possible beneficial and adaptive significance of the changes 
triggered in response to the priming effects of early life experiences.    
 
4.5.1.2 Specific effects of pre- or post-hatching B  
The experimental design and statistical approach used in this study allowed me 
to identify the gene expression patterns that were altered specifically by pre- or 
post-hatching glucocorticoid exposure. A global overview of the results clearly 
highlighted opposite magnitudes of the effects induced by the developmental B 
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protocols within the two tissues, with pre-hatching B showing a major impact in 
the hippocampal transcriptome and post-hatching B showing much larger effects 
in the hypothalamic transcriptome. Furthermore, the global gene expression 
directional changes associated with pre- or post-hatching B were opposite to one 
another. In fact, the genes’ dynamic responses to pre-hatching B were skewed 
towards an overall repression of expression signals, while the responses to post-
hatching B were markedly biased towards an up-regulation of the expression 
patterns.   
Interestingly, the top significant biological function specifically altered by the 
elevation of yolk B in the hippocampus of the adult quail was involved in the 
development of the endocrine system (Section 4.4.8.1, Figure 4.18), with 
several key genes encoding hormone and neuropeptides receptors, such as the 
gene encoding aromatase (CYP19A1); melanocortin receptor 4 and 5 (MC5R and 
MC4R), both believed to have a role in energy homeostasis in the brain (Tao, 
2010); transthyretin (TTR) and proenkephalin (PENK), which are both affected by 
glucocorticoids and are involved in developmental programming of the HPA axis 
in mammals (Fraser et al.,1997; Kohda et al., 2006). Of particular interest was 
the down-regulation of the CYP19A1 in the pre-hatching B exposed birds (i.e. BC 
and BB groups) compared to the pre-hatching controls (i.e. CC and CB groups). 
This gene is a member of the cytochrome P450 super family and in a variety of 
vertebrate species it has been shown to have a pivotal role in phenotypic 
plasticity, neuroendocrine regulation and in the mediation of several behaviours, 
such as aggressive, emotional responses and song (non-mammalian models: 
reviewed by Forlano et al., 2006; mammals: reviewed by Malone, 2013).The 
hippocampal expression signals of CYP19A1 transcripts in this study, however, 
were relatively low and the variation was high (5 < counts < 280). Given that 
RNA-seq is considered among the most sensitive technology for gene expression 
analysis, the reliability of these results should be further assessed using other 
techniques such as in situ hybridisation. Moreover, a note should be taken for 
TTR, the carrier of thyroid hormones and retinal binding protein in the 
cerebrospinal fluid. In fact, maternal separation stress has been shown to 
drastically decrease expression of TTR in the hippocampus of adult rat offspring 
(Kohda et al., 2006; Wei et al., 2012). More intriguingly, a recent microarray 
study in chicken suggested that this gene may be involved in the 
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transgenerational transmission of the brain transcriptome signature induced by 
unpredictable access to food (Nätt et al., 2009). Given that the expression of 
TTR in the brain is controlled by MR and GR receptors (Martinho et al., 2012), it 
is plausible that the hippocampal down-regulation of TTR in the pre-hatching B-
treated birds might have been directly mediated by the gene MR, which as 
discussed above, was indeed affected across all the B-exposed phenotypes.   
The functional analysis suggested a central role of the serotonin receptors (i.e. 
HTR2C, HTR3A and HTR1D) in the significant up-regulation of the genes that 
specifically responded to post-hatching B within the hypothalamus of the adult 
quail (Section 4.4.8.2, Figure 4.22). The crosstalk between serotonin 
neurotransmission and HPA axis, including the interactions of these two systems 
in the long-term effects of early life adversities and later susceptibility to 
neuroendocrine dysfunctions, has long been hypothesised (de Kloet et al., 
2005b). The results of this study provide experimental data supporting this 
hypothesis. Increases in serotonin have been reported in rats across various brain 
areas in response to different chronic stressors, such as foot shock or restraint 
(Inoue et al., 1994, Adell et al., 2006; respectively); adrenalectomy and 
exogenous supplementation of B have corroborated the primary role of 
glucocorticoids in these changes (Singh et al., 1990). Although the neural 
circuitry mediating the links between serotonin and the HPA axis systems remain 
to be fully clarified, a recent study in mice suggested important regulatory 
interactions between serotonin and corticotrophin-releasing hormone signalling 
systems via the activation of HTR2C within the hypothalamus (Heisler et al., 
2007). The latter findings support the results from the cluster analysis reported 
in this study that linked the serotonin receptor pathway with the up-regulation 
of one type of corticotrophin releasing hormone receptor 2 (CRHR2). Taken 
together, these data suggest that post-hatching exposure to B during 
development shaped, in the long-term, the brain serotonergic system, possibly 
via transcriptional changes mediated by corticotrophin-releasing hormone. This 
idea is supported at least in part by a recent study in the chicken showing that 
exposure to high dose of pre-hatching B via yolk injections caused long-lasting 
modifications in both the hypothalamic serotonergic genes (including up-
regulation of HTR1A and down-regulation of the serotonin biosynthetic enzyme 
tryptophan hydroxylase) and HPA axis genes (including down-regulation of 
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corticotrophin-releasing hormone); interestingly, these gene expression changes 
were correlated with increases in aggressive behaviour, providing evidence of 
reciprocal links between the neurocircuits for stress physiology and aggression 
(Ahmed et al., in press). In future studies it will be extremely important to 
couple investigations at the gene expression level with behavioural observations 
to further our understanding of the functional links between genes, hormones 
and behaviour.   
4.5.1.3 Interactive effects of pre- and post-hatching B 
Surprisingly, a small number of interactive genes were altered by the combined 
exposure to pre- and post-hatching exogenous B in both the hippocampus and 
hypothalamus. However, the results in the hippocampus seemed interesting. In 
fact, the overall down-regulation in gene expression patterns observed in both 
the pre-hatching (BC) or post-hatching B-exposed birds (CB) seemed augmented 
in the BB birds and appeared to have altered both GABA and glutamate neuronal 
receptor signalling (Section 4.4.8.1) and molecular transport pathways via solute 
carrier transporters (Figure 4.19). These data suggest that cumulative long-
lasting modifications in synaptic communication may have occurred in response 
to the combined stressful treatments and the biological relevance of such 
changes should be further investigated in future studies. Another significant 
result relates to the opposite effect of pre- and post-hatching B in vasotocin-
neurophyin VT (AVT) (Section 4.4.7.1, Figure 4.13-VI), with pre-hatching B 
decreasing expression and post-hatching B potentiating expression. These 
opposite gene responses were cancelled out in the BB birds, which showed AVT 
mRNA levels similar to the adult controls. Abundant evidence has shown that 
AVT is a key gene in the regulation of the HPA axis activity and behaviour across 
vertebrate species (reviewed by Goodson and Bass, 2000). A recent study in mice 
has demonstrated that the regulation of AVT is permanently altered by early life 
stressful events via DNA methylation changes at specific key promoter regions of 
this gene in the paraventricular nucleus of the hypothalamus (Murgatroyd et al., 
2009). In the present experiment, however, AVT gene expression in the 
hypothalamus was not affected by the B-treatments. I also point out that while 
AVT was hugely expressed within the hypothalamus across all the treatment 
groups (19179.1 ± 2158.5 counts), much lower gene expression levels were 
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detected within the hippocampus (566.1 ± 303.8 counts). Such tissue-specific 
gene expression differences were expected as AVT is known to be predominantly 
produced within the hypothalamus (see Chapter 1, Paragraph 1.2 and Figure 
1.2). Despite line of evidence indicating the presence of extra-hypothalamic AVT 
fibers within prosencephalic and mesencephalic areas in the chicken and 
Japanese quail brain (e.g. Panzica et al., 1986; Panzica et al., 1988), I am 
unable to define to which extent these low hippocampal AVT expression levels 
detected in this study will correspond to an actual production of AVT. 
Nevertheless, the simultaneous down-regulation of hippocampal AVTR2 observed 
in both the pre- and post-hatching B-treated birds (Paragraph 4.4.8.1) suggests 
potentially important functional changes in the vasotonergic transcriptional 
regulatory mechanisms as a consequence of the developmental B exposure that 
should be further validated in future studies. As discussed in detail in the 
Paragraph 5.5.2 below, it will be important in future studies to use a more 
specific brain dissection method in individual-non pooled samples to reduce 
biological variability, increase statistical power and investigate potential sex-
specific treatment effects.  
 
4.5.2. Further technical considerations and limitations of 
the study 
There are a number of technical limitations that must be noted when 
considering the results from this study.  
First, the alignment of the quail RNA-seq reads was performed on the chicken 
genome. Although the use of the chicken genome as a reference was the best 
choice here, the inter-specific alignment approach imposed a shrinking of the 
initial read length of 50% (Figure 4.5). Furthermore, approximately 40% of the 
reads were lost post-alignment as a consequence of annotation differences 
between the quail and the chicken genome (Table 4.2). Such reduction of the 
initial available information in the raw data might have significantly reduced the 
depth of coverage of the quail reads to the reference. Reduced depth of 
coverage has been shown to decrease sensitivity and accuracy of the differential 
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gene expression analyses (Tarazona et al., 2012). The de novo assembly of the 
quail reads would overcome this constraint as this approach does not necessarily 
need the use of a reference genome and would also be particularly useful to 
identify novel quail-specific transcripts. However, the assembly de novo is 
complex and computationally intensive. For this reason, this was not a viable 
option for this project. Importantly, the packages available to date are not 
limitation-free, especially with Illumina generated data (as in this study) due to 
(1) the higher base-calling error rates, and (2) the short-length of the reads 
relative to other sequencing platforms (e.g. 454), which can constraint the 
correct concatenation of the contigs (Francis et al., 2013).  
Another important limitation for the differential statistical analyses was the high 
intra-replicate variation observed across the treatment groups within a specific 
tissue (Figure 4.7). There may be several reasons to explain such high variation. 
For instance, the analysis was conducted on pooled samples containing both 
males and females. The inclusion of both the sexes within each biological pool 
constrained my ability to investigate sex-specific gene expression differences 
(and potential interactions with treatment) and might have increased biological 
range of variation. Furthermore, in this study I used the whole hippocampus and 
hypothalamus. In birds the region defined as the hippocampus is a V-shaped 
structure composed of a nearly homogeneous arrangement of densely packed 
neurons which progressively merge into the parahippocampal region without 
precise boundaries (Karten and Hodos, 1967; Krebs et al., 1989; Gupta et al., 
2012). Although extreme care was taken during the dissections, which were 
always performed with the use of the brain topography of the chicken brain 
atlas, it is likely that the hippocampal punches contained also some 
parahippocampal neurons adjacent to the hippocampus. Moreover, the 
hypothalamus is known to encompass several specific nuclei. Discrete and 
specific transcriptome signatures across differing nuclei within the same neural 
structure have been reported in rats (Gautvik et al., 1996). As a consequence, 
the high variation in the RNA samples observed in this study might be associated 
with potentially different gene expression patterns between the two main sub-
divisions in the hippocampal complex (i.e. hippocampus and parahippocampus) 
and across the different hypothalamic nuclei. Furthermore, the PCA graphs 
suggested lower within replicate variation of the gene expression signals in the 
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birds that were specifically treated in ovo (i.e. BC) compared to those that 
experienced post-natal developmental stress (i.e. CB and BB). The post-hatching 
doses of B employed here were carefully validated in pilot work. In this 
experiment the juvenile quail received a fixed daily amount of exogenous B 
according to the specific post-hatching age range. However, it is possible that 
individual variation in body mass across the birds may have produced different 
effects on the HPA axis sensitivity. In contrast, body mass trajectories of the 
embryos are likely to be much less variable compared to those in the hatchlings 
due to the space constraint imposed by the egg. Future studies, therefore, may 
wish to consider the use of a better standardised oral hormonal administration 
protocol by adjusting the doses by daily body mass values of each individual 
bird. However, a mass-scaled approach would also mean frequent handling, and 
the consequent habituation and dampening of the HPA axis that this is likely to 
generate should be carefully considered when designing the experiment. Finally, 
as the magnitude of the B treatment on the brain transcriptome signature was 
not high it would be sensible in future studies to conduct global gene expression 
analysis at the individual level. This approach was not a viable option for the 
present work due to the high costs of the analyses, but the progressive reduction 
in the sequencing costs may make this option practically possible in future 
studies.     
A third aspect that needs further discussion regards the statistical analysis. 
Differential gene expression analysis of RNA-seq generated data are a well 
known challenging task in bioinformatics and the available statistical packages 
are still under development. The results from the pair-wise statistical 
comparison across Cufflinks, Bayseq and RankProducts showed an overall good 
reproducibility between Cufflinks and RankProducts, but not between these two 
and Bayseq (Figures 4.8-4.11). In fact, Bayseq hardly detected differentially 
expressed genes except for a few treatment contrasts in which between-
replicate variation was relatively small (i.e. BC vs CC in the hippocampus and BB 
vs CC in the hypothalamus). Bayseq was even more conservative in the models 
that considered the four treatments simultaneously, possibly because of the 
increased variance in the data. Bayseq’s poor performances may, therefore, be 
linked to the large variation across biological replicates, which may have limited 
the derivatisation of the empirically determined prior distribution from the 
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dataset. This statistical package has been shown to give meaningful better 
performances than other existing methods (including Cufflinks) when the 
datasets have (1) approximately constant dispersion, (2) a large proportion of 
differential expressed genes, or (3) unidirectional differential expression, with 
all the differentially expressed genes down- or up-regulated (Hardcastle and 
Kelly, 2010; Kvam et al., 2012). None of these three criteria appear to be 
satisfied in my data. Regardless, the latter studies did not take into account the 
variability of biological replication, which is frequently high in RNA-seq data due 
to the low (if any) number of replicates and has a significant impact on gene 
calling performances (Zheng, 2012). For instance, recent studies propose that 
non-parametric statistics may control better for false positive rates than 
parametric methods in datasets with large biological variation (Zheng, 2012; 
Tarazona et al., 2012). This would then suggest that RankProducts statistics may 
be a more flexible and more data-adaptive tool than the other inferential 
methods, such as Cuffdiff and Bayseq for RNA-seq differential expression 
analysis. Furthermore, RankProducts tended to be less conservative than Cuffdiff 
and found larger number of differentially expressed candidates in most of the 
contrasts. These data appear to suggest that RankProducts may be a powerful 
statistical method also with RNA-seq data, as previously demonstrated with 
microarray-generated data (Breitling et al., 2004; Breitling and Herzyk, 2005; 
Jeffery et al., 2006). More work with real and simulated data, taking into 
account the coefficient of variation across biological replicates, would be 
extremely useful to further our understanding of the applicability of 
RankProducts in RNA-seq. As I could not exclude the possibility that 
RankProducts analysis may also have less control of type 1 error and increase in 
false positives rates, I further filtered the data using the Vector Analysis in 
accordance with the relevant biological questions of the study. Importantly, this 
tool allowed me to (1) control for the biological variability by identifying the 
consistent genes’ dynamic responses to the early life treatments across the pair-
wise contrasts, and importantly to (2) overcome the limitation due to the 
comparisons between groups in a one-way layout.  
The validation analysis was conducted using both microarrays and qPCR on 
specific candidate genes. The correlation of the absolute expression signals 
between Microarray and RNA-seq was significant, but the coefficient of 
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correlation was not very high (approximately 0.60). However, these results are 
in line with other published work (e.g. Mortazavi et al., 2008; Chen et al., 2011; 
Brennan et al., 2012). In fact, consistent with the latter previous work, the 
correlation was not linear and there was a slight compression in the microarrays 
data at the high end. The scatter increased at the low expression values, which, 
again, was not surprising as background correction methods for microarrays are 
known to be complicated when signal levels approach the noise levels (Ramdas 
et al., 2004). Another aspect to point out is that there was an overall poor 
agreement between the two platforms at the level of the differential statistical 
analysis. RNA-seq tended to detect larger number of differentially expressed 
genes, which was expected as it is known to be more sensitive than microarrays 
(Mortazavi et al., 2008). Other than the lower general sensitivity of microarrays, 
however, it must be noted that the chicken annotation release used for RNA-seq 
data was more recent than the annotation release used for the microarray data. 
This was something I could not control for because the library files are provided 
by Affymetrix and they were downloaded just before starting the analysis. In this 
study, I merged the datasets obtained by the two technologies using the Ensembl 
Identifiers. However, while all the genes from RNA-seq data had an Ensembl 
Identifier, many probe-sets did not and were provided with only the official gene 
names. All these genes were excluded from the comparison. Therefore it is likely 
that these annotation differences underestimated the real actual agreement 
between the two platforms.  
Finally, as expected, the qPCR data on the 5 candidate genes showed highly 
similar expression signals and fold changes across the treatment groups with 
both RNA-seq and Microarrays.  
 
4.6 Conclusion 
The genome-wide results obtained in this study suggest that early life stressful 
condition mimicked via physiological overexposure to B have the potential to 
induce distinct brain tissue-specific modifications in adult transcriptome 
signature in the hippocampus and hypothalamus of the Japanese quail. This 
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study reinforces the importance of well known key genes for the control of the 
HPA axis and brain development. Importantly this is the first experimental 
attempt to disentangle the specific or combined long-lasting effects of pre- and 
post-hatching exposure to B on gene expression patterns. The data in this 
respect contribute to novel knowledge on the overall transcriptional regulation 
and functional trends of developmental glucocorticoid programming, 
emphasising the importance of considering the effects of interactive 
environmental cues across differing developmental periods as these may induce 
both cumulative and opposing gene expression responses in the brain. Future 
studies will be needed to test if these changes are associated with changes in 
reproductive performances and life expectancy in order to further our 
understanding of the potential adaptive or maladaptive significance of 
developmental stress programming.     
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Developmental post-hatching stress can alter the 
effects of pre-hatching stress on the adult redox 
balance  
 
A version of this chapter is published as: Marasco, V., Spencer, K.A., Robinson, 
J., Herzyk, P. and Costantini, D. 2013. Developmental post-natal stress can alter 
the effects of pre-hatching stress on the adult redox balance. General and 
Comparative Endocrinology, 191, 239-246. 
 
5.1 Abstract 
Across diverse vertebrate taxa, stressful environmental conditions during 
development can shape phenotypic trajectories of developing individuals, which, 
while adaptive in the short-term, may impair health and survival in adulthood. 
Regardless, the long-lasting benefits or costs of early life stress are likely to 
depend on the conditions experienced across differing stages of development. 
Here, I use the Japanese quail to experimentally manipulate exposure to the 
glucocorticoid hormone corticosterone (B) in developing individuals. I test the 
hypothesis that interactions occurring between pre- and post-hatching 
developmental periods can induce long-term shifts in the adult oxidant 
phenotype in non-breeding sexually mature individuals. I show that 
developmental exposure to B can induce long-term alterations in the basal 
antioxidant defences. The magnitude of these effects depends upon the timing 
of glucocorticoid exposure and upon interactions between the pre- and post-
hatching B. I also find differences among tissues with stronger effects in the 
erythrocytes than in the brain in which the long-term effects of glucocorticoids 
on antioxidant biomarkers appear to be region-specific. Recent experimental 
work has demonstrated that developmental exposure to stress hormones can 
markedly reduce adult survival. The results from this study suggest that long-
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term shifts in basal antioxidant defences might be one of the potential 
mechanisms driving such accelerated ageing processes and that post-
natal/hatching interventions during development may be a potential tool to 
shape the effects induced by pre-natal/hatching glucococorticoid-exposed 
phenotypes. 
 
5.2 Introduction 
Early life events can drive phenotypic traits of developing individuals (Mousseau 
and Fox, 1998; Monaghan, 2008). A growing scientific interest focuses on 
furthering our understanding of the long-term effects associated with poor 
quality developmental environments on important phenotypic traits that can 
impact health and adult survival. Pioneering studies in mammals have linked a 
variety of perinatal stressors (e.g. intrauterine growth restriction, maternal 
separation, reduced maternal care and child abuse) with persistent metabolic 
changes in the developing individuals that are thought to be important in 
determining adult health outcomes (for recent reviews see Meaney et al., 2007; 
Cottrell and Seckl, 2009). Changes in adult phenotypes in response to stressful 
developmental conditions have now been reported in a broader range of 
vertebrate taxa (e.g. fish: Roche et al., 2012; reptiles: De Fraipont et al., 2000; 
birds: Monaghan et al., 2012). It is now widely believed that “developmental 
programming” may reflect a conserved biological phenomenon across vertebrate 
species, with significant consequences for a range of health indicators in later 
life (Love et al., 2013).  
Glucocorticoid stress hormones are the main candidates as mediators of 
developmental stress programming (Seckl, 2004). Growing individuals are 
exposed to glucocorticoids during their pre-natal/pre-hatching development, 
primarily via maternal routes (e.g. McCormick, 1999; Hayward and Wingfield, 
2004; see also review by Henriksen et al., 2011) or during post-natal/post-
hatching development, for instance via the direct effects of environmental 
stressors on their own physiological systems (e.g. Meylan et al., 2002; Spencer et 
al., 2009). It has been proposed that maternal stress hormones induce 
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anticipatory responses in the embryo that could prime its phenotype to better 
cope with future post-natal/hatching environmental stimuli (Bateson et al., 
2004; Gluckman and Hanson, 2004). However, delayed costs may arise because 
of inevitable physiological constraints (i.e. “silver spoon hypothesis”, Grafen, 
1988), for example those associated with poor maternal conditions, or because 
of a mismatch between the predicted and the encountered post-natal/hatching 
environmental conditions (i.e. “the mismatching hypotheses”, reviewed by 
Monaghan, 2008; see also Hales and Barker, 2001). Acute and persistent 
exposure to stress hormones can be damaging for key self-maintenance 
processes, such as energetic metabolism, cellular differentiation, myelination, 
apoptosis or neurogenesis (Sapolsky et al., 1990; de Kloet et al., 2005a). 
Oxidative stress, a condition of unbalance between the products of oxygen 
metabolism (i.e. reactive oxygen species) and the individual’s capacity to 
contrast/ease their damaging effects, may play a key role in mediating these 
long-term costs. In fact, oxidative stress can lead to the production of 
biomolecular oxidative damage to cells (Halliwell and Gutteridge, 2007; 
Costantini and Verhulst, 2009) and is implicated in cell senescence and 
neurodegenerative disorders (Finkel and Holbrook, 2000). Prolonged exposure to 
exogenous glucocorticoids promotes cellular oxidative stress in the body (e.g. 
McIntosh and Sapolsky, 1996; McIntosh et al., 1998; Costantini et al., 2011a). A 
recent meta-analysis showed that the magnitude of these effects significantly 
differs among tissues, with the brain and blood showing respectively high and 
moderately high effect sizes (Costantini et al., 2011a). Further, these effects 
change across an individuals’ life cycle, with juvenile stressed individuals being 
more vulnerable than adults (Costantini et al., 2011a).  
The hypothesised links between early life stress and shifts in an individual’s 
basal oxidative balance is beginning to be explored (Haussmann and Marchetto, 
2010; Haussmann et al., 2012). For example, in marmoset monkeys (Callithrix 
jacchus) maternal overexposure to dexamethasone led to enhanced gene 
expression of antioxidant defences in the aorta of adult offspring and these 
effects were more pronounced when the hormone was administered during the 
later stages of gestation compared to the earlier stages of gestation (Atanasova 
et al., 2009). In the chicken (Gallus gallus) in ovo exposure to  corticosterone 
(B, the primary glucocorticoid in birds) produced significant increases in 
190 
Chapter 5 
 
oxidative damage and cell senescence rate at three weeks post-hatching 
compared to control birds (Haussmann et al., 2012). However, the “molecular 
imprinting” initiated in the stressed embryos is likely to be plastic and mediated 
by the environment encountered at birth/hatching and throughout post-
natal/hatching development (Monaghan, 2008). Therefore, the degree of 
developmental plasticity and the long-term consequences arising from these 
potential adjustments may depend on the nature of both pre- and early post-
natal/hatching cues. For instance, pre- and post-natal/hatching stressful 
developmental conditions may have cumulative effects on cellular energetic 
state, exacerbating oxidative insults to tissues as a result of additive 
physiological constraints or stimulating investment in antioxidants to prevent 
damage to biomolecules. The potential long-lasting effects of such interactions 
have hitherto been untested.  
The aim of the present study was to examine the long-term potential interactive 
effects of pre- and post-hatching physiological exposure to elevated B on adult 
oxidative status in the Japanese quail. More specifically, the main objectives 
were to analyse whether early life stress would induce long-lasting alterations to 
adult body oxidative defences, ultimately causing oxidative damage. These 
objectives were accomplished by measuring enzymatic (i.e. superoxide 
dismutase, glutathione peroxidase) and non-enzymatic (i.e. total non-enzymatic 
antioxidant capacity) antioxidant biomarkers, as well as protein carbonyl 
content as a marker of oxidative damage, in both the blood and brain tissues in 
adult non-breeding quail between 9-10 weeks of age (puberty in this species is 
reached between 6-8 weeks of age, Ottinger, 2001). Measurements in the blood 
and the brain allowed me to estimate body oxidative status in two target tissues 
of body oxidative balance in both proliferating and non-proliferating (i.e. post-
mitotic) cells, respectively. The highly precocial nature of the Japanese quail, 
allowed me to independently manipulate B concentrations in the egg yolk and/or 
in the endogenous circulation of the hatchlings during the linear phase of 
growth. This is the first experiment that was specifically designed to study the 
effects of pre-hatching conditions under differing post-hatching developmental 
environments in the absence of the potential confounding factors of maternal 
care and, hence, appropriately testing the hypothesis of key interactions 
affecting phenotypic plasticity during developmental periods. I predicted that 
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the developmental B manipulations would lead to changes in body oxidative 
balance via modifications in the antioxidant lines of defences (Atanasova et al., 
2009), which in turn may be linked with increased biomolecular damage 
(Haussmann et al., 2012). Furthermore, in light of the high vulnerability of the 
nervous system to oxidative stress (e.g. Halliwell, 1992) and the results observed 
in the recent meta-analysis mentioned above (Costantini et al., 2011a), I 
expected that the early life treatments would induce a stronger effect in the 
brain than in the blood.   
 
5.3 Materials and methods 
5.3.1 Pre- and post-hatching hormonal manipulation  
The birds used in this study are part of the main experiment described in detail 
in Chapter 3 (Section 3.3.1). Briefly, pre-hatching stress exposure was mimicked 
by injecting a physiological dose of B into the yolk of fertile eggs at day 5 of 
incubation, whilst post-hatching (PN) stress was mimicked via daily oral 
administration of a physiological dose of B to the quail hatchlings from PN5 to 
PN19. The experiment was repeated twice (Batch 1 and Batch 2).  
 
5.3.2 Measuring the long-term effects of early life 
hormonal manipulation on oxidative status 
5.3.2.1 Tissue collection and brain dissections  
At day PN64, blood samples (taken within 1.5 min of opening the cage) were 
collected as described in Chapter 3 (Section 3.3.2.2) and, here, the red blood 
cells were used to measure oxidative stress biomarkers (see Section 5.3.2.2 
below). Erythrocytes are considered to be a valid group of cells for the 
measurement of oxidative stress due to their high content of oxygen and 
haemoglobin (Pandey et al., 2011). Furthermore, recent experimental work 
demonstrated a strong correlation between antioxidant biomarkers measured in 
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red blood cells and plasma, with a parallel co-variation between these two blood 
compartments both in the enzymatic (i.e. glutathione peroxidase) and non-
enzymatic antioxidant capacity at the individual level (Costantini et al., 2011b). 
Therefore the measurements in the red blood cells can reliably give an overall 
indication of the cellular redox status in the blood circulation.  
Between days PN69-73, the birds were sacrificed and the brains dissected as 
described in detail in Chapter 4 (Sections 4.3.1, 4.3.2). For the present study, 
two equivalent bilateral punches (2 mm diameter each) surrounding the lateral 
ventricle and including both telencephalic (i.e. nidopallium) and diencephalic 
thalamic nuclei (i.e. dorsolateral anterior nuclei) (herein referred as midbrain) 
were obtained (Figure A1, Appendix). Subsequently, the cerebellum was also 
dissected out. Tissues from midbrain and cerebellum were stored separately in 
collection tubes and placed back to -80 ºC until analyses. The midbrain samples 
were chosen because the main purpose of the study was to obtain a general 
measurement of oxidative status in the brain rather than in one specific brain 
nucleus; the punch technique allowed me to precisely standardise the position of 
the punches across the experimental birds. As the effects of glucocorticoids on 
cellular oxidative state can spatially vary in the brain (McIntosh et al., 1998), by 
taking also the cerebellum samples I ensured a replicated measurement from 
each individual bird. Brain tissues from 2 females (1 in the BC group and 1 in the 
CB group) could not be dissected out and, therefore, were excluded from the 
later analyses; red blood cells from 1 female (BC group) were missing and this 
individual was also excluded from the analyses.     
 
5.3.2.2 Laboratory analyses  
In each tissue that was collected 4 oxidative biomarkers were measured: 
superoxide dismutase (SOD); glutathione peroxidase (GPX), non-enzymatic 
antioxidant capacity (OXY), and protein carbonyls (PC). SOD, GPX and OXY are 
established indicators of antioxidant defences preventing oxidation of cell 
components; while PC measures the degree of protein carbonylation and is 
considered a reliable proxy of cellular oxidative protein damage. Japanese quail 
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reach puberty between 6-8 weeks of age (Ottinger, 2001). Quail used in this 
study were sampled between 9-10 weeks of age and were fully grown and 
capable of breeding if they would have been stimulated with an appropriate 
reproductive induction protocol (Robinson and Follett, 1982). Therefore, my 
sampling schedule was a reliable long-term measurement of the effects of early 
life stress on individuals’ redox physiology in non-breeding sexually mature 
individuals.  
Midbrain and cerebellum tissues were homogenised in ice cold PBS (pH = 7.19-
7.59; molarity = 0.150M; supplemented with 20% (v/v) of glycerol and with 
0.2mM of phenylmethylsulfonyl fluoride as an inhibitor of proteases) using a 
pestle and mortar. Samples were then sonicated for 10min and then centrifuged 
for 10min at 10,000rpm. The supernatant was split into different aliquots, which 
were stored at -80°C for later analyses. Haemolysates were centrifuged to 
separate cell membranes from the supernatant, which were used immediately 
for the analyses. Preliminary tests were conducted to determine the appropriate 
dilution factors in order to assure that each biomarker across the different 
tissues was within the linear range of the assay. A Thermo Scientific Multiskan 
Spectrum (ThermoFisher, Vantaa, Finland) was used to read the absorbance of 
the assay reactions.  
The Ransod assay (RANDOX Laboratories, Crumlin, UK) was used to quantify the 
concentration of SOD. As shown in Figure 5.1, this enzyme is involved in the first 
step of the antioxidant enzymatic cascade catalysing the dismutation of 
superoxide radical into oxygen and hydrogen peroxide. The assay employs 
xanthine and xanthine oxidase to generate superoxide radicals, which react with 
2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chloride to form a red 
formazan dye. SOD is then measured by the degree of inhibition of this reaction. 
Red blood cells and homogenates of midbrain and cerebellum were diluted 
1:600, 1:50 and 1:100 with distilled water, respectively. The assay laboratory 
steps were performed following the Manufacturer’s instructions. The assay was 
adapted to 96-well plate readers (Corning Life Sciences, Amsterdam, NL) by 
scaling down the volume of the assay reagents and experimental samples by a 
factor of 2.5. This allowed a reduction in the volume of tissue samples to 6µl. 
Values were calculated using a calibration curve for each assay. Analyses were 
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run in duplicate and the mean coefficients of intra- and inter-assay variation 
were 5.8 and 6.9%, respectively.  
The Ransel assay (RANDOX Laboratories, Crumlin, UK) was used to quantify the 
concentration of GPX. This peroxidase decomposes hydrogen peroxides resulting 
from SOD activity and other cellular processes in water and molecular oxygen by 
oxidising the reduced form of glutathione (Figure 5.1). The assay laboratory 
steps are based on the original method (see Paglia and Valentine, 1967) and 
analyses were carried out according to previous studies (e.g. Costantini et al., 
2011b). The samples were diluted 1:40 using the diluting agent provided by the 
Manufacturer. The assay was adapted to 96-well plate readers (Corning Life 
Sciences, Amsterdam, NL) by scaling down the volume of the assay reagents and 
experimental samples by a factor of 5 (the volume of tissue sample used in the 
assay was 4µl). Analyses were run in duplicate and the mean coefficients of 
intra- and inter-assay variation were 6.5 and 7.3%, respectively.  
The OXY-Adsorbent test (Diacron International, Grosseto, Italy) was used to 
quantify the capacity of non-enzymatic antioxidant compounds (OXY) present in 
the sample to cope with the in vitro oxidant action of hypochlorous acid (HOCl; 
an endogenously-produced oxidant). The OXY assay measures a variety of non-
enzymatic antioxidants, including vitamins, carotenoids, flavonoids and, most 
importantly glutathione, which is present in millimolar concentrations in animal 
cells; in fact OXY significantly correlates with thiols in the blood (r = 0.65-0.67, 
Palleschi et al., 2007). Importantly, a recent longitudinal study in a wild bird 
population has suggested that the OXY assay is a biological predictor of long-
term survival (Saino et al., 2011). Red blood cells and homogenates of midbrain 
and cerebellum were diluted 1:600, 1:50 and 1:35 with distilled water, 
respectively. The procedure was carried out following the Manufacturer’s 
instructions (see also Costantini et al., 2011b). The assay was adapted to 96-well 
plate readers (Corning Life Sciences, Amsterdam, NL) by scaling down the 
volume of the assay reagents and experimental samples by a factor of 5 (the 
volume of tissue sample used in the assay was 200µl). The absorbance was read 
at a wavelength of 490 nm. Values were calculated according to a reference 
standard. Analyses were run in duplicate and the mean coefficients of intra- and 
inter-assay variation were 5.4 and 7.3%, respectively.  
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Protein carbonyls (PC) were measured according to Levine (Levine et al., 1990; 
see also Cao and Cutler, 1995; Montgomery et al., 2011). Carbonyl groups are 
introduced into the proteins from free radicals or via reactions with lipid 
peroxidation products or carbohydrates (Figure 5.1); protein carbonylation is 
mostly irreversible (Halliwell and Gutteridge, 2007). Nucleic acids were removed 
by adding 1 volume of a 10% solution of streptomycin sulfonate to 9 volumes of 
sample. PC were derivatised to 2,4-dinitrophenylhydrazone by reaction with 2,4-
dinitrophenylhydrazine (DNPH). The pellet was precipitated with cold 
trichloroacetic acid at 20% and then washed three times with a solution 1:1 of 
cold ethanol-ethyl acetate. The pellet was finally re-suspended in 350μl of 6M 
guanidine hydrochloride. The absorbance was read at 370nm. Analyses were run 
in duplicate and the mean coefficients of intra- and inter-assay variation were 
9.0 and 12.3% respectively.  
 
Figure 5.1 Mechanisms of oxidative cellular damage (from Morón and Castilla-Cortázar, 2012). 
Free radicals are reduced into water via the action of the enzyme superoxide dismutase (SOD) 
first, and then of Catalase and gluthathione peroxidise (GPX). The generation of hydroxyl radicals 
from hydroperoxide leads to the development of oxidative cell injury: DNA damage; carboxylation 
of proteins; and lipid peroxidation, including the lipids forming mitochondrial membranes. By these 
pathways, oxidative damage can eventually lead to cellular death. 
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Measures of all the biomarkers were then standardized by expressing the 
concentrations per mg of proteins as measured by the Bradford protein assay 
(Bio-Rad Laboratories, Hercules, USA) using a standard curve of bovine serum 
albumin. Red blood cells and the homogenates of midbrain and cerebellum were 
diluted 1:600, 1:16 and 1:16, respectively with distilled water. For PCs, all 
samples were first diluted with distilled water in order to have a concentration 
of 1mg of protein per ml. Analyses were run in duplicate and the mean 
coefficients of intra- and inter-assay variation were 4.8 and 5.8%, respectively.  
 
5.3.3 Statistical analysis 
Analyses were performed in PASW statistics, 18.0.0 (SPSS, Inc., 2009, Chicago, 
IL) using Linear Mixed Effect models (LMEs) fitted by Restricted Maximum 
Likelihood. Data were analysed by tissue and separately for each biomarker. In 
all LMEs, the fixed factors were pre-hatching treatment, post-hatching 
treatment, sex, and all the two- and three-way interactions; while batch and 
maternal identity were entered as random factors to control for sources of 
variation between the two batches and pseudo-replication, respectively. Non-
significant effects (p > 0.05) were removed from the models following a 
backward procedure (Crawley, 1993). To meet the assumptions of the LME, SOD 
in the red blood cells and PC in the midbrains were square root-transformed for 
normality; cerebellum GPX was log10-transformed to improve normality. All 
model residuals were normally distributed. Unless otherwise specified, the data 
are presented as means ± s.e.m. 
 
5.4 Results  
5.4.1 Red blood cells 
Descriptive statistics for each oxidative stress biomarker across the treatment 
groups and separately by sex is presented in Table 5.1a. There were no 
significant treatment or sex effects on SOD in the red blood cells (Table 5.2a for 
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full statistics). Developmental exposure to B had a significant effect on red 
blood cell GPX in the adult quail (pre-hatching treatment: F1,67.58 = 4.87, p = 
0.031; post-hatching treatment: F1,54.62 = 5.47, p = 0.023, respectively) explained 
by up-regulated enzymatic activity in the early B-exposed birds compared with 
the controls (Figure 5.2a). There were no significant interacting effects between 
the pre- and post-hatching treatment, or among the B treatments and sex in this 
variable; there was no effect of sex as a main factor (Table 5.2a). I found a 
significant interaction between the pre- and post-hatching treatment explaining 
OXY in the red blood cells (F1,65.50 = 5.75, p = 0.019, Figure 5.2b). This was due 
to lower OXY in all the B-exposed birds compared to the controls, but overall 
this reduction was less pronounced in the BB birds compared to the BC or CB 
birds (Figure 5.2b). None of the other factors in the model were significant 
(Table 5.2a). PC were significantly higher in females compared to males (F1,69.28 
= 7.80, p = 0.008; females: 12.24 ± 0.96 ; males: 8.48 ± 0.81), but the 
concentration of PC was unaffected by exposure to B, and none of the 
interactions among the B treatments and  sex were statistically significant 
(Table 5.2a).  
 
5.4.2 Brain 
Descriptive statistics for each oxidative stress biomarker across the treatment 
groups and separately by sex is presented in Table 5.1b, c. There were no 
significant treatment or sex effects on any biomarker measured in the midbrain 
samples (Table 5.2b). In the cerebellum, GPX was marginally up-regulated in 
birds that experienced post-hatching exposure to B (F1, 63.84 = 3.57, p = 0.063), 
but not in the birds that were exposed to the pre-hatching B treatment alone 
(F1, 70.43 = 1.11, p = 0.297); none of the other factors were statistically significant 
(Figure 5.3a; Table 5.2c). I did find a significant interaction between the pre- 
and post-hatching B treatment explaining cerebellum OXY (F1,66.20 = 4.428, p = 
0.039; p > 0.1 for all the other factors, see Table 5.2c) due to lower OXY in the 
BB birds in contrast with the pattern observed in the BC or CB birds (Figure 
5.3b).  
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Figure 5.2 The effects of physiological overexposure to corticosterone (B) during the pre- and/or 
post-hatching development on (a) red blood cell glutathione peroxidase (GPX) and (b) red blood 
cell non-enzymatic antioxidant capacity (OXY) in adult Japanese quail. (a) The B-treated quail (BC, 
CB, BB groups) showed overall higher GPX activity than the CC group, and these effects were 
more pronounced in the BB quail (Linear Mixed Model: pre-hatching treatment, p = 0.03; post-
hatching treatment, p = 0.02); whereas OXY levels were significantly lower in all the B-treated birds 
compared to the CC group, but this reduction was less pronounced in the BB birds (Linear Mixed 
Model: pre-hatching x post-hatching interaction, p = 0.02). On both graphs, * denotes p < 0.05. CC 
= pre-hatching untreated and post-hatching untreated birds; BC = pre-hatching B-treated and post-
hatching untreated birds; CB = pre-hatching untreated and post-hatching B-treated birds; BB = pre-
hatching B-treated and post-hatching B-treated birds. Sample sizes: CC: females = 9, males = 14; 
BC: females = 8, males = 6; CB: females = 9, males = 10; BB: females = 9, males = 9.  Data 
represent un-transformed means ± s.e.m.  
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Figure 5.3 The effects of physiological overexposure to corticosterone (B) during the pre- and/or 
post-hatching development on (a) cerebellum glutathione peroxidase (GPX) and (b) cerebellum 
non-enzymatic antioxidant capacity (OXY) in adult Japanese quail. (a) Cerebellum GPX was 
marginally up-regulated in the birds that were treated with B post-hatching (CB and BB groups) 
compared to the CC birds (Linear Mixed Model: post-hatching treatment, p = 0.06); (b) Cerebellum 
OXY in the BB birds was significantly lower compared to the levels in the BC or CB birds (Linear 
Mixed Model: pre-hatching x post-hatching interaction, * p = 0.04). CC = pre-hatching untreated 
and post-hatching untreated birds, BC = pre-hatching B-treated and post-hatching untreated birds; 
CB = pre-hatching untreated and post-hatching B-treated birds; BB = pre-hatching B-treated and 
post-hatching B-treated birds. Sample sizes: CC: females = 9, males = 14; BC: females = 8, males 
= 6; CB: females = 9, males = 10; BB: females = 9, males = 9.  Data represent un-transformed 
means ± s.e.m.  
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Table 5.1 Mean ± s.e.m. of the oxidative stress biomarkers (superoxide dismutase, SOD; 
glutathione peroxidase, GPX; non-enzymatic antioxidant capacity, OXY; and protein carbonyls, PC) 
across the different treatment groups (CC, BC, CB, BB) measured in (a) the red blood cells, (b) 
midbrain, and (c) cerebellum tissues in the adult Japanese quail (post-hatching day 64-73), 
separately by sex.  
 
  
(a) Red Blood Cells
Female:
Biomarker mean s.e.m. mean s.e.m. mean s.e.m. mean s.e.m.
SOD 0.8871 0.1088 0.7677 0.1376 0.8272 0.1433 0.7912 0.1182
GPX 0.0080 0.0004 0.0092 0.0018 0.0085 0.0008 0.0126 0.0016
OXY 5.5022 0.2301 5.1564 0.2444 5.1000 0.1979 5.3088 0.1754
PC 13.2553 2.2177 11.4723 1.8916 10.0878 1.4878 14.0637 2.0300
Male:
Biomarker mean s.e.m. mean s.e.m. mean s.e.m. mean s.e.m.
SOD 0.6490 0.0675 0.6657 0.0477 0.7168 0.0798 0.7772 0.0861
GPX 0.0067 0.0006 0.0074 0.0016 0.0085 0.0010 0.0091 0.0010
OXY 5.5204 0.1201 4.7992 0.2231 4.9830 0.1495 4.9717 0.2121
PC 7.2634 1.5828 10.3836 1.2792 9.5222 1.6430 7.9276 1.5140
(b) Midbrain
Female:
Biomarker mean s.e.m. mean s.e.m. mean s.e.m. mean s.e.m.
SOD 5.3958 0.2009 6.7881 0.4584 6.1202 0.4564 6.2948 0.2983
GPX 0.0902 0.0082 0.1144 0.0110 0.1042 0.0085 0.1091 0.0134
OXY 17.7458 1.3445 19.1167 1.3611 17.6180 1.2871 19.7754 1.7084
PC 12.6329 1.4267 8.2373 2.6900 10.2774 2.0570 10.0165 2.3946
Male:
Biomarker mean s.e.m. mean s.e.m. mean s.e.m. mean s.e.m.
SOD 6.0460 0.4598 5.8433 0.2084 5.5059 0.4291 5.8367 0.3075
GPX 0.0067 0.0006 0.0074 0.0016 0.0085 0.0010 0.0091 0.0010
OXY 18.9335 1.0700 17.0323 0.9868 18.0475 1.3385 19.8249 2.0350
PC 8.9668 1.4793 7.7708 1.3903 10.3069 2.4990 7.6081 0.9878
(c) Cerebellum
Female:
Biomarker mean s.e.m. mean s.e.m. mean s.e.m. mean s.e.m.
SOD 3.0723 0.1927 2.7341 0.1835 2.6855 0.2474 2.8901 0.2083
GPX 0.0773 0.0095 0.1158 0.0129 0.1087 0.0123 0.1117 0.0120
OXY 10.8112 0.5022 10.6479 0.9174 10.9963 0.8443 8.9539 0.7967
PC 11.5053 1.7998 10.9484 1.2433 10.7885 3.0476 8.5073 1.9590
Male:
Biomarker mean s.e.m. mean s.e.m. mean s.e.m. mean s.e.m.
SOD 2.9475 0.1147 3.1109 0.2679 3.0227 0.1636 3.0173 0.1302
GPX 0.0888 0.0107 0.0915 0.0120 0.1053 0.0104 0.0940 0.0101
OXY 10.0170 0.7052 12.1001 1.3477 10.6748 0.8337 9.5611 0.8460
PC 12.6398 1.9469 11.8698 3.0155 14.3266 2.3671 11.4430 2.4430
CC BC CB BB
CC BC CB BB
CC BC CB BB
BB
BB
CC BC CB BB
CB
CC BC CB
CC BC
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Table 5.2 Results of the LME modelling of potential long-term effects of the pre- and post-hatching 
treatment (in the table referred as PRE and POST, respectively), sex, and their interactions on 
basal oxidative stress biomarkers (superoxide dismutase, SOD; glutathione peroxidase, GPX; non-
enzymatic antioxidant capacity, OXY; and protein carbonyls, PC) in the adult Japanese quail. 
Outcomes in bold indicate the factors included in the final model; the other factors were 
subsequently excluded from the model as they were not significant (p > 0.05), although the effects 
of both pre- and post-hatching treatments were always maintained in the final model. 
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5.5 Discussion 
The results of the present study reinforce the idea that overexposure to stress 
hormones in early life causes long-term changes in the cellular redox status. This 
study represents the first experimental evidence that the magnitude of these 
changes is also dependent upon interactions across different developmental 
stages. The results also suggest that some tissues may be more sensitive to the 
long-term effects of glucocorticoid programming, with important implications 
for the design of future studies as well as the potential long-term effects of 
early life stress on adult phenotypes.  
Developmental B had an impact on the blood redox physiology, with both the 
pre- and post-hatching B-exposed individuals showing on average elevated 
activity of the antioxidant enzyme GPX compared to the controls. The 
magnitude of this effect was markedly larger in the individuals that experienced 
the combined pre- and post-hatching B treatments, with a 50% higher GPX 
activity than the controls. Blood non-enzymatic antioxidant capacity (OXY) 
decreased in the pre- or post-hatching B-treated birds compared with the 
controls, but conversely, such a decrease was less pronounced in the birds that 
were exposed to the combined pre- and post-hatching B treatments. Altogether, 
these results suggest that matching pre- and post-hatching stressful 
developmental environments triggered both additive and interactive responses 
in the developing individuals, which gave rise to a distinct oxidant challenge 
compared with that induced in the pre- or post-hatching glucocorticoid-exposed 
birds. Erythrocytes are among the most abundant circulatory cells in the 
vertebrate organism and their antioxidant system provides protection not only to 
themselves but also to other tissues and organs (Pandey et al., 2011). The lack 
of treatment differences on protein carbonyls, a biomarker of oxidative damage, 
suggests that the up-regulation of GPX in the pre- and post-hatching B-treated 
birds may be an adaptive compensatory strategy to enhance resistance to 
reactive oxygen species-damage in the body. Clearly, the burden of reactive 
oxygen species is counteracted by a complex antioxidant defence system 
(Pamplona and Costantini, 2011). As I found no treatment effect on SOD, the 
first line of antioxidant defence, it is likely that developmental B altered the 
secondary rather than primary oxidant-antioxidant signalling pathways (Figure 
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5.1). I interpreted the observed trends towards the reduction of OXY across the 
B-treated individuals as a consequence of the increased GPX activity. In fact, 
GPX uses the reduced glutathione to detoxify the cell from hydrogen peroxide 
derived from SOD activity, but also from early peroxidation compounds (i.e. 
hydroperoxides) continuously produced in the cell and known precursors of end-
products of oxidative damage (Halliwell and Gutteridge, 2007). I, therefore, 
propose that the developmental B-exposed birds, especially those that 
experienced the combined B protocols, were challenged with higher production 
of these intermediate damaging compounds, which were efficiently quenched by 
prioritising up-regulation of GPX. Future work integrating other measures, 
specifically glutathione, will be needed to further validate this possibility. 
Nevertheless, such a hypothesis finds support from a recent study in the chicken 
(Gallus gallus) in which in ovo overexposure to B has been found to elevate 
baseline plasma hydroperoxides in 3-week-old juveniles (Haussmann et al., 
2012). However, in the latter study no post-hatching manipulations were 
undertaken. The results of the present study clearly indicate that post-hatching 
cues during development do occur and do interact with the effects of previous 
pre-hatching stimuli. Such effects may be interpreted as potential adaptive 
regulatory responses occurring during the individual’s development. These 
results suggest that the plasticity/propensity of the redox system to 
glucocorticoid-induced change differs among the developmental phases, possibly 
depending on the maturation of the antioxidant defences (Surai, 2002; Spicer 
and Burggren, 2003). Further studies in ovo and early post-hatching are needed 
to test this possibility.     
The magnitude of the effects of the developmental B manipulation on brain 
oxidative balance was lower than that predicted and, importantly, differed 
between brain tissue types. In fact, treatment differences were observed in the 
cerebellum but not in the midbrain samples, suggesting that the developmental 
treatment, which was designed to increase pre- and post-hatching glucocorticoid 
exposure within the relevant biological ranges, induced brain local-specific 
changes rather than a general unified effect. Brain region-specific effects on 
antioxidants have also been reported in juvenile rats that experienced adverse 
events during neonatal life (maternal separation, diet manipulation, and 
handling) (Marcolin et al., 2012; Uysal et al., 2012). Although cerebellum GPX, 
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similarly to the response  in the erythrocytes, tended to be higher in the B-
treated birds compared with the controls, the magnitude of this up-regulation 
was relatively low (around 25%), clearly limiting statistical power. However, as 
the brain contains low concentrations of antioxidants compared with other body 
tissues (Halliwell and Gutteridge, 1985), the observed increase in GPX activity 
may be biologically important. It should be noted that the BB birds showed 
consistent antioxidant patterns in the cerebellum as seen in the erythrocytes, 
with higher GPX activity and lower OXY. These data reinforce the idea that such 
individuals were more challenged by pro-oxidants than the adult birds that had 
experienced elevated exogenous B only as embryos (BC) or as juveniles (CB). 
Taken together, these data suggest that prolonged stressful experiences across 
developmental stages can produce stronger signalling effects on secondary 
antioxidant pathways, not only in the blood circulation, but also in specific post-
mitotic neuronal tissues. BC or CB birds could maintain high levels of cerebellar 
OXY probably because of remobilisation of thiols and other dietary-derived 
antioxidants from other tissues through the blood circulation (Dass et al., 1992). 
This would suggest competition among tissues for antioxidant protection that 
could be solved by prioritising tissues whose functions are key in specific 
developmental windows or are more vulnerable to oxidative stress. Although it 
was beyond the scope of this work, further studies may wish to test this “tissue 
competition hypothesis” by extending oxidative stress measures to other tissues, 
including heart, spleen and liver. The cerebellum is a vital brain structure 
controlling motor skills and cognition, and increased protein carbonylation in 
this area is often linked with loss of such abilities (Forster et al., 1996; Manda et 
al., 2008). Therefore, it is plausible that the alterations observed in the 
antioxidant capacity in the BB birds may have been activated as a defence 
mechanism to avoid rises in cerebellum protein carbonyls, thereby protecting 
impairment in cognitive abilities. On the other hand, since elevated 
developmental glucocorticoids can markedly reduce long-term individual’s 
lifespan (Monaghan et al., 2012), probably via increasing the rates of telomere 
shortening (Haussmann et al., 2012), it is also possible that such changes in the 
antioxidant defences over a longer term may impinge on neuronal integrity and 
enhance vulnerability to neurodegenerative diseases (Ramassamy et al., 1999; 
Schuessel et al., 2004).  
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I do not know the underlying mechanisms that may explain the observed region-
specific actions of glucocorticoids in the brain. Among the variety of factors 
involved, such as the magnitude and timing of glucocorticoid overexposure, the 
distribution of brain corticosteroid receptors (i.e. MR and GR) is likely to play an 
important role (You et al., 2009). Across vertebrate species, corticosteroid 
receptors in the brain are more concentrated in areas such as the hippocampus, 
hypothalamus, amygdala and the cerebellum (e.g. Kovacs et al., 1989; Patel et 
al., 2000; Dickens et al., 2009), and their densities may differ even across brain 
nuclei. In fact, the transcriptome analysis described in Chapter 4 clearly showed 
marked differences in the overall gene expression patterns between 
hippocampus and hypothalamus, and such differences also included the 
expression of both MR and GR. Furthermore, a recent study in young zebra 
finches (Taeniopygia guttata) demonstrated that the labelling intensities of GR 
immunoreactive neurones differed in the nuclei located in the telencephalon 
and diencephalon (Shahbazi et al., 2011). As the midbrain punches also 
contained telencephalic and diencephalic nuclei, I am not able to exclude the 
possibility that unequal amounts of corticosteroid receptors between these two 
brain regions may have diluted out the effects of elevated exogenous B on the 
antioxidant pathways as seen in the cerebellum. Further studies looking at the 
effects of glucocorticoids within specific neuronal nuclei and across different 
brain areas will be needed in order to test the biological relevance of this 
hypothesis.    
 
5.6 Conclusion 
In conclusion, this study shows that interactions between environmental 
conditions during key developmental stages can shape adult oxidative status 
through the action of glucocorticoids. These results reinforce the importance of 
early post-natal/hatching interventions as a mechanism to manipulate previous 
pre-natal/pre-hatching phenotypic adjustments (Vickers et al., 2005). Overall, 
my data suggest that prolonged stressful experiences during pre- and post-
hatching development can produce interactive effects that result in changes in 
the antioxidant defences in the blood and in post-mitotic neuronal tissues, 
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depending on the brain region. These long-term shifts in the basal antioxidant 
defences may represent adaptive phenotypic adjustments to efficiently prevent 
oxidative damage to biomolecules, but leave open the possibility that any 
potential long-term consequences affecting cellular senescence may arise 
through high investment in antioxidant protection. This study is relevant to both 
biomedical researchers and evolutionary ecologists attempting to probe the 
underlying mechanisms linking stress hormones and oxidative status changes in 
an early development framework, and how they may be potentially associated 
with health and long-term survival.  
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6.1 Review of the findings  
The main aim of this thesis was to investigate how and the extent to which, 
physiological overexposure to glucocorticoid stress hormones during pre- and 
post-hatching development influences an individual’s phenotypic trajectories 
that may persist throughout life, using the Japanese quail as the study species. 
This avian model provided me with the opportunity to easily manipulate both 
pre- and post-hatching environmental conditions, removing the confounding 
factors caused by the physiological intimacy between mother and offspring that 
is present in other vertebrate taxa, such as mammals (Spencer et al., 2009; 
Henriksen et al., 2011).  
I first performed an experiment that allowed me to investigate the potential 
changes in adrenocortical activity in response to a standardised environmental 
stressor presented during the linear phase of post-hatching growth, at day 8 and 
day 16 (Chapter 2). The main results from this study suggested that the 
magnitude of the acute stress response declined with age, the same directional 
trend that has been previously found in the other few studied precocial birds 
(e.g. Holmes et al., 1989; Dickens and Romero, 2010). Interestingly, the 
opposite directional changes, an increase of adrenocortical activity in response 
to acute stress, have been reported in altricial birds (e.g. Sims and Holberton, 
2000; Love et al., 2003; Walker et al., 2005; Wada et al., 2007). Altogether, 
these results supported the “Developmental Hypothesis” (e.g. Schwabl, 1999) 
and warrant further investigations.  
In the main experiment of this project (Chapter 3, 4, and 5), I exposed the 
embryos to exogenous corticosterone (B, the main avian glucocorticoid), via egg-
injections directly into the yolk, and/or the juveniles (from post-hatching days 
5-19), via oral hormone supplementation using B-injected mealworms. At both 
developmental stages, the exogenous B doses were within the physiological 
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ranges of the study species. The pre-hatching treatment, designed to simulate 
maternal transfer of B into the egg, may be of great adaptive importance as it is 
believed to ‘physiologically prime” the embryo to survive in an environment that 
may be potentially stressful following hatching (e.g. Saino et al., 2005; Hayward 
et al., 2006), whilst the post-hatching treatment mimicked prolonged stressful 
environmental conditions (Spencer et al., 2009) in early post-hatching 
development. The three stress-phenotypes (i.e. BC, CB, and BB birds) allowed 
me to disentangle physiological and global gene expression responses that 
occurred as a consequence of pre-hatching exposure to B, post-hatching 
exposure to B or a combination of both the treatments. I showed that both pre- 
and post-hatching B induced changes in the Hypothalamic-Pituitary-Adrenal axis 
(HPA axis) responsiveness and circulating energy sources (glucose and 
triglycerides) in the blood (Chapter 3). The main results suggested that the 
effects of post-hatching B on the activity of the HPA axis and blood biochemistry 
were predominantly over the short-term (post-hatching day 22) and these 
effects were sex-dependent. Specifically, the juvenile females that experienced 
post-hatching B, regardless of the previous pre-hatching experiences, showed 
shorter stress responses in comparison with the other treatment groups. Post-
hatching B also caused significant changes in basal triglycerides, which 
interacted with sex and basal glucose concentrations. In contrast, the effects of 
pre-hatching B on the stress physiology were mainly evident over the long-term 
in the adults (post-hatching day 64).  In fact, the adult birds previously stressed 
in ovo exhibited higher B concentrations over the stress response than control 
birds. Interestingly, this effect was not evident in the birds that had been 
subjected to the combined treatments. Also, the birds that experienced pre-
hatching B had reversed basal sex-specific glucose concentrations compared to 
the other treatment groups. Although to the best of my knowledge, this is the 
first study that have attempted to analyse the effects of elevated 
glucocorticoids on glucose and lipid concentrations in the blood, there are 
previous studies in birds that have examined the effects of early life stressors on 
HPA axis activity. The results from these studies showed different outcomes 
even within the same species (Chapter 3, Section 3.5; see also reviewed by 
Henriksen et al., 2011). In this regard, a very recent study in the Japanese quail 
using the same pre-hatching treatment as in the present study but a different 
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post-hatching stressful protocol (unpredictable food regime), found opposite 
directional changes in the B stress responses compared to this study, with the 
pre-hatching injected birds showing truncated stress responses when 42-44 days 
of age than the pre-hatching controls (Zimmer et al., 2013). Therefore other 
than the actual hormonal dose, other factors including husbandry and housing 
conditions, handling for morphological measurements, and the type of post-
hatching conditioning imposed on the animals might be very important and 
differences in experimental designs across studies need to be carefully 
evaluated in the comparative approach.  
Chapter 4 focused on the influences of elevated exposure to B during pre- and 
post-hatching development on the transcriptome signature in two target brain 
structures controlling the HPA axis, the hippocampus and hypothalamus, of the 
adult quail. The main findings suggested that early life stress induced distinct 
tissue-specific modifications in global gene expression patterns. The number of 
genes that were differentially expressed was not large, a finding that was 
consistent with previous studies that examined the effects of variations in early 
life conditions in other species (Weaver et al., 2006; Lindqvist et al., 2007; Nätt 
et al., 2009; Goerlich et al., 2012). The significantly altered gene expression 
patterns involved well known key candidate genes in the regulation of the HPA 
axis, such as the mineralocorticoid receptor (MR), vasotonergic system, brain-
derived neurotrophic factor, and serotonin receptors. The study also suggested 
important novel regulatory mechanisms/pathways that appeared to be modified 
by pre- and post-hatching B exposure into adulthood, such as those regulating 
oxidation processes. Importantly, the analysis showed that there were distinct 
tissue-specific cumulative, as well as some opposite effects, on the brain 
transcriptome signature induced by the interactions between pre- and post-
hatching B treatments.  
Chapter 5 focused on the effects of pre- and post-hatching B on body oxidative 
stress in adult birds. This was assessed by looking at both non-enzymatic (total 
non-enzymatic antioxidant capacity) and enzymatic antioxidant defences 
(superoxide dismutase and glutathione peroxidise) as well as oxidative damage 
(protein carbonyls) in key target tissues, the red blood cells and the brain 
(cerebellum and midbrain). The main results showed that the effects of the B 
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treatments produced specific modifications in the secondary line of antioxidant 
defence pathways in the erythrocytes and cerebellum tissues (glutathione 
peroxidise and non-enzymatic antioxidant capacity), but no effects were 
observed in the midbrain regions. The magnitude of the significant differences 
on the antioxidant defences depended upon interactions between pre- and post-
hatching stimuli. I also found differences among tissues with stronger effects in 
the blood than in the cerebellum.  
Overall, the general theme of this thesis suggested that development is a very 
complex phenomenon, encompassing dynamic changes in the physiological stress 
responses that are likely to be linked with the species’ life histories and 
developmental strategies. Importantly, both pre- and post-hatching exposure to 
B can have the potential to “re-set” individuals’ phenotypic trajectories. The 
multidisciplinary approach undertaken in this work highlighted the complexity of 
these phenotypic responses as they appeared to be tissue specific, with 
alterations at both the physiological and the gene expression level. One of the 
main questions arising after the overview of the main findings is: are these 
changes ecologically important? Specifically, can early life stress affect 
Darwinian fitness and survival?   
 
6.2 Developmental plasticity and early life stress: 
an evolutionary perspective 
The data presented in Chapter 2 supported the “Developmental Hypothesis” as 
mentioned above (Section 6.1). The main principle of such hypothesis is the co-
evolution of species’ developmental strategies and the hormonal signalling 
pathways. The stress response becomes demonstrable much earlier in the life of 
precocial birds (at least from the later stages of pre-hatching development) 
compared to altricial species that show adult-like stress responses close to or at 
fledgling (reviewed by Wada, 2008). From an evolutionary perspective, these 
differences may be explained by variations in the developmental mode between 
precocial and altricial species (see Chapter 2). It would be interesting, however, 
to appraise the biological variability in the maturation of the HPA axis system in 
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birds that have evolved semi-altricial/semi-precocial developmental strategies 
and examine if, and how, they fit within the comparative framework of the 
available literature. Ideally, such experiments should be conducted in the wild 
and would require careful considerations of the specific time of sampling, which 
should take into account ecologically relevant developmental windows (e.g. 
hatching, fledgling, nutritional independence) and the variation in parental care 
across specific nestling stages. We also lack studies in the natural context that 
have examined the variation of the juvenile stress responses within populations 
of the same species. It is plausible that the development of stress physiology 
may vary depending on the environment, such as different degrees of predator 
densities. Again, this hormonal phenotypic plasticity would be expected to be 
dependent on the developmental mode. Under this scenario, future studies in 
juveniles of bird species adapted to cope with extreme environments, such as 
desert and high latitude, will be extremely important for comparative research 
with the scope to assess the evolutionary meaning for variation in the ontogeny 
of the stress responses across species.   
Whether the effects of early life stress on the phenotype are adaptive because 
they convey ecologically relevant information on the current/future 
environmental conditions to the growing individuals or maladaptive physiological 
constraints that negatively affect Darwinian fitness has been hotly debated 
(Henriksen et al., 2011, Schoech et al., 2011; Love et al., 2013). The 
predominant idea is that phenotypic plasticity, driven by early life experiences, 
exerts adaptive responses largely over the short-term, but may have 
physiological costs later in adult life (Gluckman et al., 2007). However, new 
theories, supported by some empirical work are emerging and have emphasised 
the importance of testing predictions on the potential adaptive value of the 
early environment in different post-natal/hatching environmental contexts and 
across multiple individual life stages (Monaghan, 2008). Although the main 
experiment of this thesis was not specifically designed to test adaptive or non-
adaptive predictions of early life stress, some overall conclusions may be drawn 
by interpreting the phenotypic and genomic results together. For example, the 
physiological effects of post-hatching B were mainly visible over the short-term 
and induced sex-specific changes on the dynamics of the stress response, basal 
triglycerides and basal glucose concentrations (see Chapter 3). These results 
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suggested that the post-hatching B-treated quail can adapt to the current 
prevailing stressful environment with immediate physiological changes that “re-
set” the regulation of the stress response as well as the allocation of available 
energy resources in the bloodstream. Similar condition-driven adrenocortical 
plasticity has been described in previous work in young free-living European 
Starlings experiencing poor quality maternal care and has been termed the 
“Reactive Adaptive Response” (Love and Williams, 2008). The data reported 
here (Chapter 3) suggested that these immediate/short-term responses cause 
changes not only to the activity of the HPA axis, but also to other important 
physiological mechanisms involved in energy transport and lipid deposition. 
Furthermore, in the study conducted by Love and Williams (2008) the pre-
hatching programming cues of B constrained the degree of post-hatching 
reactive plasticity in the responsiveness of the HPA axis of the juvenile birds. In 
contrast, in this study post-hatching B-mediated effects on the young quail did 
not interact with the pre-hatching experiences. This suggested that post-
hatching environmental cues are of primary importance in quail. Clearly, 
precocial birds reach nutritional independence soon after hatching and rely less 
on maternal care than altricial birds. Therefore, they need to adapt quickly to 
unpredictable environmental conditions and the evolution of a hormonal 
signalling system that is highly sensitive to the immediate post-hatching cues 
may be a better strategy than relying on previous maternal predictions 
(assuming that elevated yolk B is a key coding signal integrated by the embryo). 
In this regard, glucocorticoids may be very important as they can enhance fear, 
mobility and vigilance behaviours, so allowing the juveniles to better avoid 
predators and reduce risk-taking behaviours (Breuner et al., 1998a, b; Janczak 
et al., 2006).  
Intriguingly, the physiological effects of pre-hatching B on the activity of the 
HPA axis and energy metabolism were visible predominantly during adulthood 
and they appeared dependent on early post-hatching conditions (Chapter 3). An 
overview of these results, including those observed on cellular redox balance 
(Chapter 5), suggested that matching pre- and post-hatching B  triggered 
interactive long-term effects on the pre-hatching glucocorticoid-exposed 
phenotypes when adults. A variety of long-term context-dependent responses 
were observed in the pre- and post-hatching B-treated birds. Specifically, a post-
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natal stressful environment had on some occasions intensified (e.g. effects on 
red blood cell glutathione peroxidise, Chapter 5), or mitigated/buffered (e.g. 
results on the HPA axis responsiveness shown in Chapter 3) the effects of 
previous embryonic exposure to B. But what may be the mechanism mediating 
this developmental-glucocorticoid-dependent physiological plasticity?  
Corticosteroid receptors (mineralocorticoid and glucocorticoid receptors, MR and 
GR respectively) act as transcription factors and are well known to be actively 
involved in regulation of the stress responsiveness and several stress-related 
behaviours (de Kloet et al., 2005a, b; Joel et al., 2008). As mentioned in more 
detail elsewhere (Chapter 1), glucocorticoids have an affinity to MR 5-10 times 
higher than GR and, therefore, MR remain tonically activated by basal 
glucocorticoid levels. As a result of the different affinity of MR and GR in binding 
glucocorticoids, the balance of expression of both MR and GR is thought to be 
critical to maintain homeostasis within an organism (Reul and de Kloet, 1985; de 
Kloet et al., 2005a). Previous studies in birds have shown that both MR and GR 
receptors in the brain can be affected by early life stressful conditions (Banerjee 
et al., 2012) or chronic exposure to stress (Dickens et al., 2009), similar to what 
has been observed in many mammalian studies (reviewed by Oitzl et al., 2010). 
Here, I found a higher expression of the gene coding MR (NR3C2) in the 
hippocampus of the adult B-exposed phenotypes compared to the controls 
(Chapter 4). While hippocampal GR transcript levels (NR3C1) did not differ 
across the treatment groups, the analysis of the balance between MR:GR 
expression abundances showed different trends across the treatments, with the 
adult quail that experienced stress during both pre- and post-hatching 
developmental periods having lower MR/GR ratio compared to the pre- or post-
hatching B-treated birds (Chapter 4). I propose that this different hippocampal 
MR: GR ratio in the adult pre- and post-hatching B-exposed birds might be an 
important regulatory mechanism to explain the interactions between pre- and 
post-hatching B both at the physiological (Chapter 3 and 5) and gene expression 
level (Chapter 4). However, as the transcriptional analysis was limited to pooled 
RNA samples, investigations at the individual level on MR and GR would be a 
future important step to experimentally validate this hypothesis. Ideally, these 
further investigations should examine both gene expression levels and protein 
content of corticosteroid receptors as these measurements may not necessarily 
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correlate between each other (e.g. Ahmed et al., in press). In the awareness of 
the high variations across the results in the area of developmental stress (e.g. 
Henriksen et al., 2011), it would be important to test this hypothesis on multiple 
post-hatching scenarios, especially under stressful and non stressful conditions, 
and across different species in order to sample the variability underlying the 
regulatory mechanisms in the brain associated with early life stress. Also, in this 
study, the modifications across treatments observed in MR gene expression were 
shown to be functionally linked to several other genes, such as those coding 
neurotrophic factors, neuronal oxidation processes, and other neurohormones. 
Therefore, it is likely that developmental exposure to glucocorticoids exerted 
changes in an array of inter-connected transcriptional pathways rather than on 
the expression of single candidate genes (Chapter 4). In fact, the data presented 
in Chapter 4 suggest that such transcriptional pathways are likely to be linked 
with neurotrophin factors (hippocampal BDNF expression was increased in all the 
B-treated birds compared to the control birds) as well as the serotonergic system 
(3 hypothalamic serotonin receptors, HTR3A, HTR2C, and HTR1D, were all up-
regulated in the birds treated with B post-hatching compared to the post-
hatching control birds). Another important possible route by which 
developmental stress can induce gene expression changes is via epigenetic 
processes, such as DNA methylation and histone modifications (Murgatroyd et 
al., 2009; Weaver et al., 2004). For example, childhood adversities have been 
shown to increase CpG methylation of the GR promoter in human leukocytes 
(Tyrka et al., 2012) and the methylation of the corticotrophin releasing hormone 
(CRH) promoter in different brain areas in rats (Sterrenburg et al., 2011). 
Interestingly, enhanced CpG methylation of both the GR and CRH promoters 
have been observed recently in the hypothalamus of adult chickens exposed to B 
pre-hatching in comparison with adult controls, providing evidence that such 
changes can be attributed to the direct effects of B exposure itself (Ahmed et 
al., in press). Taken together these data open the question of possible enduring 
trans-generational effects of developmental stress via epigenetic mechanisms 
and future research should attempt to integrate gene expression analysis with 
DNA methylation measurements. But can the combined effects of stress during 
the pre- and post-natal/hatching periods result in a better adapted adult 
phenotype compared to that induced by pre- or post-natal/hatching stress on 
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their own? At this stage, this remains unclear. The functional analysis pointed to 
a series of negative cumulative effects associated with the combined early life 
stressful treatments, such as cancer, neurological diseases, and hereditary 
disorders. However, the available literature in genome-wide analyses is highly 
biased by research in the biomedical field, which rarely consider the potential 
adaptive benefits of developmental stress in later life. We do have several line 
of evidence across studies in mammals and birds showing that developmental 
stress can exert long-term changes on an array of behaviours, including 
exploratory behaviours in novel environments, neophobia, song, memory and 
spatial learning, and aggressive responses (e.g. reviews by Henriksen et al., 
2011; Schoech et al., 2011). Some of these effects do not appear to be simply 
unavoidable physiological developmental constraints, but rather adaptive 
responses that prepare the individual to adopt appropriate behavioural 
responses in environments in which stressors may be frequently encountered 
(Meylan and Clobert, 2005; Zimmer et al., 2013; see also review by Love et al., 
2013). In the present thesis, the data on the redox physiology concur to provide, 
at least in part, some support for the hypothesis of adaptive advantages of 
developmental stress programming. In fact, the analysis of redox oxidative 
balance in the blood of the adult quail clearly showed that the activity of 
glutathione peroxidise in the erythrocytes, an important vehicle for the 
transport of antioxidants in the body, was 50% higher in the BB birds than in the 
CC birds, suggesting that the combined action of pre- and post-hatching B may 
have triggered cumulative long-term adaptive protective responses in the 
antioxidant system of these birds. Moreover, as I found no significant increases 
of protein damage in any of the tissues examined, it seems likely that the BB 
birds could avoid a condition of oxidative stress potentially via the observed 
alterations in antioxidant defences. On the other hand, as overexposure to post-
hatching B has the potential to significantly reduce life expectancy in adulthood 
(Monaghan et al., 2012) and embryonic exposure to stress hormones can 
accelerate telomere loss in red blood cells (Haussmann et al., 2012), it is also 
possible that the phenotypic modifications in the BB quail may actually have 
negative effects on later fitness and/or survival. To the best of my knowledge, 
this is the first evidence showing that oxidative balance may be plastic to both 
pre- and post-hatching environmental cues and I do hope that it will encourage 
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future research in this area. For future research, it will be extremely important 
to perform longitudinal studies in short-lived animal models, including the 
Japanese quail, and track changes on reproductive success, survival and ageing 
trajectories across the multiple stage of adult life. These data are fundamental 
to provide a framework to interpret from an evolutionary perspective fitness 
costs and benefits of the physiological changes associated with developmental 
stress programming. We also need more experimental work to examine whether 
the effects of developmental stress can be transmitted/extended to the 
following generations and to elucidate the underlying mechanisms of actions 
mediating such inheritance (likely associated with changes in the epigenome). 
These studies are critical to fully understand the complicated interplay among 
developmental stress, Darwinian fitness and survival. The study of such interplay 
may also help to reconcile the well known paradigm “nature vs nurture” and 
explore in more depth the relationships between development and evolutionary 
processes.  
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Appendix 
 
Table A1. TopHat arguments that were deviated from the default settings in the final alignment of 
the RNA-seq quail reads to the chicken reference genome. Full detail regarding the alignment is 
presented in Section 4.3.10.   
 
  
TopHat parameters Setting used 
--initial-read-mismatches 
(i.e. number of mismatches allowed for each read) 
3 (default 2) 
--segment-length 
(i.e. minimum segment read length) 
18 (default 25) 
--segment-mismatches 
(i.e. number of mismatches allowed in each segment alignment) 
1 (default 2) 
--min-anchor-length 
(i.e. number of bases supporting every junction involved in sliced 
alignments by at least one read) 
12 (default 8) 
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Figure A1 Schematic of one of the coronal brain section (interaural 2.56mm, Fig. 18 from the 
chicken brain atlas by Puelles et al., 2007) used a reference for obtaining the hippocampal (in 
yellow), hypothalamic (in red) and midbrain (in green) punches from the 2-mm-tick coronal sections 
of the quail brains. Hippocampal and midbrain punches were taken bilaterally; hippocampal and 
hypothalamic punches were used for the study presented in Chapter 4 while the midbrain punches 
were used for the study presented in Chapter 5. The size of each hippocampal punch was of 1mm 
diameter, whereas the size of each hypothalamic and midbrain punch was 2mm diameter.  
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Figure A2. RNA quality control of the hippocampal RNA pooled samples assessed prior the start of 
the microarray experiments. In each graph is indicated the treatment group (CC, BC, CB or BB) 
with the numbers (1, 2, 3) representing the biological replicate in each treatment group.  
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Table A2. Ensembl Identifiers (Ensembl ID) and functional description of the genes with FRD ≤ 
0.20 in the Bayseq models (DE); # indicates the row number in the inputted dataset.     
 
DE2   
Ensembl ID # Description 
ENSGALG00000023456 16295 Homeobox CMIX 
ENSGALG00000004239 3115 interferon induced transmembrane protein 5 
ENSGALG00000006051 4537 cell division cycle 7-related protein kinase [Homo sapiens] 
- 97% max identity 
ENSGALG00000021242 14436 phosphohistidine phosphatase 1 
ENSGALG00000013268 10001 Novel 
ENSGALG00000016221 12114 EF-hand domain-containing family member 
ENSGALG00000017405 13056 nitrogen permease regulator-like 3 (S. cerevisiae) 
ENSGALG00000014773 10946 erbb2 interacting protein 
ENSGALG00000004467 3295 CAP-Gly domain-containing linker protein 1 
ENSGALG00000010928 8299 bone sialoprotein II 
ENSGALG00000022843 15690 Novel 
 
 
DE4   
Ensembl ID # Description 
ENSGALG00000013362 10050 calcium binding protein 7 
ENSGALG00000016884 12655 solute carrier family 15 (oligopeptide transporter), member 
1 ENSGALG00000015205 11302 tyrosinase-related protein-1 
ENSGALG00000006726 5079 GATA binding protein 3 
ENSGALG00000005978 4472 retinol binding protein 3, interstitial 
ENSGALG00000011813 8954 HEG homolog 1 (zebrafish) 
ENSGALG00000010718 8142 thrombospondin, type I, domain containing 7A 
ENSGALG00000016095 12014 homeobox protein EMX1 
ENSGALG00000011236 8532 brain-enriched guanylate kinase-associated homolog (rat) 
DE6   
Ensembl ID # Description 
ENSGALG00000001807 1272 Homeobox 
ENSGALG00000013155 9924 Novel 
ENSGALG00000011424 8677 Eomesodermin 
DE7   
Ensembl ID # Description 
ENSGALG00000023973 16812 alpha-1 collagen (I), partial 
ENSGALG00000013294 10017 cytochrome P450, family 19, subfamily A, polypeptide 1 
ENSGALG00000003541 2585 solute carrier family 32 (GABA vesicular transporter), 
member 1 
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ENSGALG00000012544 9517 UDP-N-acetyl-alpha-D-galactosamine:polypeptide  
N-acetylgalactosaminyltransferase 5 (GalNAc-T5) 
ENSGALG00000003895 2853 PR domain containing 12 
ENSGALG00000015419 11478 Proenkeph lin 
ENSGALG00000023913 16752 urocortin 3 (stresscopin) 
ENSGALG00000013890 10383 melanocortin 5-receptor 
ENSGALG00000008883 6745 transcription factor 7-like 2 (T-cell specific, HMG-box) 
DE5   
Ensembl ID # Description 
ENSGALG00000000168 91 Adenosine receptor A1 
ENSGALG00000008940 6789 Novel 
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Table A3. Normalised counts across the 3 biological replicates in each treatment group (CC, BC, 
CB and BB) of the genes with FDR ≤ 0.20 among the Bayseq models (DE2, DE4, DE5, DE6 and 
DE7) in the (a) hippocampus and (b) hypothalamus; # indicates the row number in the original 
dataset. 
 
(a) Hippocampus
DE2
# 1 2 3 1 2 3 1 2 3 1 2 3 FDR
16295 0 0 0 0 0 0 0 0 0 6 0 2 0.078
3115 5 2 4 2 2 8 1 3 5 3 2 152 0.081
4537 5 6 1 4 5 5 3 5 4 31 5 23 0.099
14436 302 313 333 341 312 328 319 309 289 443 364 430 0.112
10001 384 336 285 289 287 339 258 319 337 146 233 159 0.124
12114 107 109 114 119 118 111 102 124 128 66 84 82 0.134
13056 74 54 73 56 43 61 57 46 43 24 27 29 0.145
10946 751 628 706 717 734 712 675 734 693 570 581 470 0.155
3295 2180 2492 2271 2369 2403 2457 2278 2226 2314 3523 2228 3407 0.167
8299 4 14 17 12 9 21 9 6 11 7 14 220 0.181
15690 220 220 219 231 250 227 229 230 184 320 264 349 0.194
# 1 2 3 1 2 3 1 2 3 1 2 3 FDR
10050 845 50 98 56 66 62 75 62 57 44 73 56 0.020
12655 31 14 24 5 4 6 2 4 8 3 6 3 0.021
11302 24 14 27 1 1 5 4 3 6 0 7 3 0.053
5079 136 6 3 4 4 5 1 7 7 3 5 6 0.073
4472 11 4 0 0 0 1 0 0 0 0 0 0 0.094
8954 444 226 336 145 154 180 185 141 199 189 160 130 0.112
8142 1350 871 870 740 776 730 763 713 792 747 702 652 0.134
12014 243 249 235 491 384 504 412 353 463 306 402 336 0.156
8532 751 750 876 972 1015 1012 1045 914 977 959 1012 1002 0.181
DE6
# 1 2 3 1 2 3 1 2 3 1 2 3 FDR
1272 302 297 300 194 236 191 162 238 184 285 295 329 0.028
9924 614 541 411 330 358 325 342 379 376 588 367 623 0.123
8677 125 148 91 75 93 74 94 87 85 211 70 314 0.183
DE7
# 1 2 3 1 2 3 1 2 3 1 2 3 FDR
16812 35 34 35 35 19 225 23 49 41 34 43 3423 0.015
10017 9 72 36 5 4 5 5 281 7 4 2 4 0.033
2585 1902 2186 2661 1490 1415 1432 1437 2755 1643 1488 1484 1466 0.039
9517 53 74 65 132 176 155 55 71 92 114 121 140 0.044
2853 15 90 19 6 3 3 3 209 8 1 2 4 0.074
11478 442 1536 1910 492 487 526 447 3740 583 377 376 449 0.109
16752 4 19 17 1 0 1 1 155 2 1 2 2 0.136
10383 63 88 78 25 26 23 41 173 26 26 38 21 0.165
6745 135 25 57 25 29 23 25 106 29 27 29 22 0.188
(b) Hypothalamus
DE5
# 1 2 3 1 2 3 1 2 3 1 2 3 FDR
91 146 141 153 159 137 148 151 389 274 312 228 255 0.048
6789 33 25 44 34 36 26 31 138 127 97 80 86 0.153
CC BC CB BB
DE4 CC BC CB BB
CC BC CB BB
CC BC CB BB
CC BC CB BB
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Table A4. Annotated list of Ensembl identifiers (Ensembl IDs) from the RNA-seq data with FDR ≤ 
0.20 using Cufflinks, Bayseq and RankProducts algorithms among the pair-wise contrast in the (a) 
hippocampus and (b) hypothalamus.   
 
(a) Hippocampus 
 
Contrast: BC vs CC (2nd class vs 1st class): up-regulated genes under 2nd class  
 Ensembl ID Description 
 ENSGALG00000000184 solute carrier family 27 (fatty acid transporter), member 6 
 ENSGALG00000002744 uncharacterised 
 ENSGALG00000004064 G protein-coupled estrogen receptor 1 
 ENSGALG00000004623 angiotensin II receptor-associated protein 
 ENSGALG00000005209 aquaporin 1 (Colton blood group) 
 ENSGALG00000008139 uncharacterised 
 ENSGALG00000009021 
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-
acetylgalactosaminide alpha-2,6-sialyltransferase 5 
 ENSGALG00000009308 cornichon homolog 3 (Drosophila) 
 ENSGALG00000010035 nuclear receptor subfamily 3, group C, member 2 
 ENSGALG00000011258 ATPase, Ca++ transporting, plasma membrane 1 
 ENSGALG00000011592 muscle RAS oncogene homolog 
 ENSGALG00000012440 zinc finger E-box binding homeobox 2 
 ENSGALG00000013925 v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog 
 ENSGALG00000014186 metallophosphoesterase domain containing 1 
 ENSGALG00000015271 filamin A interacting protein 1-like 
 ENSGALG00000016095 empty spiracles homeobox 1 
 ENSGALG00000016109 
potassium channel, subfamily V, member 1; similar to neuronal 
potassium channel alpha subunit 
 ENSGALG00000023441 reticulon 4 receptor-like 2 
   
Contrast: BC vs CC (2nd class vs 1st class): down-regulated genes under 2nd class  
 Ensembl ID Description 
 ENSGALG00000000112 
proteolipid protein 1 (Pelizaeus-Merzbacher disease, spastic 
paraplegia 2, uncomplicated) 
 ENSGALG00000000713 zinc finger homeobox 3 
 ENSGALG00000000733 myosin VIIA 
 ENSGALG00000000745 solute carrier family 26, member 9 
 ENSGALG00000001063 PR domain containing 16 
 ENSGALG00000001115 membrane metallo-endopeptidase-like 1 
 ENSGALG00000001211 hypothetical protein LOC769183 
 ENSGALG00000002161 similar to MGC80370 protein 
 ENSGALG00000002331 calbindin 2, 29kDa (calretinin) 
 ENSGALG00000003034 somatostatin II 
 ENSGALG00000003457 2',3'-cyclic nucleotide 3' phosphodiesterase 
 ENSGALG00000003573 hippocalcin 
 ENSGALG00000003770 annexin A2 
 ENSGALG00000004607 heme binding protein 2 
 ENSGALG00000004729 
solute carrier family 7, (neutral amino acid transporter, y+ system) 
member 10 
 ENSGALG00000005030 dedicator of cytokinesis 10 
 ENSGALG00000006807 uncharacterised  
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 ENSGALG00000006838 similar to iron binding protein 
 ENSGALG00000007226 osteocrin 
 ENSGALG00000007772 cerebellin 4 precursor 
 ENSGALG00000007875 endothelin converting enzyme-like 1 
 ENSGALG00000007945 crystallin, alpha B 
 ENSGALG00000008306 fibrinogen-like 2 
 ENSGALG00000009471 phosphatidic acid phosphatase type 2 domain containing 1A 
 ENSGALG00000012381 neurexophilin 2 
 ENSGALG00000012906 cadherin 20, type 2 
 ENSGALG00000013168 islet amyloid polypeptide 
 ENSGALG00000013362 calcium binding protein 7 
 ENSGALG00000013640 myelin basic protein 
 ENSGALG00000013890 melanocortin 5 receptor 
 ENSGALG00000014978 IQ motif containing GTPase activating protein 2 
 ENSGALG00000015143 transthyretin 
 ENSGALG00000015419 proenkephalin 
 ENSGALG00000016428 
similar to autotaxin-t; ectonucleotide 
pyrophosphatase/phosphodiesterase 2 (autotaxin) 
 ENSGALG00000016551 adaptor-related protein complex 1, sigma 2 subunit 
 ENSGALG00000016828 growth hormone regulated TBC protein 1 
 ENSGALG00000017343 folate receptor 1 (adult) 
 ENSGALG00000018557 
similar to extracellular-superoxide dismutase (EC 1.15.1.1); 
superoxide dismutase 3, extracellular 
 ENSGALG00000021636 similar to CASP gene product 
 ENSGALG00000021873 hypothetical protein LOC771339 
 ENSGALG00000023689 argininosuccinate synthetase 1; hypothetical LOC425164 
   
Contrast: BB vs CC (2nd class vs 1st class): up-regulated genes under 2nd class  
 Ensembl ID Description 
 ENSGALG00000023973 alpha-1 collagen (I) 
   
Contrast: BB vs CC (2nd class vs 1st class): down-regulated genes under 2nd class  
 Ensembl ID Description 
 ENSGALG00000000713 zinc finger homeobox 3 
 ENSGALG00000000733 myosin VIIA 
 ENSGALG00000001063 PR domain containing 16 
 ENSGALG00000001115 membrane metallo-endopeptidase-like 1 
 ENSGALG00000002389 integrin, beta 4 
 ENSGALG00000007269 gamma-aminobutyric acid (GABA) A receptor, alpha 3 
 ENSGALG00000014967 synaptic vesicle glycoprotein 2C 
 ENSGALG00000016017 solute carrier family 4, sodium borate transporter, member 11 
   
Contrast: CB vs BC (2nd class vs 1st class): up-regulated genes under 2nd class  
 Ensembl ID Description 
 ENSGALG00000015143 transthyretin 
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Contrast: BB vs BC (2nd class vs 1st class): down-regulated genes under 2nd class  
 Ensembl ID Description 
 ENSGALG00000006485 uncharacterised  
 ENSGALG00000010971 family with sequence similarity 130, member A2 
 ENSGALG00000013568 nuclear receptor subfamily 4, group A, member 3 
 ENSGALG00000017229 FAT tumor suppressor homolog 3 (Drosophila) 
   
(b) Hypothalamus  
Contrast: BB vs CC (2nd class vs 1st class): up-regulated genes under 2nd class   
 Ensembl ID Description  
 ENSGALG00000000168 adenosine A1 receptor  
 ENSGALG00000000376 uncharacterised   
 ENSGALG00000001282 gamma-aminobutyric acid (GABA) A receptor, delta  
 ENSGALG00000001505 neuronal guanine nucleotide exchange factor  
 ENSGALG00000001727 leucine zipper, putative tumor suppressor 1  
 ENSGALG00000004011 uncharacterised   
 ENSGALG00000005721 diacylglycerol kinase, gamma 90kDa  
 ENSGALG00000005853 5-hydroxytryptamine (serotonin) receptor 2C  
 ENSGALG00000006021 calcium channel, voltage-dependent, gamma subunit 3  
 ENSGALG00000006406 bombesin-like receptor 3  
 ENSGALG00000006576 glutamate receptor, metabotropic 3  
 ENSGALG00000007004 5-hydroxytryptamine (serotonin) receptor 3A  
 ENSGALG00000007141 leucine-rich repeat kinase 1  
 ENSGALG00000008135 SATB homeobox 2  
 ENSGALG00000008308 basic helix-loop-helix domain containing, class B, 2  
 ENSGALG00000008365 cholinergic receptor, muscarinic 4  
 ENSGALG00000008885 phosphodiesterase 1A, calmodulin-dependent  
 ENSGALG00000008940 spectrin, beta, non-erythrocytic 5  
 ENSGALG00000009853 forkhead box G1  
 ENSGALG00000009859 TBC1 domain family, member 30  
 ENSGALG00000010939 lin-7 homolog A (C. elegans)  
 ENSGALG00000011122 uncharacterised   
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 ENSGALG00000011254 SATB homeobox 1  
 ENSGALG00000011613 copine IV  
 ENSGALG00000011721 A kinase (PRKA) anchor protein 5  
 ENSGALG00000011883 C-type lectin domain family 3, member B  
 ENSGALG00000012235 neurogenic differentiation 6  
 ENSGALG00000012367 tripartite motif-containing 9  
 ENSGALG00000012542 RASD family, member 2  
 ENSGALG00000012732 phosphatase and actin regulator 1  
 ENSGALG00000012890 diacylglycerol kinase, iota  
 ENSGALG00000013795 
human immunodeficiency virus type I enhancer binding 
protein 2 
 
 ENSGALG00000013948 RAS-like, family 11, member B  
 ENSGALG00000014634 silver homolog (mouse)  
 ENSGALG00000014645 
MADS box transcription enhancer factor 2, polypeptide C 
(myocyte enhancer factor 2C) 
 
 ENSGALG00000014907 discoidin, CUB and LCCL domain containing 1  
 ENSGALG00000015271 filamin A interacting protein 1-like  
 ENSGALG00000015626 regulator of G-protein signalling 12  
 ENSGALG00000015842 T-cell lymphoma invasion and metastasis 1  
 ENSGALG00000016154 activity-regulated cytoskeleton-associated protein  
 ENSGALG00000016920 LIM domain 7  
 ENSGALG00000018942 neurogranin (protein kinase C substrate, RC3)  
 ENSGALG00000019842 transcription factor AP-2delta  
 
Contrast: BB vs BC (2nd class vs 1st class): up-regulated genes under 2nd class  
 
 Ensembl ID Description  
 ENSGALG00000000168 adenosine A1 receptor  
 ENSGALG00000000695 major facilitator superfamily domain containing 4  
 ENSGALG00000001564 ATPase, Ca++ transporting, ubiquitous  
 ENSGALG00000007004 5-hydroxytryptamine (serotonin) receptor 3A  
 ENSGALG00000007278 glutamate receptor, ionotropic, N-methyl D-aspartate 2A  
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 ENSGALG00000008135 SATB homeobox 2  
 ENSGALG00000008940 spectrin, beta, non-erythrocytic 5  
 ENSGALG00000009556 prickle homolog 1 (Drosophila)  
 ENSGALG00000011122 uncharacterised  
 ENSGALG00000012183 neuronal pentraxin receptor  
 ENSGALG00000012235 neurogenic differentiation 6  
 ENSGALG00000012254 
potassium inwardly-rectifying channel, subfamily J, 
member 4 
 
 ENSGALG00000018942 neurogranin (protein kinase C substrate, RC3)  
 ENSGALG00000019842 transcription factor AP-2delta  
 ENSGALG00000022001 hypothetical LOC415928  
 ENSGALG00000023441 reticulon 4 receptor-like 2  
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Table A5. Top 20 up- or down-regulated significant (FDR ≤ 0.10) transcripts across the pair-wise 
contrasts in the (a) hippocampus and (b) hypothalamus. Genes were sorted according to the 
RankProducts statistics in ascending order and cut at the level of FDR 0.1. FC denotes the fold 
change.  
(a) Hippocampus       
Contrast: BC vs CC       
(1) Top 20 up-regulated genes under 2nd class     
  Ensembl ID Description FDR  FC 
  ENSGALG00000006137 Rho GTPase activating protein 22  0.0020 1.9148 
  
ENSGALG00000012544 
UDP-N-acetyl-alpha-D-galactosamine: 
polypeptide N-cetylgalactosaminyltransferase 
5 (GalNAc-T5)  
0.0023 1.9347 
  
ENSGALG00000008723 
complement component 1, q subcomponent-
like 3  
0.0025 1.9635 
  ENSGALG00000016465 similar to egg envelope component ZPAX  0.0040 1.9502 
  
ENSGALG00000014414 
gamma-aminobutyric acid (GABA) receptor, 
rho 3  
0.0050 1.9303 
  ENSGALG00000012327 inhibin, beta A  0.0051 1.8766 
  
ENSGALG00000000184 
solute carrier family 27 (fatty acid 
transporter), member 6  
0.0053 1.8676 
  ENSGALG00000008135 SATB homeobox 2  0.0053 1.7825 
  ENSGALG00000006676 retinaldehyde binding protein 1  0.0060 1.9513 
  ENSGALG00000016095 empty spiracles homeobox 1  0.0064 1.7828 
  ENSGALG00000016499 hypothetical protein LOC770429  0.0075 1.7465 
  ENSGALG00000000507 copine VII  0.0078 1.7435 
  ENSGALG00000005347 similar to ADAMTS18 protein  0.0079 1.7224 
  ENSGALG00000005802 fms-related tyrosine kinase 4  0.0082 1.7570 
  ENSGALG00000016500 FK506 binding protein 1B, 12.6 kDa  0.0083 1.7559 
  ENSGALG00000005772 BCL2-related ovarian killer  0.0085 1.7838 
  ENSGALG00000015720 chondrolectin  0.0088 1.7736 
  ENSGALG00000015271 filamin A interacting protein 1-like  0.0090 1.6675 
  
ENSGALG00000013925 
v-kit Hardy-Zuckerman 4 feline  
sarcoma viral oncogene homolog  
0.0096 1.6287 
  ENSGALG00000017064 replication factor C (activator 1) 3, 38kDa 0.0114 1.6222 
          
(2) Top 20 down-regulated genes under 2nd class     
  Ensembl ID Description FDR  FC 
  ENSGALG00000001696 S-antigen; retina and pineal gland (arrestin)  < 0.0001 -18.196 
  
ENSGALG00000013154 
solute carrier organic anion transporter 
family, member 1C1  
< 0.0001 -8.0053 
  ENSGALG00000015143 transthyretin  < 0.0001 -5.8174 
  ENSGALG00000007875 endothelin converting enzyme-like 1  0.0003 -3.2126 
  ENSGALG00000011859 eye-globin  0.0012 -3.5947 
  ENSGALG00000011369 LIM homeobox 8  0.0013 -3.6024 
  ENSGALG00000016553 transmembrane protein 27  0.0015 -3.2546 
  ENSGALG00000001490 uncharacterised 0.0017 -2.8839 
257 
 
 
  
ENSGALG00000018557 
similar to extracellular-superoxide 
dismutase (EC 1.15.1.1); superoxide 
dismutase 3, extracellular  
0.0018 -2.8748 
  
ENSGALG00000012908 
solute carrier family 13 (sodium/sulfate 
symporters), member 4  
0.0019 -3.6478 
  
ENSGALG00000007367 
WAP, follistatin/kazal, immunoglobulin,  
kunitz and netrin domain containing 2  
0.0019 -2.6331 
  ENSGALG00000016020 chloride intracellular channel 6  0.0021 -2.9338 
  ENSGALG00000017343 folate receptor 1 (adult)  0.0027 -2.4622 
  ENSGALG00000007179 ATPase type 13A5  0.0028 -2.6189 
  ENSGALG00000003034 somatostatin II  0.0028 -2.4014 
  ENSGALG00000015918 EF-hand calcium binding protein 1  0.0030 -2.3182 
  ENSGALG00000015595 G protein-coupled receptor 78  0.0031 -2.3334 
  ENSGALG00000000733 myosin VIIA  0.0031 -2.3271 
  ENSGALG00000003573 hippocalcin  0.0033 -2.4069 
  ENSGALG00000013168 islet amyloid polypeptide  0.0041 -2.2804 
 
Contrast: CB vs CC       
(1) Top 20 up-regulated genes under 2nd class     
  Ensembl ID Description FDR  FC 
  
ENSGALG00000002577 
StAR-related lipid transfer (START) domain 
containing 10 
0.0300 1.9365 
  ENSGALG00000004322 uncharacterised 0.0773 1.6685 
  
ENSGALG00000014414 
gamma-aminobutyric acid (GABA) receptor, 
rho 3 
0.0840 1.8285 
          
(2) Top 20 down-regulated genes under 2nd class     
  Ensembl ID Description FDR  FC 
  
ENSGALG00000013154 
solute carrier organic anion transporter 
family, member 1C1 
0.0045 -3.3707 
  
ENSGALG00000012908 
solute carrier family 13 (sodium/sulfate 
symporters), member 4 
0.0050 -2.8656 
  
ENSGALG00000007367 
WAP, follistatin/kazal, immunoglobulin,  
kunitz and netrin domain containing 2 
0.0090 -2.6494 
  ENSGALG00000011859 eye-globin 0.0205 -2.6732 
  ENSGALG00000015143 transthyretin 0.0242 -4.1646 
  ENSGALG00000001490 uncharacterised 0.0427 -2.1829 
  ENSGALG00000016553 transmembrane protein 27 0.0441 -2.2201 
  ENSGALG00000001696 S-antigen; retina and pineal gland (arrestin) 0.0503 -2.9875 
  
ENSGALG00000011858 
potassium voltage-gated channel,  
subfamily H (eag-related), member 5 
0.0530 -1.9626 
  ENSGALG00000010934 InaD-like (Drosophila) 0.0650 -1.9627 
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ENSGALG00000018557 
similar to extracellular-superoxide 
dismutase (EC 1.15.1.1); superoxide 
dismutase 3, extracellular 
0.0673 -2.0535 
  ENSGALG00000017343 folate receptor 1 (adult) 0.0718 -1.9214 
  
ENSGALG00000016017 
solute carrier family 4, sodium borate 
transporter, member 11 
0.0871 -1.8846 
  
ENSGALG00000007179 ATPase type 13A5 0.0915 -1.9503 
  
ENSGALG00000013515 
solute carrier family 4, sodium bicarbonate 
cotransporter, member 5;  
similar to sodium bicarbonate 
cotransporter-like protein 
0.0940 -1.8976 
  
ENSGALG00000008874 
solute carrier family 13 (sodium/sulfate 
symporters), member 1 
0.0943 -1.9148 
  
ENSGALG00000016554 
angiotensin I converting enzyme (peptidyl-
dipeptidase A) 2 
0.0952 -1.8784 
  ENSGALG00000006838 similar to iron binding protein 0.0970 -1.6450 
  ENSGALG00000011813 HEG homolog 1 (zebrafish) 0.0974 -1.7349 
  ENSGALG00000017059 mab-21-like 1 (C. elegans) 0.0979 -2.0561 
 
Contrast: BB vs CC       
(1) Top 20 up-regulated genes under 2nd class     
  Ensembl ID Description FDR  FC 
  ENSGALG00000012226 chromosome 7 open reading frame 16  0.0473 3.1520 
  ENSGALG00000004322 uncharacterised 0.0502 1.9054 
  ENSGALG00000015018 calsequestrin 2 (cardiac muscle)  0.0533 3.1243 
  ENSGALG00000015857 carbonic anhydrase III, muscle specific  0.0548 1.9855 
  ENSGALG00000008193 reelin  0.0615 2.4139 
  ENSGALG00000012285 BAI1-associated protein 2-like 2  0.0620 3.2025 
  ENSGALG00000005985 growth differentiation factor 10  0.0683 2.1699 
  ENSGALG00000024278 uncharacterised 0.0725 2.8673 
  ENSGALG00000003894 cerebellin 1 precursor  0.0730 2.9982 
  ENSGALG00000008908 neurogenic differentiation 1  0.0756 2.1326 
  ENSGALG00000004527 hypothetical protein LOC776119  
unc-13 homolog C (C. elegans); similar to 
Munc13-3  
0.0852 2.0334 
  ENSGALG00000023430 uncharacterised 0.0865 2.4479 
  
ENSGALG00000001695 
gamma-aminobutyric acid (GABA) A receptor, 
alpha 6  
0.0878 2.6068 
  ENSGALG00000000920 cingulin  0.0896 2.5918 
  ENSGALG00000012544 UDP-N-acetyl-alpha-D-galactosamine: 
polypeptide N-
acetylgalactosaminyltransferase 5 (GalNAc-
T5)  
0.0962 1.6314 
  ENSGALG00000009241 secreted frizzled-related protein 2  0.0968 2.0671 
  ENSGALG00000017417 similar to ubiquitin specific proteinase 43  0.0984 2.2327 
  ENSGALG00000000441 potassium voltage-gated channel,  
shaker-related subfamily, member 10  
0.0994 2.5667 
  ENSGALG00000005842 glycerophosphodiester phosphodiesteras e 
domain containing 2 
0.0995 2.8442 
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(2) Top 20 down-regulated genes under 2nd class     
  Ensembl ID Description FDR  FC 
  ENSGALG00000015143 transthyretin  < 0.0001 -28.0977 
  ENSGALG00000013154 solute carrier organic anion transporter 
family, member 1C1  
< 0.0001 -6.5400 
  ENSGALG00000011859 eye-globin  < 0.0001 -4.5587 
  ENSGALG00000001696 S-antigen; retina and pineal gland (arrestin)  < 0.0001 -9.8715 
  
ENSGALG00000007367 
WAP, follistatin/kazal, immunoglobulin,  
kunitz and netrin domain containing 2  
0.0003 -3.0221 
  ENSGALG00000016553 transmembrane protein 27  0.0003 -3.5302 
  ENSGALG00000001490 uncharacterised 0.0004 -3.2100 
  ENSGALG00000016020 chloride intracellular channel 6  0.0004 -3.3355 
  ENSGALG00000000733 myosin VIIA  0.0004 -2.8969 
  ENSGALG00000016017 solute carrier family 4, sodium borate 
transporter, member 11  
0.0007 -2.7615 
  ENSGALG00000012908 solute carrier family 13 (sodium/sulfate 
symporters), member 4  
0.0014 -3.7024 
  ENSGALG00000014967 synaptic vesicle glycoprotein 2C  0.0018 -2.4284 
  ENSGALG00000001063 PR domain containing 16  0.0030 -2.2823 
  ENSGALG00000017343 folate receptor 1 (adult)  0.0031 -2.3754 
  ENSGALG00000001115 membrane metallo-endopeptidase-like 1  0.0032 -2.4286 
  ENSGALG00000018557 similar to extracellular-superoxide dismutase 
(EC 1.15.1.1);  
superoxide dismutase 3, extracellular  
0.0032 -2.8380 
  ENSGALG00000011369 LIM homeobox 8  0.0033 -3.2484 
  ENSGALG00000015419 proenkephalin  0.0043 -2.6196 
  ENSGALG00000005628 collagen, type IX, alpha 3  0.0065 -2.7236 
  ENSGALG00000017068 klotho  0.0072 -2.2514 
  
Contrast: CB vs BC     
(1) Top 20 up-regulated genes under 2nd class   
  Ensembl ID Description FDR  FC 
  ENSGALG00000015143 transthyretin 0.0010 4.3747 
  
ENSGALG00000014117 
arginine vasopressin (neurophysin II, 
antidiuretic hormone,  
diabetes insipidus, neurohypophyseal) 
0.0020 4.2093 
  ENSGALG00000001696 S-antigen; retina and pineal gland (arrestin) 0.0373 2.7064 
  ENSGALG00000020975 uncharacterised 0.0465 1.7710 
          
(2) Top 20 down-regulated genes under 2nd class     
  Ensembl ID Description FDR  FC 
  
ENSGALG00000004320 
FAT tumor suppressor homolog 2 
(Drosophila) 
0.0020 -2.6134 
  
ENSGALG00000008723 
complement component 1, q subcomponent-
like 3 
0.0080 -1.8987 
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ENSGALG00000005842 
glycerophosphodiester phosphodiesterase 
domain containing 2 
0.0115 -2.4758 
  
ENSGALG00000012544 
UDP-N-acetyl-alpha-D-galactosamine: 
polypeptide N-etylgalactosaminyltransferase 
5 (GalNAc-T5) 
0.0128 -1.7961 
  ENSGALG00000012285 BAI1-associated protein 2-like 2 0.0320 -1.8686 
  ENSGALG00000008135 SATB homeobox 2 0.0338 -1.5855 
  ENSGALG00000009431 uncharacterised 0.0881 -1.6929 
  ENSGALG00000005802 fms-related tyrosine kinase 4 0.0906 -1.3155 
  ENSGALG00000016465 similar to egg envelope component ZPAX 0.0907 -1.5696 
  ENSGALG00000002945 chromosome 15 open reading frame 27 0.0948 -1.5645 
 
Contrast: BB vs BC   
(1) Top 20 up-regulated genes under 2nd class 
  Ensembl ID Description FDR  FC 
  ENSGALG00000000681 
similar to PAK3 protein; p21 (CDKN1A)-
activated kinase 3; p21 protein 
(Cdc42/Rac)-activated kinase 1 
0.0522 1.9490 
  
ENSGALG00000000920 cingulin 0.0373 2.9528 
  ENSGALG00000001172 kainate binding protein 0.0506 2.6320 
  
ENSGALG00000002161 similar to MGC80370 protein 0.0495 2.0372 
  ENSGALG00000003354 
potassium voltage-gated channel, 
subfamily H (eag-related), member 4 
0.0471 1.9794 
  
ENSGALG00000003894 cerebellin 1 precursor 0.0350 2.9906 
  ENSGALG00000004320 
FAT tumor suppressor homolog 2 
(Drosophila) 
0.0284 2.6243 
  
ENSGALG00000004527 hypothetical protein LOC776119;  
unc-13 homolog C (C. elegans); similar to 
Munc13-3 
0.0364 3.0010 
  ENSGALG00000005409 LIM homeobox 1 0.0526 2.6154 
  
ENSGALG00000005842 
glycerophosphodiester phosphodiesterase 
domain containing 2 
0.0486 2.3907 
  ENSGALG00000006811 
Zic family member 1 (odd-paired homolog, 
Drosophila) 
0.0404 2.9334 
  
ENSGALG00000008193 reelin 0.0379 2.6058 
  ENSGALG00000008945 nexilin (F actin binding protein) 0.0228 2.8774 
  
ENSGALG00000009012 zinc finger protein 533 0.0242 3.2279 
  ENSGALG00000009431 uncharacterised 0.0490 2.5611 
  
ENSGALG00000010934 InaD-like (Drosophila) 0.0499 2.5613 
  ENSGALG00000011262 
potassium voltage-gated channel, 
subfamily H (eag-related), member 8 
0.0293 2.2552 
  
ENSGALG00000012226 chromosome 7 open reading frame 16 0.0409 2.1956 
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ENSGALG00000015018 calsequestrin 2 (cardiac muscle) 0.0485 2.4365 
  
ENSGALG00000023430 uncharacterised 0.0394 3.0591 
          
(2) Top 20 down-regulated genes under 2nd class     
  Ensembl ID Description FDR  FC 
  ENSGALG00000006473 plexin A4, B 0.0160 -1.8857 
  ENSGALG00000017173 guanylate cyclase 1, soluble, alpha 2 0.0292 -1.7813 
  
ENSGALG00000005347 similar to ADAMTS18 protein 0.0307 -1.9930 
  ENSGALG00000007871 
similar to similar to glutamate transporter 
1 variant;  
solute carrier family 1 (glial high affinity 
glutamate transporter), member 2 
0.0310 -1.8935 
  ENSGALG00000014967 synaptic vesicle glycoprotein 2C 0.0310 -1.8210 
  ENSGALG00000011577 contactin associated protein-like 5 0.0329 -1.7609 
  ENSGALG00000008885 
phosphodiesterase 1A, calmodulin-
dependent 
0.0362 -1.7029 
  ENSGALG00000006485 uncharacterised 0.0378 -1.7609 
  ENSGALG00000005802 fms-related tyrosine kinase 4 0.0405 -1.6421 
  ENSGALG00000001608 unc-5 homolog D (C. elegans) 0.0483 -1.6998 
  ENSGALG00000015080 
solute carrier family 24 
(sodium/potassium/calcium exchanger), 
member 2  
0.0513 -1.6969 
  ENSGALG00000009737 
tachykinin, precursor 1 (substance K, 
substance P, neurokinin 1, neurokinin 2,  
neuromedin L, neurokinin alpha, 
neuropeptide K, neuropeptide gamma) 
0.0525 -1.6675 
  ENSGALG00000017281 uncharacterised 0.0525 -1.6908 
  ENSGALG00000012248 
similar to MAP3K9 protein; mitogen-
activated protein kinase kinase kinase 9 
0.0528 -1.6407 
  ENSGALG00000008723 
complement component 1, q 
subcomponent-like 3 
0.0541 -1.6211 
  ENSGALG00000002799 chromosome 2 open reading frame 21 0.0554 -1.6813 
  ENSGALG00000008544 
similar to Na+/Ca2+ exchanger; solute 
carrier family 8 
(sodium/calcium exchanger), member 1 
0.0567 -1.6168 
  ENSGALG00000000184 
solute carrier family 27 (fatty acid 
transporter), member 6 
0.0568 -1.6835 
  ENSGALG00000015737 neural cell adhesion molecule 2 0.0569 -1.6369 
  ENSGALG00000007993 doublecortex 0.0569 -1.6449 
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Contrast: BB vs CB   
(1) Top 20 up-regulated genes under 2nd class 
  Ensembl ID Description FDR  FC 
  ENSGALG00000003894 cerebellin 1 precursor 0.0095 4.4751 
  
ENSGALG00000004320 
FAT tumor suppressor homolog 2 
(Drosophila) 
0.0100 6.8750 
  
ENSGALG00000005842 
glycerophosphodiester phosphodiesterase 
domain containing 2 
0.0108 5.9259 
  ENSGALG00000012285 BAI1-associated protein 2-like 2 0.0117 6.1420 
  ENSGALG00000000920 cingulin 0.0122 4.6988 
  
ENSGALG00000004527 
hypothetical protein LOC776119; unc-13 
homolog C (C. elegans); similar to Munc13-
3 
0.0133 4.4623 
  ENSGALG00000024278 uncharacterised 0.0164 3.5586 
  
ENSGALG00000006811 
Zic family member 1 (odd-paired homolog, 
Drosophila) 
0.0181 3.4901 
  ENSGALG00000008945 nexilin (F actin binding protein) 0.0220 2.8214 
  ENSGALG00000009012 zinc finger protein 533 0.0238 3.4529 
  ENSGALG00000009431 uncharacterised 0.0245 4.3605 
  ENSGALG00000012226 chromosome 7 open reading frame 16 0.0254 3.1649 
  ENSGALG00000008908 neurogenic differentiation 1 0.0258 2.5441 
  
ENSGALG00000003354 
potassium voltage-gated channel, 
subfamily H (eag-related), member 4 
0.0268 2.1464 
  ENSGALG00000016988 chromosome 13 open reading frame 18 0.0328 3.3360 
  ENSGALG00000008193 reelin 0.0331 3.6453 
  ENSGALG00000023430 uncharacterised 0.0333 3.8019 
  ENSGALG00000015018 calsequestrin 2 (cardiac muscle) 0.0335 3.2215 
  ENSGALG00000003149 inositol 1,4,5-triphosphate receptor, type 3 0.0336 2.9759 
  
ENSGALG00000015778 
gamma-aminobutyric acid (GABA) 
receptor, rho 1 
0.0337 3.5362 
          
(2) Top 20 down-regulated genes under 2nd class     
  Ensembl ID Description FDR  FC 
  ENSGALG00000015143 transthyretin 0.0020 -6.7550 
  ENSGALG00000001696 S-antigen; retina and pineal gland (arrestin) 0.0590 -3.3422 
 
(b) Hypothalamus   
Contrast: BC vs CC   
(1) Top 20 up-regulated genes under 2nd class 
  Ensembl ID Description FDR  FC 
  ENSGALG00000009740 PR domain containing 16 0.0000 3.4815 
  ENSGALG00000011369 LIM homeobox 8 0.0005 2.3797 
  ENSGALG00000015529 Wolfram syndrome 1 (wolframin) 0.0007 2.4260 
  
ENSGALG00000017194 
transient receptor potential cation 
channel, subfamily C, member 6 
0.0016 2.0623 
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ENSGALG00000007980 
phosphodiesterase 1A, calmodulin-
dependent 
0.0016 2.2307 
  ENSGALG00000001074 LIM homeobox 6 0.0018 2.1270 
  ENSGALG00000001347 PR domain containing 12 0.0020 2.0098 
  
ENSGALG00000017044 
transient receptor potential cation 
channel, subfamily C, member 4 
0.0041 2.1187 
  
ENSGALG00000001063 
hypothetical gene supported by 
CR385622 
0.0041 1.9595 
  
ENSGALG00000007139 
potassium voltage-gated channel, 
subfamily G, member 1 
0.0051 2.0885 
  ENSGALG00000009853 forkhead box G1 0.0055 1.9958 
  ENSGALG00000014804 thrombospondin 4 0.0066 1.8216 
  
ENSGALG00000003895 
family with sequence similarity 107, 
member A 
0.0069 2.0431 
  ENSGALG00000015857 carbonic anhydrase III, muscle specific 0.0072 1.8534 
  ENSGALG00000014843 tumor protein D52-like 1 0.0076 1.9745 
  
ENSGALG00000008885 
similar to RAS guanyl releasing protein 1 
(calcium and DAG-regulated);  
RAS guanyl releasing protein 1 (calcium 
and DAG-regulated) 
0.0084 1.8739 
  ENSGALG00000009799 Meis homeobox 2 0.0085 1.8950 
  
ENSGALG00000011170 
WAS/WASL interacting protein family, 
member 3 
0.0132 1.8970 
  ENSGALG00000014484 uncharacterised 0.0207 1.8127 
  ENSGALG00000016866 fibroblast growth factor 14 0.0358 1.6506 
          
(2) Top 20 down-regulated genes under 2nd class     
  Ensembl ID Description FDR  FC 
  ENSGALG00000000507 copine VII 0.0080 -2.7013 
  ENSGALG00000003839 glutamate receptor, metabotropic 2 0.0110 -2.4097 
  
ENSGALG00000009095 
luteinizing hormone/choriogonadotropin 
receptor 
0.0118 -2.2222 
  
ENSGALG00000008883 
transcription factor 7-like 2 (T-cell 
specific, HMG-box) 
0.0120 -2.2245 
  ENSGALG00000004919 uncharacterised 0.0135 -3.0885 
  ENSGALG00000009791 prospero-related homeobox 1 0.0185 -1.9404 
  ENSGALG00000002331 calbindin 2, 29kDa (calretinin) 0.0207 -1.8891 
  ENSGALG00000024278 uncharacterised 0.0207 -1.6992 
  ENSGALG00000006838 similar to iron binding protein 0.0211 -1.6637 
  ENSGALG00000003894 cerebellin 1 precursor 0.0213 -1.7183 
  ENSGALG00000003562 neuronal pentraxin II 0.0231 -1.8905 
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ENSGALG00000016600 
proopiomelanocortin 
(adrenocorticotropin/ beta-lipotropin/ 
alpha-melanocyte stimulating hormone/ 
 beta-melanocyte stimulating hormone/ 
beta-endorphin) 
0.0234 -1.5726 
  ENSGALG00000014477 CD4 molecule 0.0234 -2.0514 
  ENSGALG00000013193 iroquois homeobox 2 0.0304 -1.9073 
  ENSGALG00000002223 LIM homeobox 9 0.0343 -1.8817 
  ENSGALG00000016083 similar to Angiopoietin 1; angiopoietin 1 0.0350 -1.8203 
  ENSGALG00000021567 uncharacterised 0.0353 -1.7714 
  
ENSGALG00000008735 
beaded filament structural protein 1, 
filensin 
0.0377 -1.8273 
  
ENSGALG00000015824 
glycoprotein hormones, alpha 
polypeptide 
0.0536 -1.6450 
  ENSGALG00000016904 SLIT and NTRK-like family, member 6 0.0555 -1.7264 
 
Contrast: CB vs CC   
(1) Top 20 up-regulated genes under 2nd class 
  Ensembl ID Description FDR  FC 
  ENSGALG00000008135 SATB homeobox 2 0.0037 3.0762 
  ENSGALG00000014907 
discoidin, CUB and LCCL domain 
containing 1 
0.0038 3.2824 
  ENSGALG00000002821 gastrin-releasing peptide 0.0040 3.0643 
  ENSGALG00000012235 neurogenic differentiation 6 0.0055 2.9570 
  ENSGALG00000006406 bombesin-like receptor 3 0.0122 2.8584 
  ENSGALG00000014011 lymphoid-restricted membrane protein 0.0168 2.4149 
  ENSGALG00000001282 
gamma-aminobutyric acid (GABA) A 
receptor, delta 
0.0170 2.3082 
  ENSGALG00000015626 regulator of G-protein signalling 12 0.0171 2.5448 
  ENSGALG00000004270 
aldehyde dehydrogenase 1 family, 
member A2 
0.0175 2.5447 
  ENSGALG00000007141 leucine-rich repeat kinase 1 0.0184 2.6677 
  ENSGALG00000011122 uncharacterised 0.0208 2.7867 
  ENSGALG00000015271 filamin A interacting protein 1-like 0.0247 2.3942 
  ENSGALG00000014645 
MADS box transcription enhancer factor 
2, polypeptide C (myocyte enhancer 
factor 2C) 
0.0321 2.2620 
  ENSGALG00000008885 
phosphodiesterase 1A, calmodulin-
dependent 
0.0367 2.2236 
  ENSGALG00000016920 LIM domain 7 0.0371 2.1656 
  ENSGALG00000019842 transcription factor AP-2delta 0.0374 2.2918 
  ENSGALG00000023441 reticulon 4 receptor-like 2 0.0406 1.9892 
  ENSGALG00000018942 
neurogranin  
(protein kinase C substrate, RC3) 
0.0765 1.9119 
  ENSGALG00000020515 uncharacterised 0.0794 1.9019 
  ENSGALG00000012254 
potassium inwardly-rectifying channel, 
subfamily J, member 4 
0.0853 2.0097 
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(2) Top 20 down-regulated genes under 2nd class     
  Ensembl ID Description FDR  FC 
  ENSGALG00000004919 uncharacterised 0.0020 -4.6928 
  ENSGALG00000015143 transthyretin 0.0065 -4.1969 
  ENSGALG00000004572 natriuretic peptide precursor C 0.0467 -2.2076 
  ENSGALG00000003894 cerebellin 1 precursor 0.0510 -2.0654 
  ENSGALG00000012464 SOUL protein 0.0740 -2.1329 
Contrast: BB vs CC   
(1) Top 20 up-regulated genes under 2nd class 
  Ensembl ID Description FDR  FC 
  ENSGALG00000006406 bombesin-like receptor 3 0.0000 3.3041 
  ENSGALG00000008135 SATB homeobox 2 0.0000 4.4087 
  ENSGALG00000011122 uncharacterised 0.0000 3.4907 
  ENSGALG00000012235 neurogenic differentiation 6 0.0000 4.0161 
  
ENSGALG00000014907 
discoidin, CUB and LCCL domain 
containing 1 
0.0000 4.2754 
  
ENSGALG00000014645 
MADS box transcription enhancer factor 
2, polypeptide C (myocyte enhancer 
factor 2C) 
0.0001 2.5816 
  
ENSGALG00000001282 
gamma-aminobutyric acid (GABA) A 
receptor, delta 
0.0001 2.7574 
  
ENSGALG00000004270 
aldehyde dehydrogenase 1 family, 
member A2 
0.0001 2.9466 
  ENSGALG00000015626 regulator of G-protein signalling 12 0.0001 2.7538 
  ENSGALG00000007141 leucine-rich repeat kinase 1 0.0001 2.8333 
  
ENSGALG00000008885 
phosphodiesterase 1A, calmodulin-
dependent 
0.0002 2.5087 
  
ENSGALG00000009740 
similar to RAS guanyl releasing protein 1 
(calcium and DAG-regulated);  
RAS guanyl releasing protein 1 (calcium 
and DAG-regulated) 
0.0002 2.5902 
  ENSGALG00000019842 transcription factor AP-2delta 0.0002 2.9304 
  ENSGALG00000014011 lymphoid-restricted membrane protein 0.0004 2.5451 
  ENSGALG00000015271 filamin A interacting protein 1-like 0.0006 2.3232 
  ENSGALG00000009853 forkhead box G1 0.0006 2.3101 
  ENSGALG00000011721 A kinase (PRKA) anchor protein 5 0.0008 2.2408 
  
ENSGALG00000018942 
neurogranin (protein kinase C substrate, 
RC3) 
0.0008 2.2257 
  
ENSGALG00000013154 
solute carrier organic anion transporter 
family, member 1C1 
0.0010 2.3958 
  ENSGALG00000011254 SATB homeobox 1 0.0013 2.1602 
          
(2) Top 20 down-regulated genes under 2nd class     
  Ensembl ID Description FDR  FC 
  ENSGALG00000004919 uncharacterised 0.0000 -4.8313 
  ENSGALG00000009791 prospero-related homeobox 1 0.0425 -1.8623 
  ENSGALG00000014477 CD4 molecule 0.0427 -1.8734 
  ENSGALG00000008900 tetra-peptide repeat homeobox-like 0.0544 -1.5701 
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ENSGALG00000009095 
luteinizing hormone/choriogonadotropin 
receptor 
0.0555 -1.7583 
  ENSGALG00000002331 calbindin 2, 29kDa (calretinin) 0.0565 -1.6316 
  ENSGALG00000016904 SLIT and NTRK-like family, member 6 0.0571 -1.7489 
  ENSGALG00000002223 LIM homeobox 9 0.0597 -1.7723 
  
ENSGALG00000008883 
transcription factor 7-like 2 (T-cell 
specific, HMG-box) 
0.0624 -1.7920 
  ENSGALG00000006236 tryptophan hydroxylase 1 0.0693 -1.4720 
  ENSGALG00000013193 iroquois homeobox 2 0.0694 -1.7682 
  ENSGALG00000012911 synaptotagmin X 0.0700 -1.7574 
  ENSGALG00000012495 uncharacterised 0.0822 -1.6020 
  ENSGALG00000007772 cerebellin 4 precursor 0.0841 -1.6096 
  
ENSGALG00000008671 
ST8 alpha-N-acetyl-neuraminide alpha-
2,8-sialyltransferase 6 
0.0859 -1.5017 
  ENSGALG00000010461 early B-cell factor 3 0.0869 -1.5718 
  ENSGALG00000010402 prostaglandin-D synthase 0.0909 -1.4618 
  ENSGALG00000023036 uncharacterised 0.0931 -1.5130 
  
ENSGALG00000006384 
interferon-induced protein with 
tetratricopeptide repeats 5 
0.0956 -1.6101 
  ENSGALG00000003894 cerebellin 1 precursor 0.0983 -1.4688 
 
Contrast: CB vs BC   
(1) Top 20 up-regulated genes under 2nd class 
  Ensembl ID Description FDR  FC 
  ENSGALG00000002821 gastrin-releasing peptide 0.0010 2.8454 
  ENSGALG00000012235 neurogenic differentiation 6 0.0020 3.7793 
  ENSGALG00000008135 SATB homeobox 2 0.0083 2.8284 
  ENSGALG00000007141 leucine-rich repeat kinase 1 0.0172 2.4867 
  
ENSGALG00000004270 
aldehyde dehydrogenase 1 family, 
member A2 
0.0200 2.4217 
  ENSGALG00000014011 lymphoid-restricted membrane protein 0.0200 2.4001 
  ENSGALG00000023441 reticulon 4 receptor-like 2 0.0204 2.2214 
  ENSGALG00000001564 ATPase, Ca++ transporting, ubiquitous 0.0205 2.7068 
  ENSGALG00000019842 transcription factor AP-2delta 0.0206 2.4529 
  
ENSGALG00000014907 
discoidin, CUB and LCCL domain 
containing 1 
0.0298 2.1306 
  ENSGALG00000011271 lumican 0.0318 1.8437 
  ENSGALG00000011122 uncharacterised 0.0322 1.8973 
  ENSGALG00000000507 copine VII 0.0328 2.1166 
  
ENSGALG00000012254 
potassium inwardly-rectifying channel, 
subfamily J, member 4 
0.0328 2.2816 
  ENSGALG00000015271 filamin A interacting protein 1-like 0.0342 2.2372 
  
ENSGALG00000018942 
neurogranin (protein kinase C substrate, 
RC3) 
0.0346 1.8758 
  ENSGALG00000003839 glutamate receptor, metabotropic 2 0.0352 2.0836 
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  ENSGALG00000008908 neurogenic differentiation 1 0.0361 2.1278 
  ENSGALG00000008032 G protein-coupled receptor 22 0.0374 2.1532 
  ENSGALG00000015626 regulator of G-protein signalling 12 0.0424 1.9791 
          
(2) Top 20 down-regulated genes under 2nd class     
  Ensembl ID Description FDR  FC 
  ENSGALG00000001063 PR domain containing 16 0.0230 -2.0024 
  
ENSGALG00000003149 
inositol 1,4,5-triphosphate receptor,  
type 3 
0.0660 -2.0682 
  ENSGALG00000003895 PR domain containing 12 0.0546 -1.8305 
  
ENSGALG00000006112 
sodium channel, voltage-gated,  
type V, alpha subunit 
0.0327 -1.9275 
  ENSGALG00000007047 galanin prepropeptide 0.0549 -1.9036 
  
ENSGALG00000007972 
transient receptor potential cation 
channel, subfamily C, member 5 
0.0556 -1.7112 
  
ENSGALG00000008621 
similar to neuropilin-2a1 receptor; 
neuropilin 2 
0.0514 -1.6908 
  ENSGALG00000009173 GDNF family receptor alpha 1 0.0630 -1.6382 
  
ENSGALG00000009740 
similar to RAS guanyl releasing protein 1 
(calcium and DAG-regulated);  
RAS guanyl releasing protein 1 (calcium 
and DAG-regulated) 
0.0358 -1.8443 
  ENSGALG00000011022 neuropeptide VF precursor 0.0625 -1.5799 
  ENSGALG00000011369 LIM homeobox 8 0.0600 -1.7260 
  ENSGALG00000012464 SOUL protein 0.0445 -2.1554 
  
ENSGALG00000013294 
cytochrome P450, family 19, subfamily A, 
polypeptide 1 
0.0459 -2.0576 
  ENSGALG00000014484 uncharacterised 0.0584 -1.7314 
  ENSGALG00000014843 tumor protein D52-like 1 0.0541 -1.8108 
  ENSGALG00000015143 transthyretin 0.0635 -2.5067 
  ENSGALG00000016455 uncharacterised 0.0560 -1.8658 
  ENSGALG00000016707 chloride intracellular channel 5 0.0554 -1.7380 
  
ENSGALG00000017044 
transient receptor potential cation 
channel, subfamily C, member 4 
0.0258 -2.0181 
  
ENSGALG00000017194 
transient receptor potential cation 
channel, subfamily C, member 6 
0.0522 -1.7468 
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Contrast: BB vs BC   
 (1) Top 20 up-regulated genes under 2nd class   
      FDR  FC 
  ENSGALG00000001564 ATPase, Ca++ transporting, ubiquitous <0.0001 2.8468 
  
ENSGALG00000004270 
aldehyde dehydrogenase 1 family, 
member A2 
<0.0001 2.8057 
  ENSGALG00000008135 SATB homeobox 2 <0.0001 4.0256 
  ENSGALG00000012235 neurogenic differentiation 6 <0.0001 5.1060 
  ENSGALG00000019842 transcription factor AP-2delta <0.0001 3.0998 
  ENSGALG00000011122 Uncharacterised 0.00013 2.3724 
  
ENSGALG00000013154 
solute carrier organic anion transporter 
family, member 1C1 
0.00014 2.6388 
  
ENSGALG00000014907 
discoidin, CUB and LCCL domain 
containing 1 
0.00017 2.7727 
  ENSGALG00000023441 reticulon 4 receptor-like 2 0.00018 2.2530 
  
ENSGALG00000012254 
potassium inwardly-rectifying channel, 
subfamily J, member 4 
2.00E-
04 
2.2675 
  ENSGALG00000007141 leucine-rich repeat kinase 1 0.00022 2.6386 
  ENSGALG00000003839 glutamate receptor, metabotropic 2 0.00031 2.3058 
  
ENSGALG00000018942 
neurogranin (protein kinase C substrate, 
RC3) 
0.00033 2.1826 
  ENSGALG00000015271 filamin A interacting protein 1-like 0.00071 2.1682 
  ENSGALG00000014829 R-spondin 3 homolog (Xenopus laevis) 0.00138 2.0225 
  ENSGALG00000008032 G protein-coupled receptor 22 0.0014 2.1012 
  ENSGALG00000014011 lymphoid-restricted membrane protein 0.00141 2.4858 
  ENSGALG00000015626 regulator of G-protein signalling 12 0.00189 2.1415 
  ENSGALG00000008940 spectrin, beta, non-erythrocytic 5 0.00205 1.8481 
  
ENSGALG00000000820 
5-hydroxytryptamine (serotonin) 
receptor 1D 
0.0043 1.8261 
 (2) Top 20 down-regulated genes under 2nd class     
  Ensembl ID Description FDR  FC 
  
ENSGALG00000013294 
cytochrome P450, family 19, subfamily A, 
polypeptide 1 0.0060 -1.7109 
  
ENSGALG00000004754 
obscurin, cytoskeletal calmodulin and 
titin-interacting RhoGEF 0.0070 -1.7063 
  ENSGALG00000011369 LIM homeobox 8 0.0080 -1.7391 
  ENSGALG00000011973 sushi domain containing 5 0.0150 -1.7180 
  ENSGALG00000014967 synaptic vesicle glycoprotein 2C 0.0168 -1.5968 
  
ENSGALG00000019144 
gamma-aminobutyric acid (GABA) A 
receptor, gamma 3 0.0275 -1.5698 
  
ENSGALG00000006112 
sodium channel, voltage-gated, type V, 
alpha subunit 0.0389 -1.5659 
  ENSGALG00000006473 plexin A4, B 0.0717 -1.4899 
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  ENSGALG00000012495 uncharacterised 0.0722 -1.4865 
  ENSGALG00000009173 GDNF family receptor alpha 1 0.0724 -1.5144 
  
ENSGALG00000007972 
transient receptor potential cation 
channel, 
 subfamily C, member 5 0.0775 -1.5231 
  ENSGALG00000015529 Wolfram syndrome 1 (wolframin) 0.0778 -1.4117 
  ENSGALG00000014717 uncharacterised 0.0789 -1.4625 
  
ENSGALG00000004838 
BUB1 budding uninhibited by 
benzimidazoles 
 1 homolog beta (yeast) 0.0799 -1.5141 
  ENSGALG00000006485 uncharacterised 0.0836 -1.4800 
  ENSGALG00000012324 chromosome 7 open reading frame 10 0.0859 -1.4490 
  
ENSGALG00000013177 
branched chain aminotransferase 1, 
cytosolic 0.0872 -1.4502 
  ENSGALG00000001608 unc-5 homolog D (C. elegans) 0.0952 -1.4394 
  
ENSGALG00000016804 
solute carrier family 5 (choline 
transporter), member 7 0.0979 -1.4437 
 
Contrast: BB vs CB   
(1) Top 20 up-regulated genes under 2nd class 
  Ensembl ID Description FDR  FC 
  ENSGALG00000015143 transthyretin 0.0020 7.8399 
  ENSGALG00000001696 
S-antigen; retina and pineal gland 
(arrestin) 0.0200 3.2449 
  ENSGALG00000014634 silver homolog (mouse) 0.0300 2.3372 
  ENSGALG00000016020 chloride intracellular channel 6 0.0610 1.9277 
  ENSGALG00000001063 PR domain containing 16 0.0686 1.7119 
  ENSGALG00000007179 ATPase type 13A5 0.0688 1.9963 
  ENSGALG00000011859 eye-globin 0.0710 1.9526 
  ENSGALG00000008941 uncharacterised 0.0711 1.6936 
  ENSGALG00000013154 
solute carrier organic anion transporter 
family, member 1C1 0.0855 2.4170 
  ENSGALG00000009867 WNT inhibitory factor 1 0.0947 1.7129 
          
(2) Top 20 down-regulated genes under 2nd class     
  ENSGALG00000014118 mitochondrial ribosomal protein S26 0.0000 -2.2201 
  ENSGALG00000018808 mitochondrial ribosomal protein S26 0.0075 -1.9027 
  ENSGALG00000002821 gastrin-releasing peptide 0.0423 -1.7801 
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Table A6. List of genes that met the behavioural filtering categories in the (a) hippocampus and 
(b) hypothalamus as described in detail in the Methods (Chapter 4, Section 4.3.13.1).   
(a) Hippocampus   
Pre- and post-hatching B responsive genes 
Ensembl ID Description 
ENSGALG00000000713 zinc finger homeobox 3 
ENSGALG00000000745 solute carrier family 26, member 9 
ENSGALG00000001115 membrane metallo-endopeptidase-like 1 
ENSGALG00000001490 Uncharacterised 
ENSGALG00000002041 agrin 
ENSGALG00000002757 Uncharacterised 
ENSGALG00000002854 Uncharacterised 
ENSGALG00000003115 Uncharacterised 
ENSGALG00000003473 secreted frizzled-related protein 1 
ENSGALG00000004322 Uncharacterised 
ENSGALG00000004414 leucine zipper protein 2 
ENSGALG00000004448 family with sequence similarity 5, member B 
ENSGALG00000004630 similar to cHz-cadherin 
ENSGALG00000004814 rhophilin, Rho GTPase binding protein 2 
ENSGALG00000005259 vasoactive intestinal peptide receptor 1 
ENSGALG00000005956 annexin A8-like 1 
ENSGALG00000006269 Uncharacterised 
ENSGALG00000006306 urocanase domain containing 1 
ENSGALG00000006313 interleukin 4 receptor 
ENSGALG00000007211 cadherin-like 22 
ENSGALG00000007226 osteocrin 
ENSGALG00000007367 
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin 
domain containing 2 
ENSGALG00000007410 similar to hDDM36 
ENSGALG00000007487 chromosome 21 open reading frame 58 
ENSGALG00000007596 hypothetical LOC416086 
ENSGALG00000008150 RAS protein activator like 1 (GAP1 like) 
ENSGALG00000008263 contactin 4 
ENSGALG00000008874 solute carrier family 13 (sodium/sulfate symporters), member 1 
ENSGALG00000008926 Ca2+-dependent activator protein for secretion 2 
ENSGALG00000008980 von Willebrand factor A domain containing 2 
ENSGALG00000009006 six transmembrane epithelial antigen of the prostate 1 
ENSGALG00000009315 Uncharacterised 
ENSGALG00000009497 arginine vasopressin receptor 2 (nephrogenic diabetes insipidus) 
ENSGALG00000009515 guanine nucleotide binding protein (G protein), gamma 11 
ENSGALG00000009684 G protein-coupled receptor 26 
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ENSGALG00000009799 Meis homeobox 2 
ENSGALG00000010035 nuclear receptor subfamily 3, group C, member 2 
ENSGALG00000011717 hypothetical LOC417937 
ENSGALG00000011813 HEG homolog 1 (zebrafish) 
ENSGALG00000011836 solute carrier family 6 (proline IMINO transporter), member 20 
ENSGALG00000011858 
potassium voltage-gated channel, subfamily H (eag-related), 
member 5 
ENSGALG00000012163 brain-derived neurotrophic factor 
ENSGALG00000012183 neuronal pentraxin receptor 
ENSGALG00000012235 neurogenic differentiation 6 
ENSGALG00000012421 Rho GTPase activating protein 15 
ENSGALG00000012568 TIMP metallopeptidase inhibitor 3) 
ENSGALG00000012908 solute carrier family 13 (sodium/sulfate symporters), member 4 
ENSGALG00000013154 solute carrier organic anion transporter family, member 1C1 
ENSGALG00000013168 islet amyloid polypeptide 
ENSGALG00000013515 
solute carrier family 4, sodium bicarbonate cotransporter, 
member 5; similar to sodium bicarbonate cotransporter-like 
protein 
ENSGALG00000014414 gamma-aminobutyric acid (GABA) receptor, rho 3 
ENSGALG00000014634 silver homolog (mouse) 
ENSGALG00000014978 IQ motif containing GTPase activating protein 2 
ENSGALG00000015205 tyrosinase-related protein 1 
ENSGALG00000015720 chondrolectin 
ENSGALG00000016411 
similar to collagen XIV; collagen, type XIV, alpha 1 (undulin); 
similar to collagen, type XIV, alpha 1 (undulin) 
ENSGALG00000016616 similar to Kallmann syndrome gene product;  
ENSGALG00000016884 solute carrier family 15 (oligopeptide transporter), member 1 
ENSGALG00000017343 folate receptor 1 (adult) 
ENSGALG00000018557 
similar to extracellular-superoxide dismutase (EC 1.15.1.1); 
superoxide dismutase 3, extracellular 
ENSGALG00000023051 Uncharacterised 
ENSGALG00000023580 Uncharacterised 
 
Specific pre-hatching B responsive genes 
Ensembl ID Description 
ENSGALG00000001396 serpin peptidase inhibitor, clade D (heparin cofactor), member 1 
ENSGALG00000001696 S-antigen; retina and pineal gland (arrestin) 
ENSGALG00000002223 LIM homeobox 9 
ENSGALG00000003842 growth hormone releasing hormone 
ENSGALG00000003895 PR domain containing 12 
ENSGALG00000007025 copine VIII 
ENSGALG00000007588 glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) 
ENSGALG00000007908 EGF-containing fibulin-like extracellular matrix protein 1 
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ENSGALG00000008188 tripartite motif-containing 36 
ENSGALG00000008883 transcription factor 7-like 2 (T-cell specific, HMG-box) 
ENSGALG00000009129 distal-less homeobox 5 
ENSGALG00000009737 
tachykinin, precursor 1 (substance K, substance P, neurokinin 1, 
neurokinin 2, neuromedin L, neurokinin alpha, neuropeptide K, 
neuropeptide gamma) 
ENSGALG00000009739 adhesion molecule with Ig-like domain 2 
ENSGALG00000009740 
similar to RAS guanyl releasing protein 1 (calcium and DAG-
regulated); RAS guanyl releasing protein 1 (calcium and DAG-
regulated) 
ENSGALG00000010865 transmembrane protein 196 
ENSGALG00000012907 melanocortin 4 receptor 
ENSGALG00000012911 synaptotagmin X 
ENSGALG00000013294 cytochrome P450, family 19, subfamily A, polypeptide 1 
ENSGALG00000013890 melanocortin 5 receptor 
ENSGALG00000014233 fibulin 1 
ENSGALG00000015143 transthyretin 
ENSGALG00000015419 proenkephalin 
ENSGALG00000015529 Wolfram syndrome 1 (wolframin) 
ENSGALG00000016035 GFR receptor alpha 4; similar to GFR receptor alpha 4 
ENSGALG00000016324 glutathione S-transferase alpha 3 
ENSGALG00000017418 neuronal pentraxin I 
ENSGALG00000019277 solute carrier organic anion transporter family, member 1B3 
ENSGALG00000020381 deiodinase, iodothyronine, type III 
ENSGALG00000022819 Purkinje cell protein 4 
 
Interacting pre- and post-hatching B responsive genes: “cumulative effect”  
Ensembl ID Description 
ENSGALG00000000733 myosin VIIA 
ENSGALG00000001006 tumor protein p73 
ENSGALG00000001063 PR domain containing 16 
ENSGALG00000002389 integrin, beta 4 
ENSGALG00000004879 
solute carrier family 6 (neurotransmitter transporter, GABA), 
member 11 
ENSGALG00000005400 calcium channel, voltage-dependent, alpha 2/delta 3 subunit 
ENSGALG00000005985 growth differentiation factor 10 
ENSGALG00000006325 similar to netrin 4 
ENSGALG00000006413 KIAA1199 
ENSGALG00000006449 glutamate receptor interacting protein 2 
ENSGALG00000008445 
solute carrier family 24 (sodium/potassium/calcium exchanger), 
member 3 
ENSGALG00000008465 sortilin-related VPS10 domain containing receptor 1 
ENSGALG00000009034 anaplastic lymphoma kinase (Ki-1) 
ENSGALG00000009589 glutamate decarboxylase 1 (brain, 67kDa) 
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ENSGALG00000010781 glycine receptor, alpha 3 
ENSGALG00000010858 low density lipoprotein-related protein 2 
ENSGALG00000012917 
cadherin 6, type 2, K-cadherin (fetal kidney); similar to CDH6 
protein 
ENSGALG00000013953 tachykinin receptor 1 
ENSGALG00000015673 zinc finger homeodomain 4 
ENSGALG00000015857 carbonic anhydrase III, muscle specific 
ENSGALG00000015865 similar to C6orf37 
ENSGALG00000016017 solute carrier family 4, sodium borate transporter, member 11 
ENSGALG00000016577 otoferlin 
ENSGALG00000016866 fibroblast growth factor 14 
ENSGALG00000017021 ATPase, Cu++ transporting, beta polypeptide 
ENSGALG00000017040 Uncharacterised 
ENSGALG00000017068 klotho 
ENSGALG00000017405 Uncharacterised 
ENSGALG00000021039 hexokinase domain containing 1 
ENSGALG00000023552 Uncharacterised 
 
(b) Hypothalamus 
Pre- and post-hatching B responsive genes  
Ensembl ID Description 
ENSGALG00000001136 similar to enhancer of split related protein-7 
ENSGALG00000001896 netrin G1 
ENSGALG00000002111 SEC14-like 5 (S. cerevisiae) 
ENSGALG00000002331 calbindin 2, 29kDa (calretinin) 
ENSGALG00000005526 hairy and enhancer of split 6 (Drosophila) 
ENSGALG00000006271 Rac GTPase activating protein 1 
ENSGALG00000006838 similar to iron binding protein 
ENSGALG00000007772 cerebellin 4 precursor 
ENSGALG00000008306 fibrinogen-like 2 
ENSGALG00000009058 ectonucleoside triphosphate diphosphohydrolase 2 
ENSGALG00000009791 prospero-related homeobox 1 
ENSGALG00000009861 retinal degeneration 3 
ENSGALG00000010065 potassium channel, subfamily K, member 5 
ENSGALG00000010461 early B-cell factor 3 
ENSGALG00000010583 vitrin 
ENSGALG00000011066 calmin (calponin-like, transmembrane) 
ENSGALG00000011127 B-cell CLL/lymphoma 11B (zinc finger protein) 
ENSGALG00000011940 cholecystokinin 
ENSGALG00000012732 phosphatase and actin regulator 1 
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Specific pre-hatching B responsive genes  
Ensembl ID Description 
ENSGALG00000001063 PR domain containing 16 
ENSGALG00000003149 inositol 1,4,5-triphosphate receptor, type 3 
ENSGALG00000003895 PR domain containing 12 
ENSGALG00000004860 RAS, dexamethasone-induced 1 
ENSGALG00000006014 protein kinase C, beta 
ENSGALG00000007113 Uncharacterised 
ENSGALG00000009095 luteinizing hormone/choriogonadotropin receptor 
ENSGALG00000010402 prostaglandin-D synthase 
ENSGALG00000013193 iroquois homeobox 2 
ENSGALG00000014484 Uncharacterised 
ENSGALG00000014843 tumor protein D52-like 1 
ENSGALG00000015824 glycoprotein hormones, alpha polypeptide 
ENSGALG00000015857 carbonic anhydrase III, muscle specific 
ENSGALG00000017044 transient receptor potential cation channel, subfamily C, 
member 4  
Specific post-hatching B responsive genes  
Ensembl ID Description 
ENSGALG00000000098 anthrax toxin receptor 1 
ENSGALG00000000168 adenosine A1 receptor 
ENSGALG00000000376 Uncharacterised  
ENSGALG00000000694 Uncharacterised  
ENSGALG00000000695 major facilitator superfamily domain containing 4 
ENSGALG00000000820 5-hydroxytryptamine (serotonin) receptor 1D 
ENSGALG00000001227 Uncharacterised  
ENSGALG00000001282 gamma-aminobutyric acid (GABA) A receptor, delta 
ENSGALG00000001505 neuronal guanine nucleotide exchange factor 
ENSGALG00000002260 cytokine inducible SH2-containing protein 
ENSGALG00000002470 cytochrome P450, family 27, subfamily A, polypeptide 1 
ENSGALG00000003285 protocadherin 24 
ENSGALG00000003437 Uncharacterised  
ENSGALG00000003670 v-maf musculoaponeurotic fibrosarcoma oncogene homolog B 
ENSGALG00000004011 Uncharacterised  
ENSGALG00000004074 
potassium voltage-gated channel, delayed-rectifier, subfamily S, 
member 1 
ENSGALG00000004270 aldehyde dehydrogenase 1 family, member A2 
ENSGALG00000004838 
BUB1 budding uninhibited by benzimidazoles 1 homolog beta 
(yeast) 
ENSGALG00000005258 somatostatin receptor 5 
ENSGALG00000005657 corticotropin releasing hormone receptor 2 
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ENSGALG00000005721 diacylglycerol kinase, gamma 90kDa 
ENSGALG00000005752 ATP-binding cassette, sub-family A (ABC1), member 4 
ENSGALG00000005853 5-hydroxytryptamine (serotonin) receptor 2C 
ENSGALG00000006008 homer homolog 2 (Drosophila) 
ENSGALG00000006021 calcium channel, voltage-dependent, gamma subunit 3 
ENSGALG00000006439 Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 
ENSGALG00000006886 dachshund homolog 2 (Drosophila) 
ENSGALG00000007004 5-hydroxytryptamine (serotonin) receptor 3A 
ENSGALG00000007141 leucine-rich repeat kinase 1 
ENSGALG00000007184 FEZ family zinc finger 2 
ENSGALG00000007278 glutamate receptor, ionotropic, N-methyl D-aspartate 2A 
ENSGALG00000007349 RAS-like, family 12 
ENSGALG00000007415 SH3 domain containing ring finger 2 
ENSGALG00000008032 G protein-coupled receptor 22 
ENSGALG00000008135 SATB homeobox 2 
ENSGALG00000008308 basic helix-loop-helix domain containing, class B, 2 
ENSGALG00000008631 TYRO3 protein tyrosine kinase 
ENSGALG00000008671 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 
ENSGALG00000008940 spectrin, beta, non-erythrocytic 5 
ENSGALG00000009252 phospholipase D1, phosphatidylcholine-specific 
ENSGALG00000009859 TBC1 domain family, member 30 
ENSGALG00000010705 zinc finger protein 238 
ENSGALG00000010801 transmembrane protein 61 
ENSGALG00000011122 Uncharacterised  
ENSGALG00000011254 SATB homeobox 1 
ENSGALG00000011406 netrin 4 
ENSGALG00000011592 muscle RAS oncogene homolog 
ENSGALG00000012046 similar to ARPP-21 protein 
ENSGALG00000012054 doublecortin-like kinase 3 
ENSGALG00000012154 F-box protein 34 
ENSGALG00000012235 neurogenic differentiation 6 
ENSGALG00000012254 potassium inwardly-rectifying channel, subfamily J, member 4 
ENSGALG00000012322 potassium channel tetramerisation domain containing 16 
ENSGALG00000012367 tripartite motif-containing 9 
ENSGALG00000012542 RASD family, member 2 
ENSGALG00000012890 diacylglycerol kinase, iota 
ENSGALG00000013051 
sema domain, seven thrombospondin repeats (type 1 and type 
1-like), transmembrane domain (TM) and short cytoplasmic 
domain, (semaphorin) 5A 
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ENSGALG00000013795 
human immunodeficiency virus type I enhancer binding protein 
2 
ENSGALG00000013948 RAS-like, family 11, member B 
ENSGALG00000014011 lymphoid-restricted membrane protein 
ENSGALG00000014186 metallophosphoesterase domain containing 1 
ENSGALG00000014812 SID1 transmembrane family, member 1 
ENSGALG00000014907 discoidin, CUB and LCCL domain containing 1 
ENSGALG00000015271 filamin A interacting protein 1-like 
ENSGALG00000015403 EPH receptor A3 
ENSGALG00000015626 regulator of G-protein signalling 12 
ENSGALG00000015970 collagen, type IX, alpha 1 
ENSGALG00000016084 R-spondin 2 homolog (Xenopus laevis) 
ENSGALG00000016095 empty spiracles homeobox 1 
ENSGALG00000016155 collagen, type XIX, alpha 1; hypothetical protein LOC772348 
ENSGALG00000016391 connector enhancer of kinase suppressor of Ras 2 
ENSGALG00000016396 collectin sub-family member 11 
ENSGALG00000016744 gamma-aminobutyric acid (GABA) A receptor, alpha 5 
ENSGALG00000016843 collagen, type IV, alpha 2 
ENSGALG00000016920 LIM domain 7 
ENSGALG00000016944 protocadherin 8 
ENSGALG00000016983 Uncharacterised  
ENSGALG00000017378 cartilage acidic protein 1 
ENSGALG00000017690 
potassium voltage-gated channel, delayed-rectifier, subfamily S, 
member 2 
ENSGALG00000018942 neurogranin (protein kinase C substrate, RC3) 
ENSGALG00000019842 transcription factor AP-2delta 
ENSGALG00000020975 Uncharacterised  
ENSGALG00000022001 hypothetical LOC415928 
ENSGALG00000022782 Uncharacterised  
ENSGALG00000022988 Uncharacterised  
ENSGALG00000023441 reticulon 4 receptor-like 2 
ENSGALG00000023881 plexin domain containing 1 
ENSGALG00000024111 Uncharacterised  
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Table A7. Lists of down- and up-regulated genes (highlighted in green and red, respectively) in the 
(a) hippocampus and (b) hypothalamus submitted to Ingenuity Pathway Analysis (IPA) after filtering 
the Vector Analysis data according to the behavioural categories as described in full detail in 
Chapter 4 (Section 4.3.13.1). The genes highlighted in black are the non-redundant “focus” genes 
with records in the IPA server, whilst in blue are the “non-focus” genes.    
 
(a) Hippocampus     
Pre- and post-hatching B responsive genes  
  Ensembl ID Symbol Description 
  ENSGALG00000000713 ZFHX3 zinc finger homeobox 3 
  ENSGALG00000000745 SLC26A9 solute carrier family 26, member 9 
  ENSGALG00000001115 MMEL1 membrane metallo-endopeptidase-like 1 
  ENSGALG00000002041 AGRN agrin 
  ENSGALG00000003115 COL4A3 
collagen, type IV, alpha 3 (Goodpasture 
antigen) 
  ENSGALG00000003473 SFRP1 secreted frizzled-related protein 1 
  ENSGALG00000004448 FAM5B family with sequence similarity 5, member B 
  ENSGALG00000004814 RHPN2 rhophilin, Rho GTPase binding protein 2 
  ENSGALG00000005259 VIPR1 vasoactive intestinal peptide receptor 1 
  ENSGALG00000006269 TMEM72 transmembrane protein 72 
  ENSGALG00000006306 UROC1 urocanate hydratase 1 
  ENSGALG00000007211 CDH22 cadherin 22, type 2 
  ENSGALG00000007226 OSTN osteocrin 
  ENSGALG00000007367 WFIKKN2 
WAP, follistatin/kazal, immunoglobulin, kunitz 
and netrin domain containing 2 
  ENSGALG00000007410 IGDCC4 
immunoglobulin superfamily, DCC subclass, 
member 4 
  ENSGALG00000007487 C21orf58 chromosome 21 open reading frame 58 
  ENSGALG00000008263 CNTN4 contactin 4 
  ENSGALG00000008874 SLC13A1 
solute carrier family 13 (sodium/sulfate 
symporters), member 1 
  ENSGALG00000008980 VWA2 von Willebrand factor A domain containing 2 
  ENSGALG00000009006 STEAP1 
six transmembrane epithelial antigen of the 
prostate 1 
  ENSGALG00000009497 AVPR2 arginine vasopressin receptor 2 
  ENSGALG00000009515 GNG11 
guanine nucleotide binding protein (G protein), 
gamma 11 
  ENSGALG00000009684 GPR26 G protein-coupled receptor 26 
  ENSGALG00000009799 MEIS2 Meis homeobox 2 
  ENSGALG00000011717 2010107G12Rik RIKEN cDNA 2010107G12 gene 
  ENSGALG00000011858 KCNH5 
potassium voltage-gated channel, subfamily H 
(eag-related), member 5 
  ENSGALG00000012568 TIMP3 TIMP metallopeptidase inhibitor 3 
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  ENSGALG00000012908 SLC13A4 
solute carrier family 13 (sodium/sulfate 
symporters), member 4 
  ENSGALG00000013154 SLCO1C1 
solute carrier organic anion transporter family, 
member 1C1 
  ENSGALG00000013515 SLC4A5 
solute carrier family 4, sodium bicarbonate 
cotransporter, member 5 
  ENSGALG00000014634 PMEL premelanosome protein 
  ENSGALG00000015205 TYRP1 tyrosinase-related protein 1 
  ENSGALG00000016411 COL14A1 collagen, type XIV, alpha 1 
  ENSGALG00000016616 KAL1 Kallmann syndrome 1 sequence 
  ENSGALG00000016884 SLC15A1 
solute carrier family 15 (oligopeptide 
transporter), member 1 
  ENSGALG00000017343 FOLR1 folate receptor 1 (adult) 
  ENSGALG00000018557 SOD3 superoxide dismutase 3, extracellular 
  ENSGALG00000023580 CLDN19 claudin 19 
  ENSGALG00000002757 PCDH15 protocadherin-related 15 
  ENSGALG00000004414 LUZP2 leucine zipper protein 2 
  ENSGALG00000008926 CADPS2 Ca++-dependent secretion activator 2 
  ENSGALG00000010035 NR3C2 
nuclear receptor subfamily 3, group C, member 
2 
  ENSGALG00000012163 BDNF brain-derived neurotrophic factor 
  ENSGALG00000012183 Npcd neuronal pentraxin chromo domain 
  ENSGALG00000012235 NEUROD6 neuronal differentiation 6 
  ENSGALG00000012421 ARHGAP15 Rho GTPase activating protein 15 
  ENSGALG00000014414 Gabrr3 
gamma-aminobutyric acid (GABA) receptor, 
rho 3 
  ENSGALG00000015720 CHODL chondrolectin 
 
Specific pre-hatching B responsive genes   
 Ensembl ID Symbol Description 
 
ENSGALG00000001396 SERPIND1 
serpin peptidase inhibitor, clade D (heparin 
cofactor), member 1 
 ENSGALG00000001696 SAG S-antigen; retina and pineal gland (arrestin) 
 ENSGALG00000002223 LHX9 LIM homeobox 9 
 ENSGALG00000003895 PRDM12 PR domain containing 12 
 ENSGALG00000007025 CPNE8 copine VIII 
 
ENSGALG00000007588 GAD2 
glutamate decarboxylase 2 (pancreatic islets and 
brain, 65kDa) 
 
ENSGALG00000007908 EFEMP1 
EGF containing fibulin-like extracellular matrix 
protein 1 
 ENSGALG00000008188 TRIM36 tripartite motif containing 36 
 
ENSGALG00000008883 TCF7L2 
transcription factor 7-like 2 (T-cell specific, HMG-
box) 
 ENSGALG00000009129 DLX5 distal-less homeobox 5 
 ENSGALG00000009737 TAC1 tachykinin, precursor 1 
 ENSGALG00000009739 AMIGO2 adhesion molecule with Ig-like domain 2 
 
ENSGALG00000009740 RASGRP1 
RAS guanyl releasing protein 1 (calcium and DAG-
regulated) 
 ENSGALG00000010865 TMEM196 transmembrane protein 196 
279 
 
 
 
 ENSGALG00000012907 MC4R melanocortin 4 receptor 
 ENSGALG00000012911 SYT10 synaptotagmin X 
 
ENSGALG00000013294 CYP19A1 
cytochrome P450, family 19, subfamily A, 
polypeptide 1 
 ENSGALG00000013890 MC5R melanocortin 5 receptor 
 ENSGALG00000014233 FBLN1 fibulin 1 
 ENSGALG00000015143 TTR transthyretin 
 ENSGALG00000015419 PENK proenkephalin 
 ENSGALG00000015529 WFS1 Wolfram syndrome 1 (wolframin) 
 ENSGALG00000016324 Gsta3 glutathione S-transferase, alpha 3 
 
ENSGALG00000019277 SLCO1B1 
solute carrier organic anion transporter family, 
member 1B1 
 ENSGALG00000017418 NPTX1 neuronal pentraxin I 
 
Interacting pre- and post-hatching B responsive genes: "cumulative effect" 
  Ensembl ID Symbol Description 
  ENSGALG00000000733 MYO7A myosin VIIA 
  ENSGALG00000001006 TP73 tumor protein p73 
  ENSGALG00000001063 PRDM16 PR domain containing 16 
  ENSGALG00000002389 ITGB4 integrin, beta 4 
  
ENSGALG00000004879 SLC6A11 
solute carrier family 6 (neurotransmitter 
transporter, GABA), member 11 
  
ENSGALG00000005400 CACNA2D3 
calcium channel, voltage-dependent, alpha 2/delta 
subunit 3 
  ENSGALG00000006413 KIAA1199 KIAA1199 
  ENSGALG00000006449 GRIP2 glutamate receptor interacting protein 2 
  
ENSGALG00000008445 SLC24A3 
solute carrier family 24 (sodium/potassium/calcium 
exchanger), member 3 
  ENSGALG00000008465 SORCS1 sortilin-related VPS10 domain containing receptor 1 
  ENSGALG00000009034 ALK anaplastic lymphoma receptor tyrosine kinase 
  ENSGALG00000009589 GAD1 glutamate decarboxylase 1 (brain, 67kDa) 
  ENSGALG00000010781 GLRA3 glycine receptor, alpha 3 
  ENSGALG00000010858 LRP2 low density lipoprotein receptor-related protein 2 
  ENSGALG00000012917 CDH6 cadherin 6, type 2, K-cadherin (fetal kidney) 
  ENSGALG00000013953 TACR1 tachykinin receptor 1 
  ENSGALG00000015673 ZFHX4 zinc finger homeobox 4 
  ENSGALG00000015865 FAM46A family with sequence similarity 46, member A 
  
ENSGALG00000016017 SLC4A11 
solute carrier family 4, sodium borate transporter, 
member 11 
  ENSGALG00000016577 OTOF otoferlin 
  ENSGALG00000017021 ATP7B ATPase, Cu++ transporting, beta polypeptide 
  ENSGALG00000017068 KL klotho 
  
ENSGALG00000017405 NPR3 
natriuretic peptide receptor C/guanylate  cyclase C  
(atrionatriuretic peptide receptor C) 
  ENSGALG00000021039 HKDC1 hexokinase domain containing 1 
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  ENSGALG00000005985 GDF10 growth differentiation factor 10 
  ENSGALG00000015857 CA3 carbonic anhydrase III, muscle specific 
 
(b) Hypothalamus 
Pre- and post-hatching B 
responsive genes                           
  Ensembl ID Symbol Description 
  ENSGALG00000001896 NTNG1 netrin G1 
  ENSGALG00000002331 CALB2 calbindin 2 
  ENSGALG00000007772 CBLN4 cerebellin 4 precursor 
  ENSGALG00000009791 PROX1 prospero homeobox 1 
  ENSGALG00000011940 CCK cholecystokinin 
  ENSGALG00000002111 SEC14L5 SEC14-like 5 (S. cerevisiae) 
  ENSGALG00000006271 RACGAP1 Rac GTPase activating protein 1 
  ENSGALG00000008306 FGL2 fibrinogen-like 2 
  ENSGALG00000009058 ENTPD2 ectonucleoside triphosphate diphosphohydrolase 2 
  ENSGALG00000009861 RD3 retinal degeneration 3 
  ENSGALG00000010065 KCNK5 potassium channel, subfamily K, member 5 
  ENSGALG00000012732 PHACTR1 phosphatase and actin regulator 1 
 
Specific pre-hatching B responsive genes  
  Ensembl ID Symbol Description 
  ENSGALG00000009095 LHCGR luteinizing hormone/choriogonadotropin receptor 
  ENSGALG00000010402 HPGDS hematopoietic prostaglandin D synthase 
  ENSGALG00000013193 IRX2 iroquois homeobox 2 
  ENSGALG00000015824 CGA glycoprotein hormones, alpha polypeptide 
  ENSGALG00000001063 PRDM16 PR domain containing 16 
  ENSGALG00000003149 ITPR3 inositol 1,4,5-trisphosphate receptor, type 3 
  ENSGALG00000003895 PRDM12 PR domain containing 12 
  ENSGALG00000004860 RASD1 RAS, dexamethasone-induced 1 
  ENSGALG00000006014 PRKCB protein kinase C, beta 
  ENSGALG00000014843 TPD52L1 tumor protein D52-like 1 
  ENSGALG00000015857 CA3 carbonic anhydrase III, muscle specific 
  
ENSGALG00000017044 TRPC4 
transient receptor potential cation channel, 
subfamily C, member 4 
 
Specific post-hatching B responsive genes    
  Ensembl ID Symbol Description 
  ENSGALG00000004838 BUB1B BUB1 mitotic checkpoint serine/threonine kinase B 
  
ENSGALG00000008671 ST8SIA6 
ST8 alpha-N-acetyl-neuraminide alpha-2,8-
sialyltransferase 6 
  
ENSGALG00000013051 SEMA5A 
sema domain, seven thrombospondin repeats (type 1 
and type 1-like), transmembrane domain (TM) and 
short cytoplasmic domain, (semaphorin) 5A 
  ENSGALG00000000098 ANTXR1 anthrax toxin receptor 1 
  ENSGALG00000000168 ADORA1 adenosine A1 receptor 
  ENSGALG00000000694 FMNL1 formin-like 1 
  ENSGALG00000000695 MFSD4 major facilitator superfamily domain containing 4 
  
ENSGALG00000000820 HTR1D 
5-hydroxytryptamine (serotonin) receptor 1D, G 
protein-coupled 
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  ENSGALG00000001227 PIK3R6 phosphoinositide-3-kinase, regulatory subunit 6 
  ENSGALG00000001282 GABRD gamma-aminobutyric acid (GABA) A receptor, delta 
  ENSGALG00000001505 NGEF neuronal guanine nucleotide exchange factor 
  ENSGALG00000002260 CISH cytokine inducible SH2-containing protein 
  
ENSGALG00000002470 CYP27A1 
cytochrome P450, family 27,  subfamily A, 
polypeptide 1 
  ENSGALG00000003285 CDHR2 cadherin-related family member 2 
  
ENSGALG00000003670 MAFB 
v-maf musculoaponeurotic fibrosarcoma oncogene 
homolog B (avian) 
  
ENSGALG00000004074 KCNS1 
potassium voltage-gated channel, delayed-rectifier, 
subfamily S, member 1 
  ENSGALG00000004270 ALDH1A2 aldehyde dehydrogenase 1 family, member A2 
  ENSGALG00000005258 SSTR5 somatostatin receptor 5 
  ENSGALG00000005657 CRHR2 corticotropin releasing hormone receptor 2 
  ENSGALG00000005721 DGKG diacylglycerol kinase, gamma 90kDa 
  ENSGALG00000005752 ABCA4 ATP-binding cassette, sub-family A (ABC1), member 4 
  
ENSGALG00000005853 HTR2C 
5-hydroxytryptamine (serotonin) receptor 2C, G 
protein-coupled 
  ENSGALG00000006008 HOMER2 homer homolog 2 (Drosophila) 
  
ENSGALG00000006021 CACNG3 
calcium channel, voltage-dependent, gamma subunit 
3 
  
ENSGALG00000006439 ARHGEF6 
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 
6 
  ENSGALG00000006886 DACH2 dachshund homolog 2 (Drosophila) 
  
ENSGALG00000007004 HTR3A 
5-hydroxytryptamine (serotonin) receptor 3A, 
ionotropic 
  ENSGALG00000007141 LRRK1 leucine-rich repeat kinase 1 
  ENSGALG00000007184 FEZF2 FEZ family zinc finger 2 
  
ENSGALG00000007278 GRIN2A 
glutamate receptor, ionotropic, N-methyl D-aspartate 
2A 
  ENSGALG00000007349 RASL12 RAS-like, family 12 
  ENSGALG00000008032 GPR22 G protein-coupled receptor 22 
  ENSGALG00000008135 SATB2 SATB homeobox 2 
  ENSGALG00000008308 BHLHE40 basic helix-loop-helix family, member e40 
  ENSGALG00000008631 TYRO3 TYRO3 protein tyrosine kinase 
  ENSGALG00000008940 SPTBN5 spectrin, beta, non-erythrocytic 5 
  ENSGALG00000009859 TBC1D30 TBC1 domain family, member 30 
  ENSGALG00000010705 ZBTB18 zinc finger and BTB domain containing 18 
  ENSGALG00000010801 TMEM61 transmembrane protein 61 
  ENSGALG00000011254 SATB1 SATB homeobox 1 
  ENSGALG00000011406 NTN4 netrin 4 
  ENSGALG00000011592 MRAS muscle RAS oncogene homolog 
  ENSGALG00000012046 ARPP21 cAMP-regulated phosphoprotein, 21kDa 
  ENSGALG00000012054 DCLK3 doublecortin-like kinase 3 
  ENSGALG00000012154 FBXO34 F-box protein 34 
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  ENSGALG00000012235 NEUROD6 neuronal differentiation 6 
  
ENSGALG00000012254 KCNJ4 
potassium inwardly-rectifying channel, subfamily J, 
member 4 
  
ENSGALG00000012322 KCTD16 
potassium channel tetramerisation domain 
containing 16 
  ENSGALG00000012542 RASD2 RASD family, member 2 
  ENSGALG00000012890 DGKI diacylglycerol kinase, iota 
  ENSGALG00000013948 RASL11B RAS-like, family 11, member B 
  ENSGALG00000014011 LRMP lymphoid-restricted membrane protein 
  ENSGALG00000014186 MPPED1 metallophosphoesterase domain containing 1 
  ENSGALG00000014812 SIDT1 SID1 transmembrane family, member 1 
  ENSGALG00000014907 DCBLD1 discoidin, CUB and LCCL domain containing 1 
  ENSGALG00000015271 FILIP1L filamin A interacting protein 1-like 
  ENSGALG00000015403 EPHA3 EPH receptor A3 
  ENSGALG00000015626 RGS12 regulator of G-protein signaling 12 
  ENSGALG00000015970 COL9A1 collagen, type IX, alpha 1 
  ENSGALG00000016084 RSPO2 R-spondin 2 
  ENSGALG00000016095 EMX1 empty spiracles homeobox 1 
  ENSGALG00000016391 CNKSR2 connector enhancer of kinase suppressor of Ras 2 
  ENSGALG00000016396 COLEC11 collectin sub-family member 11 
  ENSGALG00000016744 GABRA5 gamma-aminobutyric acid (GABA) A receptor, alpha 5 
  ENSGALG00000016843 COL4A2 collagen, type IV, alpha 2 
  ENSGALG00000016920 LMO7 LIM domain 7 
  ENSGALG00000016944 PCDH8 protocadherin 8 
  ENSGALG00000017378 CRTAC1 cartilage acidic protein 1 
  
ENSGALG00000017690 KCNS2 
potassium voltage-gated channel, delayed-rectifier, 
subfamily S, member 2 
  ENSGALG00000022001 CAMKV CaM kinase-like vesicle-associated 
  ENSGALG00000023441 RTN4RL2 reticulon 4 receptor-like 2 
  ENSGALG00000024111 FNDC9 fibronectin type III domain containing 9 
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Table A8. Significant functional biological categories identified by the Ingenuity Pathways Analysis 
(IPA) performed using the gene lists after filtering the Vector Analysis data with specific behavioural 
categories (full details in Chapter 4, paragraph 4.3.13.1 for details) in the (a) hippocampus and (b) 
hypothalamus.   
 
(a) Hippocampus 
  
 
Pre- and post-hatching B responsive genes  
 
Category  p-value Genes 
Renal and Urological 
Disease 
1.89E-05-2.73E-02 
SLC4A5,TIMP3,AVPR2,CLDN19,COL4A3, 
NR3C2,SFRP1,SLC13A1 
Cellular Function and 
Maintenance 
3.67E-05-2.48E-02 
SLC4A5,NEUROD6,SLC26A9,BDNF, 
CNTN4,CLDN19,PCDH15,CADPS2,NR3C2,AGRN 
Cardiovascular 
System Development 
and Function 
8.35E-05-2.09E-02 
SLC4A5,TIMP3,AVPR2,BDNF, 
COL4A3,NR3C2,SOD3 
Hematological 
System Development 
and Function 
8.35E-05-2.73E-02 
SLC4A5,TIMP3,AVPR2,VIPR1,BDNF, 
COL4A3,NR3C2,SFRP1,AGRN,SOD3 
Cell-To-Cell Signaling 
and Interaction 
1.28E-04-2.73E-02 
TIMP3,VIPR1,BDNF,CNTN4,CLDN19, 
NR3C2,CADPS2,SFRP1,AGRN 
Cellular Assembly 
and Organization 
1.28E-04-2.48E-02 
NEUROD6,BDNF,CNTN4,CLDN19, 
PCDH15,CADPS2,NR3C2,SFRP1,AGRN 
Nervous System 
Development and 
Function 
1.28E-04-2.97E-02 
SLC4A5,NEUROD6,BDNF,CNTN4,CLDN19,KAL1,PCD
H15,CADPS2,SOD3,FOLR1,VIPR1, 
NR3C2,SFRP1,AGRN 
Tissue Development 1.28E-04-2.9E-02 
NEUROD6,TIMP3,COL14A1,BDNF,MMEL1,CLDN19,
CNTN4,COL4A3,CADPS2,FOLR1, 
SFRP1,AGRN,ZFHX3 
Cellular Movement 1.35E-04-2.9E-02 
TIMP3,VIPR1,BDNF,COL4A3,CNTN4,KAL1,CADPS2,
NR3C2,SFRP1,SOD3,FOLR1 
Immune Cell 
Trafficking 
1.35E-04-3.14E-03 TIMP3,VIPR1,COL4A3,NR3C2,SFRP1,SOD3 
Inflammatory 
Response 
1.35E-04-1.5E-02 PMEL,TIMP3,VIPR1,COL4A3,NR3C2,SFRP1,SOD3 
Molecular Transport 1.92E-04-2.95E-02 
SLC4A5,TIMP3,SLCO1C1,SLC26A9,BDNF,SLC15A1, 
COL4A3,SLC13A4,NR3C2,CADPS2,SLC13A1,FOLR1 
Cellular 
Development 
4.7E-04-2.73E-02 
TIMP3,NEUROD6,BDNF,MMEL1,COL4A3,CNTN4, 
WFIKKN2,MEIS2,PCDH15,CADPS2,SOD3,FOLR1, 
TYRP1,NR3C2,SFRP1,AGRN,ZFHX3 
Behavior 5.48E-04-2.73E-02 
SLC4A5,TIMP3,BDNF,CLDN19,PCDH15, 
NR3C2,CADPS2,GPR26,SOD3 
Connective Tissue 
Disorders 
7.43E-04-5.01E-03 TIMP3,COL14A1,COL4A3 
Tissue Morphology 8.15E-04-2.73E-02 BDNF,CNTN4,NR3C2,CADPS2,AGRN,SOD3,FOLR1 
Cell Morphology 8.39E-04-2.73E-02 
SLC4A5,NEUROD6,TIMP3,SLC26A9,BDNF, 
CNTN4,COL4A3,PCDH15,CADPS2,NR3C2,AGRN 
Amino Acid 
Metabolism 
9.15E-04-2.73E-02 PMEL,TYRP1,SLCO1C1,BDNF,FOLR1 
Hair and Skin 
Development and 
Function 
9.15E-04-9.99E-03 TYRP1,PMEL,TIMP3,BDNF 
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Small Molecule 
Biochemistry 
9.15E-04-2.87E-02 
PMEL,TYRP1,SLC4A5,TIMP3,SLCO1C1,BDNF, 
COL4A3,NR3C2,CADPS2,SLC13A1,FOLR1 
Reproductive System 
Disease 
1.5E-03-1.5E-02 KAL1,NR3C2,SLC13A1 
Cardiovascular 
Disease 
2.12E-03-2.41E-02 TIMP3,AVPR2,BDNF,NR3C2 
Auditory Disease 2.51E-03-9.1E-03 BDNF,COL4A3,PCDH15 
Auditory and 
Vestibular System 
Development and 
Function 
2.51E-03-9.99E-03 BDNF,FOLR1 
Carbohydrate 
Metabolism 
2.51E-03-9.99E-03 TIMP3,SLCO1C1,BDNF 
Cell Cycle 2.51E-03-7.51E-03 MEIS2,ZFHX3 
Cell Death and 
Survival 
2.51E-03-2.24E-02 BDNF,SFRP1,AGRN,SOD3 
Cellular Compromise 2.51E-03-2.73E-02 TYRP1,BDNF 
Cellular Growth and 
Proliferation 
2.51E-03-2.48E-02 TIMP3,BDNF,WFIKKN2,SFRP1,AGRN,ZFHX3 
Dermatological 
Diseases and 
Conditions 
2.51E-03-2.24E-02 TYRP1,PMEL,COL14A1,BDNF,COL4A3,CLDN19 
Developmental 
Disorder 
2.51E-03-1.99E-02 
TYRP1,NEUROD6,VIPR1,BDNF,KAL1,SFRP1, 
SLC13A1,AGRN,FOLR1 
Drug Metabolism 2.51E-03-2.73E-02 SLCO1C1,SLC15A1,FOLR1 
Embryonic 
Development 
2.51E-03-2.9E-02 
TIMP3,NEUROD6,MMEL1,BDNF,CADPS2, 
SFRP1,AGRN,ZFHX3,FOLR1 
Endocrine System 
Development and 
Function 
2.51E-03-2.24E-02 SLC4A5,SLCO1C1,BDNF,CADPS2,SLC13A1 
Endocrine System 
Disorders 
2.51E-03-1.74E-02 AVPR2,BDNF,KAL1,NR3C2 
Gastrointestinal 
Disease 
2.51E-03-2.24E-02 
SLCO1C1,TIMP3,COL14A1,AVPR2,BDNF, 
COL4A3 
Hematological 
Disease 
2.51E-03-2.73E-02 AVPR2,COL4A3,CLDN19,NR3C2,SLC13A1 
Hereditary Disorder 2.51E-03-1.99E-02 
TYRP1,TIMP3,AVPR2,COL14A1,BDNF,CLDN19, 
COL4A3,KAL1,PCDH15,NR3C2,FOLR1 
Immunological 
Disease 
2.51E-03-5.01E-03 COL4A3 
Inflammatory 
Disease 
2.51E-03-1.5E-02 COL4A3 
Lipid Metabolism 2.51E-03-2.87E-02 SLC4A5,TYRP1,SLCO1C1,BDNF,COL4A3,SLC13A1 
Metabolic Disease 2.51E-03-2.73E-02 
SLC4A5,TYRP1,AVPR2,BDNF,COL4A3,NR3C2, 
SLC13A1 
Neurological Disease 2.51E-03-2.48E-02 
AVPR2,RHPN2,BDNF,COL4A3,KAL1,PCDH15, 
CADPS2,SLC13A1,SFRP1,AGRN,FOLR1 
Nutritional Disease 2.51E-03-5.01E-03 AVPR2,BDNF 
Ophthalmic Disease 2.51E-03-7.51E-03 TYRP1,TIMP3,CLDN19,PCDH15,CADPS2 
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Organ Development 2.51E-03-2.24E-02 NEUROD6,MMEL1,BDNF,ZFHX3 
Organ Morphology 2.51E-03-2.73E-02 SLC4A5,NEUROD6,BDNF,CADPS2,FOLR1 
Organismal 
Development 
2.51E-03-2.9E-02 
NEUROD6,TIMP3,MMEL1,BDNF,COL4A3,SFRP1, 
ZFHX3,FOLR1 
Organismal 
Functions 
2.51E-03-2.24E-02 TIMP3,BDNF,COL4A3,NR3C2 
Organismal Injury 
and Abnormalities 
2.51E-03-2.48E-02 
TYRP1,TIMP3,COL14A1,AVPR2,BDNF,COL4A3, 
NR3C2,SOD3 
Psychological 
Disorders 
2.51E-03-1.5E-02 BDNF 
Respiratory Disease 2.51E-03-1.99E-02 BDNF,KAL1 
Skeletal and 
Muscular System 
Development and 
Function 
2.51E-03-2.7E-02 BDNF,WFIKKN2,ZFHX3 
Hepatic System 
Disease 
3.08E-03-2.24E-02 SLCO1C1,TIMP3,AVPR2 
Cancer 5.01E-03-2.7E-02 
PMEL,TIMP3,RHPN2,GNG11,BDNF,NR3C2,SFRP1, 
AGRN,FOLR1 
Skeletal and 
Muscular Disorders 
5.01E-03-1.5E-02 BDNF,AGRN 
Tumor Morphology 5.01E-03-1.99E-02 PMEL,BDNF,SFRP1 
Hematopoiesis 7.51E-03-7.51E-03 AGRN 
Infectious Disease 7.51E-03-2.24E-02 FOLR1 
Reproductive System 
Development and 
Function 
7.51E-03-7.51E-03 MMEL1 
Visual System 
Development and 
Function 
7.51E-03-7.51E-03 BDNF 
Connective Tissue 
Development and 
Function 
9.99E-03-9.99E-03 COL14A1 
Gene Expression 9.99E-03-9.99E-03 NR3C2 
Cell Signaling 1.06E-02-2.48E-02 AVPR2,VIPR1,BDNF,GPR26,AGRN 
Post-Translational 
Modification 
1.25E-02-1.25E-02 COL4A3 
Protein Degradation 1.5E-02-1.5E-02 TIMP3 
Protein Synthesis 1.5E-02-2.24E-02 TIMP3,FOLR1 
Renal and Urological 
System Development 
and Function 
1.5E-02-1.5E-02 TIMP3 
Respiratory System 
Development and 
Function 
1.5E-02-1.5E-02 SOD3 
Vitamin and Mineral 
Metabolism 
1.5E-02-2.73E-02 BDNF,FOLR1 
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Specific pre-hatching B responsive genes 
Category  p-value Genes 
Endocrine System 
Development and 
Function 
8.05E-07-4.03E-02 
TTR,CYP19A1,TAC1,WFS1, 
SLCO1B1,MC4R,TCF7L2,LHX9 
Molecular Transport 8.05E-07-4.13E-02 
TTR,TAC1,MC4R,NPTX1,MC5R, 
GAD2,CYP19A1,RASGRP1,PENK,SLCO1B1, 
WFS1,TCF7L2,LHX9 
Small Molecule 
Biochemistry 
8.05E-07-4.99E-02 
MC5R,GAD2,Gsta3,TTR,CYP19A1,TAC1,WFS1,SLC
O1B1,MC4R,TCF7L2,LHX9 
Behavior 2.39E-06-4.53E-02 
MC5R,TTR,GAD2,CYP19A1, 
PENK,TAC1,NPTX1,MC4R 
Carbohydrate 
Metabolism 
2.44E-06-4.28E-02 
GAD2,CYP19A1,TAC1,WFS1, 
SLCO1B1,MC4R,TCF7L2 
Lipid Metabolism 4.89E-06-4.99E-02 
MC5R,Gsta3,GAD2,TTR,CYP19A1, 
TAC1,SLCO1B1,MC4R,TCF7L2,LHX9 
Nutritional Disease 9.88E-06-4.28E-02 MC5R,GAD2,CYP19A1,MC4R,TCF7L2 
Psychological 
Disorders 
2.27E-05-4.65E-02 
TTR,GAD2,CYP19A1,PENK,SAG, 
TAC1,WFS1,MC4R,NPTX1,TCF7L2 
Drug Metabolism 2.5E-05-4.03E-02 
Gsta3,TTR,CYP19A1,TAC1,WFS1, 
SLCO1B1,MC4R,LHX9 
Cell Death and 
Survival 
3.28E-05-3.16E-02 
GAD2,TTR,CYP19A1,RASGRP1,PENK,TAC1, 
EFEMP1,WFS1,NPTX1,AMIGO2,TCF7L2 
Embryonic 
Development 
7.03E-05-2.41E-02 CYP19A1,DLX5,TAC1,TCF7L2,LHX9 
Organismal 
Development 
7.03E-05-4.01E-02 
MC5R,GAD2,CYP19A1,FBLN1,DLX5,TAC1, 
EFEMP1,MC4R,TCF7L2,LHX9 
Cellular Function and 
Maintenance 
7.19E-05-4.05E-02 
Gsta3,CYP19A1,RASGRP1,DLX5, 
PENK,TAC1,EFEMP1,WFS1,MC4R,TCF7L2 
Cell-To-Cell Signaling 
and Interaction 
8.58E-05-4.77E-02 
GAD2,CYP19A1,RASGRP1, 
PENK,TAC1,EFEMP1,NPTX1,MC4R 
Reproductive System 
Development and 
Function 
1.26E-04-4.53E-02 
Gsta3,CYP19A1,TAC1,TRIM36, 
EFEMP1,MC4R,LHX9 
Cell Signaling 1.29E-04-4.46E-02 MC5R,TTR,CYP19A1,TAC1,WFS1,MC4R 
Nucleic Acid 
Metabolism 
1.29E-04-3.16E-02 MC5R,TAC1,WFS1,SLCO1B1,MC4R 
Cancer 1.42E-04-3.91E-02 
Gsta3,TTR,CYP19A1,RASGRP1, 
FBLN1,EFEMP1,WFS1,SLCO1B1, NPTX1,TCF7L2 
Endocrine System 
Disorders 
1.42E-04-3.91E-02 TTR,GAD2,CYP19A1,WFS1,MC4R,TCF7L2 
Reproductive System 
Disease 
1.42E-04-3.91E-02 CYP19A1,EFEMP1,MC4R,TCF7L2,LHX9 
Organismal Injury and 
Abnormalities 
2.34E-04-4.77E-02 
Gsta3,GAD2,CYP19A1,RASGRP1, 
PENK,TAC1,EFEMP1,NPTX1,MC4R 
Nervous System 
Development and 
Function 
2.65E-04-4.89E-02 
TTR,GAD2,CYP19A1,DLX5,PENK, 
TAC1,NPTX1,MC4R,TCF7L2,AMIGO2 
Cellular Compromise 3.06E-04-2.29E-02 TAC1,EFEMP1,WFS1,MC4R 
287 
 
 
 
Protein Synthesis 7.63E-04-4.03E-02 Gsta3,TTR,CYP19A1,RASGRP1,WFS1,MC4R 
Hereditary Disorder 9.33E-04-4.16E-02 
TTR,DLX5,TAC1,NPTX1,GAD2, 
CYP19A1,RASGRP1,PENK,FBLN1,SAG, 
EFEMP1,SLCO1B1,WFS1,TCF7L2 
Neurological Disease 9.33E-04-4.65E-02 
GAD2,TTR,CYP19A1,DLX5,PENK,SAG, 
TAC1,EFEMP1,WFS1,NPTX1,TCF7L2 
Cardiovascular 
Disease 
1.28E-03-4.03E-02 TTR,FBLN1 
Cell Cycle 1.28E-03-1.53E-02 TAC1 
Cell Morphology 1.28E-03-4.89E-02 GAD2,CYP19A1,DLX5,TAC1,NPTX1,TCF7L2 
Cellular Assembly and 
Organization 
1.28E-03-4.05E-02 
GAD2,TTR,CYP19A1,DLX5,PENK,TAC1,NPTX1, 
MC4R 
Cellular Development 1.28E-03-4.53E-02 TTR,CYP19A1,RASGRP1,DLX5,TAC1, TCF7L2, LHX9 
Cellular Growth and 
Proliferation 
1.28E-03-4.28E-02 
GAD2,TTR,CYP19A1,RASGRP1,DLX5,PENK,FBLN1,
TAC1,EFEMP1,TCF7L2,LHX9 
Developmental 
Disorder 
1.28E-03-4.65E-02 
TTR,CYP19A1,DLX5,FBLN1,EFEMP1,SLCO1B1, 
MC4R,TCF7L2,LHX9 
Digestive System  
Development and 
Function 
1.28E-03-4.28E-02 GAD2,DLX5,TAC1,SLCO1B1,MC4R,TCF7L2 
Energy Production 1.28E-03-3.16E-02 MC5R,CYP19A1,TAC1 
Gastrointestinal 
Disease 
1.28E-03-4.03E-02 
GAD2,CYP19A1,DLX5,EFEMP1, 
SLCO1B1,WFS1,MC4R,TCF7L2 
Immune Cell 
Trafficking 
1.28E-03-3.74E-02 CYP19A1,RASGRP1,PENK,TAC1, NPTX1,MC4R 
Metabolic Disease 1.28E-03-4.16E-02 
GAD2,TTR,CYP19A1,EFEMP1, 
SLCO1B1,WFS1,MC4R,TCF7L2 
Organ Development 1.28E-03-1.28E-02 CYP19A1,DLX5,TAC1,SLCO1B1,TCF7L2 
Skeletal and Muscular  
Disorders 
1.28E-03-4.29E-02 
GAD2,CYP19A1,DLX5,FBLN1,PENK, 
SAG,TAC1,EFEMP1,TCF7L2 
Tissue Development 1.28E-03-4.16E-02 
TTR,CYP19A1,RASGRP1,DLX5, 
TAC1,EFEMP1,NPTX1,TCF7L2 
Tissue Morphology 1.28E-03-4.01E-02 
CYP19A1,RASGRP1,PENK,DLX5, 
FBLN1,TAC1,MC4R,TCF7L2 
Tumor Morphology 1.28E-03-2.79E-02 CYP19A1,RASGRP1,TAC1,EFEMP1,TCF7L2 
Organismal Functions 1.37E-03-4.79E-03 MC5R,Gsta3,CYP19A1,MC4R 
Cardiovascular System 
Development and 
Function 
2.57E-03-4.01E-02 CYP19A1,DLX5,FBLN1,TAC1 
Immunological 
Disease 
2.57E-03-1.78E-02 GAD2,CYP19A1,RASGRP1, TAC1,WFS1,TCF7L2 
Post-Translational  
Modification 
2.57E-03-2.57E-03 GAD2 
Skeletal and Muscular 
System Development 
and Function 
2.57E-03-1.53E-02 CYP19A1,DLX5,TAC1,EFEMP1 
Free Radical 
Scavenging 
3.85E-03-3.85E-03 Gsta3 
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Cellular Movement 5.13E-03-4.89E-02 
CYP19A1,RASGRP1,DLX5,FBLN1, 
PENK,TAC1,NPTX1,MC4R 
Hematological Disease 5.13E-03-1.78E-02 CYP19A1,FBLN1 
Organ Morphology 5.13E-03-3.66E-02 DLX5,TCF7L2 
Protein Trafficking 5.13E-03-8.96E-03 RASGRP1,TAC1 
Cell-mediated 
Immune Response 
5.5E-03-5.5E-03 RASGRP1,TAC1 
Hypersensitivity 
Response 
1.78E-02-4.28E-02 TAC1 
DNA Replication, 
Recombination, and 
Repair 
2.41E-02-2.41E-02 TAC1 
Organismal Survival 2.66E-02-2.66E-02 TAC1 
Interacting pre- and post-hatching B responsive genes: "cumulative effect" 
Category  p-value Genes 
Neurological Disease 1.12E-05-4.93E-02 
ATP7B,LRP2,TP73,GLRA3,MYO7A, 
TACR1,CA3,SLC6A11,OTOF,GAD1, 
ITGB4,KIAA1199,CACNA2D3 
Molecular Transport 1.79E-04-4.34E-02 
ATP7B,TP73,LRP2,SLC24A3,MYO7A,GRIP2, 
SLC4A11,TACR1,CA3,SLC6A11,OTOF, 
NPR3,KL,GAD1,PRDM16,CACNA2D3 
 
Cancer 3.01E-04-4.34E-02 
ATP7B,TP73,LRP2,SLC24A3,CDH6, 
TACR1,CA3,GDF10,ITGB4,KIAA1199, 
PRDM16,CACNA2D3,ALK 
Lipid Metabolism 4.19E-04-3.59E-02 TACR1,SLC6A11,LRP2,KL,GAD1 
Small Molecule 
Biochemistry 
4.19E-04-4.34E-02 
TACR1,SLC6A11,ATP7B,NPR3, 
SLC24A3,LRP2,KL,GAD1 
Psychological 
Disorders 
5.34E-04-4.61E-02 TACR1,SLC6A11,CA3,TP73,GAD1, CACNA2D3 
Organismal Injury and 
Abnormalities 
1.04E-03-4.34E-02 
TACR1,CA3,ATP7B,NPR3,LRP2,TP73,KL,GAD1,ITG
B4,CACNA2D3 
Cell Signaling 1.53E-03-3.16E-02 TACR1,NPR3,TP73,ALK 
Cell Cycle 1.53E-03-4.02E-02 TP73,KL,PRDM16 
Cell Morphology 1.53E-03-4.78E-02 
TACR1,OTOF,NPR3,KL,TP73, 
LRP2,MYO7A,GAD1,ITGB4 
Cell-To-Cell Signaling 
and Interaction 
1.53E-03-4.34E-02 
TACR1,SLC6A11,OTOF,NPR3, 
LRP2,MYO7A,ITGB4,ALK 
Cellular Function and 
Maintenance 
1.53E-03-4.34E-02 
TACR1,ATP7B,OTOF,TP73, 
LRP2,SLC24A3,KL,MYO7A,ITGB4 
Developmental 
Disorder 
1.53E-03-4.93E-02 
ATP7B,TP73,KL,LRP2,SLC4A11, 
GRIP2,ITGB4,ZFHX4 
Immunological 
Disease 
1.53E-03-4.64E-02 CA3,LRP2,TP73,ALK 
Nervous System 
Development and 
Function 
1.53E-03-4.64E-02 
TACR1,OTOF,LRP2,TP73,MYO7A, 
GAD1,ITGB4,CACNA2D3,ALK 
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Organ Development 1.53E-03-4.49E-02 NPR3,LRP2,TP73 
Organ Morphology 1.53E-03-4.49E-02 NPR3,TP73,LRP2,ITGB4 
Reproductive System 
Development and 
Function 
1.53E-03-4.05E-02 TACR1,TP73,GAD1 
Skeletal and Muscular  
Disorders 
1.53E-03-4.64E-02 CA3,LRP2,TP73,KL,ZFHX4,CACNA2D3,ALK 
Tissue Development 1.53E-03-4.49E-02 TACR1,NPR3,LRP2,TP73,ALK 
Tissue Morphology 1.53E-03-4.64E-02 
OTOF,NPR3,KL,TP73,LRP2, 
GAD1,ITGB4,PRDM16,ALK 
Behavior 1.61E-03-4.78E-02 TACR1,TP73,GAD1,ALK 
Cellular Assembly and 
Organization 
3.06E-03-4.93E-02 OTOF,LRP2,TP73,MYO7A,ITGB4 
Cellular Compromise 3.06E-03-4.93E-02 TACR1,TP73,ITGB4,PRDM16 
Cellular Development 3.06E-03-4.2E-02 CA3,NPR3,TP73,MYO7A,ITGB4, PRDM16,ALK 
Cellular Growth and 
Proliferation 
3.06E-03-4.2E-02 TACR1,CA3,NPR3,TP73,ITGB4, PRDM16,ALK 
Drug Metabolism 3.06E-03-2.12E-02 ATP7B,NPR3,LRP2,KL 
Endocrine System  
Development and 
Function 
3.06E-03-9.14E-03 TACR1,LRP2,GAD1 
Organismal 
Development 
3.06E-03-4.49E-02 TACR1,NPR3,TP73 
Organismal Functions 3.06E-03-3.02E-02 TACR1 
Post-Translational  
Modification 
3.06E-03-5.67E-03 TP73,GAD1,ALK 
Cellular Movement 3.29E-03-4.34E-02 TACR1,OTOF,GAD1,ITGB4,ALK 
Gene Expression 4.01E-03-2.27E-02 TP73,ALK 
Gastrointestinal 
Disease 
4.27E-03-4.05E-02 
TACR1,CA3,ATP7B,TP73,GAD1, 
CDH6,ITGB4,KIAA1199,CACNA2D3 
Cell Death and 
Survival 
4.58E-03-4.93E-02 TACR1,ATP7B,CA3,LRP2,TP73,KL,ALK 
Free Radical 
Scavenging 
4.58E-03-1.79E-02 CA3,KL,PRDM16 
Metabolic Disease 4.58E-03-4.93E-02 CA3,ATP7B,NPR3,KL,TP73,LRP2 
Hematological Disease 6.1E-03-4.49E-02 ATP7B,TP73,KL,GAD1,ALK 
Skeletal and Muscular 
System Development 
and Function 
7.62E-03-4.64E-02 NPR3,KL 
Cardiovascular 
Disease 
9.14E-03-4.78E-02 CA3,NPR3,KL,CACNA2D3 
Tumor Morphology 9.14E-03-4.34E-02 ATP7B,TP73,ITGB4 
Cardiovascular System 
Development and 
Function 
9.79E-03-1.67E-02 TACR1,NPR3,TP73,KL 
Immune Cell 
Trafficking 
1.07E-02-1.07E-02 TACR1 
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Endocrine System 
Disorders 
1.57E-02-4.78E-02 TACR1,CA3,TP73,KL,LRP2,ITGB4, CACNA2D3 
Reproductive System 
Disease 
1.84E-02-3.45E-02 TACR1,SLC24A3,TP73,LRP2,ITGB4,ALK 
Protein Synthesis 2.12E-02-4.64E-02 NPR3,TP73 
Organismal Survival 2.32E-02-2.32E-02 ATP7B,TP73,KL,ALK 
Hypersensitivity 
Response 
2.72E-02-2.72E-02 TACR1 
Embryonic 
Development 
3.61E-02-4.49E-02 TACR1,NPR3 
 
(b) Hypothalamus 
  Pre- and post-hatching B responsive genes  
Category p-value Genes 
Behavior 6.73E-04-4.16E-02 RACGAP1,CCK 
Cancer 6.73E-04-4.22E-02 CALB2,RACGAP1,PROX1,CCK 
Carbohydrate 
Metabolism 
6.73E-04-3.84E-02 KCNK5,CCK 
Cardiovascular 
System 
Development 
 and Function 
6.73E-04-4.35E-02 PROX1 
Cell Morphology 6.73E-04-4.35E-02 NTNG1,PROX1,CCK 
Cell-To-Cell 
Signaling and 
Interaction 
6.73E-04-4.8E-02 CCK 
Digestive System 
Development  
and Function 
6.73E-04-2.4E-02 CCK 
Drug Metabolism 6.73E-04-2.02E-03 CCK 
Embryonic 
Development 
6.73E-04-9.38E-03 PROX1 
Endocrine System 
Development  
and Function 
6.73E-04-1.35E-03 CCK 
Hereditary Disorder 6.73E-04-6.73E-04 RD3 
Immunological 
Disease 
6.73E-04-6.73E-04 PROX1 
Nervous System 
Development  
and Function 
6.73E-04-3.64E-02 NTNG1,CALB2,PROX1,CCK 
Nucleic Acid 
Metabolism 
6.73E-04-2.73E-02 ENTPD2,CCK 
Organ 
Development 
6.73E-04-9.38E-03 PROX1 
Organ Morphology 6.73E-04-6.73E-04 CCK 
Organismal 
Development 
6.73E-04-4.35E-02 PROX1 
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Organismal 
Functions 
6.73E-04-6.73E-04 CCK 
Skeletal and 
Muscular System 
Development and 
Function 
6.73E-04-6.73E-04 CCK 
Small Molecule 
Biochemistry 
6.73E-04-4.8E-02 ENTPD2,PROX1,CCK 
Tissue 
Development 
6.73E-04-3.96E-02 NTNG1,PROX1,CCK 
Cell Cycle 1.35E-03-1.35E-03 CCK 
Cellular Growth and 
Proliferation 
1.35E-03-2.69E-03 CCK 
Developmental 
Disorder 
1.35E-03-1.35E-03 CCK 
Endocrine System 
Disorders 
1.35E-03-3.71E-02 CALB2,RACGAP1,CCK 
Gastrointestinal 
Disease 
1.35E-03-4.03E-02 CCK 
Cellular Movement 2.02E-03-3.96E-02 PROX1 
DNA Replication, 
Recombination,  
and Repair 
2.02E-03-2.73E-02 ENTPD2,RACGAP1 
Immune Cell 
Trafficking 
2.02E-03-2.02E-03 PROX1 
Molecular 
Transport 
2.02E-03-4.95E-02 KCNK5,RACGAP1,CBLN4,CCK 
Cellular 
Development 
2.69E-03-4.35E-02 NTNG1,PROX1,CCK 
Energy Production 2.69E-03-2.73E-02 ENTPD2 
Reproductive 
System Disease 
3.34E-03-1.67E-02 CALB2,RACGAP1 
Cell Death and 
Survival 
4.7E-03-4.93E-02 CALB2,CCK 
Cell Signaling 6.71E-03-4.93E-02 PROX1,CCK 
Cellular Assembly 
and Organization 
7.18E-03-3.44E-02 NTNG1,CCK 
Cellular Function 
and Maintenance 
7.18E-03-1.87E-02 NTNG1,CCK 
Nutritional Disease 8.71E-03-2.26E-02 PROX1,CCK 
Psychological 
Disorders 
8.71E-03-2.26E-02 CCK 
Lipid Metabolism 1.54E-02-1.54E-02 PROX1 
Post-Translational 
Modification 
1.6E-02-1.6E-02 CCK 
Reproductive 
System 
Development  
and Function 
1.8E-02-1.8E-02 FGL2 
Metabolic Disease 3.71E-02-3.71E-02 CCK 
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Specific pre-hatching B responsive genes  
Category  p-value Genes 
Lipid Metabolism 4.76E-06-2.32E-02 LHCGR,TRPC4,CGA,HPGDS,PRKCB 
Molecular Transport 4.76E-06-4.25E-02 
CA3,ITPR3,LHCGR,TRPC4,CGA, 
HPGDS,PRDM16,RASD1,PRKCB 
Small Molecule 
Biochemistry 
4.76E-06-4.74E-02 LHCGR,TRPC4,CGA,HPGDS,RASD1,PRKCB 
Drug Metabolism 3.25E-05-3.96E-02 LHCGR,CGA,PRKCB 
Endocrine System 
Development  
and Function 
3.25E-05-3.89E-02 ITPR3,LHCGR,CGA 
Cell Signaling 5.91E-05-4.96E-02 
ITPR3,TPD52L1,LHCGR,TRPC4, 
CGA,RASD1,PRKCB 
Vitamin and Mineral 
Metabolism 
5.91E-05-4.25E-02 ITPR3,LHCGR,TRPC4,CGA,PRKCB 
Protein Synthesis 2.42E-04-9.5E-03 LHCGR,CGA 
Cancer 3.24E-04-4.04E-02 
CA3,ITPR3,TPD52L1,LHCGR,HPGDS,IRX2, 
CGA,PRDM16,PRKCB 
Amino Acid 
Metabolism 
4.39E-04-3.54E-02 TRPC4,CGA,PRKCB 
Cardiovascular 
Disease 
5.93E-04-4.88E-02 CA3,LHCGR,TRPC4,CGA,HPGDS,PRKCB 
Cell Cycle 7.34E-04-4.18E-02 TPD52L1,CGA,PRDM16,PRKCB 
Developmental 
Disorder 
7.34E-04-1.46E-02 LHCGR,CGA 
Endocrine System 
Disorders 
7.34E-04-2.32E-02 CA3,ITPR3,LHCGR,CGA,PRKCB 
Hereditary Disorder 7.34E-04-4.74E-02 CA3,LHCGR,CGA 
Metabolic Disease 7.34E-04-4.88E-02 CA3,ITPR3,LHCGR,PRKCB 
Neurological Disease 7.34E-04-4.88E-02 CA3,HPGDS,CGA,PRKCB 
Organismal Injury 
and Abnormalities 
7.34E-04-2.47E-02 CA3,CGA,HPGDS,PRKCB 
Reproductive System 
Development  
and Function 
7.34E-04-4.39E-02 LHCGR,CGA,PRKCB 
Reproductive System 
Disease 
7.34E-04-2.83E-02 LHCGR,CGA 
Tissue Morphology 7.34E-04-4.04E-02 LHCGR,HPGDS,CGA,PRDM16,PRKCB 
Dermatological 
Diseases and 
Conditions 
4.03E-02-4.03E-02 PROX1 
Amino Acid 
Metabolism 
4.8E-02-4.8E-02 CCK 
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Tumor Morphology 7.34E-04-9.5E-03 LHCGR,IRX2 
Organ Morphology 1.47E-03-7.32E-03 ITPR3,CGA 
Cell Death and 
Survival 
1.83E-03-3.4E-02 
CA3,ITPR3,LHCGR,TPD52L1, 
HPGDS,PRDM16,PRKCB 
Cell Morphology 2.2E-03-4.32E-02 ITPR3,LHCGR,TRPC4 
Cellular Compromise 2.2E-03-1.39E-02 TRPC4,HPGDS,PRDM16 
Cellular 
Development 
2.2E-03-4.32E-02 LHCGR,TRPC4,CGA,PRDM16,PRKCB 
Embryonic 
Development 
2.2E-03-3.57E-02 LHCGR,CGA,PRKCB 
Organ Development 2.2E-03-3.57E-02 LHCGR,CGA 
Organismal 
Development 
2.2E-03-4.32E-02 ITPR3,LHCGR,TRPC4,CGA 
Tissue Development 2.2E-03-4.32E-02 LHCGR,TRPC4,HPGDS,CGA 
Cell-To-Cell Signaling 
and Interaction 
2.93E-03-3.96E-02 LHCGR,PRKCB 
Cellular Assembly 
and Organization 
2.93E-03-4.53E-02 ITPR3,RASD1 
Cellular Function and 
Maintenance 
2.93E-03-2.32E-02 ITPR3,LHCGR,PRKCB 
Cellular Movement 2.93E-03-4.74E-02 CA3,CGA,IRX2,PRKCB 
Nervous System 
Development  
and Function 
2.93E-03-9.5E-03 LHCGR,CGA,HPGDS,RASD1 
Free Radical 
Scavenging 
4.23E-03-4.23E-03 CA3,PRDM16 
Behavior 4.4E-03-4.44E-02 
ITPR3,LHCGR,HPGDS, 
RASD1,PRKCB 
Cardiovascular 
System Development  
and Function 
4.4E-03-4.32E-02 TRPC4 
Cellular Growth and 
Proliferation 
4.4E-03-3.89E-02 
CA3,LHCGR,TRPC4,CGA,HPGDS, 
PRDM16,RASD1,PRKCB 
Renal and Urological 
System  
Development and 
Function 
4.4E-03-3.75E-02 LHCGR,CGA 
Nucleic Acid 
Metabolism 
4.42E-03-2.18E-02 LHCGR,CGA,RASD1,PRKCB 
Carbohydrate 
Metabolism 
5.13E-03-4.74E-02 LHCGR,PRKCB 
Gastrointestinal 5.86E-03-4.6E-02 CA3,ITPR3,PRKCB 
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Disease 
Infectious Disease 5.86E-03-1.17E-02 CA3,PRKCB 
Digestive System 
Development  
and Function 
7.32E-03-1.46E-02 ITPR3 
Energy Production 1.1E-02-1.1E-02 PRKCB 
Respiratory Disease 1.1E-02-1.1E-02 CA3 
Organismal 
Functions 
1.17E-02-2.75E-02 HPGDS,PRKCB 
Nutritional Disease 1.24E-02-4.43E-02 CA3,PRKCB 
Psychological 
Disorders 
1.24E-02-4.18E-02 CA3,PRKCB 
Skeletal and 
Muscular Disorders 
1.39E-02-2.25E-02 CA3,PRKCB 
Post-Translational 
Modification 
1.6E-02-1.82E-02 PRKCB 
Renal and Urological 
Disease 
1.6E-02-2.32E-02 CA3 
Immunological 
Disease 
2.05E-02-2.61E-02 CA3,ITPR3,HPGDS,PRKCB 
DNA Replication, 
Recombination,  
and Repair 
3.4E-02-3.4E-02 TPD52L1 
Skeletal and 
Muscular System  
Development and 
Function 
3.61E-02-3.61E-02 HPGDS 
Immune Cell 
Trafficking 
4.74E-02-4.74E-02 IRX2,PRKCB 
 
Specific post-hatching B responsive genes  
Category  p-value Genes 
Neurological Disease 1.77E-07-4.82E-02 
CNKSR2,GABRA5,GRIN2A,RASD2,TYRO3,HTR1D, 
COL4A2,RGS12,CNJ4,SATB2,HTR2C,SSTR5, 
PCDH8,ADORA1,GABRD,NGEF,CYP27A1,ABCA4, 
SEMA5A,DCLK3,EPHA3,RASL12,BHLHE40, 
ARHGEF6,HTR3A,ALDH1A2,ARPP21 
Psychological 
Disorders 
1.77E-07-2.58E-02 
NGEF,GABRA5,GRIN2A,CNKSR2,RASD2,CYP27A1, 
SEMA5A,HTR1D,COL4A2,DCLK3,RGS12, 
RASL12,HTR2C,SATB2,KCNJ4,BHLHE40, 
SSTR5,HTR3A,ARPP21,PCDH8,GABRD,ADORA1 
Nervous System 
Development  
and Function 
6.12E-06-4.46E-02 
GRIN2A,GABRA5,CRHR2,RASD2,TYRO3,HTR1D,SA
TB2,HTR2C,FEZF2,PCDH8,ADORA1,GABRD,EURO
D6,LMO7,ABCA4,SEMA5A,EMX1,CRTAC1,EPHA3,
BTB18,BHLHE40,ALDH1A2,HTR3A,MAFB,ARPP21 
Organ Morphology 6.12E-06-4.46E-02 
ZBTB18,NEUROD6,ABCA4,ALDH1A2, 
TYRO3,FEZF2,EMX1  
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Cell-To-Cell Signaling 
 and Interaction 
8.68E-06-4.09E-02 
GABRA5,CRHR2,GRIN2A,RASD2,NTN4,ANTXR1, 
TYRO3,HTR1D,HTR2C,HTR3A,PCDH8,ADORA1, 
GABRD 
Hereditary Disorder 2.05E-05-2.25E-02 
NGEF,GABRA5,GRIN2A,RASD2,COL9A1,CYP27A1,
ABCA4,SEMA5A,HTR1D,BUB1B,RGS12,RASL12, 
HTR2C,KCNJ4,BHLHE40,SSTR5,HTR3A,ARHGEF6, 
CISH,ARPP21,PCDH8,GABRD 
Skeletal and 
Muscular Disorders 
3.16E-05-4.31E-02 
RASD2,GABRA5,NGEF,GRIN2A,COL9A1,SEMA5A, 
ANTXR1,HTR1D,RASL12,HTR2C,KCNJ4,SATB2, 
BHLHE40,HTR3A,MAFB,ARPP21,ADORA1,GABRD 
Nutritional Disease 3.98E-05-2.25E-02 
CACNG3,HTR2C,CRHR2,GRIN2A,GABRA5, 
HTR3A,SSTR5,HTR1D,ADORA1,GABRD 
Organismal Injury  
and Abnormalities 
7.7E-05-2.97E-02 
HTR2C,GRIN2A,GABRA5,COL9A1,HTR3A, 
TYRO3,HTR1D,COL4A2,ADORA1,GABRD 
Cell Signaling 9.93E-05-2.63E-02 
HTR2C,CRHR2,CISH,SSTR5, 
DGKG,HTR1D,ADORA1,RGS12 
Post-Translational 
Modification 
9.93E-05-1.68E-02 CRHR2,CISH,DGKG,ADORA1 
Cellular Assembly  
and Organization 
1.27E-04-4.71E-02 
NEUROD6,SEMA5A,FEZF2,ANTXR1,TYRO3, 
MRAS,CRTAC1,FILIP1L,FMNL1,PCDH8, 
EPHA3,BUB1B 
Behavior 1.34E-04-4.46E-02 
HTR2C,GRIN2A,RASD2,GABRA5,CRHR2, 
HOMER2,BHLHE40,FEZF2,PCDH8, 
GABRD,ADORA1 
Cellular Movement 2.94E-04-4.09E-02 
SATB2,GABRA5,SEMA5A,FMNL1,MAFB, 
EPHA3,ADORA1 
Developmental 
Disorder 
3.12E-04-4.46E-02 
GABRA5,GRIN2A,COL9A1,CYP27A1, 
BUB1B,HTR2C,SATB2,ARHGEF6,SSTR5,HTR3A, 
ALDH1A2,RSPO2,GABRD,ADORA1 
Tissue Development 9.11E-04-4.46E-02 
NEUROD6,GRIN2A,GABRA5,NTN4, 
ABCA4,SEMA5A,TYRO3,EMX1,ANTXR1, 
FILIP1L,ZBTB18,BHLHE40,ALDH1A2,FEZF2, 
PCDH8,MAFB,ADORA1 
Gastrointestinal 
Disease 
1.44E-03-4.46E-02 
HTR2C,SATB2,GRIN2A,COL9A1,SSTR5, 
ANTXR1,HTR3A,RSPO2,COL4A2 
Embryonic 
Development 
1.49E-03-4.46E-02 
NEUROD6,NTN4,ABCA4,ANTXR1,TYRO3,EMX1, 
FILIP1L,COL4A2,EPHA3,ZBTB18,SATB2,FEZF2, 
ALDH1A2,RSPO2,MAFB 
Organ Development 1.49E-03-4.46E-02 
ZBTB18,NEUROD6,ABCA4,FEZF2,EMX1,ALDH1A2,
TYRO3,FILIP1L,MAFB 
Organismal 
Development 
1.49E-03-4.46E-02 
NEUROD6,CRHR2,ABCA4,ANTXR1,TYRO3,EMX1, 
COL4A2,FILIP1L,ZBTB18,SATB2,ALDH1A2, 
FEZF2,RSPO2,MAFB 
Digestive System 
Development  
and Function 
1.81E-03-4.46E-02 
SATB2,HTR2C,CRHR2,HOMER2,ANTXR1, 
FEZF2,RSPO2,GABRD 
Tissue Morphology 1.92E-03-4.09E-02 
GRIN2A,GABRA5,COL9A1,SEMA5A,ANTXR1, 
CRTAC1,EPHA3,COL4A2,ZBTB18,SATB2, 
ALDH1A2,RSPO2,MAFB,ADORA1 
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Cardiovascular 
Disease 
2.57E-03-4.6E-02 
GRIN2A,GABRA5,TYRO3,ANTXR1,SSTR5, 
EPHA3,ADORA1,GABRD,RASL12 
Inflammatory 
Disease 
3.11E-03-1.88E-02 HTR2C,GRIN2A,COL9A1,HTR3A,ADORA1 
Skeletal and 
Muscular System 
Development  
and Function 
3.7E-03-4.46E-02 
COL9A1,BHLHE40,ALDH1A2,RSPO2, 
FILIP1L,MAFB 
Carbohydrate 
Metabolism 
3.79E-03-3.73E-02 HTR2C,ABCA4,MRAS,ADORA1 
Cell Cycle 3.79E-03-3.36E-02 BHLHE40,SSTR5,FMNL1,BUB1B 
Cell Morphology 3.79E-03-4.93E-02 
GRIN2A,CRHR2,GABRA5,NGEF,NTN4,SEMA5A, 
ANTXR1,COL4A2,FMNL1,BHLHE40,RSPO2,PCDH8,
ADORA1 
Cellular Function  
and Maintenance 
3.79E-03-4.93E-02 
NEUROD6,GRIN2A,CRHR2,GABRA5, 
NTN4,ANTXR1,TYRO3,EPHA3,COL4A2, 
ZBTB18,FEZF2,MRAS,PCDH8,MAFB,ADORA1 
Cellular Growth and 
Proliferation 
3.79E-03-4.09E-02 MRAS,COL4A2,MAFB 
Lipid Metabolism 3.79E-03-4.82E-02 
HTR2C,HOMER2,CYP27A1,ABCA4,BHLHE40, 
ALDH1A2,MRAS,ADORA1,BUB1B 
Molecular Transport 3.79E-03-4.82E-02 
CRHR2,GRIN2A,GABRA5,CYP27A1,KCNS1,ABCA4, 
RGS12,HTR2C,KCNJ4,BHLHE40,SATB1,MRAS, 
ADORA1 
Small Molecule 
Biochemistry 
3.79E-03-4.82E-02 
HTR2C,GRIN2A,CRHR2,HOMER2,CYP27A1, 
ABCA4,BHLHE40,ALDH1A2,MRAS,RGS12,BUB1B,
ADORA1 
Visual System 
Development 
 and Function 
3.79E-03-1.88E-02 ABCA4 
Cell Death a d 
Survival 
4.67E-03-4.46E-02 
GABRA5,CRHR2,NTN4,ALDH1A2,ANTXR1, 
COL4A2,GABRD 
Cancer 5.52E-03-4.72E-02 
GRIN2A,LMO7,ABCA4,SEMA5A,ANTXR1,EPHA3, 
COL4A2,RGS12,BUB1B,RASL12,CACNG3,SATB2, 
BHLHE40,SATB1,SSTR5,ALDH1A2,HTR3A,MAFB 
Reproductive System 
Disease 
5.52E-03-4.82E-02 
CACNG3,SATB2,HTR2C,ABCA4,BHLHE40, 
ALDH1A2,SSTR5,ANTXR1,RASL12 
Endocrine System 
Disorders 
5.75E-03-4.82E-02 HTR2C,ABCA4,ALDH1A2,SSTR5 
Metabolic Disease 5.75E-03-1.13E-02 HTR2C,CYP27A1,SSTR5 
Cellular 
Development 
7.57E-03-4.46E-02 
ZBTB18,NEUROD6,GABRA5,BHLHE40,SEMA5A, 
ALDH1A2,EMX1,RSPO2,MRAS,ARPP21,COL4A2, 
MAFB 
DNA Replication, 
Recombination,  
and Repair 
7.57E-03-7.57E-03 ABCA4 
Drug Metabolism 7.57E-03-4.09E-02 HTR2C,HOMER2,ALDH1A2,ADORA1 
Immune Cell 
Trafficking 
7.57E-03-7.57E-03 ADORA1 
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Inflammatory 
Response 
7.57E-03-3.73E-02 TYRO3,MRAS,ADORA1 
Nucleic Acid 
Metabolism 
7.57E-03-4.09E-02 HTR2C,CRHR2,ABCA4,RGS12,ADORA1 
Tumor Morphology 7.57E-03-7.57E-03 SEMA5A 
Cellular Compromise 1.13E-02-3.36E-02 NGEF,GABRA5,SEMA5A,FMNL1,ADORA1,GABRD 
Energy Production 1.13E-02-2.63E-02 CYP27A1,ALDH1A2 
Organismal 
Functions 
1.13E-02-4.76E-02 CRHR2,GRIN2A,RASD2,FEZF2 
Amino Acid 
Metabolism 
1.16E-02-4.49E-02 HTR2C,GRIN2A,HOMER2,ADORA1 
Immunological 
Disease 
1.51E-02-1.51E-02 HTR3A 
Reproductive System 
Development 
 and Function 
1.51E-02-4.09E-02 SSTR5,GABRD 
Lymphoid Tissue 
Structure  
and Development 
1.88E-02-4.46E-02 ALDH1A2,MAFB 
Protein Synthesis 1.88E-02-1.88E-02 SATB1 
Protein Trafficking 1.88E-02-1.88E-02 SATB1 
Endocrine System 
Development 
 and Function 
2.25E-02-4.82E-02 HTR2C,HOMER2 
Hepatic System 
Disease 
2.25E-02-3.36E-02 SSTR5 
Cardiovascular 
System Development 
 and Function 
3.62E-02-3.62E-02 CRHR2,COL4A2 
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Table A9. Gene lists of the common significantly down-regulated genes (FDR ≤ 0.20) across the 
pair-wise comparison between the RNA-seq and Microarrays data obtained from the RankProducts 
statistics. FC indicates the fold change. Genes are sorted using the fold changes from RNA-seq.  
(a) Contrast BC vs CC (2nd class vs 1st class): down-regulated genes in 2nd class 
 
Ensembl ID Description 
RNA-seq:  
FC 
Microarrays: 
FC 
 
ENSGALG00000015143 transthyretin -18.1960 -3.9350  
ENSGALG00000012908 
solute carrier family 13 (sodium/sulfate 
symporters), member 4 
-3.6478 -15.2708 
 
ENSGALG00000011369 LIM homeobox 8 -3.6024 -3.2358  
ENSGALG00000011859 eye-globin -3.5947 -6.9906  
ENSGALG00000016553 transmembrane protein 27 -3.2546 -2.5394  
ENSGALG00000018557 superoxide dismutase 3, extracellular -2.8748 -3.2401  
ENSGALG00000005628 collagen, type IX, alpha 3 -2.7318 -3.3814  
ENSGALG00000015918 EF-hand calcium binding protein 1 -2.3182 -2.9294  
ENSGALG00000014884 ISL LIM homeobox 1 -2.2846 -6.3441  
ENSGALG00000013168 islet amyloid polypeptide -2.2804 -3.4750  
ENSGALG00000013362 calcium binding protein 7 -2.2529 -4.1170  
ENSGALG00000012911 synaptotagmin X -2.1913 -3.5970  
ENSGALG00000014117 
arginine vasopressin (neurophysin II, 
diuretic hormone, diabetes insipidus, 
neurohy)  
-2.1489 -3.0358 
 
ENSGALG00000009471 
phosphatidic acid phosphatase type 2 
domain containing 1A 
-2.1392 -2.6570 
 
ENSGALG00000004729 
solute carrier family 7,  
(neutral amino acid transporter,  
y+ system) member 10 
-2.1070 -3.3570 
 
ENSGALG00000002161 similar to MGC80370 protein -2.0896 -2.1696  
ENSGALG00000012381 neurexophilin 2 -2.0355 -3.0618  
ENSGALG00000007772 cerebellin 4 precursor -2.0005 -3.1788  
ENSGALG00000016428 ectonucleotide 
pyrophosphatase/phosphodiesterase 2 
-1.9213 -2.6038  
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ENSGALG00000015890 hypothetical LOC421856 -1.8966 -9.2777  
ENSGALG00000007945 crystallin, alpha B -1.8723 -2.1622  
ENSGALG00000009515 
guanine nucleotide binding protein (G 
protein), gamma 11 
-1.8053 -2.6799 
 
ENSGALG00000015023 serine/threonine kinase 32B -1.7229 -2.8817  
ENSGALG00000002652 frizzled homolog 10 (Drosophila) -1.7185 -3.1692  
ENSGALG00000014233 fibulin 1 -1.6910 -3.4437  
ENSGALG00000013775 cadherin 19, type 2 -1.6873 -3.7677  
ENSGALG00000005030 dedicator of cytokinesis 10 -1.6581 -2.8015  
ENSGALG00000012362 
thrombospondin, type I, domain 
containing 7B 
-1.5833 -2.2458 
 
ENSGALG00000009424 forkhead box P2 -1.5490 -3.8299  
ENSGALG00000015744 tumor protein D52 -1.5429 -2.1328  
ENSGALG00000005293 
guanine nucleotide binding protein (G 
protein), gamma 13 
-1.5404 -2.5342 
 
ENSGALG00000016396 collectin sub-family member 11 -1.5396 -2.2619  
ENSGALG00000016324 glutathione S-transferase alpha 3 -1.4809 -3.3354  
ENSGALG00000013615 mitochondrial tumor suppressor 1 -1.4476 -2.2854  
   
(b) BC vs CC (2nd class vs 1st class): up-regulated genes in 2nd class  
 
Ensembl ID  Description 
RNA-seq:  
FC 
Microarrays: 
FC 
 
ENSGALG00000006676 retinaldehyde binding protein 1 1.9513 2.3279  
ENSGALG00000012327 inhibin, beta A 1.8766 2.5241  
ENSGALG00000000184 
solute carrier family 27 (fatty acid 
transporter), member 6 
1.8676 2.5283 
 
ENSGALG00000015720 chondrolectin 1.7736 2.4228  
ENSGALG00000009705 ryanodine receptor 3 1.4683 2.1439  
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(c) CB vs CC (2nd class vs 1st class): down-regulated genes in 2nd class 
 
Ensembl ID  Description 
RNA-seq:  
FC 
Microarrays: 
FC 
 
ENSGALG00000012908 solute carrier family 13  
(sodium/sulfate symporters),  
member 4 
-2.8656 -4.1753  
ENSGALG00000011859 ey -globin -2.6732 -4.1945  
ENSGALG00000016553 transmembrane protein 27 -2.2201 -2.6108  
ENSGALG00000002652 frizzled homolog 10 (Drosophila) -1.5761 -3.6016  
   
(d) CB vs CC (2nd class vs 1st class): up-regulated genes in 2nd class  
 
Ensembl ID  Description 
RNA-seq:  
FC 
Microarrays: 
FC 
 
ENSGALG00000002577 StAR-related lipid transfer (START) 
domain containing 10 
1.9365 2.2739  
    
(e) BB vs CC (2nd class vs 1st class): down-regulated genes in 2nd 
class 
  
 
Ensembl ID  Description 
RNA-seq:  
FC 
Microarrays:  
FC 
 
ENSGALG00000015143 transthyretin -28.0977 -5.3525  
ENSGALG00000011859 eye-globin -4.5587 -12.6967  
ENSGALG00000012908 
solute carrier family 13 (sodium/sulfate 
symporters), member 4 
-3.7024 -26.6424 
 
ENSGALG00000016553 transmembrane protein 27 -3.5302 -2.8991  
ENSGALG00000011369 LIM homeobox 8 -3.2484 -3.1794  
ENSGALG00000018557 superoxide dismutase 3, extracellular -2.8380 -3.7259  
ENSGALG00000005628 collagen, type IX, alpha 3 -2.7236 -4.0469  
ENSGALG00000014967 synaptic vesicle glycoprotein 2C -2.4284 -2.1571  
ENSGALG00000013362 calcium binding protein 7 -2.3472 -4.1754  
ENSGALG00000014884 ISL LIM homeobox 1 -2.1360 -6.6107  
ENSGALG00000013168 islet amyloid polypeptide -2.1270 -3.4644  
ENSGALG00000007772 cerebellin 4 precursor -2.1090 -3.1000  
ENSGALG00000016428 ectonucleotide 
pyrophosphatase/phosphodiesterase 2 
-2.0265 -2.3026  
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ENSGALG00000015673 zinc finger homeodomain 4 -1.9412 -2.2448  
ENSGALG00000009006 
six transmembrane epithelial antigen of 
the prostate 1 
-1.8268 -2.2244 
 
ENSGALG00000015890 hypothetical LOC421856 -1.8257 -8.0570  
ENSGALG00000014233 fibulin 1 -1.6756 -2.9153  
ENSGALG00000009424 forkhead box P2 -1.6691 -3.4193  
ENSGALG00000009471 
phosphatidic acid phosphatase type 2 
domain containing 1A 
-1.6659 -2.1419 
 
ENSGALG00000009515 
guanine nucleotide binding protein (G 
protein), gamma 11 
-1.6160 -3.0470 
 
ENSGALG00000015685 hypothetical gene supported by 
CR390999 
-1.6069 -2.3245  
ENSGALG00000016324 glutathione S-transferase alpha 3 -1.5903 -2.4798  
ENSGALG00000013616 similar to opioid receptor B -1.4556 -2.2046  
   
(f) BB vs CC (2nd class vs 1st class): up-regulated genes in 2nd class  
 
Ensembl ID  Description 
RNA-seq: 
FC 
Microarrays:  
FC 
 
ENSGALG00000015018 calsequestrin 2 (cardiac muscle) 3.1243 3.9900  
ENSGALG00000001695 
gamma-aminobutyric acid (GABA) A 
receptor, alpha 6 
2.6068 3.3897 
 
ENSGALG00000012120 engrailed homeobox 1 2.0521 4.3129  
ENSGALG00000004527 unc-13 homolog C (C. elegans) 2.0334 3.1369  
(g) CB vs BC (2nd class vs 1st class): up-regulated genes in 2nd class 
 
Ensembl ID  Description 
RNA-seq: 
FC 
Microarrays:  
FC 
 
ENSGALG00000014117 
arginine vasopressin (neurophysin II, 
antidiuretic hormone, diabetes 
insipidus, neurohy) 
4.2093 5.7604 
 
ENSGALG00000021552 RAP2B, member of RAS oncogene family 1.4544 2.0854 
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(h) BB vs BC (2nd class vs 1st class): down-regulated genes in 2nd class 
 
Ensembl ID  Description 
RNA-seq: 
FC 
Microarrays:  
FC 
 
ENSGALG00000000184 
solute carrier family 27 (fatty acid 
transporter), member 6 
-1.6835 -2.6016 
 
ENSGALG00000016244 leucine rich repeat containing 6 -1.5007 -4.0329  
ENSGALG00000008058 p21 (CDKN1A)-activated kinase 3 -1.4974 -3.7297  
ENSGALG00000006445 aryl-hydrocarbon receptor nuclear 
translocator 2 
-1.4794 -2.4832  
     
 
(i) BB vs BC (2nd class vs 1st class): up-regulated genes in 2nd class 
 
Ensembl ID  Description 
RNA-seq:  
FC 
Microarrays: 
FC 
 
ENSGALG00000004527 unc-13 homolog C (C. elegans) 3.0010 4.1285  
ENSGALG00000006811 
Zic family member 1 (odd-paired 
homolog, Drosophila) 
2.9334 2.1557 
 
ENSGALG00000001695 
gamma-aminobutyric acid (GABA) A 
receptor, alpha 6 
2.4376 3.8743 
 
ENSGALG00000015018 calsequestrin 2 (cardiac muscle) 2.4365 2.8243  
ENSGALG00000012120 engrailed homeobox 1 2.1794 4.9536  
ENSGALG00000008881 regulator of G-protein signalling 3 2.1723 3.3568  
ENSGALG00000012362 
thrombospondin, type I, domain 
containing 7B 
2.0578 2.4080 
 
ENSGALG00000001282 
gamma-aminobutyric acid (GABA) A 
receptor, delta 
2.0039 3.0420 
 
ENSGALG00000000681 p21 protein  
(Cdc42/Rac)-activated  
kinase 1 
1.9490 2.8240  
ENSGALG00000002652 frizzled homolog 10 (Drosophila) 1.8741 4.2778  
ENSGALG00000015472 
chromodomain helicase DNA binding 
protein 7 
1.8383 4.3689 
 
ENSGALG00000013615 mitochondrial tumor suppressor 1 1.8085 4.6785  
ENSGALG00000024428 chromosome 17 open reading frame 67 1.6762 2.6410  
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(l) BB vs BC (2nd class vs 1st class): down-regulated genes in 2nd class 
Ensembl ID  Description 
RNA-seq: 
FC 
Microarrays:  
FC 
 
ENSGALG00000015143 transthyretin -6.7550 -2.8937  
   
(m) BB vs BC (2nd class vs 1st class): up-regulated genes in 2nd class  
 
Ensembl ID  Description 
RNA-seq: 
FC 
Microarrays:  
FC 
 
ENSGALG00000000681 p21 protein (Cdc42/Rac)-activated kinase 
1 
1.7877 2.7422  
ENSGALG00000001695 
gamma-aminobutyric acid (GABA) A 
receptor, alpha 6 
3.6483 3.9011 
 
ENSGALG00000003149 
inositol 1,4,5-triphosphate receptor,   
type 3 
2.9759 2.3960 
 
ENSGALG00000004527 unc-13 homolog C (C. elegans) 4.4623 4.2945  
ENSGALG00000006811 
Zic family member 1 (odd-paired 
homolog, Drosophila) 
3.4901 2.8128 
 
ENSGALG00000008881 regulator of G-protein signalling 3 2.3773 3.7291  
ENSGALG00000008908 neurogenic differentiation 1 2.5441 2.4565  
ENSGALG00000010939 lin-7 homolog A (C. elegans) 2.5249 3.1744  
ENSGALG00000012120 engrailed homeobox 1 2.6720 6.5281  
ENSGALG00000012522 parvalbumin 2.2450 2.2449  
ENSGALG00000015018 calsequestrin 2 (cardiac muscle) 3.2214 5.4047  
ENSGALG00000015472 
chromodomain helicase DNA binding 
protein 7 
2.1577 4.6159 
 
ENSGALG00000023818 heat shock protein 25 1.8641 4.3193  
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Table A10. Hippocampal genes that were consistently down-regulated in the adult birds that were 
exposed to B in ovo compared to the control birds (BC vs CC and BB vs CC contrasts) in both RNA-
seq and Microarrays. Genes are sorted by RNA-seq fold changes (FC). 
 
Ensembl ID  Description 
ENSGALG00000015143 transthyretin 
ENSGALG00000012908 solute carrier family 13 (sodium/sulfate symporters), member 4 
ENSGALG00000011369 LIM homeobox 8 
ENSGALG00000011859 eye-globin 
ENSGALG00000016553 transmembrane protein 27 
ENSGALG00000018557 superoxide dismutase 3, extracellular 
ENSGALG00000005628 collagen, type IX, alpha 3 
ENSGALG00000014884 ISL LIM homeobox 1 
ENSGALG00000013168 islet amyloid polypeptide 
ENSGALG00000013362 calcium binding protein 7 
ENSGALG00000009471 phosphatidic acid phosphatase type 2 domain containing 1A 
ENSGALG00000007772 cerebellin 4 precursor 
ENSGALG00000016428 ectonucleotide pyrophosphatase/phosphodiesterase 2 
ENSGALG00000015890 hypothetical LOC421856 
ENSGALG00000009515 guanine nucleotide binding protein (G protein), gamma 11 
ENSGALG00000014233 fibulin 1 
ENSGALG00000009424 forkhead box P2 
ENSGALG00000016324 glutathione S-transferase alpha 3 
 
